FORM 20-F
As filed with the Securities Exchange Commission on
April 11, 2006
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
Form 20-F
|
|
|
o
|
|
REGISTRATION STATEMENT PURSUANT
TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
OR
|
þ
|
|
ANNUAL REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
|
For the Fiscal Year Ended
December 31, 2005
|
OR
|
|
|
|
|
|
|
|
|
|
o
|
|
TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
|
|
|
|
|
|
|
|
o
|
|
SHELL COMPANY REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
SAIFUN SEMICONDUCTORS
LTD.
(Exact name of Registrant as
specified in its charter)
Israel
(Jurisdiction of incorporation or organization)
ELROD Building
45 Hamelacha Street
Sappir Industrial Park
Netanya 42504
Israel
(Address of principal executive offices)
Securities registered or to be registered pursuant to
Section 12(b) of the Act:
None.
Securities registered or to be registered pursuant to
Section 12(g) of the Act:
Ordinary Shares, par value NIS 0.01 per share
Securities for which there is a reporting obligation pursuant
to Section 15(d) of the Act:
None.
The number of outstanding shares of each of the issuers
classes of capital or
common stock as of December 31, 2005:
29,456,722 Ordinary Shares, par value NIS 0.01 per
share
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act.
days. Yes o No þ
If this report is an annual or transition report, indicate by
check mark if the registrant is not required to file reports
pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934. Yes o No þ
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, or a non-accelerated
filer. See definition of accelerated filer and large
accelerated filer in
Rule 12b-2
of the Exchange Act. (Check one):
Large accelerated
filer o
Accelerated
filer o
Non-accelerated filer þ
Indicate by check mark which financial statement item the
registrant has elected to
follow. Item 17 o
Item 18 þ
If this is an annual report, indicate by check mark whether the
registrant is a shell company (as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
TABLE OF
CONTENTS
The SAIFUN logo is our trademark or registered trademark. All
other registered trademarks appearing herein are owned by their
holders.
2
PART I
|
|
ITEM 1.
|
IDENTITY
OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS
|
Not applicable.
|
|
ITEM 2.
|
OFFER
STATISTICS AND EXPECTED TIMETABLE
|
Not applicable.
A. SELECTED
FINANCIAL DATA
You should read the following selected consolidated financial
data in conjunction with our consolidated financial statements
and related notes, as well as Item 5 Operating and
Financial Review and Prospects, included elsewhere in this
Annual Report. Commencing in fiscal year 2005, we used a
calendar year ending on December 31. For fiscal years 2003
and 2004, we used a
52-week
fiscal year ending on the last Sunday in December. For fiscal
years 2003 and 2004, the fiscal year ended on December 28 and
December 26, respectively. For prior fiscal years, the
fiscal year ended on December 31. The consolidated
statements of operations data for the years ended
December 28, 2003, December 26, 2004 and
December 31, 2005 and the consolidated balance sheet data
as of December 26, 2004 and December 31, 2005 are
derived from our audited consolidated financial statements
included elsewhere in this Annual Report, which have been
prepared in accordance with generally accepted accounting
principles in the United States. The consolidated statements of
operations for the years ended December 31, 2001 and 2002
and the consolidated balance sheet data as of December 31,
2001, December 31, 2002 and December 28, 2003 have been
derived from our audited consolidated financial statements which
are not included in this Annual Report.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2001
|
|
|
2002
|
|
|
2003(3)
|
|
|
2004(3)
|
|
|
2005
|
|
|
|
(in thousands, except share and
per share data)
|
|
|
Statements of operations
data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues:(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Licenses
|
|
$
|
2,468
|
|
|
$
|
3,170
|
|
|
$
|
7,817
|
|
|
$
|
22,640
|
|
|
$
|
65,790
|
|
Services
|
|
|
1,914
|
|
|
|
3,438
|
|
|
|
6,639
|
|
|
|
7,926
|
|
|
|
12,811
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
4,382
|
|
|
|
6,608
|
|
|
|
14,456
|
|
|
|
30,566
|
|
|
|
78,601
|
|
Cost of services(2)
|
|
|
1,146
|
|
|
|
2,086
|
|
|
|
4,147
|
|
|
|
7,084
|
|
|
|
12,048
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
3,236
|
|
|
|
4,522
|
|
|
|
10,309
|
|
|
|
23,482
|
|
|
|
66,553
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development(2)
|
|
|
7,022
|
|
|
|
6,583
|
|
|
|
9,132
|
|
|
|
6,792
|
|
|
|
7,427
|
|
Marketing and selling(2)
|
|
|
967
|
|
|
|
920
|
|
|
|
2,543
|
|
|
|
2,914
|
|
|
|
4,889
|
|
General and administrative(2)
|
|
|
783
|
|
|
|
3,426
|
|
|
|
1,779
|
|
|
|
2,115
|
|
|
|
6,216
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
8,772
|
|
|
|
10,929
|
|
|
|
13,454
|
|
|
|
11,821
|
|
|
|
18,532
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
(5,536
|
)
|
|
|
(6,407
|
)
|
|
|
(3,145
|
)
|
|
|
11,661
|
|
|
|
48,021
|
|
Financial income, net
|
|
|
2,209
|
|
|
|
1,030
|
|
|
|
1,137
|
|
|
|
1,699
|
|
|
|
1,749
|
|
Equity in losses of equity method
investees
|
|
|
(3,468
|
)
|
|
|
(6,851
|
)
|
|
|
(12,820
|
)
|
|
|
(26,172
|
)
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2001
|
|
|
2002
|
|
|
2003(3)
|
|
|
2004(3)
|
|
|
2005
|
|
|
|
(in thousands, except share and
per share data)
|
|
|
Compensation expense related to
issuance of options to employees of equity method investees
|
|
|
|
|
|
|
|
|
|
|
(206
|
)
|
|
|
(569
|
)
|
|
|
|
|
Capital loss from sale of equity
method investees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(17,334
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing
operations
|
|
|
(6,795
|
)
|
|
|
(12,228
|
)
|
|
|
(15,034
|
)
|
|
|
(30,715
|
)
|
|
|
49,770
|
|
Loss from discontinued
operations(2)(3)
|
|
|
|
|
|
|
|
|
|
|
(156
|
)
|
|
|
(7,189
|
)
|
|
|
(5,263
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(6,795
|
)
|
|
$
|
(12,228
|
)
|
|
$
|
(15,190
|
)
|
|
$
|
(37,904
|
)
|
|
$
|
44,507
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) from
continuing operations per ordinary share
|
|
$
|
(0.44
|
)
|
|
$
|
(0.76
|
)
|
|
$
|
(0.89
|
)
|
|
$
|
(1.81
|
)
|
|
$
|
0.46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss from discontinued
operations per ordinary share
|
|
|
|
|
|
|
|
|
|
$
|
(0.01
|
)
|
|
$
|
(0.43
|
)
|
|
$
|
(0.29
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net earnings (loss) per
ordinary share
|
|
$
|
(0.44
|
)
|
|
$
|
(0.76
|
)
|
|
$
|
(0.90
|
)
|
|
$
|
(2.24
|
)
|
|
$
|
0.17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
ordinary shares used in computing net earnings (loss) per
share basic
|
|
|
15,479,375
|
|
|
|
16,102,326
|
|
|
|
16,896,134
|
|
|
|
16,927,087
|
|
|
|
29,452,828
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) from
continuing operations per ordinary share
|
|
$
|
(0.44
|
)
|
|
$
|
(0.76
|
)
|
|
$
|
(0.89
|
)
|
|
$
|
(1.81
|
)
|
|
$
|
0.36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted loss from discontinued
operations per ordinary share
|
|
|
|
|
|
|
|
|
|
$
|
(0.01
|
)
|
|
$
|
(0.43
|
)
|
|
$
|
(0.20
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net earnings (loss) per
ordinary share
|
|
$
|
(0.44
|
)
|
|
$
|
(0.76
|
)
|
|
$
|
(0.90
|
)
|
|
$
|
(2.24
|
)
|
|
$
|
0.16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
ordinary shares used in computing net earnings (loss) per
share diluted
|
|
|
15,479,375
|
|
|
|
16,102,326
|
|
|
|
16,896,134
|
|
|
|
16,927,087
|
|
|
|
31,947,043
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2001
|
|
|
2002
|
|
|
2003(3)
|
|
|
2004(3)
|
|
|
2005
|
|
|
|
(in thousands, except share and
per share data)
|
|
|
Pro forma basic earnings from
continuing operations per ordinary share(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2.06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma basic loss from
discontinued operations per ordinary share(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(0.22
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma basic net earnings per
ordinary share(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1.84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
ordinary shares used in computing pro forma net earnings per
share basic
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,154,318
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma diluted earnings from
continuing operations per ordinary share(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma diluted loss from
discontinued operations per ordinary share(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(0.20
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma diluted net earnings per
ordinary share(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
ordinary shares used in computing pro forma net earnings per
share diluted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26,240,525
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2001
|
|
|
2002
|
|
|
2003(3)
|
|
|
2004(3)
|
|
|
2005
|
|
|
|
(in thousands)
|
|
|
Balance sheet data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
12,290
|
|
|
$
|
40,576
|
|
|
$
|
29,384
|
|
|
$
|
27,228
|
|
|
$
|
100,327
|
|
Short-term investments
|
|
|
25,769
|
|
|
|
771
|
|
|
|
514
|
|
|
|
161
|
|
|
|
|
|
Held-to-maturity
marketable securities
|
|
|
|
|
|
|
|
|
|
|
10,868
|
|
|
|
17,065
|
|
|
|
81,496
|
|
Working capital(5)
|
|
|
36,075
|
|
|
|
36,894
|
|
|
|
25,499
|
|
|
|
(2,433
|
)
|
|
|
166,487
|
|
Total assets
|
|
|
52,166
|
|
|
|
50,211
|
|
|
|
51,894
|
|
|
|
64,934
|
|
|
|
193,738
|
|
Total liabilities
|
|
|
9,960
|
|
|
|
16,087
|
|
|
|
22,038
|
|
|
|
59,996
|
|
|
|
17,665
|
|
Capital stock
|
|
|
58
|
|
|
|
60
|
|
|
|
60
|
|
|
|
60
|
|
|
|
120
|
|
Accumulated deficit
|
|
|
(14,976
|
)
|
|
|
(27,204
|
)
|
|
|
(42,394
|
)
|
|
|
(80,298
|
)
|
|
|
(35,791
|
)
|
Total shareholders equity
|
|
|
42,206
|
|
|
|
34,124
|
|
|
|
29,856
|
|
|
|
4,938
|
|
|
|
176,073
|
|
5
|
|
(1)
|
Includes revenues from related parties, principally from design
and product development services provided to our former joint
venture, consisting of $3.2 million for 2002,
$6.4 million for 2003, and $8.4 million for 2004.
License revenues for 2005 include non-cash revenues of
$19.2 million resulting from the termination of our former
joint venture.
|
|
(2)
|
Expenses include stock-based compensation related to options
granted to employees and others as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
Year ended
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
|
(in thousands)
|
|
|
Cost of services
|
|
$
|
175
|
|
|
$
|
834
|
|
Research and development
|
|
|
220
|
|
|
|
330
|
|
Marketing and selling
|
|
|
87
|
|
|
|
667
|
|
General and administrative
|
|
|
96
|
|
|
|
2,410
|
|
Loss from discontinued operations
|
|
|
23
|
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
601
|
|
|
$
|
4,295
|
|
|
|
|
|
|
|
|
|
|
During the third quarter of 2004, we adopted the fair value
recognition provisions of FAS 123, as amended by
FAS 148 for stock-based employee compensation. Effective
December 29, 2003, we elected to apply the Modified
Prospective Method under FAS 148. Accordingly, unvested
options were accounted for under the fair value recognition
provision of FAS 123 from December 29, 2003 as if the
fair value method had been applied since the date of grant.
|
|
(3)
|
We decided to discontinue product sales in the second quarter of
2005. During the quarter ended September 25, 2005, we began
accounting for products sales operations as discontinued
operations and prior year financial information has been
reclassified.
|
|
(4)
|
Pro forma basic and diluted net earnings (loss) per ordinary
share gives effect to the automatic conversion of all of our
issued and outstanding convertible preferred shares and options
into ordinary shares at a ratio of 1:1 that occurred prior to
the completion of our initial public offering on
November 8, 2005, as if the conversion occurred at the
beginning of the fiscal year ended December 31, 2005. We
apply the two-class method as required by EITF No. 03-6,
Participating Securities and the Two-Class Method under
FASB Statement No. 128, Earnings per Share. EITF
No. 03-6
requires earnings per share for each class of shares (ordinary
shares and preferred shares) to be calculated assuming 100% of
our earnings were distributed as dividends to each class of
shares based on their contractual rights. The numerator of the
pro forma basic and diluted net earnings (loss) per ordinary
share excludes $39,259 of the allocation of undistributed
earnings related to convertible preferred shares. Since all the
preferred shares were converted as a result of our initial
public offering, the pro forma presentation provides a better
comparison of the earnings per share data following our initial
public offering.
|
|
(5)
|
Current assets less current liabilities.
|
6
CAUTIONARY
LANGUAGE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report contains forward-looking statements. We have
based these forward-looking statements on our current
expectations and projections about future events. These
statements include but are not limited to:
|
|
|
|
|
the amount and timing of the recognition of deferred revenue and
of additional license fees from our current licensees and the
impact of adding additional licenses;
|
|
|
|
statements as to the timing of our future research and
development expenses;
|
|
|
|
statements as to our discontinued operations;
|
|
|
|
statements as to the future technological innovations, including
the implementation of our NROM technology with multi-level cell
functionality;
|
|
|
|
statements as to our ability to meet anticipated cash needs
based on our current business plan;
|
|
|
|
statements as to the impact of timing of integrating additional
manufacturers or subcontractors;
|
|
|
|
expectations as to any increase in the amount and proportion of
our revenues derived from royalties and the timing of
recognition of these revenues; and
|
|
|
|
statements as to the impact of the rate of inflation and the
political and security situation on our business.
|
In addition, statements that use the terms believe,
expect, plan, intend,
estimate, anticipate and similar
expressions are intended to identify forward-looking statements.
All forward-looking statements in this Annual Report reflect our
current views about future events and are based on assumptions
and are subject to risks and uncertainties that could cause our
actual results to differ materially from future results
expressed or implied by the forward-looking statements. Many of
these factors are beyond our ability to control or predict. You
should not put undue reliance on any forward-looking statements.
Unless we are required to do so under U.S. federal
securities laws or other applicable laws, we do not intend to
update or revise any forward-looking statements.
B. CAPITALIZATION
AND INDEBTEDNESS
Not applicable.
C. REASON
FOR THE OFFER AND USE OF PROCEEDS
Not applicable.
7
D. RISK
FACTORS
Risks
Related to Our Business
|
|
|
Our
historical financial data may be of limited value in evaluating
our future prospects.
|
To date, we have derived substantially all of our revenues from
licensing our intellectual property to third parties and from
the provision of design and product development services to
Infineon Technologies Flash. Almost all of our license revenues
have consisted of license fees and a small portion of our
revenues has consisted of license royalties based on a
percentage of our licensees net sales of products
incorporating our intellectual property. Subject to our
licensees increasing sales of products incorporating our
licensed intellectual property, we expect that the proportion of
our revenues derived from license royalties will increase
relative to license fees. As a result, the components of our
revenues may change substantially in future periods. In
addition, because we exited our joint venture with Infineon
Technologies in December 2004, we will no longer include in our
net loss a percentage share of the net loss of the joint
venture. Furthermore, in the second quarter of 2005, we decided
to discontinue product sales in order to focus on our licensing
and services activities. Our product-related activities are
presented in our financial statements as a separate line item
entitled Loss from discontinued operations. As a
result of these factors, our historical financial data may be of
limited value in evaluating our future prospects.
|
|
|
We
depend on a small number of licensees for our revenues and if we
lose any of these licensees our revenues may decrease
substantially.
|
To date, we have derived the majority of our revenues from
license and service agreements with semiconductor manufacturers
in the code, data and embedded flash memory segments. Three
licensees accounted for 90% of our licensing and service
revenues in 2004 and 87% of our licensing and service revenues
in 2005:
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
Macronix International Co.,
Ltd.
|
|
|
37
|
%
|
|
|
18
|
%
|
Infineon Technologies AG
|
|
|
28
|
*
|
|
|
57
|
|
Spansion LLC
|
|
|
25
|
|
|
|
12
|
|
|
|
* |
Includes revenues from Infineon Technologies Flash Israel, the
Israeli entity in our former joint venture which we exited in
December 2004.
|
As of December 31, 2005, our license agreements contained
contractual commitments for license fees payable to us before
December 31, 2007 totaling approximately $42 million,
the substantial majority of which we expect to recognize prior
to December 31, 2007. The majority of this amount is
payable by Infineon Technologies and the majority of the
remaining balance by Semiconductor Manufacturing International
Corporation. Substantially all of these fees are subject to
cancellation by our licensees. Subject to these licensees
successfully incorporating our intellectual property into their
products, we expect that a significant portion of our future
revenues will continue to be derived from them for the
foreseeable future. The loss of any of these licensees or any
other significant customer in the future could cause our
revenues to decrease substantially.
|
|
|
Our
reputation and revenues could be adversely affected if our
licensees do not successfully implement our NROM technology in a
wide range of their products.
|
An important element of our strategy is to accelerate the
adoption of our NROM technology by our licensees in the code,
data and embedded flash segments of the non-volatile memory
market. In particular, the data flash market is projected by
Web-Feet Research to grow between 2005 and 2010 at a compound
annual growth rate of 24.0% to $34.8 billion while the code
flash market is projected to grow at 7.8% to $11.7 billion
over the same period. We have granted a license to use our NROM
technology in data flash applications to Infineon Technologies,
Macronix, Semiconductor Manufacturing International Corporation
and Spansion,
8
although only Infineon Technologies is selling data flash
devices incorporating our technology. Our licensees may fail to
implement our NROM technology in a timely manner or in a large
number of their products. While certain of our license
agreements contain provisions for prepaid royalty payments
irrespective of sales by our licensees, these amounts are less
than the amounts we would expect to earn from royalty payments
based on substantial sales of products incorporating our NROM
technology. In addition, our licensees may elect to rely on
other licensed or internally-developed technologies for some or
all of their products instead of implementing our NROM
technology. If a leading semiconductor manufacturer adopts and
achieves success with another technology or incorporates our
NROM technology but fails to achieve success with its products,
our reputation and revenues could be adversely affected.
|
|
|
Our
growth and future prospects could be harmed if we are unable to
enter into favorable agreements to license our NROM technology
to other semiconductor manufacturers.
|
We intend to license our NROM technology to other semiconductor
manufacturers in the code, data and embedded flash segments of
the non-volatile memory market. In order to successfully license
our NROM technology to additional licensees, we must persuade
them of the benefits of our technology over existing floating
gate technology. The code and data flash memory segments are
each dominated by a small number of large manufacturers.
According to Web-Feet Research, the top six manufacturers
accounted for 82.0% of revenues in the code and data memory
segments in 2005. Due to the projected growth in the data flash
market compared to the code flash market, a failure to enter
into license agreements in the data flash segments or the
failure of our existing licensees to penetrate this market could
adversely affect our growth and future prospects. In addition,
we have agreed with Macronix that we will be allowed to grant a
license to manufacture products incorporating our NROM
technology to only one other new licensee in Taiwan for code and
data flash products, provided we pay Macronix a portion of the
license fees that we receive from any such license. If
additional significant manufacturers of non-volatile memory
products are established in Taiwan in the future, this
restriction may limit the revenues that we can derive from this
market, or result in additional costs, to enter into license
agreements with these manufacturers. If a leading semiconductor
manufacturer in the code or data flash memory segment adopts and
achieves success with a competing technology or incorporates our
technology but fails to achieve success with its products, our
reputation and revenues could be adversely affected. It takes a
significant amount of time to design, develop and manufacture
non-volatile memory devices and, as a result, if a competitor
starts to manufacture products based on a competing technology,
it may be difficult for us to displace that technology. In
addition, we must negotiate license agreements with favorable
license fees and royalty payments. The license fees and
royalties under our current license agreements vary
significantly among our licensees. For example, our first
license agreement with Spansion, which in 2004, according to
Web-Feet Research, was the largest vendor worldwide of code
flash with total sales of $2.4 billion, or 24.3% of the
total code flash market, contains a uniform royalty rate that is
lower than the royalty rates in some of our other license
agreements and stepped thresholds that limit the amount from
which we can derive royalties to $1.2 billion of annual net
sales of products by Spansion incorporating our NROM technology.
If we are unable to negotiate favorable license agreements with
other semiconductor manufacturers, our growth and future
prospects could be harmed.
|
|
|
If we
are unable to successfully protect our inventions through the
issuance and enforcement of patents, our business could be
significantly harmed.
|
As we derive a significant portion of our revenue from licensing
activities, our ability to innovate and protect our innovations
by applying for, obtaining and enforcing our patents is
important to our business and revenues. As of December 31,
2005, we owned over 65 issued U.S. patents (including 10
co-owned U.S. patents) and seven
non-U.S. patents,
and we had over 55 pending U.S. patent applications and
over 100 pending
non-U.S. patent
applications. If we fail to obtain patents, are unable to obtain
patents with claims of a scope necessary to cover our
technology, or our issued patents are determined invalid or not
to cover our technology, our licensees and others could use
portions of our intellectual property without paying license
fees and royalties, which could weaken our competitive position,
significantly harm our revenues and prospects, and increase the
likelihood of costly litigation. We have an active program to
protect our proprietary inventions
9
through the filing of patent applications and taking certain
steps to preserve the confidentiality of our confidential and
proprietary information. There can be no assurance, however,
that:
|
|
|
|
|
current or future U.S. or foreign patent applications will
be approved;
|
|
|
|
our issued patents will protect our intellectual property and
not be challenged by third parties;
|
|
|
|
the validity of our patents will be upheld;
|
|
|
|
the patents of others will not have an adverse effect on our
ability to do business; or
|
|
|
|
others will not independently develop similar or competing
products or methods or design around any patents that may be
issued to us.
|
|
|
|
Our
failure to protect the intellectual property created by us would
cause our business to suffer.
|
In addition to patent protection, we rely on a combination of
trade secret, copyright and trademark laws and restrictions on
disclosure to protect our intellectual property rights,
including through confidentiality agreements with our employees,
consultants and customers. We cannot be certain that these
contracts have not been and will not be breached, that we will
have adequate remedies for any breach or that our trade secrets
will not otherwise become known or be independently discovered
by competitors. Further, the growth of our business depends in
large part on our ability to convince third parties of the
applicability of our intellectual property to their products,
and our ability to enforce our intellectual property rights
against them. As part of our marketing efforts, we disclose to
our prospective customers some of our proprietary information,
not all of which is patent protected. Monitoring unauthorized
use of our technology is difficult, and we cannot be certain
that the steps we have taken will prevent unauthorized use of
our technology, particularly in foreign countries where the laws
may not protect our proprietary rights as fully as do the laws
of the United States or in countries where we have not obtained
or have limited patents on our technology, including China and
Taiwan. We cannot be certain that the steps we have taken to
protect our proprietary information will be sufficient.
|
|
|
Potential
intellectual property claims by and against us and resulting
litigation could subject us to significant costs and could
invalidate our proprietary rights.
|
In the semiconductor industry, it is not unusual for companies
to receive notices alleging infringement of patents or other
intellectual property rights of others. We are not currently
subject to any proceedings for infringement of patents or
intellectual property rights of others and are not aware of any
parties that intend to pursue such claims against us. If it
appears necessary or desirable, we may seek to license
intellectual property that we are alleged to be infringing.
Licenses may not be offered and the terms of any offered
licenses may not be acceptable to us. The failure to obtain a
license under a key patent or intellectual property directly
from a third party for technology used by us or provided by us
to our licensees could cause us to incur substantial liabilities
and to suspend the manufacture of the products utilizing certain
technology or to attempt to develop non-infringing products, any
of which could harm our business. We may find it necessary to
litigate to enforce our patents and other intellectual property
rights, to protect our trade secrets, to determine the validity
and scope of the proprietary rights of others or to defend
against claims of infringement of others intellectual
property or invalidity of our own intellectual property. For
example, in 2002 we incurred expenses of approximately
$2.2 million in connection with a settlement and license
agreement with Fujitsu Limited and Advanced Micro Devices, Inc.
pursuant to which we agreed to settle a claim that we filed in
the United States District Court for the Southern District of
New York for infringement of patents, breach of contract and
unjust enrichment. In addition, we have provided a limited
indemnity to certain of our licensees against losses resulting
from claims that our NROM technology incorporated into their
products infringes certain third party intellectual property
rights, and we may agree to indemnify other licensees in the
future. These indemnification obligations could result in
significant expense. Litigation is inherently uncertain and any
adverse decision could result in a loss of our proprietary
rights, subject us to significant liabilities, require us to
seek licenses from others, limit the value of our licensed
technology and otherwise negatively impact our business. Even if
we adequately protect our intellectual property rights,
litigation may be necessary to enforce these rights,
10
which could result in substantial costs to us and a substantial
diversion of management attention, which could harm our business.
|
|
|
The
timing and amount of our revenues from new license agreements
and the amount of our revenues from royalties is difficult to
predict and may fluctuate.
|
The amount of time it takes to enter into a new license
agreement and generate a license fee and to establish a royalty
stream can range from three or more months, for the entry into
the license agreement, to two years or more, for establishment
of a royalty stream. As such, it is difficult to make an
accurate prediction of future license fees and royalties from
new licensees. In addition, we recognize license fees ratably
over the period during which we expect to provide initial
customer support to our licensees to assist them in
incorporating our intellectual property into their products,
independent of the actual payment schedules under the license
agreement, but provided that payment is due or guaranteed
according to the terms of the agreement. We review our
assumptions regarding the support periods on a regular basis;
however, there can be no assurance that we will accurately
estimate the period during which we will provide initial
customer support to our licensees, or that we will have, or be
able to expend, sufficient resources required to complete a
project. We have in the past experienced changes and delays to
our licensees projected product development schedules and
there can be no assurance that they will not be changed or
delayed in the future. Royalties are also dependent upon
fluctuating sales volumes and prices of products that include
our NROM technology, all of which are beyond our ability to
control or assess in advance. As a result of these
uncertainties, the timing and amount of license revenues and the
amount of royalty revenues are difficult to predict. This may
make accurate financial forecasts difficult to achieve, which
could cause our stock price to become volatile and decline.
|
|
|
Our
licensees may be subject to intellectual property infringement
claims by third parties or other licensees of our
technology.
|
Our licensees use various aspects of their own patents and
intellectual property in the manufacture, design and testing of
non-volatile memory products incorporating our NROM technology.
Third parties may claim that the products manufactured by our
licensees infringe the third partys patents and other
intellectual property. In addition, our licensees may sue each
other for infringement of each others patent and
intellectual property rights. While two of our licensees have
agreed not to block certain other licensees from manufacturing
products incorporating our NROM technology, these arrangements
are subject to exceptions and may be difficult to enforce. The
code and data flash memory segments of the non-volatile memory
market are each dominated by a small number of large
manufacturers. As a result, there are a limited number of
companies to which we can license our patents and intellectual
property in these segments. While there are a larger number of
potential licensees in the embedded flash memory market, these
licensees too could be subject to intellectual property
infringement claims from third parties or each other. Our
ability to receive royalties depends on our licensees
sales of products incorporating our NROM technology. Our royalty
revenues may be adversely affected if third parties attempt to
block our licensees, or our licensees attempt to block other
licensees, from manufacturing products incorporating our NROM
technology.
|
|
|
Our
difficulties in verifying royalty amounts and other payments
owed to us under our license and other agreements may cause us
to lose revenues.
|
Our long-term success depends in part on future royalties paid
to us by licensees. Royalties are based on a percentage of the
revenues received by licensees on sales of products
incorporating our licensed intellectual property. We are
dependent upon our ability to enforce agreements for the payment
of royalties. The standard terms of our license agreements
require our licensees to document the manufacture and sale of
products that incorporate our NROM technology and report this
data to us on a periodic basis. We have also entered into a
collaboration and distribution agreement with Spansion pursuant
to which we share the profits from sales of agreed-upon serial
flash products. Although our license agreements and this
collaboration and distribution agreement give us the right to
audit books and records of our counterparties and to verify this
information, audits can be expensive, time consuming, and
potentially detrimental to our ongoing business relationships.
In
11
addition, our agreements generally limit our audit rights to one
audit each year. As a result, to date, we have relied
exclusively on the accuracy of the reports themselves without
independently verifying the information in them. Any
inaccuracies or reporting errors that we fail to discover may
result in us receiving less revenue than we are entitled to
receive.
|
|
|
A
decrease in the demand for consumer electronic, communications,
automotive and industrial products may significantly decrease
the demand for the products sold by our licensees and reduce our
revenues and profitability.
|
Flash memory devices that are based on our NROM technology are
incorporated into products for consumer electronic,
communications, automotive and industrial markets. These
products include mobile phones, still and video digital cameras,
personal digital assistants (or PDAs), portable computers,
portable digital music players, digital video recorders, set-top
boxes, network computers, communication routers and switches,
digital televisions and other electronic systems. A significant
decrease in the demand for these products may decrease the
demand for the products of our licensees and could adversely
affect our results of operations.
|
|
|
Our
revenues and business will be harmed if we do not develop new
innovations in a timely and cost-effective manner.
|
We operate in highly competitive, quickly changing markets,
which are characterized by rapid obsolescence of existing
products. As a result, our future success depends on our ability
to develop new technology and introduce this new technology that
our customers choose to use or buy in significant quantities. In
particular, the non-volatile memory market has been
characterized by downward price pressure together with the
demand for:
|
|
|
|
|
increased memory and features on same size or smaller chip;
|
|
|
|
migration to smaller process technologies;
|
|
|
|
faster read and write speeds, which allow a systems
microprocessor to access data without having to wait;
|
|
|
|
lower power consumption to allow for longer operating times
using the same power source;
|
|
|
|
ability to withstand extreme temperature fluctuations; and
|
|
|
|
the ability to read and modify data many times without adversely
impacting reliability.
|
These challenges make developing new generations of products
substantially more difficult than prior generations. In 2005,
several of our licensees began developing products incorporating
our next generation QUAD NROM technology which enables the
storage of four bits of information in a single cell. We face
challenges in implementing four-bit-per-cell devices based on
our NROM technology. In particular, in order to program and read
a QUAD NROM device, each cell must be capable of reliably
storing and reading multiple voltage levels. The need to program
and reliably distinguish between multiple voltage levels,
without generating unacceptable error levels or materially
degrading performance, requires more precise and sophisticated
operation control. This is similar to the challenge that
companies face when attempting to make two-bit-per-cell devices
using floating gate technology. We invest in research and
development and provide design and product development services
to our licensees to assist them in meeting the manufacturing
challenges presented by these demands. If our licensees are
unsuccessful in introducing products that meet the demands
described above or in migrating products incorporating our NROM
technology to more advanced manufacturing processes, our
business and financial results could be seriously harmed.
|
|
|
Cyclicality
in the semiconductor industry may affect our revenues and, as a
result, our operating results could be adversely
affected.
|
The semiconductor industry has historically been cyclical and is
characterized by wide fluctuations in product supply and demand.
From time to time, the industry has experienced significant
downturns, often in
12
connection with, or in anticipation of, maturing product and
technology cycles, excess inventories and declines in general
economic conditions. This cyclicality could cause our operating
results to decline dramatically from one period to the next. Our
royalty revenues will depend heavily upon sales by our licensees
and products incorporating our NROM technology, which, in turn,
depend upon the current and anticipated market demand for
semiconductors and products that use semiconductors. Our design
and product development service revenues depend in part upon the
outsourcing of design and product development projects by our
licensees. Semiconductor manufacturers generally have adopted a
variable cost structure, which has allowed them to sharply
curtail their spending during industry downturns. Historically,
many of these manufacturers have lowered their spending more
than the decline in their revenues. As a result, if we are
unable to control our expenses adequately in response to lower
revenues from our licensees and service customers, our operating
results will suffer and we might experience operating losses.
|
|
|
The
average selling prices of non-volatile memory devices has tended
to decrease historically and this trend may negatively impact
our revenue and gross margins.
|
Average selling prices of non-volatile memory devices have
historically declined over the course of a particular
devices life. For example, according to Web-Feet Research,
the average selling price per megabyte is forecasted to decline
from 2005 to 2006 by 37.6% in a data flash device and by 41.0%
in a code flash device. We expect this trend to continue in the
future. Because royalty payments under our license agreements
are based on a percentage of our licensees net sales, any
decrease in the average selling prices of non-volatile memory
devices incorporating our NROM technology will adversely impact
our revenues.
|
|
|
The
semiconductor memory market in which we participate is highly
competitive and, if we do not compete effectively, our operating
results would be harmed.
|
We consider the primary competition for our NROM technology to
be traditional floating gate technology in its
single-bit-per-cell and multi-level cell implementations. This
technology and its enhancements are developed primarily by the
internal research and development departments of large
semiconductor companies, some of which are our licensees and
many of which we believe are potential licensees of our NROM
technology. In the code flash memory market, the leading
manufacturers are Spansion, Intel Corporation,
STMicroelectronics and Sharp Electronics Corporation. In the
data flash memory market, the leading manufacturers include
Samsung Electronics Co. Ltd., Toshiba Corporation, SanDisk
Corporation and Hynix Semiconductor. In addition, Intel and
Micron recently formed a joint venture targeting the data flash
market. Intel, Samsung, STMicroelectronics, Toshiba and SanDisk
(through its joint venture with Toshiba) market floating gate
devices incorporating multi-level-cell technology. Other
companies have indicated that they are developing
multi-level-cell floating gate technology. While we believe that
floating gate cells suited to mass production are currently
incapable of storing four bits per cell, there can be no
assurance that one of our competitors will not successfully
introduce such technology in the future, which could materially
harm our competitive position. Many of these companies consider
flash memory research and development to be one of their core
competencies. In the serial flash memory market, our technology
competes principally with technology developed by
STMicroelectronics and Silicon Storage Technologies, Inc. In the
embedded flash memory market, we compete directly with the
technology of application companies that manufacture embedded
products, as well as with a number of other companies that
license their intellectual property, principally Silicon Storage
Technologies, Inc. Many of our competitors have significantly
greater name recognition, larger customer bases, more
established customer relationships and greater financial,
technical, manufacturing, marketing and other resources than us.
Our failure to compete successfully in these or other areas
could harm our business and financial results.
|
|
|
If we
fail to support our growth in operations, particularly by
enhancing our sales and marketing, and internal controls
systems, our business could suffer.
|
Over the last five years, our business has grown rapidly with
revenues increasing from $14.5 million in 2003 to
$78.6 million in 2005. As of December 31, 2005, we had
236 employees compared to 137 employees as of December 28,
2003. We plan to expand our operations, domestically and
internationally, and may do so
13
through both internal growth and acquisitions. We may face
significant challenges and risks in building and managing our
growth. To succeed in the implementation of our business
strategy, we must expand our business development and marketing
activities and enhance our internal controls systems. Our
systems, procedures and controls may not be adequate to support
our expected growth in operations. Failure to manage our future
growth effectively could result in increased costs and harm our
financial results.
|
|
|
We
depend on our ability to attract and retain our key management
and technical personnel.
|
Our success depends, in large part, on the continued service of
our key management, engineering, business development, marketing
and finance personnel, many of whom are highly skilled and would
be difficult to replace. In particular, we depend on the
continued service of Dr. Boaz Eitan, our founder, Chief
Executive Officer and Chairman. None of our senior management,
key technical personnel or key sales personnel are bound by
written employment contracts to remain with us for a specified
period. In addition, we do not currently maintain key personnel
life insurance covering any of our personnel. The loss of any of
our senior management or other key personnel could harm our
ability to implement our business strategy and respond to the
rapidly changing market conditions in which we operate. Our
success also depends on our ability to attract, train and retain
highly skilled managerial, engineering, sales, marketing, legal
and finance personnel and on the abilities of new personnel to
function effectively, both individually and as a group. Further,
we must train our new personnel, especially our technical
support personnel, to respond to and support our licensees and
customers. If we fail to do this, it could lead to
dissatisfaction among our licensees or customers, which could
slow our growth or result in a loss of business.
|
|
|
The
international nature of our business exposes us to financial and
regulatory risks and we may have difficulty protecting our
intellectual property in some foreign countries.
|
To date, we have derived the substantial majority of our
licensing and service revenues from licensees headquartered
outside the United States, principally in Europe and the
Asia-Pacific region, and these revenues accounted for 88% of our
licensing and service revenues in the fiscal year ended
December 31, 2005. International operations are subject to
a number of risks, including the following:
|
|
|
|
|
laws and business practices favoring local companies;
|
|
|
|
withholding tax obligations on license revenues that we may not
be able to offset fully against our tax obligations, including
the further risk that foreign tax authorities may
re-characterize license fees or increase tax rates, which could
result in increased tax withholdings and penalties;
|
|
|
|
less effective protection of intellectual property than is
afforded to us in the United States, or other developed
countries;
|
|
|
|
technology export license requirements and trade restrictions;
|
|
|
|
imposition of or increases in tariffs; and
|
|
|
|
changes in regulatory requirements.
|
Our intellectual property is also used in a large number of
countries. There are countries, including China, in which we
currently have no issued patents, and others, such as Taiwan, in
which we have a limited number of issued patents. In addition,
effective intellectual property enforcement may be unavailable
or limited in some foreign countries. It may be difficult for us
to protect our intellectual property from misuse or infringement
by other companies in these countries. We expect this to become
a greater problem for us as our licensees increase their
manufacturing in countries that provide less protection for
intellectual property. Our inability to enforce our intellectual
property rights in some countries may harm our business.
|
|
|
Our
international operations expose us to the risk of fluctuations
in currency exchange rates.
|
In 2005, we derived all of our revenues in U.S. dollars.
However, 46% of our expenses were denominated in New Israeli
Shekels. Our shekel-denominated expenses consist principally of
salaries and related personnel expenses, as well as vehicle
lease payments. We anticipate that a material portion of our
expenses will
14
continue to be denominated in shekels. If the U.S. dollar
weakens against the shekel, there will be a negative impact on
our profit margins. In addition, to the extent that our
licensees sales are not denominated in U.S. dollars,
they are translated into U.S. dollars at the prevailing
exchange rate for the purpose of calculating the royalty payable
to us. Therefore, if the U.S. dollar strengthens against
the currency in which any of our licensees makes its sales, the
dollar-denominated amount of the royalties that we receive would
be reduced and subject to fluctuations. If the effective price
of licensed semiconductors sold by our foreign licensees were to
increase as a result of fluctuations in the exchange rate of
relevant currencies, demand for licensed semiconductors could
fall, which in turn would reduce our royalties.
|
|
|
If our
prototypes or products based on our designs are used in
defective products, we may be subject to product liability or
other claims.
|
If products incorporating our technology are used in defective
or malfunctioning products, we could be sued for damages,
especially if the defect or malfunction causes physical harm to
people. The occurrence of a problem could result in product
liability claims and/or a recall of, or safety alert or advisory
notice relating to, the product. While we believe the amount of
product liability insurance maintained by us combined with the
indemnities that we have been granted under our license
agreements are adequate, there can be no assurance that these
will be adequate to satisfy claims made against us in the future
or that we will be able to obtain insurance in the future at
satisfactory rates or in adequate amounts. Product liability
claims in the future, regardless of their ultimate outcome,
could have a material adverse effect on our business, financial
condition and reputation, and on our ability to attract and
retain licensees and customers.
|
|
|
We may
need to raise additional capital in the future and may be unable
to do so on acceptable terms. This could limit our ability to
grow and carry out our business plan.
|
Our future capital requirements will depend on the acceptance of
our licensees products that incorporate our NROM
technology and the costs associated with the growth of our
business. If the proceeds from our initial public offering in
November 2005 and follow-on offering in April 2006,
together with other sources of cash and cash flows, are not
sufficient to fund our activities, we may need to raise
additional capital, which may not be available on favorable
terms, or at all. In addition, we may seek to take advantage of
any capital raising opportunities that arise in the future. We
cannot be certain that we will be able to obtain additional
financing on commercially reasonable terms or at all, which
could limit our ability to grow, or that any such additional
financing, if raised through the issuance of equity securities,
will not be dilutive to our existing shareholders.
|
|
|
Under
current U.S. and Israeli law, we may not be able to enforce
covenants not to compete and therefore may be unable to prevent
our competitors from benefiting from the expertise of some of
our former employees.
|
We have entered into non-competition agreements with all of our
employees. These agreements prohibit our employees, if they
cease working for us, from competing directly with us or working
for our competitors for a limited period. Under current U.S. and
Israeli law, we may be unable to enforce these agreements and it
may be difficult for us to restrict our competitors from gaining
the expertise our former employees gained while working for us.
For example, Israeli courts have recently required employers
seeking to enforce non-compete undertakings of a former employee
to demonstrate that the competitive activities of the former
employee will harm one of a limited number of material interests
of the employer which have been recognized by the courts, such
as the secrecy of a companys confidential commercial
information or its intellectual property. If we cannot
demonstrate that harm would be caused to us, we may be unable to
prevent our competitors from benefiting from the expertise of
our former employees.
|
|
|
Our
reported financial results may be adversely affected by changes
in accounting principles generally accepted in the United
States.
|
We prepare our financial statements in conformity with generally
accepted accounting principles in the United States. These
accounting principles are subject to interpretation by the
Financial Accounting Standards
15
Board, the American Institute of Certified Public Accountants,
the Securities and Exchange Commission and various bodies formed
to interpret and create appropriate accounting principles. A
change in these principles or interpretations could have a
significant effect on our reported financial results, and could
affect the reporting of transactions completed before the
announcement of a change.
We may
become subject to a claim by Tower Semiconductor Ltd. that we
breached provisions of our license agreement with
it.
On March 14, 2006, Tower forwarded to us a letter from
Towers counsel, which alleged that we breached various
provisions of our license agreement with Tower. Among other
allegations, the letter alleges that we failed to make certain
payments to Tower, failed to include in certain license
agreements provisions regarding the licensees possible
manufacturing of their licensed products at Tower, failed to
manufacture certain of our own products at Tower and that we
were not entitled to take certain offsets. There can be no
assurance that we will prevail in any legal proceedings
instituted by Tower, or that such proceedings will not have a
material adverse effect on our business, financial condition or
results of operations. See Item 8 Financial
Information Legal Proceedings.
Risks
Relating to our Ordinary Shares
|
|
|
Our
quarterly financial performance is likely to vary in the future,
and may not meet our guidance or the expectations of analysts or
investors, which may lead to additional volatility in our share
price.
|
The market price of our ordinary shares may be volatile and
could fluctuate substantially due to many factors, including:
|
|
|
|
|
announcements or introductions of technological innovations or
new products, or product enhancements or pricing policies by us
or our competitors;
|
|
|
|
disputes or other developments with respect to our or our
competitors intellectual property rights;
|
|
|
|
announcements of strategic partnerships, joint ventures or other
agreements by us or our competitors;
|
|
|
|
recruitment or departure of key personnel;
|
|
|
|
the gain or loss of licensees;
|
|
|
|
regulatory developments in the United States, Israel and abroad;
|
|
|
|
our sale of ordinary shares or other securities in the future;
|
|
|
|
changes in the estimation of the future size and growth of our
markets; and
|
|
|
|
market conditions in our industry, the industries of our
customers and the economy as a whole.
|
Share price fluctuations may be exaggerated if the trading
volume of our ordinary shares is too low. The lack of a trading
market may result in the loss of research coverage by securities
analysts. Moreover, we cannot assure you that any securities
analysts will initiate or maintain research coverage of our
company and our ordinary shares. If our future quarterly
operating results are below the expectations of securities
analysts or investors, the price of our ordinary shares would
likely decline. Securities class action litigation has often
been brought against companies following periods of volatility.
Any securities litigation claims brought against us could result
in substantial expense and divert managements attention
from our business.
|
|
|
Our
Chief Executive Officer and Chairman, Dr. Boaz Eitan, has
significant influence over matters requiring shareholder
approval, which could delay or prevent a change of
control.
|
The largest beneficial owner of our ordinary shares, our Chief
Executive Officer and Chairman, Dr. Boaz Eitan,
beneficially owns 36.1% of our outstanding ordinary shares. As a
result, Dr. Eitan has significant
16
influence over our operations and business strategy, as well as
sufficient voting power to control the outcome of matters
requiring shareholder approval. These matters may include:
|
|
|
|
|
the composition of our board of directors, which has the
authority to direct our business and to appoint and remove our
officers;
|
|
|
|
approving or rejecting a merger or other business combination;
|
|
|
|
raising future capital; and
|
|
|
|
amending our Articles of Association, which govern the rights
attached to our ordinary shares.
|
This concentration of ownership of our ordinary shares could
delay or prevent proxy contests, mergers, tender offers,
open-market purchase programs or other purchases of our ordinary
shares that might otherwise give you the opportunity to realize
a premium over the then-prevailing market price of our ordinary
shares. This concentration of ownership may also adversely
affect our share price.
Substantial
future sales of our ordinary shares in the public market may
cause the price of our shares to decline.
As of April 6, 2006, we had 30,532,699 ordinary shares
outstanding. If our shareholders sell substantial amounts of our
ordinary shares in the public market, including shares issued
upon the exercise of outstanding options, the market price of
our ordinary shares could fall. Such sales also might make it
more difficult for us to issue equity or equity-related
securities in the future at a time and price that we deem
appropriate.
As of April 6, 2006, we had outstanding approximately
10.2 million ordinary shares that are freely tradable
without restriction or registration under the Securities Act,
unless purchased by affiliates as that term is defined under
Rule 144 of the Securities Act. We expect that the
remaining ordinary shares will become available for resale into
the public markets as follows:
|
|
|
|
|
approximately 1.8 million shares beginning on May 8,
2006, unless earlier released from lock-up agreements entered
into with the underwriters of our initial public offering in
November 2005;
|
|
|
|
approximately 16.3 million shares beginning June 28,
2006, approximately 13.6 million of which are subject to
volume limitations under Rule 144, unless earlier release
from lock-up agreements entered into with the underwriters of
our follow-on public offering in April 2006; and
|
|
|
|
approximately 1.6 million shares after June 28, 2006
pursuant to lock-up agreements with us or other restrictions.
|
As of April 6, 2006, we had outstanding (i) options to
purchase approximately 4.2 million ordinary shares of which
approximately 1.3 million were vested and exercisable and
(ii) approximately 0.9 million shares issued pursuant
to our share option plans. The majority of these shares may be
sold, if such options are exercised, pursuant to Rule 701
under the Securities Act and, shortly following the filing of
this Annual Report, we intend to file a registration statement
on Form S-8 to enable the resale of such shares. Sales of a
significant amount of shares underlying options or following the
termination of the lock-up agreements described above, or the
perception that such sales may occur, may cause the price of our
shares to decline.
Any
shareholder that acquires more than 9.9% of our shares will have
limited voting rights with respect to those
shares.
Each Ten Percent Shareholder in a
non-U.S. corporation
that is classified as a controlled foreign
corporation, or a CFC, for United States federal income
tax purposes in any taxable year is required to include in
income for U.S. tax purposes such Ten Percent
Shareholders pro rata share of the CFCs
Subpart F income and investment of earnings in
U.S. property, even if the CFC has made no distributions to
its shareholders. A
non-U.S. corporation
will be classified as a CFC for United States federal income tax
purposes in any taxable year in which Ten Percent
Shareholders own, directly or indirectly, more than 50.0%
of either the total combined voting power of all classes of
stock of such corporation entitled to vote or of the total value
of the stock entitled to vote of such corporation. A Ten
Percent Shareholder is a United
17
States person (as defined by the U.S. Internal Revenue Code
of 1986, as amended (the Code)) who owns or is
considered to own, on any day during such taxable year, 10% or
more of the total combined voting power of all classes of stock
entitled to vote of such corporation.
Although we were a CFC in the beginning of the 2005 tax year, we
believe based on our current ownership that we are no longer so
classified and expect that, because of the anticipated
dispersion of our share ownership as a result of our initial
public offering, provisions limiting voting power in our
Articles of Association and other factors, we ceased to be
classified as a CFC after our initial public offering. In order
to reduce the risk that we will once again be considered a CFC
in future years, our Articles of Association provide that any
United States persons that purchase our shares, directly,
indirectly or constructively, after September 29, 2005 will
be limited to voting a maximum of 9.9% of our total combined
voting power, to the extent that their voting rights
notwithstanding such limitation would cause us to be considered
a CFC.
See Memorandum and Articles of
Association Limitations on Voting and
Taxation United States Federal Income
Taxation Controlled Foreign Corporation
Considerations.
|
|
|
Our
U.S. shareholders may suffer adverse tax consequences if we
are characterized as a Passive Foreign Investment
Company.
|
Generally, if for any taxable year 75.0% or more of our gross
income is passive income, or at least 50.0% of our assets are
held for the production of, or produce, passive income, we may
be characterized as a passive foreign investment company for
U.S. federal income tax purposes. If we are characterized
as a passive foreign investment company, our
U.S. shareholders may suffer adverse tax consequences,
including having gains realized on the sale of our ordinary
shares treated as ordinary income, rather than capital gain, the
loss of the preferential rate applicable to dividends received
on our ordinary shares by individuals who are U.S. holders,
and having potentially punitive interest charges apply to the
proceeds of share sales. Because the market price of our
ordinary shares is likely to fluctuate after a proposed
follow-on offering and the market price of the shares of
technology companies has been especially volatile, and because
that market price may affect the determination of whether we
will be considered a passive foreign investment company, there
can be no assurance that we will not be considered a passive
foreign investment company for any taxable year. See
Taxation United States Federal Income
Taxation Passive Foreign Investment Company
Considerations.
Risks
Relating to our Location in Israel
|
|
|
Conditions
in Israel could adversely affect our business.
|
We are incorporated under Israeli law and our principal offices
and our research and development facilities are located in
Israel. Therefore, political, economic and military conditions
in Israel directly affect our operations. Although Israel has
entered into various agreements with Egypt, Jordan and the
Palestinian Authority, there has been an increase in unrest and
terrorist activity, which began in September 2000 and which has
continued with varying levels of severity into 2006. The
election of Hamas representatives to a majority of seats in the
Palestinian Legislative Council may create additional unrest and
uncertainty. We do not believe that the political and security
situation has had any material impact on our business to date;
however, we can give no assurance that security and political
conditions will have no such effect in the future. Any armed
conflict, political instability or continued violence in the
region may have a negative effect on our business condition,
harm our results of operations and adversely affect the share
price of publicly traded Israeli companies such as us.
|
|
|
Our
operations could be disrupted as a result of the obligation of
key personnel in Israel to perform military
service.
|
Generally, all male adult citizens and permanent residents of
Israel under the age of 45 (or older, for citizens with certain
occupations) are, unless exempt, obligated to perform military
reserve duty annually. Additionally, all Israeli residents of
this age are subject to being called to active duty at any time
under emergency circumstances. Many of our officers and
employees are currently obligated to perform annual reserve
duty. In response to the increase in terrorist activity and the
Palestinian uprising, there have been, at times, significant
call-ups of military reservists, and it is possible that there
will be additional call-ups in the
18
future. Our operations could be disrupted by the absence for a
significant period of one or more of our executive officers or
key employees due to military service. Any disruption to our
operations could materially adversely affect the development of
our business and our financial condition.
|
|
|
We
have recently applied to the Office of the Chief Scientist for
government grants for research and development expenditures. If
our application is approved, it will limit our ability to
manufacture products and transfer technologies outside of Israel
and will require us to satisfy specified
conditions.
|
In January 2006, we applied for grants of up to approximately
$625,000 from the Office of the Chief Scientist of the Israeli
Ministry of Industry and Trade to finance research and
development expenditures in Israel in connection with our
controller card activity project. If we receive any grants, we
will be required to pay royalties to the Chief Scientist of
between 3% and 6% of revenues derived from technology developed
using these grants until 100% of the grants are repaid, together
with an annual interest as set forth in the research and
development regulations (currently equal to the 12 month
London Interbank Offered Rate). In addition, the terms of the
grants prohibit recipients from manufacturing products developed
using these grants outside of Israel without special approvals.
Even if we receive approval to manufacture the products
developed with government grants outside of Israel, we will be
required to pay an increased total amount of royalties (possibly
up to 300% of the grant amount plus interest), depending on the
manufacturing volume that is performed outside of Israel, as
well as a possible increased royalty rates.
Additionally, under the law governing the research grants, we
will be prohibited from transferring the financed technologies
and related intellectual property rights outside of Israel
except under limited circumstances and provided the transfer is
approved by the Research Committee of the Office of the Chief
Scientist. Approval of the transfer of technology to residents
of Israel is required, and may be granted in specific
circumstances only if the recipient abides by the provisions of
applicable laws, including the restrictions on the transfer of
know-how and the obligation to pay royalties in an amount that
may be increased. If our application for grants is approved, we
will be subject to the above mentioned restrictions and cannot
provide any assurance that consent, if requested, will be
granted. Such restrictions may impair our ability to outsource
manufacturing, engage in
change-of-control
transactions or otherwise transfer our technology developed with
government grants outside Israel.
Further, if we fail to comply with any of the conditions imposed
by the Office of the Chief Scientist, we may be required to
refund any grants received together with interest and penalties,
and may be subject to criminal charges. In recent years, the
government of Israel has accelerated the rate of repayment of
Chief Scientist grants and may further accelerate them in the
future. In addition, the Israeli government has, from time to
time, discussed reducing or eliminating the availability of
these grants. There can be no assurance that the Israeli
governments support of such grants will continue.
|
|
|
We
receive tax benefits that may be reduced or eliminated in the
future.
|
Our investment program in equipment at our facility in Netanya,
Israel has been granted approved enterprise status and we are
therefore eligible for tax benefits under the Israeli Law for
Encouragement of Capital Investments, 1959, referred to as the
Investments Law. Subject to compliance with applicable
requirements, the portion of our net income derived from our
licensing and services activities will be exempt from income tax
during the first two years in which these investment
programs produce taxable income, which will be after we have
utilized our net operating loss carry forwards. Thereafter it
will be subject to a reduced tax rate of between 10% and 25% for
the remaining five to eight years of the program, depending
on the extent of non-Israeli investment in our company during
the relevant year. Israeli companies are currently subject to
income tax at the corporate rate of 34% for the 2005 tax year,
31% for the 2006 tax year and the rate is set to decline
annually to 25% for the 2010 tax year and thereafter. As of
December 31, 2005, the end of our last fiscal year, our net
operating loss carry forwards for Israeli tax purposes amounted
to approximately $16.7 million. The period during which we
receive these tax benefits is limited to the earlier of
12 years from the year in which operations or production by
the enterprise commenced and 14 years from the year in
which approval of the program was granted. The benefits under
our existing approval enterprises are due to expire between 2011
and 2015. The benefits available to an approved enterprise are
conditional upon our fulfilling certain requirements stipulated
in the Investments Law and its regulations and the criteria set
forth in the specific certificate of approval. If we do
19
not meet these requirements in the future, the tax benefits may
be canceled and we could be required to refund any tax benefits
that we have already received. See
Taxation Israeli Tax Considerations and
Government Programs Taxation of
Companies Law for the Encouragement of Capital
Investments, 1959 for more information about the
requirements. In addition, in order to manage certain
investments, we have established a wholly owned subsidiary,
Saifun (BVI) Limited, a company incorporated under the laws
of the British Virgin Islands. Under our Approved Enterprise
status, we are not entitled to receive any tax benefits from any
income derived from investments made through Saifun
(BVI) Limited. As of December 31, 2005, carryforward
losses related to Saifun (BVI) Limited amounted to
approximately $3.3 million, which may be carried forward
indefinitely. After the carryforward losses are utilized, we
will be subject to Israeli income tax, which will be considered
a deemed dividend and taxed at 25% tax rate.
|
|
|
It may
be difficult to enforce a U.S. judgment against us, our
officers and directors in Israel or the United States, or to
assert U.S. securities laws claims in Israel or serve
process on our officers and directors.
|
We are incorporated in Israel. The majority of our executive
officers and directors are not residents of the United States,
and the majority of our assets and the assets of these persons
are located outside the United States. Therefore, it may be
difficult for an investor, or any other person or entity, to
enforce a U.S. court judgment based upon the civil
liability provisions of the U.S. federal securities laws
against us or any of these persons in a U.S. or Israeli
court, or to effect service of process upon these persons in the
United States. Additionally, it may be difficult for an
investor, or any other person or entity, to assert
U.S. securities law claims in original actions instituted
in Israel. Israeli courts may refuse to hear a claim based on a
violation of U.S. securities laws because Israel is not the
most appropriate forum in which to bring such a claim. In
addition, even if an Israeli court agrees to hear a claim, it
may determine that Israeli law and not U.S. law is
applicable to the claim. If U.S. law is found to be
applicable, the content of applicable U.S. law must be
proved as a fact which can be a time-consuming and costly
process. Certain matters of procedure will also be governed by
Israeli law. There is little binding case law in Israel
addressing the matters described above.
|
|
|
Provisions
of Israeli law and our Articles of Association may delay,
prevent or make undesirable an acquisition of all or a
significant portion of our shares or assets.
|
Our Articles of Association contain certain provisions that may
delay or prevent a change of control. These provisions include a
classified board of directors and a prohibition on certain
transactions with a 15% shareholder approval unless certain
board approvals are received. In addition, Israeli corporate law
regulates acquisitions of shares through tender offers and
mergers, requires special approvals for transactions involving
significant shareholders and regulates other matters that may be
relevant to these types of transactions. These provisions of
Israeli law could have the effect of delaying or preventing a
change in control and may make it more difficult for a third
party to acquire us, even if doing so would be beneficial to our
shareholders, and may limit the price that investors may be
willing to pay in the future for our ordinary shares.
Furthermore, Israeli tax considerations may make potential
transactions undesirable to us or to some of our shareholders.
|
|
ITEM 4.
|
INFORMATION
ON THE COMPANY
|
|
|
A.
|
HISTORY
AND DEVELOPMENT OF THE COMPANY
|
Our legal and commercial name is Saifun Semiconductors
Ltd. We were incorporated under the laws of the State of
Israel in November 1996 and commenced operations in July 1997.
We are registered with the Israeli registrar of companies in
Jerusalem. Our registration number is
51-239733-2.
Our principal executive offices are located at ELROD Building,
45 Hamelacha Street, Sappir Industrial Park, Netanya 42504,
Israel, and our telephone number is +972
(9) 892-8444.
Our web site address is www.saifun.com. The information on our
web site does not constitute part of this Annual Report. We have
irrevocably appointed Saifun Semiconductors, Inc. as our agent
to receive service of process in any action against us in any
United States federal or state court. The address of Saifun
Semiconductors, Inc. is 2350 Mission College Blvd., Suite 1070,
Santa Clara, CA 95054, U.S.A.
20
See Item 5 for a description of our discontinuation of
product sales activities in the second quarter of 2005. See
Items 5 and 18 for a description of capital expenditures by
us for the past three fiscal years. We have not made any
divestitures during the same time period.
Overview
We have invented and patented a technology that we refer to as
nitride-read-only memory, or NROM, that we believe is leading a
revolutionary shift in the non-volatile semiconductor memory
market. Unlike volatile semiconductor memory devices which lose
stored information after electrical power is turned off,
non-volatile semiconductor memory devices retain stored
information even without a power source. Demand for non-volatile
memory is experiencing rapid growth as consumer electronics,
communications, automotive and industrial products proliferate,
and require increasingly complex programming codes, and as
digitization of information, including photographs, video, music
and documents require increased data storage capacity. According
to market estimates from Web-Feet Research, a market research
firm in the electronics and the semiconductor industry, the code
flash and data flash devices that our technology addresses
accounted for sales of $19.9 billion in 2005, and are
expected to grow to $46.5 billion by 2010, representing a
compound annual growth rate of 18.5%. Web-Feet Research
estimates that the embedded flash devices that our technology
addresses accounted for sales of $3.3 billion in 2005, and
are expected to grow to $6.3 billion by 2010, representing
a compound annual growth rate of 13.8%. Taken as a whole, our
NROM technology can be applied in semiconductor memory devices
that in 2005 accounted for sales of $23.2 billion and that
are expected to grow to $52.8 billion by 2010, representing
a compound annual growth rate of 17.9%.
We believe that our NROM technology represents a breakthrough in
the non-volatile memory market because it offers a number of
significant advantages over existing non-volatile memory
technology. These advantages include a doubling of storage
capacity of a basic semiconductor memory cell resulting from our
two-bit-per-cell and four-bit-per-cell architectures and a
simpler cell architecture that enable semiconductor
manufacturers to reduce manufacturing costs as a result of fewer
manufacturing steps. In addition, we believe that our technology
is the only commercially-available technology that can be
applied to all segments of the non-volatile memory market using
principally the same manufacturing process. We are growing
rapidly through licensing our intellectual property and
providing design and product development services to our
licensees. Our goal is to establish our NROM technology as a
leading technology in the non-volatile memory market. We are
addressing the four primary segments of the non-volatile
semiconductor memory market as follows:
|
|
|
|
|
Code flash. Code flash is typically used to
store executable code, such as the operating system software of
a cellular phone. One of our licensees is Spansion (formerly
known as Fujitsu AMD Semiconductor LLC), the largest global
vendor of code flash in 2004 with total sales of
$2.4 billion representing 24.3% of the total code flash
market, according to Web-Feet Research. In 2005, we derived
license fees of $7.7 million from Spansion, which we
believe relate primarily to sales of code flash memory devices.
|
|
|
|
Data flash. Data flash is used for high
density storage of information, such as in memory cards for
digital cameras. One of our licensees targeting the data flash
market is Infineon Technologies (with which we formerly had a
joint venture with respect to data flash that we exited in
2004). According to Gartner, Infineon Technologies was the
seventh largest vendor of semiconductors globally in 2005. In
January 2004, Infineon Technologies launched its TwinFlash
technology, which incorporates our NROM technology. Infineon
Technologies is currently marketing 512 megabit and 1 gigabit
data flash devices.
|
|
|
|
Embedded flash. Embedded flash combines
non-volatile memory and programmable logic on a single chip for
use in applications such as smart cards. One of our licensees
targeting the embedded flash market is Matsushita, one of the
worlds largest vendors of consumer electric and electronic
products and, according to Gartner, the
16th
largest semiconductor manufacturer in 2005, with revenues of
$3.8 billion from semiconductor sales. To date, we have
derived limited revenues from Matsushita which have not
constituted a significant part of our total revenues.
|
21
Another one of our licensees in this segment is Sony
Corporation, one of the worlds largest vendors of consumer
electronic and electronic products. Gartner ranks Sony
Corporation as the 15th largest semiconductor manufacturer
with revenues of $4.3 billion from semiconductor sales in
2005. To date, we have derived limited revenues from Sony
Corporation, which have not constituted a significant portion of
our total revenues.
|
|
|
|
|
Serial flash. Serial flash is characterized as
small, low-power flash memory that uses a serial interface for
data access used in applications such as computer graphic cards,
hard disk drives, cordless phones and set top boxes. We are
targeting this market through our collaboration with Spansion,
pursuant to which Spansion shares with us the profits from sales
of agreed-upon serial flash products.
|
We believe that our strong patent portfolio and intellectual
property position, with over 65 issued U.S. patents
(including 10
co-owned
U.S. patents) and seven
non-U.S. patents,
and over 55 pending U.S. patent applications and over 100
pending non-U.S. patent applications, as well as our continuing
investment in research and development, will allow us to
continue to expand our business as demand for non-volatile
memory grows.
Industry
Overview
Demand for non-volatile memory devices has grown rapidly in
recent years due to the expansion of digital computing and
processing beyond desktop computer systems to include a broader
array of consumer electronic, communications, automotive and
industrial products. These products include mobile phones, still
and video digital cameras, personal digital assistants, or PDAs,
portable computers, portable digital music players, digital
video recorders, set-top boxes, communication routers and
switches, digital televisions and other electronic systems. Each
of these products requires a non-volatile memory device to store
the products operating system and may also require data
storage capabilities.
Non-volatile memory was developed in the late 1960s. Since then,
non-volatile memory architectures have evolved, differentiated
primarily by the ability of the user to reprogram the device:
|
|
|
|
|
ROM. Read Only Memory is programmed once
during manufacture and cannot subsequently be reprogrammed by
the user. As a result of this limitation,
ROM-device
sales have declined substantially in recent years.
|
|
|
|
PROM. Programmable Read Only Memory is
programmed once during manufacture and can then be reprogrammed
once by the user. A major drawback to PROM devices is that they
require special equipment to reprogram the PROM. As a result of
this limitation, PROM has been discontinued.
|
|
|
|
EPROM. In 1971, the first Erasable
Programmable Read Only Memory device was introduced. EPROM
devices can be reprogrammed by the user a limited number of
times by removing the device from the circuit board and erasing
it using ultraviolet light. As a result of this complexity of
reprogramming, EPROM is rarely used today.
|
|
|
|
EEPROM. Electrically Erasable Programmable
Read Only Memory was introduced in 1983 and overcomes some of
the limitations of EPROM because it can be reprogrammed by
applying an electrical voltage. EEPROM is erased and
reprogrammed at the individual cell level. While this results in
high functionality which makes it well suited to particular
applications, such as smart cards, EEPROM devices are generally
less cost-effective and are slower to program and erase than
flash memory devices.
|
|
|
|
Flash. Flash memory was invented in 1984.
Flash memory is the largest segment of the non-volatile memory
market and is similar to EEPROM in that it can also be erased
and reprogrammed repeatedly through the application of an
electrical voltage. Unlike EEPROM, flash memory cells can be
erased in blocks by a single action or flash, and
unlike EEPROM, flash memory does not require two transistors per
cell. This enables flash memory devices to be more
cost-effective and to have faster program and erase speeds than
EEPROM devices.
|
22
|
|
|
Flash
Memory Applications
|
The flash memory market, which in 2005 was the largest segment
of the non-volatile semiconductor memory market, has
traditionally been divided into four segments: code flash, data
flash, embedded flash and serial flash. The following table sets
forth the principal characteristics and applications of, and
market data for, each of these segments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected
|
|
|
|
|
|
|
|
|
|
|
Projected
|
|
|
compound
|
|
|
|
|
|
|
|
|
|
|
global
|
|
|
annual growth
|
|
|
|
|
|
|
|
Global sales
|
|
|
sales in
|
|
|
rate from 2005
|
|
Segment
|
|
Characteristics
|
|
Applications
|
|
in 2005
|
|
|
2010
|
|
|
to 2010
|
|
|
|
|
|
|
|
(millions)
|
|
|
(millions)
|
|
|
|
|
|
Code flash(1)
|
|
Used to store
executable code, such as operating system software of a device
|
|
Communications
products (e.g., cellular telephones)
|
|
$
|
8,040
|
|
|
$
|
11,723
|
|
|
|
7.8
|
%
|
|
|
Characterized by
random access to stored information and fast read speeds
|
|
Consumer electronics
products (e.g., DVD players, computers, tv set-top boxes)
|
|
|
|
|
|
|
|
|
|
|
|
|
Data flash
|
|
Used for high-density
data storage
|
|
Memory cards for
digital cameras, USB flash drives and MP3 players
|
|
$
|
11,896
|
|
|
$
|
34,809
|
|
|
|
24.0
|
%
|
|
|
Characterized by
sequential access and fast write speeds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Embedded flash
|
|
Combines flash memory
and programmable logic on a single chip
|
|
Microcontroller
embedded with memory (e.g., smart cards)
|
|
$
|
3,295
|
(2)
|
|
$
|
6,301
|
(2)
|
|
|
13.8
|
%
|
|
|
Characterized by fast
access, low power consumption and increased security
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Source: Web-Feet Research.
|
|
(1)
|
Includes the serial flash market.
|
|
(2)
|
Excludes revenue attributable to the microcontroller, digital
signal processor and/or programmable logic components of an
embedded flash device.
|
|
|
|
Trends
in the Flash Memory Market
|
The following are recent trends in the flash memory market:
|
|
|
|
|
Higher volumes and densities. According to
Web-Feet Research, total demand measured in bits of information
stored in code and data flash memory devices is expected to grow
by 132.1% from 2005 to 2006, where one bit is the smallest unit
of data stored with a value of either 0 or 1. This growth is a
result of an increase in average bit density per device,
representing the average number of bits available in a memory
device, or average bit density, of 79.2% for code flash and
46.5% for data flash from 2005 to 2006, according to Web-Feet
Research.
|
23
|
|
|
|
|
Demand for greater performance and
reliability. Product manufacturers are demanding
faster read and write speeds which allow a systems
microprocessor to access data and execute program code faster,
the ability to read and modify stored information repeatedly
without adversely impacting reliability, and the ability to
retain stored information for an extended period. In addition,
product manufacturers are requiring devices with lower power
consumption to allow for longer operating times using the same
power source and the ability to operate devices under extreme
environmental conditions.
|
|
|
|
Constant price pressure and demand for device
shrink. At the same time as demand has increased
for higher density and higher performance memory devices, the
price for flash memory products, measured on a per bit basis,
has decreased. According to Web-Feet Research, the average
selling price per megabyte is forecasted to decline from 2005 to
2006 by 37.6% in a data flash device and by 41.0% in a code
flash device. In order to achieve profitability, semiconductor
manufacturers must continually reduce their unit and per bit
costs by reducing the size of the individual transistors that
make up a memory chip. The process of reducing the size of the
individual transistor is commonly referred to as device shrink
and results in an increase in the number of transistors per
wafer.
|
|
|
|
Greater design and manufacturing
challenges. The demand for higher density and
enhanced performance, at a reduced cost, has resulted in
continual design and manufacturing challenges for semiconductor
manufacturers. As a consequence, semiconductor manufacturers are
continuously seeking advancements to existing technologies,
mainly through migration to smaller manufacturing process
geometries, and exploring new technologies and materials in
order to address the demanding market requirements.
|
Prevailing
Non-Volatile Semiconductor Memory Technology
The most widely-used technology for non-volatile semiconductor
memory devices is floating gate technology, which was developed
in the late 1960s and has been the prevalent technology for
non-volatile semiconductor memory devices since then. A floating
gate device is a variation of a standard metal oxide
semiconductor in that it has an additional electrically isolated
floating gate, made of a conductive material. A
floating gate device stores information by holding electrical
charge within the floating gate. Adding or removing charge from
the floating gate changes the threshold voltage of the cell
thereby defining whether the memory cell is in a programmed or
erased state. Because a conventional floating device only has a
programmed or erased state representing a
1 or a 0 it can only
store one bit of information in each cell. Non-volatile memory
based on floating gate technology is subject to the following
limitations:
|
|
|
|
|
Barriers to device shrink. Floating gate
technology faces significant challenges in reducing cell size
and packing cells into smaller spaces on the wafer, referred to
as device shrink. As floating gate cell size is reduced, a
thinner isolating layer may lead to poorer reliability due to
potential leakage of charge from the floating gate. This is
referred to as the problem of the erratic bit and is
more prevalent at smaller cell sizes. Floating gate
manufacturers, such as Samsung, have stated that they believe
these limitations will become a substantial technology barrier
to device shrink in the future.
|
|
|
|
Complicated manufacturing
process. Semiconductor manufacturing requires the
replication onto a silicon wafer of a series of patterns
contained on a glass slide, referred to as a mask, on which an
integrated circuits design is laid out. Floating gate
technology requires a high number of these replications,
referred to as masking steps, which results in high
manufacturing costs and a long manufacturing cycle, and may also
result in lower yields. As cell size decreases, the need to move
to more advanced manufacturing processes and to develop
error-free masks has increased the cost of manufacturing
floating gate devices.
|
|
|
|
Different design and manufacturing process for each market
segment. Floating gate devices require different
cell and array architectures, and thus different manufacturing
processes for each type of non-volatile memory device. As a
result, most manufacturers of non-volatile memory devices
concentrate in a particular segment, such as code or data flash,
due to the high cost and technical challenges associated with
implementing different manufacturing processes.
|
Due to the high cost and the technological challenges that need
to be resolved to achieve device shrink, semiconductor
manufacturers have sought other methods to increase the storage
density of non-volatile
24
memory devices. One such method is through multi-level cells
which use the same architecture as single-cell memory devices,
but store fractional charge levels within a single cell. Current
implementations of multi-level cells in floating gate devices
permit the storage of two bits of information per cell.
Multi-level cells require a more precise program and read
function to identify four levels of charge on the floating gate,
the number of levels necessary to increase the number of bits
stored per cell. As a result, current implementations of
multi-level cell technology in floating gate devices have slow
read and write times compared to single-bit-per-cell devices and
a reduced overall level of reliability because the loss of even
a few electrons from the floating gate can cause data corruption
and device failure. Since the number of levels of charge that
must be identified varies exponentially with the number of bits,
increased bit storage cannot currently be achieved reliably in
floating gate devices. For example, four different levels are
required for a two-bit-per-cell floating gate device, while
sixteen different levels are required for a four-bit-per-cell
floating gate device.
Our
Solution
We believe that our NROM technology represents a breakthrough in
the non-volatile semiconductor memory market as it offers a
number of significant advantages over traditional non-volatile
memory technology:
|
|
|
|
|
Increased storage capacity. Our NROM
technology doubles the storage capacity of each memory cell by
enabling the storage of two physically distinct and independent
charges, each representing one bit of information, within a
single memory cell. This significantly reduces the amount of
silicon wafer required for each non-volatile memory device,
resulting in a significant cost reduction to semiconductor
manufacturers. In addition, our next generation NROM technology,
QUAD NROM, which enables the storage of four bits
per cell. We believe that our QUAD NROM technology will increase
storage capacity and further lower the cost per bit.
|
|
|
|
Device shrink. Due to a simpler cell
architecture than floating gate technology, we believe that
devices based on our NROM technology are easier to migrate to
smaller manufacturing process geometries, enabling them to be
highly scalable and allowing semiconductor manufacturers to
continue to be cost competitive. To date, some of our licensees
have sold devices based on our NROM technology down to 110
nanometer process geometries and are also sampling products
based on 90 nanometer processes and one licensee has announced
plans for products based on 65 nanometer processes. Based on our
advanced research and development program, we are confident that
further device shrink will be possible using our NROM technology.
|
|
|
|
Simple, low cost manufacturing
process. Non-volatile memory devices that
incorporate our NROM technology require fewer masking and
processing steps than floating gate devices. For example,
Spansion has stated that its MirrorBit products, which
incorporate our NROM technology, eliminate 10 percent of
the total manufacturing steps and 40 percent of the most
critical manufacturing steps, compared to code flash devices
based on multi-level floating gate technology. The reduction in
the number of manufacturing steps leads to higher yields,
shorter silicon cycles and lowers overall manufacturing costs
for devices based on our NROM technology.
|
|
|
|
High performance and reliability. Each cell in
a device incorporating our NROM technology stores the trapped
charge in a non-conducting material, thereby preventing the
charge from moving within the trapping layer and
leaking out through a point defect. Such point
defects may result in device failure for floating gate device.
In addition, the relatively thick oxide layers surrounding the
trapping layer of the NROM cell prevent the trapped charge from
leaking-out of the cell. This enhances the reliability of the
NROM cells at smaller process geometries when compared to
floating gate devices. A reliability study conducted by Spansion
in November 2002 determined that its MirrorBit products, which
incorporate our NROM technology, exhibit at least the same level
of reliability and data retention as its comparable floating
gate products.
|
|
|
|
Same platform for all primary segments of non-volatile memory
market. In contrast to floating gate technology,
where each segment of the non-volatile memory market requires a
different floating gate device structure, our NROM technology
uses the same manufacturing process, and cell and array
architecture for all primary segments of the non-volatile memory
market, such as code, data, and
|
25
|
|
|
|
|
embedded flash. This allows us to leverage our research and
development across all segments and allows our licensees to
compete in all segments without the need for separate
manufacturing lines for each segment.
|
We are currently developing products which incorporate our new
QUAD NROM technology with several of our licensees. These
licensees include Macronix, whom we are assisting in developing
at its facilities a 1 gigabit data flash NROM device, and
Spansion, whom we are assisting in the development of certain
products.
In a QUAD NROM implementation, the storage capacity of a single
NROM cell can be doubled to four bits per cell compared to two
bits per cell in a multi-level floating gate cell. Although
there have been reports that floating gate will require advanced
design and sophisticated controller algorithms to achieve three
bits per cell, we believe that our NROM technology is currently
the only technology that is suited to mass production of
four-bit-per-cell devices because floating gate cells would be
required to maintain as many as 16 fractional charge levels per
cell in order to store four bits.
In developing and implementing our QUAD NROM technology, we face
similar challenges to those faced by two-bit-per-cell devices
based on floating gate technology, namely, implementing a more
precise program and read function required for multi-level-cell
devices. We expect that the program function in our QUAD NROM
technology will be slower than that of a regular
two-bit-per-cell NROM device, while we believe that we can
achieve accurate read functions without compromising read speed.
We also expect that the first generation of our QUAD NROM
technology will have similar data retention characteristics, but
a lower number of program-erase cycles, than two-bit-per-cell
NROM devices.
Our NROM technology has some limitations. NROM
devices may require a higher programming electrical current than
some comparable floating gate devices. This may require a more
complex design to meet comparable specifications and may result
in a longer development time.
Our
Strategy
Our goal is to establish our NROM technology as the leading
technology in the non-volatile semiconductor memory market. We
have a business model with two revenue streams: licensing our
intellectual property and providing design and product
development services to our licensees. We intend to achieve our
goal through the following strategy:
|
|
|
|
|
Accelerate implementation of NROM technology by our
licensees. We seek to accelerate implementation
of our NROM technology in a broad range of our licensees
products and reduce their time to market by providing them with
design and product development services. In particular, our
services are designed to enable our licensees to incorporate our
NROM technology into their products using their existing
manufacturing facilities. For example, as of the date of this
Annual Report, Infineon Technologies offers 512 megabit and 1
gigabit data flash devices incorporating our NROM technology.
|
|
|
|
Continue to direct licensing efforts of our NROM technology
at market-leaders. We believe that our NROM
technology will appeal to semiconductor manufacturers in all
segments of the non-volatile memory market because it allows
them to be more competitive and potentially address segments in
which they are not currently active. We intend to continue
licensing our NROM technology selectively to market leaders. Due
to the concentrated nature of the code and data flash markets,
we believe that the addition of any single licensee could
significantly impact the penetration of our NROM technology and
provide a future source of licensing revenues. For example, we
recently signed a license agreement with Semiconductor
Manufacturing International Corporation. We believe that our
licensing strategy enables us to achieve maximum market
penetration while maintaining low capital requirements and
strong gross margins.
|
|
|
|
Continue to innovate. We believe that we can
further develop and enhance our NROM technology. For example, we
have provided engineering samples to several of our licensees of
a product implementing four bits per cell using our QUAD NROM
technology. We also have programs with several of our licensees
implementing our QUAD NROM technology. We believe that our QUAD
NROM technology is currently the only technology that is suited
to mass production of four-bit-per-cell devices.
|
26
|
|
|
|
|
Enhance our existing technology portfolio. We
believe that our strong patent portfolio and intellectual
property position, with over 65 issued U.S. patents
(including 10 co-owned U.S. patents) and seven
non-U.S. patents, and over 55 pending U.S. patent
applications and over 100 pending non-U.S. patent
applications, will allow us to maintain our competitive
position. We are committed to investing in research and
development and to continuing to expand and broaden our patent
portfolio in key jurisdictions. For example, we are currently
developing a multi-level-cell device based on our NROM
technology and we are developing technology that will permit
portable electronic devices to operate with lower power
consumption, allowing for longer operating times.
|
Licensees
As part of our strategy to accelerate the adoption of our NROM
technology in the non-volatile memory market, we have entered
into the license agreements described below.
Infineon Technologies, formerly the Siemens Semiconductor Group,
was formed in 1952 as a developer and manufacturer of
semiconductors. In April 1999, Infineon Technologies became a
separate subsidiary of Siemens and in March 2000 it was listed
on the Frankfurt Stock Exchange and the NYSE. Infineon
Technologies manufactures digital, mixed signal and analog
integrated circuits for applications such as communications,
automotive, computers, security chip cards and other industries.
According to Gartner, Infineon Technologies was the seventh
largest vendor of semiconductors globally in 2005. Infineon
Technologies was one of the first semiconductor manufacturers to
introduce 300 mm wafers in its manufacturing facilities and
similarly was among the early adopters of smaller process
geometries.
In January 2005, in connection with the termination of our
former joint venture, we entered into an amended license
agreement with Infineon Technologies. Infineon Technologies is
currently marketing 512 megabit and 1 gigabit data flash devices
and data cards based on our NROM technology at densities of 64,
128 and 256 megabytes. Infineon Technologies is marketing
these devices in the form of a multimedia card, secure digital
card, mini secure digital card, reduced size multimedia card and
USB drive. We began deriving license revenues from Infineon
Technologies in January 2004.
Pursuant to our amended license agreement, we granted Infineon
Technologies a worldwide, non-exclusive license to manufacture
and sell data flash products in card, multichip or standalone
formats, as well as code flash products, all of which
incorporate our NROM technology. The license remains in
existence until the expiration of the patents it covers, unless
terminated earlier by Infineon Technologies upon
90 days notice. We are entitled to (a) a license
fee consisting of quarterly cash payments payable over ten years
from the date of the agreement, and (b) an additional
license fee capped at a certain amount of the proceeds received
by Infineon Technologies from the sale of 1,072,407 of our
ordinary shares, payable over eight quarters commencing in the
second quarter of 2005. In addition to a license fee, we are
entitled to receive royalties based on Infineon
Technologies net sales of products incorporating our NROM
technology. Unless earlier terminated, this the amended license
agreement will terminate when the last of the patents licensed
to Infineon Technologies under the agreement expires. Infineon
Technologies is entitled to terminate the amended license
agreement or terminate the license for either code or data flash
products upon 90 days prior notice; in the case of a
partial termination, the license fees are subject to a
percentage reduction and, under certain circumstances, a cap. In
June 2005, Infineon Technologies exercised its right to
terminate the license for code flash products. Infineon
Technologies is also entitled to extend the license to include
embedded products in consideration of payment of a one-time
license fee. Infineon Technologies may require us to license our
NROM technology to one additional third party (other than
certain excluded third parties) with which it wishes to
cooperate in respect of its activities with our NROM technology.
Upon such request, we are required to negotiate a license on
terms no less favorable to the license granted to Infineon
Technologies. In this event, we would be required to reduce the
fees collected from Infineon Technologies by an agreed portion
of the amount actually received from that third party. If
Infineon Technologies becomes a subsidiary of another one of our
licensees that possesses a license of similar breadth to the
license we granted to Infineon Technologies, then certain of the
licenses granted to Infineon Technologies under this agreement
terminate, license fees are capped and future royalty payments
are limited. Nonetheless, to the extent we have entered into a
license with
27
a third party at Infineon Technologies request, that
license agreement would survive termination of the license to
Infineon Technologies.
We have agreed to provide technical and development services to
Infineon Technologies at its request based on agreed rates. We
have agreed to assign a substantial portion of the engineering
staff and managers performing these services on a full-time
basis. The services include general design services, card
integration development work, and, at the option of Infineon
Technologies, development of a multi-level cell product.
|
|
|
Macronix
International Co., Ltd.
|
Macronix is the leading Taiwanese vendor of non-volatile memory
semiconductor products. Macronix was founded in 1989, listed on
the Taiwan Stock Exchange in 1995, and in 1996, was one of the
first Taiwanese companies to be listed on The Nasdaq National
Market. Since its inception, Macronix has focused on
non-volatile memory semiconductor solutions. According to
Gartner, Macronix is the global market leader in Mask ROM, with
a 71.0% market share in 2004 and with Mask ROM sales of $251
million. According to Web-Feet Research, Macronix was ranked as
the worlds 12th largest vendor of flash memory in 2005.
Macronix operates manufacturing facilities in Taiwan and
currently produces the majority of its semiconductors at process
geometries ranging from 150 to 250 nanometers. In 2000, we
granted Macronix a worldwide, non-exclusive license to
manufacture non-volatile memory products incorporating our NROM
technology, except for certain EEPROM applications. The license
remains in existence until the expiration of the patents it
covers, unless terminated earlier at will by Macronix. In 2002,
Macronix commenced shipping code and embedded flash products
incorporating our NROM technology marketed under its own Nbit
trademark. Macronix recently announced three new code flash
products based on our NROM technology, at densities of
32 megabits, 64 megabits and 128 megabits, and
has announced its intention to introduce products up to
1 gigabit and beyond.
We have jointly announced an extension of our license under
which we will collaborate in the development of non-volatile
memory devices based on our QUAD NROM technology, manufactured
using 130 nanometer process geometries and we have provided
engineering samples to Macronix of a product implementing
four-bits-per-cell QUAD NROM technology.
We are entitled to a license fee and royalties based on
Macronixs annual net sales of products incorporating our
NROM technology. The license fees are payable in installments at
the earlier of the completion of a technological milestone or a
predetermined date. If we grant a license for similar products
to another semiconductor manufacturer, we are required to offer
those royalty rates to Macronix. In December 2005, we amended
our license agreement with Macronix to reduce the amount of
prepaid royalties that it may use each quarter to offset its
ongoing royalty obligations to us. In addition, we have agreed
with Macronix that we will be allowed to grant a license to
manufacture products incorporating our NROM technology to only
one other new licensee in Taiwan for code and data flash
products, provided we pay Macronix a portion of the license fees
that we receive from any such license. Our licensees are not
precluded from having products manufactured in Taiwan at the
facilities of another semiconductor manufacturer. Macronix may
terminate the license agreement at any time, other than the
manufacturing agreement, which may be terminated upon one
years notice. In the event that we extend a license to
another semiconductor manufacturer other than Tower
Semiconductor that permits it to manufacture products
incorporating our NROM technology for third parties, we are
required to extend the same license to Macronix. To date,
Macronix has paid us the majority of the license fee, which is
payable in installments upon the achievement of the earlier of
technological or time related milestones. The technological
milestones were not met within the prescribed dates and we have
therefore received payments based on the time-related milestones.
|
|
|
Matsushita
Electric Industrial Co., Ltd.
|
Matsushita is one of the worlds largest vendors of
consumer electric and electronic products, with revenue of
approximately $81.4 billion for the fiscal year ended
March 31, 2005. Matsushita has a broad portfolio of
products including communications and networking equipment,
household appliances and consumer electronics sold under brand
names such as Panasonic, Technics and JVC. Matsushita is also a
supplier of electronic components and semiconductors. In 2005,
the company ranked as the worlds 16th largest
semiconductor vendor and, according to Gartner, had revenues of
$3.9 billion from semiconductor sales.
28
In 2003, we granted Matsushita a worldwide, non-exclusive
license to manufacture and sell embedded products incorporating
our NROM technology. In February 2006, we amended and restated
our license agreement with Matsushita to permit it, in addition
to its existing license, to manufacture and sell embedded
products and certain system in package products
(SIPs) in a single manufacturing technology process.
To date, Matsushita has paid us a portion of a license fee,
which is payable in installments on the earlier of the
achievement of technological milestones or time-related
milestones. Matsushita is required to pay royalties based on net
sales of embedded products and SIPs incorporating our NROM
technology. If we grant a license for embedded products and SIPs
with more favorable royalty rates under substantially similar
circumstances and terms, we are required to offer those royalty
rates to Matsushita. Matsushita may terminate the agreement,
which remains in existence until the expiration of the patents
it covers unless terminated earlier by Matsushita if it
terminates development of licensed products before February 2010
or at any time after February 2010. To date, revenues from
Matsushita have not constituted a significant part of our total
revenues.
|
|
|
Semiconductor
Manufacturing International Corporation (SMIC)
|
SMIC is one of the worlds leading semiconductor foundries,
offering its customers integrated circuit manufacturing
capabilities at 0.11 to 0.35 microns and finer line
technologies. Established in 2000, SMIC has four
8-inch wafer
fabrication facilities in volume production in Shanghai and
Tianjin, China. According to Gartner, SMIC was ranked one of the
three biggest pure-play foundries in the first half of 2005 with
a 6.4% market share.
In July 2005, we granted SMIC a worldwide, non-exclusive license
to manufacture and sell data flash products incorporating our
NROM technology. We also agreed to provide design, development
and support services to SMIC in connection with these products.
We are entitled to receive a license fee which is payable in
installments on the earlier of the achievement of technological
milestones or specified dates. The license remains in existence
until the expiration of the patents it covers, unless terminated
earlier by SMIC upon three months notice or, prior to
June 30, 2006, on 30 days prior notice. In addition to
a license fee, we are entitled to receive royalties based on
SMICs net sales of products incorporating our NROM
technology. In November 2005, we signed an addendum to the
license agreement in which we agreed to license and provide
certain card form factor intellectual property. Additionally,
SMIC agreed to pay us a percentage of the profit calculated
under the agreement and derived from the cards developed under
the addendum.
Sony Corporation is one of the worlds largest vendors of
consumer electric and electronic products, with revenues of
approximately $66.9 billion for the fiscal year ended
March 31, 2005. Sony Corporation has a broad portfolio of
products including consumer electronics, home entertainment
hardware and software and image-based software. Sony Corporation
is also a supplier of semiconductors and, in 2005, the company
ranked as the worlds 15th largest semiconductor
vendor and, according to Gartner, had revenues of
$4.3 billion from semiconductor sales.
In December 2004, we granted Sony Corporation a worldwide,
non-exclusive license to manufacture and sell embedded flash
memory products incorporating our NROM technology. We also
agreed to provide design, development and support services to
Sony Corporation in connection with these embedded flash memory
products. We are entitled to receive service fees and license
fees, a portion of which were paid on the signing of the
agreement, and the remainder of which are payable in
installments on the earlier of the achievement of technological
milestones or time-related milestones. Sony Corporation is also
required to pay royalties based on its quarterly net sales of
embedded products incorporating our technology. Sony Corporation
may terminate the license agreement after December 31, 2010.
In 1993, Fujitsu Limited and Advanced Micro Devices commenced a
joint working relationship for non-volatile memory
semiconductors, which led to the creation of a joint venture,
Spansion. Spansion is the 10th largest semiconductor vendor
globally according to Gartner. Spansion is the largest vendor of
code flash memory devices with revenues of $2.4 billion and
a 24.3% market share in 2004 according to Web-Feet Research. The
company is primarily focused on solutions for wireless and
embedded flash memory solutions for automotive, networking and
consumer electronics. In 2002, Spansion introduced its MirrorBit
technology
29
which incorporates our NROM technology and during 2002 it
started shipping MirrorBit code flash memory devices. In
addition, Spansion also sells code flash products based on
floating-gate technology, but has stated that its MirrorBit
sales, as a percentage of net sales, increased to 30% for the
fourth quarter of 2005 (as compared to 24% for the third quarter
of 2005) and also expects that its sales of MirrorBit-based
products, as a percentage of total net sales, to increase in the
first quarter of 2006. Initial MirrorBit devices were based on
220 nanometer process geometry. Spansion currently offers
MirrorBit products based on 90 nanometer process geometry
and has announced plans for products based on 65 nanometer
process geometry. Current MirrorBit products based on our NROM
technology that are commercially available range from
16 megabits to 512 megabits in density. In 2002, we
granted Fujitsu Limited and Advanced Micro Devices, Inc. a
worldwide, non-exclusive license to patents that are filed
before July 2012 covering our NROM technology in their
semiconductor products as part of a settlement in connection
with an intellectual property action we had commenced against
them. The license, which terminates in July 2012, includes
implementations of our NROM technology in multi-level cell
devices and also applies to Spansion as a jointly-owned
subsidiary of Fujitsu and Advanced Micro Devices. As part of the
license, Advanced Micro Devices and Fujitsu purchased an
aggregate of 938,470 of our ordinary shares and paid fees
in consideration for the license provided and for our activities
to develop a multi-level-cell based on our NROM technology. The
license contains a uniform royalty rate that is lower than the
royalty rates in some of our other license agreements and
stepped thresholds that limit the amount from which we can
derive royalties to $1.2 billion of annual net sales of
products by Spansion incorporating our NROM technology. The
license lasts until the expiration of the last patent licensed
under the agreement. We derived from Spansion license fees of
$7.7 million in 2004 and $7.7 million in 2005. These
license fees were paid in respect of activities we undertook for
Spansion in connection with the development of multi-level cell
technology.
In 2003, we entered into a joint collaboration and distribution
agreement with Spansion. Under the agreement, we share equally
with Spansion the profit from sales of serial flash products
based on our designs that Spansion manufactures for us, and
Spansion shares with us equally the profit from sales of serial
flash products based on our designs that either we manufacture
at a third party foundry or that Spansion manufactures. Prior to
discontinuing our product activity, we used to manufacture
serial flash products at Macronixs facilities that were
subject to this arrangement. We have formed a joint
collaboration team comprised of an equal number of members from
each party to determine pricing guidelines and other matters
related to the implementation of the agreement. Either party may
deviate from the pricing guidelines set by the joint
collaboration team based on reasonable and economic marketing
conditions related to the sale of the products covered by the
agreement. We have agreed to use our best efforts to redesign
our existing products to meet the manufacturing requirements of
Spansion, although the ultimate determination whether to
manufacture a particular product at the facilities of Spansion
or through a third party foundry is made by the joint
collaboration team. We designed 4, 8 and 16 megabit
serial flash products that Spansion commenced manufacturing at
its facilities in 2005, 32 megabit and 64 megabit
serial flash products that Spansion announced will be available
in the second half of 2006 and recently started to design a 128
megabit serial flash product. The agreement is for an initial
term of five years and can be terminated by either party upon
six months notice, subject to a further two-year phase-out
period.
In July 2005, we entered into a license and development
agreement with Spansion, pursuant to which we will design,
develop and license to Spansion certain multi-bit per cell
products. Under the agreement, we have agreed upon a statement
of work for the design and development for Spansion of an
initial product in consideration for the payment of quarterly
fees during the development period. We and Spansion may agree
upon amendments to the statement of work, as well as additional
statements of work in the future. We have formed a committee
with Spansion to oversee issues relating to the implementation
of the agreement the design and development of products under
the agreement. We are entitled to receive royalty payments based
on net quarterly sales of multi-level-cell products
incorporating our technology. We have agreed that a portion of
these royalty payments may be offset against previously paid
license fees. Royalties under this agreement are not subject to
thresholds, as was the case with royalties derived under the
license we granted in 2002. In addition, a lower royalty
rate is applied in the event that Spansion designs and develops
a multi-level cell product incorporating our technology itself
because we declined to do so or because our proposal did not
meet
30
competitive specifications. The agreement terminates on
December 31, 2010, and can be terminated by Spansion upon
90-days
notice or by either party upon a change in control of the other
party.
Tower Semiconductor is an independent Israeli wafer foundry. In
1997, we granted Tower Semiconductor a license to incorporate
our NROM technology into its non-volatile memory products, other
than EEPROM, data flash, multimedia cards and smart cards. See
also Item 8 Financial
Information Legal Proceedings.
Design
and Product Development Services
In addition to initial support services to assist our licensees
incorporate our NROM technology into their products, we provide
certain of our licensees with design and product development
services that we believe accelerate the adoption of our NROM
technology in a broader range of our licensees products
and aid in our understanding of their future requirements. Our
design and product development services are focused on our
licensees leading products with a view to increasing our
future royalty stream. These services generally involve research
and development, manufacturing process development, product
design, and product testing. In 2005, we derived revenues of
$12.8 million from the provision of such services, the
majority of which was derived from Infineon Technologies in
connection with its development of data flash devices. We expect
that in the future, we will continue to provide design and
product development services for Infineon Technologies. We
currently also provide design and product development services
to Spansion, Sony, SMIC and Macronix.
Technology
Non-volatile memory devices have traditionally relied on
floating gate technology. A floating gate device is an
enhancement of standard metal oxide semiconductor, or MOS,
transistor that has three main terminals: a source, a drain and
a gate. In a MOS transistor, the gate potential directly
controls the channel conductivity, affecting the flow of current
between the source and drain terminals. The channel becomes
significantly conductive as the gate potential exceeds a certain
threshold referred to as the transistors threshold voltage.
Standard Metal-Oxide-Semiconductor Transistor
A floating gate memory cell differs from a standard MOS
transistor in that it has an additional electrically isolated
gate, a floating gate, below the standard control gate and above
the transistor channel. The floating gate is composed of a
conducting material, typically a polysilicon layer. The floating
gate memory device stores information by holding electrical
charge within the floating gate. Adding or removing charge from
the
31
floating gate changes the threshold voltage of the cell, thereby
defining whether the memory cell is in a programmed
or erased state.
Floating Gate Memory Cell
Non-volatile memory devices based on our NROM technology contain
a trapping nitride layer which stores the charge, instead of a
floating gate suspended above the cell. The nitride layer is
surrounded by two insulating silicon dioxide layers. A charge
may be accumulated and confined at each end of the nitride
layer, effectively storing two separate and independent charges.
Each charge can be maintained in one of two states, either
programmed or erased, represented by the
presence or absence of a pocket of trapped electrons. This
enables the storage of two bits of information without the
complexities associated with multi-level-cell technology.
The following is a diagram of a cell based on our NROM
technology:
The NROM Cell
Program and erase. Each storage area in an
NROM cell can be programmed or erased independently of the other
storage area. An NROM cell is programmed by applying a voltage
that causes negatively charged electrons to be injected into the
nitride layer near one end of the cell. Erasing is accomplished
by applying to a cell voltages that cause positive charges,
referred to as holes the electrical
opposite of electrons to be injected into the
nitride layer and cancel the effect of the electrons previously
stored there during programming. As a consequence of using a
localized charge trapped in the non-conducting nitride and
reading the information in a direction opposite to the direction
it was programmed, a smaller total charge may be used to
represent a bit. Because a significantly smaller amount of
trapped charges is needed to program a device, and due to the
physical mechanisms used for program and erase, the device can
be both programmed and erased faster than devices based on
traditional floating gate technology.
Because the stored charge is confined close to the ends of an
NROM cell device, numerous program-erase cycles may be performed
without significantly degrading the cells performance, and
the single bit failures that are common to floating gate
technology may be avoided even after 100,000 cycles. As a
result, it is possible to achieve estimated data retention of at
least 10 years and, unlike floating gate cells, NROM cells
are not generally susceptible to oxide defects. In addition, the
relatively thick oxide layers surrounding the trapping layer of
the NROM cell prevent the trapped charge from leaking-out of the
cell by a tunneling mechanism. This enhances the data retention
ability of NROM cells when compared to floating gate devices.
Array architecture and operation. Our
proprietary technology addresses architectural aspects of the
NROM array, such as segmentation of the array to handle
disruption in its operation, and symmetric architecture and
non-symmetric architecture for specific products, as well as the
use of NROM array as a virtual ground array. We also hold
patents directed to additional aspects at the architecture
level, including the peripheral circuits that control the NROM
array, for example, multiple select transistors per one bit line
to
32
improve the functionality and operation of the array. We have
also developed methodologies directed to several key methods of
operation of the NROM arrays, such as algorithms related to
programming, erasing, and reading NROM arrays. Our proprietary
processes include methods to control a programming level or to
complete the programming of a cell at the lowest drain level
that we believe are generic to the NROM technology. Further
protection has been obtained for our method of erasing a memory
cell by hitting it with an extra pulse.
Process technology. Features of our NROM
technology include less cumbersome manufacturing process
technology that reduce costs and improve reliability, array
architecture that may be used, for example, to increase density
and shorten programming, and read times without sacrificing
reliability. We have developed manufacturing processes, such as
the process of forming a thin nitride layer that traps the hot
electrons as they are injected into the nitride layer.
Application-specific implementations of our
technology. In addition to the above general
methods of operation, we have developed algorithms and methods
of operation for each segment or technological application, such
as:
|
|
|
|
|
fast programming methodologies in all flash memory segments,
with particular focus on the data flash segment;
|
|
|
|
smart programming algorithms in our QUAD NROM architecture, as
well as in the code flash and EEPROM segments; and
|
|
|
|
a single device containing a combination of data flash, code
flash and EEPROM.
|
Multi-level cell. We believe that our NROM
technology is currently the only solution to high density,
four-bit-per-cell, products because floating gate cells would be
required to maintain as many as 16 different levels per cell in
order to emulate four bits. We also believe that due to the
different characteristics, structure, and physical mechanisms,
multi-level-cells based on our NROM technology can overcome many
of the limitations of floating gate multi-level-cell devices.
Patents
and Intellectual Property
We have developed a significant amount of proprietary
technology, including intellectual property relating to our NROM
technology and related processes. We rely on a combination of
patent, trade secret, copyright and trademark laws and
restrictions on disclosure to protect our intellectual property
rights. An important part of our technology development strategy
is to seek protection for our proprietary technology by
obtaining patents in the United States and elsewhere. The
semiconductor industry is characterized by vigorous protection
and pursuit of intellectual property rights. We have in the past
and intend in the future to continue to prosecute and defend
aggressively the rights in our intellectual property.
In 1998, the first patent related to our NROM technology, naming
Dr. Boaz Eitan as the inventor, was issued and was assigned
to Saifun. As of December 31, 2005, we owned more than 65
issued U.S. patents, including 10 co-owned patents, none of
which expire before 2016, and seven
non-U.S. patents.
As of December 31, 2005, we had more than 55 pending
U.S. patent applications and more than 100 pending
non-U.S. patent
applications. These patents and patent applications are intended
to protect a variety of key aspects of our NROM technology. Many
of our patents protect subject matter used to practice our
technology in any market segment, including code flash, data
flash, embedded flash, or serial flash and EEPROM segments.
We operate an internal program to identify patentable
developments and to document other technological developments
that may be subject to intellectual property protection,
including trade secrets. Our policy is to require employees and
consultants to execute confidentiality agreements when their
relationship with us begins. We also seek these protective
agreements from licensees.
We have obtained U.S. trademark registration for
Saifun NROM, a term that we use to identify our
technology, and for the name Saifun.
33
Competition
The code and data flash memory markets are dominated by a small
number of large semiconductor manufacturers. As a licensor of
code and data flash memory technology, we compete primarily with
the technologies developed by these companies, principally from
their internal research and development departments. Many of
these companies consider flash memory research and development
to be one of their core competencies. To date, the technology
with which we compete is traditional floating gate technology
based on single-bit-per-cell or multi-level-cell devices.
In the code flash memory market, the leading manufacturers are
Spansion, Intel Corporation, STMicroelectronics and Sharp
Electronics Corporation. In the data flash memory market, the
leading manufacturers include Samsung Electronics Co. Ltd.,
Toshiba Corporation, Intel Corporation, Spansion and Hynix
Semiconductor, which expect to collectively account for 76% of
global flash revenues in 2005, according to Web-Feet Research.
Intel, Samsung, Toshiba, STMicroelectronics and SanDisk (through
its joint venture with Toshiba) market floating gate devices
incorporating multi-level-cell technology. Spansion is currently
a licensee of our NROM technology and we believe that other
companies are potential licensees of our NROM technology.
In the serial flash memory market, our technology competes
principally with technology developed by STMicroelectronics and
Silicon Storage Technologies, Inc. In the embedded flash memory
market, we compete directly with the technology of applications
companies that manufacture embedded products, as well as with a
number of other companies that license their intellectual
property, principally Silicon Storage Technologies, Inc.
Sales and
Marketing
Our sales and marketing activities in connection with our
licensing agreements focus primarily on developing strong,
direct relationships at the technical, marketing and executive
management levels with existing licensees and other leading
companies in the non-volatile memory market, who may license our
technology.
|
|
C.
|
ORGANIZATIONAL
STRUCTURE
|
Saifun Semiconductors Ltd. is organized under the laws of the
State of Israel and, as of December 31, 2005, held directly
and indirectly the percentage indicated of the outstanding
capital stock of the following subsidiaries:
|
|
|
|
|
|
|
Name of Subsidiary
|
|
Country of
Incorporation
|
|
Percentage Ownership
|
|
Saifun Semiconductors USA,
Inc.
|
|
USA
|
|
|
100
|
%
|
Saifun (BVI) Limited
|
|
British Virgin Islands
|
|
|
100
|
%
|
Tulip Semiconductor L.P.
|
|
Israel
|
|
|
100
|
%
|
Tulip Semiconductor Holdings
(2005) Ltd.
|
|
Israel
|
|
|
100
|
%
|
Tulip Semiconductor Ltd.
|
|
Israel
|
|
|
100
|
%
|
|
|
D.
|
PROPERTY,
PLANTS AND EQUIPMENT
|
Our principal administrative, sales, marketing and research and
development facilities occupy approximately 26,900 square
feet in one building in Netanya, Israel, under a lease that
expires in December 2006, with an option to extend the lease
until August 2008 and an additional option to further extend the
lease until August 2011. We also lease an additional
4,252 square feet in the same building pursuant to a lease
that expires in September 2009. We also leased an additional
3,057 square feet in the same building pursuant to a lease
that expires in September 2010 and an additional
3,056 square feet in the same building pursuant to a lease
that expires in November 2010. In addition, our
U.S. subsidiary occupies approximately 1,938 square
feet in one building in Santa Clara, California under a lease
that expires in January 2007. We believe that our existing
facilities will be adequate to meet our needs in Israel for the
next 12 months.
ITEM
4A. UNRESOLVED STAFF COMMENTS
Not applicable.
34
|
|
ITEM 5.
|
OPERATING
AND FINANCIAL REVIEW AND PROSPECTS
|
Overview
We have invented and patented a technology that we refer to as
nitride-read-only memory, or NROM, that we believe is leading a
revolutionary shift in the non-volatile semiconductor memory
market.
We were incorporated in Israel in November 1996 and commenced
operations in July 1997. In 1997, we entered into a license
agreement with Tower Semiconductor for the implementation of our
technology. In 1999, we generated initial fees from Advanced
Micro Devices and Fujitsu. In 2000, we entered into a license
agreement with Macronix. In 2001, we established a joint venture
with Infineon Technologies. Our 49.0% ownership interest in the
joint venture was reduced to 30.0% in January 2003. We entered
into a license agreement with Spansion in 2002 and with
Matsushita in 2003. In December 2004, we entered into a license
and service agreement with Sony Corporation. In December 2004,
we sold our interest in Infineon Technologies Flash to Infineon
Technologies and, in January 2005, we entered into an amended
license agreement and a basic agreement on development orders
with Infineon Technologies. In July 2005, we entered into a
license agreement with Semiconductor Manufacturing International
Corporation (SMIC) and in September 2005 we entered into a
service agreement with them. Our initial public offering and
listing on The Nasdaq National Market occurred in November 2005.
Since our initial public offering, we have amended or extended
our existing agreements with key licensees, including Macronix,
SMIC and Matsushita.
We generate revenues from two sources:
|
|
|
|
|
license revenues, which consist of license fees for our
intellectual property and license royalties paid by licensees
that sell products incorporating our intellectual
property; and
|
|
|
|
service revenues, from design and product development services
that we provide to our licensees.
|
To date, we have derived substantially all of our revenues from
license fees and substantially all of our remaining revenues
have been derived from design and product development services
provided to Infineon Technologies Flash, our former joint
venture.
As of December 31, 2005, our deferred revenues were
$3.8 million, which we expect to recognize in varying
amounts before the end of 2006. The period over which we
recognize deferred revenues is based on estimates which
management currently believes are reasonable but which may
change in the future. As of December 31, 2005, our license
agreements contained contractual commitments for license fees
payable to us before December 31, 2007 totaling
approximately $42 million, the substantial majority of
which we expect to recognize prior to December 31, 2007.
The majority of this amount is payable by Infineon Technologies
and the majority of the remaining balance is payable by
Semiconductor Manufacturing International Corporation.
Substantially all of these fees are subject to cancellation in
the event of early termination of our license agreements.
|
|
|
Exit
from Joint Venture with Infineon Technologies
|
In December 2004, we sold our interest in our joint venture to
Infineon Technologies. The joint venture consisted of a German
partnership, Infineon Technologies Flash GmbH & Co. KG,
which we refer to as Infineon Technologies Flash Germany, and an
Israeli entity, Infineon Technologies Flash Ltd., which we refer
to as Infineon Technologies Flash Israel, and, together,
Infineon Technologies Flash. We also entered into an amended
license agreement with Infineon Technologies and a basic
agreement on development orders, pursuant to which we may
provide development services based on a fixed fee per employee.
From the establishment of the joint venture in April 2001 until
the termination, we invested an aggregate of $18.6 million
in the equity of the joint venture and made loans of
$24.4 million, including a loan of $6.3 million to
finance, in part, the purchase by Infineon Technologies Flash
Israel of 1,072,407 of our ordinary shares intended to be used
by it for an equity incentive plan for its employees. Our
interest in the joint venture was initially 49.0% and was
reduced to 30.0% in January 2003 by means of an additional
investment of $21.3 million from Infineon Technologies. At
the time that the joint venture was ready to commence mass
production of its first product, we and Infineon Technologies
decided to terminate the joint venture so that we could focus on
our core business model of licensing and providing design and
development
35
services to semiconductor manufacturers. In furtherance of this
strategy, at the time of the termination, the parties agreed to
enter into an amended license agreement directly with Infineon
Technologies and a basic agreement on development orders in
order to provide design and development services to Infineon
Technologies in connection with that license agreement.
As a result of the termination, we (1) sold our equity
interest in Infineon Technologies Flash Germany and Infineon
Technologies Flash Israel to Infineon Technologies for an
aggregate cash payment of $1.0 million, (2) assigned
our right to Infineon Technologies to receive repayment of a
$6.3 million loan that we had made to the joint venture,
(3) cancelled our right to receive the approximately
$18.1 million of remaining indebtedness, and
(4) offered employment to certain Infineon Technologies
Flash Israel employees and undertook certain liabilities related
to those employees. In addition, Infineon Technologies Israel
transferred 1,072,407 of our ordinary shares that it owned to
Infineon Technologies which sold these shares in February 2005
to Argos Capital Appreciation Master Fund L.P. Pursuant to
our amended license agreement with Infineon Technologies, we are
entitled to additional license fees, payable over eight
quarters, which commenced in the second quarter of 2005, capped
at a certain amount of the proceeds received by Infineon
Technologies from the sale of these ordinary shares. We do not
have any further funding or guaranty obligations in connection
with the joint venture, although we have agreed to assume 30% of
any unforeseen liabilities that may arise in connection with the
dissolution of Infineon Technologies Flash Israel.
Since the termination agreement, the license agreement and the
basic agreement on development orders were signed in
contemplation of one another, for accounting purposes, the total
net consideration derived from these agreements was allocated to
the proceeds from the sale of our interest in Infineon
Technologies Flash, the development services and the license.
Since the fair value of the joint venture was more reliably
measurable, we performed a valuation of the joint venture and
allocated the consideration based on the fair value determined.
Accordingly, the residual amount of the consideration from the
agreements was allocated to the license, resulting in non-cash
license revenues in the amount of $19.2 million, all of
which was recognized in 2005. The fair value of our interest in
the joint venture was determined to be zero, after forgiveness
of loans and future capital commitments by us and Infineon
Technologies, based on a valuation prepared using the adjusted
book value method. The capital loss on the sale of the joint
venture was determined based on the difference between our
investment in the joint venture and its fair value.
|
|
|
Impact of
joint venture on historical results of operations
|
Our historical results of operations have been materially
impacted by the results of operations of the joint venture. We
accounted for the results of operations of the joint venture
under the equity method and therefore our net loss for the
periods during which we held an equity interest included our
percentage share of the net loss of the joint venture. Our
percentage share of the equity of the joint venture was 49.0%
from April 2001 through January 2003 and 30.0% until the sale of
our interest in the joint venture on December 23, 2004. In
addition, pursuant to a research and development services
agreement entered into in March 2003, Infineon Technologies
Flash Israel provided services to Infineon Technologies Flash
Germany in connection with the design, development, testing and
manufacture of data flash and code flash memory devices.
Infineon Technologies Flash Israel was reimbursed for its direct
and indirect costs and an agreed margin was applied.
We believe that the fees paid to Infineon Technologies Flash
Israel reflect the fees that would have been paid in a
comparable arms length transaction. For the year ended
December 31, 2003, Infineon Technologies Flash Israel
derived all of its revenues, totaling $11.4 million, from
Infineon Technologies Flash Germany in respect of these
services. Pursuant to an agreement between Infineon Technologies
Flash Israel and us, from time to time Infineon Technologies
Flash Israel was entitled to request that we provide design and
product development services to it in respect of certain
projects that it was undertaking for Infineon Technologies Flash
Germany. Revenues from Infineon Technologies Flash Israel for
design and product development services accounted for
$7.3 million, or 24%, of our licensing and service revenues
in 2004. In 2005, we ceased to derive revenues from Infineon
Technologies Flash Israel and derived all of our revenues from
Infineon Technologies Flash Germany. Our fees for these services
were based on a fixed hourly rate per employee agreed by the
parties that was subject to periodic updates. We will continue
to provide similar services to Infineon Technologies pursuant to
the basic agreement on development orders described above.
Infineon Technologies Flash Israel was not obligated to engage
us to provide these services and we believe that our fees
reflect the fees that would have been paid in a comparable
arms length transaction.
36
License fees. Under our license agreements, we
are typically paid an upfront license fee and then periodic
license fees. Periodic license fees are generally payable upon
achieving technological or time-based milestones, or a
combination of the two. As part of our licensing arrangements,
we provide a limited amount of initial customer support to our
licensees to assist them in incorporating our intellectual
property into their products until commercialization of their
products.
Where we are entitled to receive prepaid royalty payments
irrespective of the amount of sales by our licensees, we
consider the prepaid royalty payments to be a component of the
license fee. We recognize license fees ratably over the period
during which we expect to provide initial customer support to
our licensees and when all other criteria for revenue
recognition are met. In addition, revenue recognition is limited
to the amount that is due or billable under the agreement. Since
the initial customer support is provided until the expected
commercialization date of the licensees products, we
determine the period in which we will provide support based on
estimates of our project managers determined in conjunction with
our licensees, as well as the monitoring of the progression of
our licensees product development through the customer
support we provide them. Our licensees are all well-established
semiconductor manufacturers with significant experience in the
design, development and commercialization of products in the
semiconductor memory market. Since we typically determine
projections based on our licensees estimates and our own
experience, we believe these estimates are reliable. The
estimate of the initial support period could change due to
unexpected delays or progress by our licensees in the
development and design of the products incorporating our NROM
technology. We review assumptions regarding the initial customer
support periods on a regular basis to determine if it is
necessary to revise the estimate of the support period. The
total amount of revenues recognized over the life of the
contract would not be affected in the event of revision in the
length of the support period; however, to the extent the new
assumptions regarding support periods were less than the
original assumptions, the license fees would be recognized
ratably over a shorter period. Conversely, if the new estimated
period were longer than the original assumptions, the license
fees would be recognized ratably over a longer period.
License royalties. To date, we have derived
only limited license royalties because some of our licensees
have not commenced selling products incorporating our NROM
technology and others have not exceeded minimum royalty
thresholds or offset prepaid royalty payments.
The royalty rate and structure of royalty payments vary
significantly among our license agreements. Royalties under some
of our license agreements are based on a fixed royalty rate,
while for others the royalty rate declines as net sales of
products incorporating our NROM technology increase. In
addition, the royalty rates under our license agreements vary,
among other things, depending on which segment or segments of
the non-volatile memory market the agreement addresses. Where a
license provides for a prepaid royalty payment, the amounts of
prepaid royalties paid are deducted from ongoing royalties
payable by the licensee in the future. Generally, we expect to
recognize royalties one quarter in arrears based on reports that
we receive from a licensee in that quarter. In the case of
Infineon Technologies Flash, prior to the sale of our interest
in the joint venture, we recognized the royalties in the quarter
in which the related sales took place due to the earlier receipt
of the royalty report. Following our exit from our joint
venture, we recognize royalties in the quarter subsequent to the
quarter in which the related sales took place.
Our first license agreement with Spansion contains a uniform
royalty rate that is lower than the royalty rates in some of our
other license agreements and stepped thresholds that ultimately
limit to $1.2 billion the amount of annual net sales of
products incorporating our NROM technology by Spansion from
which we can derive royalties. In July 2005, we entered into a
multi-bit per cell license and development agreement with
Spansion, pursuant to which we will develop and license certain
multi-level cell products to Spansion. Under the new agreement
with Spansion, we are entitled to receive payments for design
and product development services, as well as royalty payments
that are not subject to the above annual threshold.
We expect that the proportion of our revenues derived from
license fees will decrease relative to license royalties as our
existing licensees move into production of products
incorporating our intellectual property and, where applicable,
start to exceed minimum royalty thresholds and prepaid royalty
payments. We intend,
37
however, to seek new licensees for our intellectual property
that would result in the payment of additional license fees in
the future.
We derive service revenues for design and product development
services that we provide to our licensees. The substantial
majority of our service revenues for the periods presented in
the financial statements were derived from arrangements with
Infineon Technologies Flash where the fee was based on a fixed
price per employee providing the respective service. For a
description of our former arrangements with Infineon
Technologies Flash Israel, see
Overview Exit from Joint Venture with
Infineon Technologies.
In fixed fee service contracts, revenues are recognized based on
the proportional performance model and completion is measured
according to the hours of employee services rendered as a
percentage of total project hours. However, revenue recognition
based on this methodology is always limited to output measures
(technological milestones) or amounts due or billable under the
agreement. Revenues from design and product development services
provided to our former joint venture based on a fixed fee per
employee are recognized over the period as the services are
rendered.
The following table sets forth information for the periods
presented regarding the percentage of our revenues derived from
license revenues and service revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
License revenues
|
|
|
54
|
%
|
|
|
74
|
%
|
|
|
84
|
%
|
Service revenues
|
|
|
46
|
|
|
|
26
|
|
|
|
16
|
|
Excluding $19.2 million in non-cash license revenues in
2005 resulting from the termination of our former joint venture,
license revenues represented 78% of our total revenues and
service revenues represented 22% of our total revenues.
The foregoing table does not include revenues from product sales
during the periods indicated since we decided to discontinue
product sales in the second quarter of 2005 and our product
sales operations are accounted for in our financial statements
as discontinued operations.
|
|
|
Customers
and customer concentration
|
To date, we have derived the majority of our revenues from
license and service agreements with semiconductor manufacturers
in the code, data and embedded flash memory segments. Our
current licensees are Advanced Micro Devices, Fujitsu, Spansion,
Infineon Technologies, Macronix, Matsushita, Sony Corporation,
Semiconductor Manufacturing International Corporation and Tower
Semiconductor Ltd. The following licensees accounted for 87% of
our licensing and services revenues in 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Macronix International Co.,
Ltd.
|
|
|
36
|
%
|
|
|
37
|
%
|
|
|
18
|
%
|
Infineon Technologies AG
|
|
|
45
|
(1)
|
|
|
28
|
(1)
|
|
|
57
|
|
Spansion LLC
|
|
|
18
|
|
|
|
25
|
|
|
|
12
|
|
|
|
(1) |
Includes revenues from Infineon Technologies Flash Israel, the
Israeli entity in our former joint venture which we exited in
December 2004.
|
We expect that a significant portion of our revenues will
continue to be concentrated among a small number of licensees.
38
Because to date we have derived our revenues from a limited
number of customers, the geographical breakdown of our revenues
is solely a function of the location of these customers. The
following table sets forth the geographic breakdown of our
licensing and service revenues for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Germany
|
|
|
|
%
|
|
|
4
|
%
|
|
|
57
|
%
|
Taiwan
|
|
|
36
|
|
|
|
37
|
|
|
|
18
|
|
United States
|
|
|
18
|
|
|
|
25
|
|
|
|
12
|
|
Japan
|
|
|
1
|
|
|
|
10
|
|
|
|
12
|
|
Israel(1)
|
|
|
45
|
|
|
|
24
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
(1) |
Consists primarily of revenues from design and product
development services provided to the Israeli entity in our
former joint venture, Infineon Technologies Flash Israel, which
we exited in December 2004.
|
The foregoing table does not include revenues from product sales
during the periods indicated since we decided to discontinue
product sales in the second quarter of 2005. Our product sales
operations are accounted for in our financial statements as
discontinued operations.
|
|
|
Cost
of revenues and gross profit
|
Services. Cost of service revenues consists
primarily of costs associated with providing design and product
development services, principally salaries and related personnel
costs, and software, as well as depreciation of equipment,
software and laboratory facilities. We account for the salaries
and related personnel costs of research and development
personnel as cost of revenues when those personnel undertake
design and product development services for a licensee. It is
often difficult for us to determine in advance exactly the costs
of fulfilling a fixed fee service contract. In 2005, compared to
prior years, we had lower overall service margins due to lower
margins on fixed fee service contracts and due to
$1.4 million of services performed for a licensee for which
no revenues were recognized in the period that such costs were
recorded. In 2003, design and product development services were
provided at a fixed price per employee.
Historically, the principal factors affecting our gross profit
were the relative proportions of our revenues derived from
services, which have associated costs of revenues. The impact on
our gross margin of design and product development services
varies from period to period depending on the mix of projects
and whether we charge on a cost plus or fixed fee basis.
We expect that our research and development, marketing and
selling, and general and administrative expenses will continue
to represent a significant percentage of our revenues. We intend
to fund these expenditures through our cash flow from operations
and our existing cash balances. Whether such expenses increase
or decrease as a percentage of revenues will be substantially
dependent upon the rate at which our revenues change. Our
incurrence of research and development expenses during each
quarter is generally unrelated to the timing of our recognition
of revenues under our license agreements because the
intellectual property generating license revenues has a long
development cycle. Our general and administrative expenses are
unrelated to our current revenues.
Research and development. Our research and
development expenses consist primarily of costs associated with
the design, development, pre-manufacture and testing of, and
enhancements to, our technology. These costs consist of salaries
and related personnel costs and consist also of wafer costs and
engineering expenses associated with the introduction of our
products, lease costs, subcontractor/outsourced engineering
services and software and depreciation of laboratory equipment.
We expense all of our research and development costs as they are
incurred. We view the total amounts we spend on research and
development, together with our cost of service revenues, as
providing a more complete picture of our overall research and
development activities
39
because our research and development activities directly benefit
from the design and product development services that we provide
to licensees.
Marketing and selling. Our marketing and
selling expenses consist of activities related to our licensing
activities. These costs consisted primarily of salaries, travel
and related costs for our licensing sales staff, commissions to
representatives, and promotional and public relations
activities. A portion of our selling and marketing expenses are
derived from the activities of our U.S. subsidiary, Saifun
Semiconductors USA, Inc., which was engaged primarily in sales
and marketing activities for our products. Although we decided
to discontinue product sales in the second quarter of 2005, we
plan to continue our marketing and selling activities for our
licensing and services business and expect to incur additional
marketing expenses.
General and administrative. Our general and
administrative expenses consist primarily of salaries and
related costs for our administrative staff and legal,
accounting, insurance and consulting expenses. We expect our
general and administrative expenses to increase for the
foreseeable future, both due to additional costs incurred as a
result of being a public company, and as our operations continue
to expand.
Financial income, net. Financial income
consists primarily of interest earned on our cash balances and
other financial investments, interest we received on loans made
to Infineon Technologies Flash prior to December 2004, interest
accrued on loans made to employees, foreign currency exchange
gains and profit on currency hedging transactions. Financing
expenses consist primarily of bank fees, foreign currency
exchange losses and any losses on currency hedging transactions.
Equity in losses of equity method
investees. Equity in losses of equity method
investees consists of the losses attributable to the equity
interest that we held until December 2004 in Infineon
Technologies Flash, our former joint venture with Infineon
Technologies.
We decided to discontinue our product sales activities in the
second quarter of 2005. We account for product sales as
discontinued operations in accordance with Financial Accounting
Standards Board (FASB) Statement No. 144,
Accounting for the Impairment or Disposal of Long-Lived
Assets. Accordingly, our results of operations for product
sales activities were reported as a separate line item entitled
Loss from discontinued operations in our statement
of operations, and financial information for prior years has
been reclassified.
The results of the operations of the product business included
in discontinued operations are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
|
(in thousands)
|
|
|
Revenues
|
|
$
|
|
|
|
$
|
1,673
|
|
|
$
|
4,495
|
|
Cost of revenues
|
|
|
|
|
|
|
5,894
|
|
|
|
8,458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross loss
|
|
|
|
|
|
|
(4,221
|
)
|
|
|
(3,963
|
)
|
Research and development
|
|
|
156
|
|
|
|
1,732
|
|
|
|
568
|
|
Marketing and selling
|
|
|
|
|
|
|
1,160
|
|
|
|
684
|
|
General and administrative
|
|
|
|
|
|
|
76
|
|
|
|
48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations
|
|
$
|
(156
|
)
|
|
$
|
(7,189
|
)
|
|
$
|
(5,263
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Israeli companies are subject to income tax at the corporate tax
rate of 34% for the 2005 tax year, 31% for the 2006 tax year,
29% for the 2007 tax year, 27% for the 2008 tax year, 26% for
the 2009 tax year and 25% for the 2010 tax year and thereafter.
In addition, our investment program in equipment and software at
our facilities in Netanya, Israel has been granted Approved
Enterprise status under the Law for the Encouragement of Capital
Investments, 1959, referred to as the Investments Law and,
therefore, we are eligible for tax benefits described later in
this section in Corporate Tax. These
benefits should result in
40
income recognized by us from our licensing and services
activities being tax exempt for a specified period after we
exhaust any net operating loss carryforwards and begin to report
taxable income. In April 2005, a comprehensive amendment to the
Investments Law came into effect. Since the amended Investments
Law does not apply retroactively to investment programs having
an approved enterprise approval certificate issued by the
Israeli Investment Center prior to December 31, 2004, our
current tax benefits are subject to the provisions of the
Investments Law prior to its revision, while new benefits that
will be received in the future, if any, will be subject to the
provisions of the Investments Law, as amended. We have received
approval from the Office of the Chief Scientist of Israel to
allow a tax deduction for part of our research and development
expenses incurred during the years 2002 and 2003. The unapproved
research and development expenses were deducted over a
three-year period in accordance with and subject to Israeli tax
law. We intend to continue applying to the Office of the Chief
Scientist of Israel in order to receive an approval to allow a
tax deduction for our research and development expenses.
In order to manage certain investments, we have established a
wholly owned subsidiary, Saifun (BVI) Limited, a company
incorporated under the laws of the British Virgin Islands. Under
our approved enterprise status, we are not entitled to receive
any tax benefits from any income derived from investments made
through Saifun (BVI) Limited. The taxable income will be
subject to Israeli income tax, which will be considered a
deemed dividend and taxed at a 25% tax rate.
Critical
Accounting Policies and Estimates
The preparation of financial statements in conformity with
U.S. generally accepted accounting principles requires
management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses
during the reporting period. These estimates and judgments are
subject to an inherent degree of uncertainty. However, certain
of our accounting policies are particularly important to the
portrayal of our financial position and results of operations.
In applying these critical accounting policies, our management
uses its judgment to determine the appropriate assumptions to be
used in making certain estimates. Those estimates are based on
our historical experience, the terms of existing contracts, our
observance of trends in our industry, information provided by
our customers and information available from other outside
sources, as appropriate. Our estimates are guided by observing
the following critical accounting policies:
Revenue recognition license
fees. License revenues are recognized when there
is persuasive evidence of an arrangement, delivery has occurred
or service has been rendered, the fee is fixed or determinable,
and collectibility is probable. All such fees are comprised of
license and support fees, as well as nonrefundable prepaid
royalties. License and support fees are accounted for as one
unit of accounting in accordance with Emerging Issues Task Force
Issue
No. 00-21
Revenue Arrangements with Multiple Deliverables. We
recognize license fees ratably over the period during which we
expect to provide initial customer support to our licensees and
when all other criteria for revenue recognition are met. In
addition, revenue recognition is limited to the amount that is
due or billable under the agreement or that is guaranteed. Since
the initial customer support is provided until the expected
commercialization date of the licensees products, we
determine the period in which we will provide support based on
estimates that our project managers determine in conjunction
with our licensees, as well as the monitoring of the progression
of our licensees product development through the customer
support we provide them. We review assumptions regarding the
customer support periods on a regular basis. If we determine
that it is necessary to revise our estimates of the customer
support periods, the total amount of revenue recognized over the
life of the contract would not be affected, but the license fees
would be recognized ratably over a longer or shorter period. We
record the excess of license fees paid to us over revenues
recognized as deferred revenues. Revenues from royalties are
recognized as earned.
Revenue
recognition services. We
recognize revenues from design and product development services
provided to our former joint venture based on a fixed fee per
employee as the services are rendered in accordance with Staff
Accounting Bulletin No. 104, Revenue
Recognition.
We recognize revenues from design and product development
services provided to licensees in fixed fee service contracts
based on the proportional performance model, using hours of
employee services rendered as
41
a percentage of total project hours. However, revenues are
always limited to output measures (technological milestones) or
amounts due or billable under the agreement.
Accounting for income taxes. We and our
subsidiaries account for income taxes in accordance with
Statement of Accounting Financial Standard (SFAS) No. 109
Accounting for Income Taxes. As part of the process
of preparing our consolidated financial statements we are
required to estimate our income taxes in each of the
jurisdictions in which we operate. This process requires us to
estimate our actual current tax exposure and make an assessment
of temporary differences resulting from differing treatment of
items, for tax and accounting purposes. We must then assess the
likelihood that our deferred tax assets will be recovered from
future taxable income and, to the extent we believe that
recovery is not likely, we must establish a valuation allowance.
Significant management judgment is required in determining our
provision for income taxes, our deferred tax assets and
liabilities and any valuation allowance recorded against our net
deferred tax assets. We expect that during the period in which
net operating loss carry forwards are utilized in Saifun
Semiconductors Ltd., our income will be substantially tax
exempt. Accordingly, there will be no tax benefit available for
such losses and no deferred income taxes were recorded as of
December 31, 2005. In addition, with respect to the
carryforward losses of Saifun Semiconductors USA, Inc. and
Saifun (BVI) Limited, a valuation allowance has been
recorded as management currently believes that it is more likely
than not that the deferred tax related to these carryforward
losses will not be realized in the foreseeable future.
Valuation of stock-based awards. During the
third quarter of 2004, we adopted the fair value recognition
provisions of FASB Statement No. 123, Accounting for
Stock-Based Compensation (SFAS 123), as
amended by FASB Statement No. 148, Accounting for
Stock-Based Compensation Transition and Disclosure
(SFAS 148) for stock-based employee
compensation. Effective December 29, 2003, we elected to
apply the Modified Prospective Method under SFAS 148,
whereby unvested options were accounted for under the fair value
recognition provision of SFAS 123 from December 29,
2003 as if the fair value method had been applied since the
option grant date. The impact of the adoptions of the fair value
method of accounting for stock-based compensation was an
increase to our stock-based compensation expense of
approximately $341,000 for the year ended December 26, 2004.
Prior to December 29, 2003, we accounted for our
stock-based employee compensation plans using the
intrinsic-value method of accounting set forth in Accounting
Principles Board Opinion No. 25, Accounting for Stock
Issued to Employees (APB 25), but
disclosed the pro forma effects on net loss had the fair value
of the options been expensed. In accordance with APB 25 and
related interpretations, compensation expense for stock options
is recognized in income based on the excess, if any, of the fair
value of the share at the grant date of the award or other
measurement date over the amount an employee must pay to acquire
the share. Generally, the exercise price for share options
granted to employees equals the fair market value of the share
at the date of grant, thereby resulting in no recognition of
compensation expense. For awards that generate compensation
expense as defined under APB 25, we calculate the amount of
compensation expense and recognize the expense over the vesting
period of the award.
In calculating the fair value of the options granted until June
2004 (initial filing date with the SEC) we applied the minimum
value method as prescribed by SFAS No. 123 for private
companies. Volatility of comparable, publicly traded companies
is used for options granted after June 2004.
We have accounted for options granted to employees of equity
method investees in accordance with Emerging Issues Task Force,
or EITF, 00-12, Accounting by an Investor for Stock-based
Compensation Granted to Employees of an Equity Method
Investee, SFAS 123 and Emerging Issues Task Force
No. 96-18 Accounting for Equity Instruments That Are
Issued to Other Than Employees for Acquiring, or in Conjunction
with Selling, Goods or Services, based on the fair value
of the options granted at the measurement date.
42
Results
of Operations
|
|
|
Year
Ended December 31, 2005 compared to Year Ended
December 26, 2004
|
Licenses. License revenues increased by
$43.2 million, or 191%, to $65.8 million in 2005 from
$22.6 million in 2004. The substantial majority of this
increase resulted from an increase in license revenues from
Infineon Technologies resulting from our amended license
agreement that we entered into upon the sale of our interest in
our former joint venture. License revenues in 2005 include
$19.2 million of non-cash license fees recognized in
connection with the sale of our interest in our former joint
venture. The remainder of the increase was attributable
principally to additional license revenues from Macronix and
Matsushita as a result of achieving contractual milestones.
Services. Service revenues increased by
$4.9 million, or 62%, to $12.8 million in 2005 from
$7.9 million in 2004. This increase resulted principally
from service revenues from Sony, Spansion and SMIC. The
remainder of the increase was attributable to an increase of
$0.9 million in service revenues from Infineon Technologies.
|
|
|
Cost of
revenues and gross margin
|
Services. Cost of services increased by
$5.0 million, or 70%, to $12.0 million in 2005 from
$7.1 million in 2004. Substantially all of this increase
resulted from increased service revenues during the same period
and from cost of services of $1.4 million performed for a
licensee pursuant to which no revenues were recognized in this
period.
Gross margin was 85% in 2005 compared to 77% in 2004. This
increase resulted from license revenues comprising a higher
proportion of our total revenues, partially offset by lower
gross margins on service projects.
Research and development. Research and
development expenses increased by $0.6 million, or 9%, to
$7.4 million in 2005 from $6.8 million in 2004.
Research and development expenses, together with cost of service
revenues, increased by $5.6 million, or 40%, to
$19.5 million in 2005 from $13.9 million in 2004. This
increase was primarily due to an increase in the number of
research and development personnel, as well as an increase of
$0.8 million in stock-based compensation expense. Research
and development expenses together with cost of services revenues
as a percentage of revenues decreased from 45% in 2004 to 25% in
2005. Excluding the non-cash component of revenues resulting
from the sale of our interest in our former joint venture,
research and development expenses together with cost of services
revenues as a percentage of revenues were 33% in 2005.
Marketing and selling. Marketing and selling
expenses increased by $2.0 million, or 68%, to
$4.9 million in 2005 from $2.9 million in 2004. This
increase was due to an increase of $0.8 million in salary
and related expenses mainly due to an increase in business
development and marketing personnel as well as due to an
increase of $0.8 million in marketing commission expenses,
and an increase of $0.6 million in stock-based compensation
expense. The increase was partially offset by a decrease of
$0.5 million in expenses representing withholding tax
deductions on licensing fees, which have been expensed.
Marketing and selling expenses as a percentage of revenues
decreased from 10% in 2004 to 6% in 2005. Excluding the non-cash
component of revenues resulting from the sale of our interest in
our former joint venture, marketing and selling expenses as a
percentage of revenues were 8% in 2005.
General and administrative. General and
administrative expenses increased by $4.1 million, or 194%,
to $6.2 million in 2005 from $2.1 million in 2004.
This increase resulted primarily from an increase of
$2.3 million in stock-based compensation expense, an
increase of $0.5 million in salary and related expenses
mainly due to an increase in administrative personnel due to the
expansion of our operations, as well as an increase of
$0.8 million in a provision recorded in respect of a legal
claim. The increase in stock-based compensation expense was
primarily due to the increase in the weighted average fair value
of options granted from $4.47 in 2004 to $8.23 in 2005, mainly
because, as of June 2004, we stopped applying the minimum value
method as prescribed by SFAS No. 123 for private
companies in calculating the fair value of options
43
granted and started using the volatility of comparable publicly
traded companies for options granted after June 2004, as well as
an appreciation of the SAR liability in the amount of
$1.1 million. General and administrative expenses as a
percentage of revenues increased from 7% in 2004 to 8% in 2005.
Excluding the non-cash component of revenues resulting from the
sale of our interest in our former joint venture, general and
administrative expenses as a percentage of revenues were 10% in
2005.
Financial income, net was $1.7 million in 2005 and in 2004.
Financial income included an increase in interest income on cash
equivalents,
held-to-maturity
marketable securities and premium on
held-to-maturity
marketable securities compared to 2004, offset by a decrease in
interest income on loans provided to our former joint venture
that we exited in December 2004 and by losses from foreign
currency exchange differences.
Loss from discontinued operations decreased by
$1.9 million, or 27%, to $5.3 million in 2005 from
$7.2 million in 2004. This decrease was due to a decrease
of $0.3 million in the gross loss on product sales, as well
as due to a decrease of $1.7 million in operating expenses
related to product-related activities. The decrease in operating
expenses resulted from our decision in the second quarter of
2005 to discontinue product sales operations.
|
|
|
Year
Ended December 26, 2004 compared to Year Ended
December 28, 2003
|
Licenses. License revenues increased by
$14.8 million, or 190%, to $22.6 million in 2004 from
$7.8 million in 2003. The substantial majority of this
increase resulted from an increase in license revenues from
Macronix and Spansion upon the achievement of contractual
milestones. The substantial majority of the balance of the
increase was attributable to license revenues from Matsushita as
a result of achieving contractual milestones.
Services. Service revenues increased by
$1.3 million, or 19%, to $7.9 million in 2004 from
$6.6 million in 2003. This increase resulted from an
increase of $0.6 million in services provided to Macronix
in connection with its development of multi-level cell
technology as well as from additional service revenues provided
to Infineon Technologies Flash Israel due to increased design
activity provided to the joint venture. The amount of service
revenues derived from Infineon Technologies Flash Israel during
this period was $7.3 million.
|
|
|
Cost of
revenues and gross margin
|
Services. Cost of services increased by
$3.0 million, or 71%, to $7.1 million in 2004 from
$4.1 million in 2003. This increase resulted from increased
service revenues during the same period, lower gross margin on
some of the service projects we entered into during this period
as well as recognition of estimated expected loss on a fixed fee
project in the amount of $0.9 million.
Gross margin was 77% in 2004 compared to 71% in 2003. This
increase resulted from license revenues comprising a higher
proportion of our total revenues, partially offset by lower
gross margins on service projects.
Research and development. Research and
development expenses decreased by $2.3 million, or 26%, to
$6.8 million in 2004 from $9.1 million in 2003. This
decrease was primarily due to the allocation of
research and development personnel to the provision of
services to our licensees. Research and development expenses,
together with cost of service revenues, increased by
$0.6 million, or 4%, to $13.9 million in 2004 from
$13.3 million in 2003. This increase resulted partially
from a recognition of estimated loss on a fixed fee project in
the amount of $0.9 million and from $0.4 million of
stock-based compensation expense due to the adoption of the fair
value recognition provisions as amended by FAS 148,
effective December 29, 2003. The increase was partially
offset by a decrease of $0.5 million in equipment
depreciation expenses. Research and development expenses
together with cost of services revenues as a percentage of
revenues decreased from 92% in 2003 to 45% in 2004.
44
Marketing and selling. Marketing and selling
expenses increased by $0.4 million in 2004, or 15%, to
$2.9 million in 2004 from $2.5 million in 2003. This
increase resulted from an increase of $0.4 million in
expenses to Tower Semiconductor representing a percentage of our
license revenues from certain third party licensees and an
increase of $0.6 million in expenses representing
withholding tax deductions on licensing fees. Marketing and
selling expenses as a percentage of revenues decreased from 18%
in 2003 to 10% in 2004.
General and administrative. General and
administrative expenses increased by $0.3 million, or 19%,
to $2.1 million in 2004 from $1.8 million in 2003.
This increase resulted from an increase of $0.3 million in
salary and related expenses mainly due to an increase in
administrative personnel due to the expansion of our operations
and payment of bonuses. General and administrative expenses as a
percentage of revenues decreased to 7% in 2004 from 12% in 2003.
Financial income, net increased by $0.6 million, or 49%, to
$1.7 million in 2004 compared to $1.1 million in 2003.
The majority of this increase is attributable to an increase in
interest on loans provided to Infineon Technologies Flash which
were waived as part of our exit from the joint venture in
December 2004.
|
|
|
Equity in
losses of equity method investees
|
Equity in losses of equity method investees (including
compensation expenses related to the issuance of options to
employees of equity method investees) increased by
$13.7 million, or 105%, to $26.7 million in 2004 from
$13.0 million in 2003. The equity method investees
losses increased primarily due to increased research and
development activities from development of new products and
technologies.
|
|
|
Loss from
discontinued operations
|
Loss from discontinued operations increased by $7.0 million
to $7.2 million in 2004 from $0.2 million in 2003.
This increase was due to our commencement of sales of products
in the first quarter of 2004. We experienced a gross loss of
$4.2 million and operating expenses of $3.0 million on
product sales during 2004 due to adjustments to inventory, low
average selling prices as part of our efforts to establish our
presence in the market, and low production yields, which are
customary in the industry with the introduction of new products.
45
Quarterly
Results of Operations
The table below sets forth unaudited consolidated statements of
operations data in dollars for each of the eight consecutive
quarters ended December 31, 2005. In managements
opinion, the unaudited consolidated financial statements have
been prepared on the same basis as our audited consolidated
financial statements contained elsewhere in this Annual Report
and include all adjustments, consisting of normal recurring
adjustments, necessary for a fair presentation of such financial
information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
|
|
March 28,
|
|
|
June 27,
|
|
|
Sept. 26,
|
|
|
Dec. 26,
|
|
|
March 27,
|
|
|
June 26,
|
|
|
Sept. 25,
|
|
|
Dec. 31,
|
|
|
|
2004
|
|
|
2004
|
|
|
2004
|
|
|
2004
|
|
|
2005
|
|
|
2005
|
|
|
2005
|
|
|
2005
|
|
|
|
(unaudited)
|
|
|
|
(in thousands)
|
|
|
Statements of operations
data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Licenses(*)
|
|
$
|
3,116
|
|
|
$
|
5,037
|
|
|
$
|
6,847
|
|
|
$
|
7,640
|
|
|
$
|
18,881
|
|
|
$
|
18,560
|
|
|
|
15,343
|
|
|
|
13,006
|
|
Services
|
|
|
1,907
|
|
|
|
1,963
|
|
|
|
2,253
|
|
|
|
1,803
|
|
|
|
3,333
|
|
|
|
3,197
|
|
|
|
2,597
|
|
|
|
3,684
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
5,023
|
|
|
|
7,000
|
|
|
|
9,100
|
|
|
|
9,443
|
|
|
|
22,214
|
|
|
|
21,757
|
|
|
|
17,941
|
|
|
|
16,690
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of services:
|
|
|
1,294
|
|
|
|
1,436
|
|
|
|
1,856
|
|
|
|
2,498
|
|
|
|
2,634
|
|
|
|
2,512
|
|
|
|
3,079
|
|
|
|
3,823
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
3,729
|
|
|
|
5,564
|
|
|
|
7,244
|
|
|
|
6,945
|
|
|
|
19,580
|
|
|
|
19,245
|
|
|
|
14,862
|
|
|
|
12,867
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
1,902
|
|
|
|
1,647
|
|
|
|
1,486
|
|
|
|
1,757
|
|
|
|
1,520
|
|
|
|
1,708
|
|
|
|
2,253
|
|
|
|
1,946
|
|
Marketing and selling
|
|
|
504
|
|
|
|
505
|
|
|
|
879
|
|
|
|
1,026
|
|
|
|
1,430
|
|
|
|
1,227
|
|
|
|
1,264
|
|
|
|
968
|
|
General and administrative
|
|
|
422
|
|
|
|
391
|
|
|
|
650
|
|
|
|
652
|
|
|
|
1,737
|
|
|
|
924
|
|
|
|
859
|
|
|
|
2,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
2,828
|
|
|
|
2,543
|
|
|
|
3,015
|
|
|
|
3,435
|
|
|
|
4,687
|
|
|
|
3,859
|
|
|
|
4,376
|
|
|
|
5,610
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
901
|
|
|
|
3,021
|
|
|
|
4,229
|
|
|
|
3,510
|
|
|
|
14,893
|
|
|
|
15,386
|
|
|
|
10,486
|
|
|
|
7,257
|
|
Financial income (expenses), net
|
|
|
(1
|
)
|
|
|
359
|
|
|
|
590
|
|
|
|
751
|
|
|
|
155
|
|
|
|
(117
|
)
|
|
|
543
|
|
|
|
1,168
|
|
Equity in losses of equity method
investees
|
|
|
(5,937
|
)
|
|
|
(5,324
|
)
|
|
|
(7,059
|
)
|
|
|
(7,852
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation income
(expense) related to issuance of options to employees of
equity method investees
|
|
|
(176
|
)
|
|
|
(326
|
)
|
|
|
(131
|
)
|
|
|
64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital loss from sale of equity
method investees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(17,334
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing
operations
|
|
|
(5,213
|
)
|
|
|
(2,270
|
)
|
|
|
(2,371
|
)
|
|
|
(20,861
|
)
|
|
|
15,048
|
|
|
|
15,269
|
|
|
|
11,029
|
|
|
|
8,425
|
|
Income (loss) from discontinued
operations
|
|
|
(613
|
)
|
|
|
(954
|
)
|
|
|
(2,046
|
)
|
|
|
(3,576
|
)
|
|
|
(3,224
|
)
|
|
|
(1,999
|
)
|
|
|
(230
|
)
|
|
|
190
|
|
Net income (loss)
|
|
$
|
(5,826
|
)
|
|
$
|
(3,224
|
)
|
|
$
|
(4,417
|
)
|
|
$
|
(24,437
|
)
|
|
$
|
11,824
|
|
|
$
|
13,270
|
|
|
$
|
10,799
|
|
|
$
|
8,615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per Ordinary
share from continuing operations
|
|
$
|
(0.31
|
)
|
|
$
|
(0.13
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(1.23
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss per Ordinary share from
discontinued operations
|
|
$
|
(0.03
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.21
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net earnings (loss) per
Ordinary share
|
|
$
|
(0.34
|
)
|
|
$
|
(0.19
|
)
|
|
$
|
(0.26
|
)
|
|
$
|
(1.44
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per
Ordinary share from continuing operations
|
|
$
|
(0.31
|
)
|
|
$
|
(0.13
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(1.23
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per
Ordinary share from discontinued operations
|
|
$
|
(0.03
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.21
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net earnings (loss) per
Ordinary share
|
|
$
|
(0.34
|
)
|
|
$
|
(0.19
|
)
|
|
$
|
(0.26
|
)
|
|
$
|
(1.44
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(*) |
License revenues include
non-cash
revenues resulting from the termination of our former joint
venture of $9.6 million, $6.8 million,
$2.4 million, and $0.4 million for the three months
ended March 27, 2005, June 26, 2005,
September 25, 2005 and December 31, 2005, respectively.
|
46
We expect that in the future our quarterly revenues will
fluctuate depending on the timing of recognition of licensee
fees and, as we start to derive more significant royalty
payments, upon the sales volumes and prices of products of our
licensees, which are beyond our ability to control or assess in
advance.
See Item 11 for a description of the impact of inflation and
foreign currency fluctuations on our business. See Item 3
Risk Factors for information regarding any
governmental economic, fiscal, monetary or political policies of
factors that could affect our operations.
|
|
B.
|
LIQUIDITY
AND CAPITAL RESOURCES
|
We do not have any long-term borrowings. Our investments consist
of cash and cash equivalents, short-term bank deposits and
interest bearing, investment-grade investments in marketable
securities with maturities of up to three years, which currently
consist mainly of corporate debt securities and auction rate
securities, and may in the future include commercial paper,
money market funds, government and non-government debt
securities.
We finance our operations through the proceeds of sales of our
equity securities and through cash derived from operations. In
our initial public offering that occurred in November 2005 we
raised net proceeds of approximately $120.9 million and in
a follow-on offering that occurred in April 2006 we raised net
proceeds of $9.4 million and an additional
$2.2 million from the exercise of stock options by certain
selling shareholders. As of December 31, 2005, we had
$100.3 million in cash and cash equivalents and
$81.5 million in marketable securities. Our working
capital, which we calculate by subtracting our current
liabilities from our current assets, was $166.5 million.
The following table of our material contractual and other
obligations known to us as of December 31, 2005, summarizes
the aggregate effect that these obligations are expected to have
on our cash flows in the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
subsequent
|
|
Contractual and other
obligations
|
|
Total
|
|
|
2006
|
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
|
periods
|
|
|
|
(in thousands)
|
|
|
Operating leases(1)
|
|
$
|
2,992
|
|
|
$
|
1,591
|
|
|
$
|
848
|
|
|
$
|
361
|
|
|
$
|
123
|
|
|
$
|
69
|
|
Software lease
|
|
|
4,901
|
|
|
|
1,823
|
|
|
|
1,811
|
|
|
|
1,267
|
|
|
|
|
|
|
|
|
|
Severance pay(2)
|
|
|
2,655
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,655
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
10,548
|
|
|
$
|
3,414
|
|
|
$
|
2,659
|
|
|
$
|
1,628
|
|
|
$
|
123
|
|
|
$
|
2,724
|
|
|
|
(1)
|
Consists of an operating lease for our facilities in Netanya,
Israel, and Santa Clara, California, and operating leases
for vehicles.
|
|
(2)
|
Severance pay relates to accrued severance obligations to our
Israeli employees as required under Israeli labor laws. These
obligations are payable only upon the termination of the
respective employee and may be reduced if the employees
termination is voluntary. As of December 31, 2005, the
severance pay funds were $2.1 million.
|
Based on our current business plan, we believe that our existing
cash balances and cash generated from operations, will be
sufficient to meet our anticipated cash needs for working
capital and capital expenditures for at least the next
12 months. The absence of cash flows from the discontinued
operations of our product business is expected to improve our
cash flow position in the future. If our estimates of revenues,
expenses or capital or liquidity requirements change or are
inaccurate or if cash generated from operations is insufficient
to satisfy our liquidity requirements, we may seek to sell
additional equity or arrange additional debt financing. In
addition, we may seek to sell additional equity or arrange debt
financing to give us financial flexibility to pursue
opportunities that may arise in the future.
47
The following table sets forth the components of our cash flows
for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Net cash provided by operating
activities
|
|
$
|
2,318
|
|
|
$
|
17,964
|
|
|
$
|
14,116
|
|
Net cash used in investing
activities
|
|
|
(17,371
|
)
|
|
|
(20,376
|
)
|
|
|
(66,068
|
)
|
Net cash provided by financing
activities
|
|
|
3,861
|
|
|
|
256
|
|
|
|
125,051
|
|
Increase (decrease) in cash and
cash equivalents
|
|
$
|
(11,192
|
)
|
|
$
|
(2,156
|
)
|
|
$
|
73,099
|
|
Our cash flow statement presents cash flows from discontinued
operations combined with cash flows from continuing operations
within each cash flow statement category (operating, investing
and financing activities).
Net cash provided by operating activities in 2005 was
$14.1 million compared to $18.0 million in 2004. Net
cash provided by operating activities in 2005 was generated
primarily by our net income of $44.5 million adjusted for
non-cash expenses of $6.9 million and
non-cash
revenues of $19.2 million, by a decrease of
$4.8 million in trade receivables, a decrease in total
assets attributed to discontinued operations of
$4.9 million and an increase in accrued expenses and other
liabilities of $1.8 million. This was offset in part by an
increase in other accounts receivable and prepaid expenses of
$1.3 million, a decrease in total liabilities attributed to
discontinued operations of $3.7 million and a decrease in
deferred revenues of $24.3 million (excluding
non-cash
revenues).
The decrease in deferred revenues during the year was due to the
recognition of previously received license fees from Macronix,
Spansion and Matsushita. The decrease in trade receivables was
primarily due to payments received from Infineon Technologies
Flash Israel. The increase in other accounts receivable and
prepaid expenses was primarily due to an increase in prepaid
expenses mainly related to operating lease prepayments and an
increase in deferred service projects costs. The decrease in
total assets attributed to discontinued operations of
$4.9 million was offset by the decrease in total
liabilities attributed to discontinued operations of
$3.7 million. This decrease was primarily due to a decline
in payables to our subcontractors for the manufacturing of our
products as a result of the discontinuance of our products sales
in the second quarter of 2005.
Net cash provided by operating activities in 2004 was
$18.0 million compared to net cash provided by operating
activities of $2.3 million in 2003. Net cash provided by
operating activities in 2004 was generated primarily by our
operating income of $11.7 million adjusted for non-cash
expenses of $1.9 million, an increase in deferred revenues
of $13.1 million, and an increase in total liabilities
attributed to discontinued operations of $3.8 million,
offset in part by an increase of $4.8 million in total
assets attributed to discontinued operations, and an increase of
$2.2 million in trade receivables.
The increase in deferred revenues was primarily due to non-cash
license revenues of $19.2 million from Infineon
Technologies. The increase in trade receivables was mainly due
to payments due from Infineon Technologies Flash. The increase
in total assets attributed to discontinued operations of
$4.8 million was offset by the increase in total
liabilities attributed to discontinued operations of
$3.8 million. This increase was mainly due to payables to
our subcontractors for the manufacturing of our products, which
we commenced selling in the first quarter of 2004.
Net cash provided by operating activities in 2003 was generated
primarily by an increase in deferred revenues of
$2.8 million and an increase in accrued expenses and other
liabilities of $1.7 million, offset in part by an increase
of $2.1 million in trade receivables. The increase in
deferred revenues was primarily due to additional license fees
received from Macronix, Spansion and Matsushita, which were not
all recognized as revenues in 2003. The increase in trade
receivables was primarily due to a license fee receivable from
Matsushita that was collected subsequent to the balance sheet
date. The increase in trade payables and accrued expenses was
primarily due to increased provision for salary and related
expenses of approximately $1.1 million and to an increase
in a legal claim provision.
Net cash used in investing activities in 2005 was
$66.1 million compared to net cash used in investing
activities of $20.4 million in 2004. The increase was
primarily due to increase in net investment in marketable
48
securities of $58.6 million which mainly resulted from
proceeds raised in our initial public offering and by an
increase of $1.2 million in capital investments primarily
in laboratory equipment and computers. This increase was
partially offset by a decrease, as a result of the termination
of our joint venture with Infineon Technologies in December
2004, of $13.1 million in loans made to Infineon
Technologies Flash Germany in 2004 as part of our agreement with
Infineon Technologies regarding the joint venture. Net cash used
in investing activities in 2004 was $20.4 million and
consisted primarily of net investment of $6.7 million in
held-to-maturity
marketable securities which had previously been held in
short-term bank deposits and cash equivalents,
$13.1 million of loans to Infineon Technologies Flash
Germany and $0.8 million of capital investments primarily
in laboratory equipment, computers and software.
Net cash used in investing activities in 2003 was
$17.4 million and consisted primarily of $10.9 million
invested in
held-to-maturity
marketable securities which had previously been held in
short-term bank deposits, $5.3 million of investments in
and loans to Infineon Technologies Flash Germany and
$1.0 million of capital investments primarily in laboratory
equipment, computers and software.
Net cash provided by financing activities was
$125.1 million in 2005, $0.3 million in 2004 and
$3.9 million in 2003. The increase in 2005 resulted from
proceeds of $123.7 million raised in our initial public
offering, net of issuance expenses.
Corporate
Tax
Israeli companies are subject to income tax at the corporate
rate of 34% for the 2005 tax year, 31% for the 2006 tax year,
29% for the 2007 tax year, 27% for the 2008 tax year, 26% for
the 2009 tax year and 25% for the 2010 tax year and thereafter.
In addition, we have net operating loss carryforwards and we are
subject to Israeli government tax benefits that will reduce our
effective statutory tax rate. Furthermore, our former equity
interest in losses of Infineon Technologies Flash Germany was
attributed to us for tax purposes. As of December 31, 2005,
the end of our last fiscal year, our net operating loss
carryforwards for Israeli tax purposes amounted to approximately
$16.7 million. We have additional carryforward capital
losses of $5.3 million. We have received from the Office of
the Chief Scientist of Israel an approval to allow a tax
deduction for part of our research and development expenses
incurred during the years 2002 and 2003. The remaining
unapproved research and development expenses are deducted for
tax purposes over a three-year period in accordance with and
subject to Israeli tax law. We intend to continue applying to
the Office of the Chief Scientist of Israel for an approval to
allow a tax deduction for our research and development expenses.
Under Israeli law, net operating losses can be carried forward
indefinitely and offset against certain future taxable income.
We expect that we will generate the substantial majority of our
taxable income in Israel.
In addition, our investment program in equipment at our facility
in Netanya, Israel has been granted approved enterprise status
and we are, therefore, eligible for tax benefits under the Law
for the Encouragement of Capital Investments, 1959, referred to
as the Investments Law. Subject to compliance with applicable
requirements, the portion of our net income derived from our
licensing and services activities will be exempt from income tax
during the first two years in which these investment programs
produce taxable income, which will be after we have utilized our
net operating loss carryforwards, and subject to a reduced tax
rate of between 10% and 25% for the remaining five to eight
years of the program, depending on the extent of non-Israeli
ownership in our company during the relevant year. The period
during which we receive these tax benefits is limited to
12 years from the year in which operations or production by
the enterprise commenced or 14 years from the year in which
approval of the program was granted, whichever is earlier. The
benefits under our existing approval enterprises are due to
expire between 2011 and 2015. In addition, availability of these
tax benefits is subject to certain requirements, including
making specified investments in property and equipment, and
financing a percentage of investments with share capital. If we
do not meet these requirements in the future, the tax benefits
may be canceled and we could be required to refund any tax
benefits that we have already received. See
Taxation Israeli Tax Considerations and
Government Programs Taxation of
Companies Law for the Encouragement of Capital
Investments, 1959. We cannot assure you that tax benefits
for approved enterprises will continue at current levels or at
all.
In addition, our effective tax rate in our statement of income
may be different than our approved enterprise tax rate because
the basis of computing theoretical taxes on income for financial
statement purposes
49
in U.S. dollars under U.S. generally accepted
accounting principles differs from the basis for computing taxes
under Israeli law where income is based on financial statements
in shekels that are adjusted for inflation in Israel. We have
elected to measure our results for tax purposes based on the
U.S. dollar exchange rate commencing January 1, 2006. In
addition, other items included in our financial statements such
as financial income, can affect our effective tax rate since
they may not be eligible for the approved enterprise benefits.
In April 2005, a comprehensive amendment to the Investments Law
came into effect. Since the amended Investments Law does not
retroactively apply for investments programs having an approved
enterprise approval certificate issued by the Israeli Investment
Center prior to December 31, 2004, our current tax benefits
are subject to the provisions of the Investments Law prior to
its revision, while new benefits that we receive in the future,
if any, will be subject to the provisions of the Investments
Law, as amended. According to the amendment to the Investments
Law, only approved enterprises receiving cash grants require the
approval of the Investment Center. Approved enterprises that do
not receive benefits in the form of governmental cash grants,
such as benefits in the form of tax benefits, are no longer
required to obtain this approval (such enterprises are referred
to as privileged enterprises). However, a privileged enterprise
is required to comply with certain requirements and make certain
investments as specified in the amended Investments Law. A
privileged enterprise may, at its discretion, in order to
provide greater certainty, elect to apply for a pre-ruling from
the Israeli tax authorities confirming that it is in compliance
with the provisions of the amended Investments Law and is
therefore entitled to receive such benefits provided under the
amended Investments Law. We have recently applied for a
pre-ruling
in order to confirm that we are in compliance with the amended
law.
In order to manage certain investments, we have established a
wholly owned subsidiary, Saifun (BVI) Limited, a company
incorporated under the laws of the British Virgin Islands. Under
our Approved Enterprise status, we are not entitled to receive
any tax benefits from any income derived from investments made
through Saifun (BVI) Limited. As of December 31, 2005,
carryforward losses related to Saifun (BVI) Limited
amounted for approximately $3.3 million, which may be
carried forward indefinitely. After the carryforward losses are
utilized, we will be subject to Israeli income tax, which will
be considered a deemed dividend and taxed at 25% tax
rate.
There can be no assurance that we will comply with the
conditions set forth in the Investments Law in the future or
that we will be entitled to any additional benefits under it.
Recent
Accounting Pronouncements
In December 2004, the Financial Accounting Standards Board
(FASB) issued Statement No. 123 (revised 2004),
Stock-based Payment (Statement 123(R)), which
is a revision of FASB Statement No. 123, Accounting for
Stock-Based Compensation (Statement 123).
Generally, the approach in Statement 123(R) is similar to
the approach described in Statement 123. However,
Statement 123 permitted, but not required, stock-based
payments to employees to be recognized based on their fair
values while Statement 123(R) requires all stock-based
payments to employees to be recognized based on their fair
values. Statement 123(R) also revises, clarifies and
expands guidance in several areas, including measuring fair
value, classifying an award as equity or as a liability and
attributing compensation cost to reporting periods. The new
standard became effective in the first fiscal year beginning
January 1, 2006. We do not expect that the adoption of
Statement 123R will have a significant effect on our
financial position, results of operations or cash flows.
In March 2005, the SEC released SEC Staff Accounting
Bulletin No. 107, Stock-based Payment
(SAB 107). SAB 107 provides the SEC
staffs position regarding the application of
FAS 123(R) and contains interpretive guidance related to
the interaction between FAS 123(R) and certain SEC rules
and regulations, and also provides the SEC staffs views
regarding the valuation of stock-based payment arrangements for
public companies. SAB 107 highlights the importance of
disclosures made relating to the accounting for stock-based
payment transactions. We do not believe that SAB 107 will
have a material effect on our financial position, results of
operations or cash flows.
In May 2005, the FASB issued Statement of Financial Accounting
Standard No. 154 (SFAS 154),
Accounting Changes and Error Corrections in
replacement of APB No. 20, Accounting Changes
and SFAS No. 3, Reporting Accounting Changes in
Interim Financial Statements. SFAS 154 provides
guidance
50
on the accounting for and reporting of accounting changes and
error corrections. APB No. 20 previously required that most
voluntary changes in accounting principles be recognized by
including in net income the cumulative effect of changing to the
new accounting principle of the period of the change.
SFAS 154 requires retrospective application to prior
periods financial statements of a voluntary change in
accounting principle unless it is impracticable. SFAS 154
is effective for accounting changes and corrections of errors
made in fiscal years beginning after December 15, 2005.
In November 2005, the FASB issued FSP FAS 115-1. The FSP
addresses the determination as to when an investment is
considered impaired, whether that impairment is other than
temporary, and the measurement of an impairment loss. The FSP
also includes accounting considerations subsequent to the
recognition of other than-temporary impairment and requires
certain disclosures about unrealized losses that have not been
recognized as other-than-temporary impairments. The guidance in
this FSP amends FASB Statements No. 115, Accounting for
Certain Investments in Debt and Equity. The FSP replaces the
impairment evaluation guidance of EITF Issue
No. 03-1,
The Meaning of Other-Than-Temporary Impairment and Its
Application to Certain Investments, with references to the
existing other-than-temporary impairment guidance. The FSP
clarifies that an investor should recognize an impairment loss
no later than when the impairment is deemed
other-than-temporary, even if a decision to sell an impaired
security has not been made. The guidance in this FSP is to be
applied to reporting periods beginning after December 15,
2005. We do not expect that the adoption of FSP FAS 115-1
will have a significant effect on our financial position,
results of operations or cash flows.
|
|
C.
|
RESEARCH
AND DEVELOPMENT
|
We conduct all of our research and development activities
in-house and as of December 31, 2005, we had 206 employees
engaged in research and development, including in connection
with design and product development services provided to
licensees, representing 87% of our total workforce.
Approximately 11% of our research and development employees have
advanced technical degrees and 7% have PhDs. We engage in
substantial research and development activities that are focused
principally on the following areas:
|
|
|
|
|
Improving the functionality and features of our NROM
technology. We, together with our licensees, seek
to develop innovative solutions based on our NROM technology to
maintain our advantage. We are developing our QUAD NROM
technology that enables storage of four bits per cell with a few
of our licensees.
|
|
|
|
Services for licensees. We work closely with
our licensees to assist them in incorporating our NROM
technology into their products. We are currently working with
licensees to develop advanced manufacturing technologies for
products incorporating our NROM technology using smaller process
geometries.
|
Our research and development expenses were $7.4 million in
2005, $6.8 million in 2004, and $9.1 million in 2003.
In addition, because our license agreements often call for us to
provide design and product development services, a portion of
our total research and development expenses have been allocated
to cost of revenues for design and product development services,
even though these services have direct applicability to our
technology development as well. We view the total amounts we
spend on research and development, together with our cost of
service revenues, as providing a more complete picture of
our overall research and development activities because our
research and development activities directly benefit from the
design and product development services that we provide to
licensees. We expect that we will continue to invest substantial
funds in research and development activities.
See discussion in Parts A and B of Item 5 Operating
Results and Financial Review and Prospects.
E. OFF-BALANCE
SHEET ARRANGEMENTS
Not applicable.
F. TABULAR
DISCLOSURE OF CONTRACTUAL OBLIGATIONS
Not applicable.
51
G. SAFE
HARBOR
Not applicable.
|
|
ITEM 6.
|
DIRECTORS,
SENIOR MANAGEMENT AND EMPLOYEES
|
A. DIRECTORS
AND SENIOR MANAGEMENT
Our executive officers and directors and their ages and
positions as of the date of this annual report are as follows:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
|
Position
|
|
Executive Officers
|
|
|
|
|
|
|
Dr. Boaz Eitan
|
|
|
57
|
|
|
Chief Executive Officer, Chairman
and Director
|
Kobi Rozengarten
|
|
|
49
|
|
|
President and Director
|
Igal Shany
|
|
|
34
|
|
|
Chief Financial Officer
|
Ramy Langer
|
|
|
52
|
|
|
Vice
President Business Development
|
Eduardo Maayan
|
|
|
45
|
|
|
Vice
President Product Development
|
Dr. Meir Janai
|
|
|
58
|
|
|
Vice
President Quality and Reliability
|
Dr. Guy Cohen
|
|
|
44
|
|
|
Vice
President Technology Development and
Productization
|
|
|
|
|
|
|
|
Directors
|
|
|
|
|
|
|
Kenneth Levy(1)(3)
|
|
|
62
|
|
|
Director
|
Matty Karp(1)(2)
|
|
|
55
|
|
|
Director
|
Dr. Shlomo Kalish(1)(4)
|
|
|
53
|
|
|
Director
|
Yossi Sela(1)(3)
|
|
|
53
|
|
|
Director
|
George Hervey(1)(2)(5)
|
|
|
59
|
|
|
Director
|
Ida Keidar-Malits(1)(2)(3)(5)
|
|
|
58
|
|
|
Director
|
|
|
(1)
|
Independent director under The Nasdaq National Market rules
|
|
(2)
|
Member of our audit committee
|
|
(3)
|
Member of our compensation, nominating and governance committee
|
|
(4)
|
Mr. Kalish will cease to be a director following the 2006
annual general meeting of shareholders at which time his term as
a director will expire
|
|
(5)
|
Outside director under the Israeli Companies Law
|
Dr. Boaz Eitan founded Saifun in 1996 and since that
time has served as our Chief Executive Officer and Chairman of
our board of directors. He is the inventor of our NROM
technology. From 1992 to 1997, Dr. Eitan managed the
Israeli design center of WaferScale Integration Inc., a design
center he established in 1992. From 1983 to 1992, Dr. Eitan
held various positions at WaferScale Integration Inc., including
manager of the Device Physics group, director of memory products
and Vice President of Product and Technology Development. From
1981 to 1983, Dr. Eitan served as a physicist at
Intels research and development center in
Santa Clara, California. Dr. Eitan holds a Ph.D. and
an M.Sc. in Applied Physics from the Hebrew University,
Jerusalem and a B.Sc. in Mathematics and Physics from the Hebrew
University, Jerusalem. Dr. Boaz Eitan is named as the
inventor on over 75 issued U.S. patents, over 40 pending
U.S. patent applications and a number of issued
non-U.S. patents
and pending
non-U.S. patent
applications.
Kobi Rozengarten has served as our President since 2004
and was appointed to our board of directors on March 7,
2006. Previously, Mr. Rozengarten was Executive Vice
President Business and Chief Executive Officer
of Saifun Semiconductors, Inc. since 1997. Prior to that, from
1994 to 1997, he served as Managing Director of Micro-Swiss
Ltd., a subsidiary of Kulicke and Soffa Industries, Inc., a
leading supplier of equipment for the semiconductor industry.
From 1987 to 1994, Mr. Rozengarten held several senior
management positions at Kulicke and Soffa Industries, including
Director of Operations and Vice President of Business
Development. From 1983 to 1987, Mr. Rozengarten worked at
Elbit Computer Ltd., an Israeli
52
defense electronics supplier, as Manager of Finance Planning and
Control. Mr. Rozengarten holds an M.Sc. in Industrial
Management and a B.Sc. in Industrial Engineering from the
Technion The Israel Institute of Technology.
Igal Shany joined our company in December 2000 and has
served as our Chief Financial Officer since July 2002. Prior to
joining us, from 1998 to 2000 he was the Director of Finance at
Agentics Ltd., an Israeli company specializing in web-based
content management. From 1995 to 1998, Mr. Shany was a
manager at Deloitte Touche Tohmatsu in Tel Aviv, Israel, where
he was responsible for clients from the high-tech,
communications and services industries. Mr. Shany is
qualified as a CPA and holds a B.A. in economics and accounting
from the Tel Aviv University and an MBA from the Recanaty School
of Business Administration at the Tel Aviv University.
Ramy Langer became General Manager and began serving as
our Vice President Business Development in
January 2005. Prior to joining us, Mr. Langer was Vice
President Marketing and Sales at Tower
Semiconductors for three years and then served as the Managing
Director of Infineon Technologies Flash Israel for two years.
Before that, Mr. Langer held senior technical and business
positions at Kulicke and Soffa Industries Inc., a supplier of
equipment for the semiconductor industry. Mr. Langer holds
a B.Sc. in Electrical Engineering from
Technion The Israel Institute of Technology and
a M.Sc. in Electrical Engineering from Drexel University,
Philadelphia.
Eduardo Maayan has served as our Vice
President Product Development since July 2002.
From 1998 to 2002, he held the position of circuit design
manager. Prior to joining us, from 1994 to 1998, Mr. Maayan
worked at Intels design center in Haifa, where he lead the
Global Circuit team in the microprocessor department and was
involved in the design of digital and analog integrated
circuits, the definition of design methodologies, and the
development of CAD tools. From 1990 to 1994, Mr. Maayan
carried out research on Selective Epitaxial MOCVD Growth
for Optoelectronic Integrated Devices at the
Microelectronics Center of the Technion Israel
Institute of Technology. Mr. Maayan also serves as a
lecturer at the Technions Electrical Engineering faculty.
Mr. Maayan holds a B.Sc. and M.Sc. in Electrical
Engineering from the Technion Israel Institute
of Technology. Mr. Maayan is named as the inventor on over
20 issued U.S. patents and over 30 pending U.S. patent
applications.
Dr. Meir Janai has served as our Vice
President Quality and Reliability since January
2006 and, prior to that, from July 2005 to January 2006, served
as our Vice President Productization, Quality
and Reliability. From 2002 to July 2005, Mr. Janai serviced
as our Vice President of Operations and, from 2001 to 2002, as
our Vice President of Quality and Reliability. Prior to joining
us, Dr. Janai served as Director of Business Development
and Vice President of Corporate Quality at Chip Express
Corporation. From 1985 to 1997, Dr. Janai served as Chief
Scientist at Chip Expresss research and development center
in Haifa, Israel. From 1978 to 1985, Dr. Janai worked for
Kulicke and Soffa Industries, Inc. as Director of Quality and as
a consultant. From 1977 to 1984, he was a senior research
associate at the Department of Physics at the Technion, Israel
Institute of Technology, and a visiting professor at the Optical
Science Center at the University of Arizona. Dr. Janai
served as a member of the Israeli National Committee for
Microelectronics Foundations and he has been a member of
numerous other scientific and governmental review boards both in
Israel and the United States. Dr. Janai holds M.Sc. and
D.Sc. degrees in Physics from the
Technion Israel Institute of Technology and a
B.Sc. in Physics and Mathematics from the Hebrew University in
Jerusalem.
Dr. Guy Cohen was appointed as our Vice
President Technology Development and
Productization in January 2006. During the three years prior to
his appointment, Dr. Cohen served as our Director of
Technology Development. From 2001 to 2003, Dr. Cohen served
as our Device Physicist and Program Manager where he engaged in
the development of the QUAD NROM concept and product. From 1995
to 2001, he served as Manager of Laser Business at
Semi-Conductor Devices. Dr. Cohen holds a Ph.D. and an
M.Sc. in Physics from the Weizmann Institute of Science,
Rehovot, and a B.Sc. in Physics and Mathematics from the Hebrew
University, Jerusalem.
Kenneth Levy has served as a director since November
2000. Mr. Levy is a founder of KLA Instruments Corporation
and since July 1999 has served as Chairman of the Board and
director of
KLA-Tencor
Corporation. From July 1998 to June 1999, he served as the Chief
Executive Officer and a director of
KLA-Tencor.
From April 1997 to June 1998, Mr. Levy was Chairman of the
Board of Directors of
53
KLA-Tencor.
From 1975 to 1997, he served as Chairman of the Board of
Directors and Chief Executive Officer of KLA Instruments
Corporation. Mr. Levy also serves on the boards of
directors of Extreme Networks, Inc. a provider of network
infrastructure solutions, since 2001, Juniper Networks, Inc., a
provider of internet infrastructure solutions, and since 2003,
PowerDsine, Inc., a provider of internet infrastructure
subsystems. In addition, Mr. Levy serves as a director
emeritus on the board of Semiconductor Equipment and Materials
Institute (SEMI), an industry trade association and is an
elected member of the National Academy of Engineering.
Mr. Levy holds as M.Sc. in Electrical Engineering from
Syracuse University and a B.Sc. in Electrical Engineering from
City College of New York.
Matty Karp has served as a director since March 2001.
Mr. Karp was appointed by the holders of a majority of the
Class A preferred shares. In 1997, Mr. Karp co-founded
Concord Ventures, a leading Israeli capital venture fund. From
1994 to 1997, Mr. Karp served as the President of Nitzanim
Venture Fund. From 1987 to 1994, Mr. Karp served as Chief
Executive Officer of Kardan Technologies. Prior to that,
Mr. Karp served as Corporate Vice President for Business
Development, Marketing, and Sales and Head of the Systems and
Products Group at Elbit Computers Ltd., a leading Israeli
high-tech company with worldwide activities in the defense and
healthcare sectors. Mr. Karp has served on the Board of
Directors of Galileo Technology, Accord Networks and Wintegra.
Mr. Karp holds a B.Sc. cum laude in Electrical Engineering
from the Technion Israel Institute of
Technology and is a graduate of the Harvard Business School
Advanced Management Program.
Dr. Shlomo Kalish has served as a director since
1998 representing Concord (K.T.) Ventures Inc., an Israeli
venture capital fund, and in 2001 was re-appointed by our
shareholder, Dr. Boaz Eitan. Dr. Kalish serves as the
Chairman and Chief Executive Officer of Jerusalem Global
Ventures Ltd., an Israeli venture capital fund, which he founded
in 2000. From 1994 to 1997, he served as the Chairman of
Jerusalem Global Group which he founded. From 1997 to 1999,
Dr. Kalish also served as a general partner of Concord
(K.T.) Ventures. From 1985 to 1994, Dr. Kalish was a member
of the faculty at Tel Aviv University School of Management.
Dr. Kalish is a member of the boards of several non-profit
organizations and academic institutions, including the Board of
Trustees of Bar Ilan University; the Board of Governors of the
Technion Israel Institute of Technology; the
Jerusalem College of Technology; and High-Tech Management
School, a joint venture between Northwestern University and Tel
Aviv University. In addition, Dr. Kalish also serves as a
director on the boards of several other public and private
technology companies. Dr. Kalish holds a Ph.D. in
Operations Research from the Massachusetts Institute of
Technology (MIT), an M.Sc. in Management from Sloan School of
Management at MIT and a B.Sc. in Mathematics from Tel Aviv
University.
Yossi Sela has served as a director since 1998.
Mr. Sela was appointed by the holders of a majority of the
Class B preferred shares. Mr. Sela is the Managing
Partner of Gemini Israel Funds, a leading Venture Capital fund,
which invests primarily in seed and early stage Israeli
technology. In this capacity, Mr. Sela sits on the board of
a number of Gemini portfolio companies, including Adimos Inc.,
Allot Communications, Ltd., and IXI Mobile, Ltd.
Mr. Selas past board positions include CommTouch
Software Ltd., Precise Software Solutions Ltd. and Envara Inc.
In 1995, he served as the Chief Executive Officer of Ornet Data
Communication Technologies Ltd., which was a Gemini portfolio
company. Mr. Sela led that company until its acquisition by
Siemens AG in September 1995. From 1990 to 1992, Mr. Sela
served as Vice President of Marketing at DSP Group, an
American-Israeli company specializing in proprietary Digital
Signal Processing for consumer and telecommunication
applications. He later served as VP Marketing at DSP
Communications, Inc., a spin-off of DSP Group. From 1985 to
1989, Mr. Sela worked at Daisy Systems Inc. where he was
Director for CAD Development and PCB Marketing Manager for
Europe. From 1974 to 1984, he served in the Israel Defense
Forces and was responsible for the definition and development of
systems for communication applications. Mr. Sela holds a
B.Sc. in Electrical Engineering from the
Technion Israel Institute of Technology and an
MBA from Tel Aviv University.
George Hervey has served as a director since August 2004
and his service as an outside director under the Israeli
Companies Law was ratified by our shareholders on March 22,
2006. Since 2000, Mr. Hervey has served as the Vice
President of Finance and Chief Financial Officer of the Marvell
Technology Group Ltd., and serves in a similar capacity for
Marvell Semiconductor, Inc. From March 1997 to April 2000,
Mr. Hervey served as Senior Vice President, Chief Financial
Officer and Secretary for Galileo Technology Ltd., which Marvell
acquired in January 2001. From June 1992 to February 1997,
Mr. Hervey was Senior Vice President
54
and Chief Financial Officer of S3 Incorporated, a designer and
manufacturer of graphics and video accelerators for personal
computers and related peripheral products. Mr. Hervey holds
a B.Sc. in Business Administration from the University of Rhode
Island.
Ms. Ida Keidar-Malits was appointed as an outside
director on March 22, 2006. The Compensation, Nominating and
Governance Committee of the Company and the Companys Board
of Directors have approved her nomination.
Ms. Keidar-Malits is a 50% owner of Adres Ltd., an Israeli
private company engaged in import, stockholding, processing and
distribution of steel as well as in real estate, and since 1998
has been a director of this company. From 1998 until July 2003,
Ms. Keidar-Malits served as a director of Packer
Steels & Metals Ltd., a leading Israeli steel and metal
service company. From 1998 until July 2002, she served as a
director of Elbit Vision Systems Ltd. (OTCBB: EVSNF.OB), as well
as the Chairman of the Audit Committee and a member of its
Remuneration Committee. Elbit Vision Systems is an Israeli
provider of computerized vision systems for industrial automatic
quality inspection processes. Ms. Keidar-Malits also acts
as a business consultant and mediator. From 1991 until 1997,
Ms. Keidar-Malits served as Vice President of Finance and
Chief Financial Officer of Elbit Ltd. (NASDAQ: ELBTF) until
completion of its November 1996 restructuring into three
companies: Elbit Systems Ltd. (NASDAQ: ESLT), Elbit Medical
Imaging Ltd. (NASDAQ: EMITF) and Elbit Ltd. Prior to the
restructuring, Elbit was engaged in worldwide operations in
three non-related business areas: defense electronics, medical
imaging and communications. From 1986 until 1991,
Ms. Keidar-Malits served as Corporate Secretary of Elbit
and from 1984 until 1996, she served as Head of the Economics
Department of Elbit. Ms. Keidar-Malits holds an M.Sc. in
industrial management from the Technion, Israel Institute of
Technology in Haifa and a B.Sc. in Chemistry &
Biochemistry from the Hebrew University in Jerusalem.
The aggregate compensation paid by us and our subsidiaries to
our directors and executive officers, including stock-based
compensation, for 2005 was $2.9 million. This amount
includes approximately $1.3 million of
stock-based
compensation, but does not include business travel, relocation,
professional and business association due and expenses
reimbursed to officer holders, and other benefits commonly
reimbursed or paid by companies in Israel. As compensation for
service on our board of directors, we will grant (1) an
initial annual grant of options to purchase 30,000 ordinary
shares (which will vest annually in three equal parts over a
three-year period) upon each non-employee directors
appointment or election to the board, (2) options to
purchase 45,000 ordinary shares for a board member who is the
Chairman of our Audit Committee or (3) options to purchase
35,000 ordinary shares for a board member who is also Chairman
of our Compensation, Nominating and Governance Committee, and
(4) subsequent grants of options to purchase 3,750 of
our ordinary shares granted each quarter to each of our
non-employee directors which options are fully vested and
exercisable upon the date of grant. None of our directors has to
date received any cash compensation for his or her services as a
director other than reimbursement of expenses. We also pay an
annual cash retainer and per meeting cash fee to each of our
directors.
Board of
Directors and Officers
Our current board of directors consists of eight directors,
certain of whom were appointed by the shareholder or group of
shareholders named in the directors biography pursuant to
rights of appointment granted to such shareholder in connection
with its purchase of our shares. Our Articles of Association
provide that we may have up to nine directors.
Under our Articles of Association, our directors (other than the
outside directors) are divided into three classes. Each class of
directors consists, as nearly as possible, of one-third of the
total number of directors constituting the entire board of
directors (other than the outside directors). At each annual
general meeting of our shareholders, the election or re-election
of directors following the expiration of the term of office of
the directors of that class of directors, is for a term of
office that expires on the third annual general meeting
following such election or re-election, such that from 2006 and
after, each year the term of office of only one class of
directors will expire. Class I directors, consisting of
Dr. Boaz Eitan, Dr. Shlomo Kalish and Kobi
Rozengarten, will hold office until our annual meeting of
shareholders to be held in 2006. Class II directors,
55
consisting of Yossi Sela and Matty Karp, will hold office until
our annual meeting of shareholders to be held in 2007.
Class III directors, consisting of Kenneth Levy, will hold
office until our annual meeting of shareholders to be held in
2008. The directors shall be elected by a vote of the holders of
a majority of the voting power present and voting at that
meeting. Each director, will hold office until the annual
general meeting of our shareholders for the year in which his or
her term expires and until his or her successor shall be elected
and qualified.
The approval of a special majority of the holders of at least
75.0% of the voting rights represented at a general meeting is
generally required to remove any of our directors from office,
other than the outside directors. A simple majority of our
shareholders at a general meeting may elect directors in their
stead or fill any vacancy, however created, in our board of
directors. In addition, vacancies on the board of directors,
other than vacancies created by an outside director, may be
filled by a vote of a majority of the directors then in office.
Our board of directors may also appoint additional directors up
to the maximum number permitted under our Articles of
Association. A director so chosen or appointed will hold office
until the next general meeting of our shareholders.
Each of our executive officers serves at the discretion of the
board of directors and holds office until his or her successor
is elected or until his or her earlier resignation or removal.
There are no family relationships among any of our directors or
executive officers.
The Companies Law was recently amended to require that, in
addition to having one outside director with financial and
accounting expertise, a public company must have such number of
directors with financial and accounting expertise as determined
by the board of directors. This amendment became effective on
January 20, 2006.
Outside
Directors
|
|
|
Qualifications
of Outside Directors
|
Under Israeli Companies Law, companies incorporated under the
laws of the State of Israel whose shares are listed on an
exchange, including The Nasdaq National Market, are required to
appoint at least two outside directors. Mr. George Hervey and
Ms. Keidar-Malits serve as our outside directors and their terms
expire in 2009.
The Companies Law provides that a person may not be appointed as
an outside director if the person, or the persons
relative, partner, employer or any entity under the
persons control has or had during the two years preceding
the date of appointment any affiliation with the company or any
entity controlling, controlled by or under common control with
the company.
The term affiliation includes:
|
|
|
|
|
an employment relationship;
|
|
|
|
a business or professional relationship maintained on a regular
basis;
|
|
|
|
control; and
|
|
|
|
service as an office holder, excluding service as a director in
a private company prior to the first offering of its shares to
the public if such director was appointed as a director of the
private company in order to serve as an outside director
following the public offering.
|
The term office holder is defined as a director, general
manager, chief business manager, deputy general manager, vice
general manager, executive vice president, vice president, other
manager directly subordinate to the general manager or any other
person assuming the responsibilities of any of the foregoing
positions, without regard to such persons title.
No person can serve as an outside director if the persons
position or other business create, or may create, a conflict of
interests with the persons responsibilities as an outside
director or may otherwise interfere with the persons
ability to serve as an outside director. If at the time an
outside director is appointed all current members of the board
of directors are of the same gender, then that outside director
must be of the other gender.
56
A recent amendment to the Companies Law requires that at least
one of the appointed outside directors have financial and
accounting expertise and that the other outside director meet
certain professional qualifications. The regulations
implementing the amendment define a director with financial and
accounting expertise as a director whose education, professional
experience and skills enable him to understand, on a high level,
matters relating to business, accounting, internal auditing and
financial statements, and who as a result is able to thoroughly
comprehend the financial statements of the company and initiate
debate regarding the manner in which financial information is
presented. The regulations define a director who meets certain
professional qualifications as a director who satisfies one of
the following requirements: (i) the director holds an
academic degree in either economics, business administration,
accounting, law or public administration, (ii) the director
either holds an academic degree in any other field or has
completed higher education in the primary field of business of
the company or in an area which is relevant to the office of an
outside director, (iii) the director has at least five
(5) years of experience serving in one or more of the
following capacities: (a) in a senior management position
of a corporation with a substantial scope of business,
(b) in a senior position in the primary field of business
of the company or (c) in a senior position of public
administration. Based on information provided by Mr. George
Hervey and Ms. Ida Keidar-Malits, our board of directors has
resolved that each such individual possesses the requisite
financial and accounting expertise as required under the
Companies Law and the regulations promulgated thereunder.
Until the lapse of two years from termination of office, a
company may not engage an outside director to serve as an office
holder and cannot employ or receive services from that person,
either directly or indirectly, including through a corporation
controlled by that person.
|
|
|
Election
of Outside Directors
|
Outside directors are elected by a majority vote at a
shareholders meeting, provided that either:
|
|
|
|
|
the majority of shares voted at the meeting (not including
abstentions), including at least one-third of the shares of
non-controlling shareholders voted at the meeting, vote in favor
of the election of the outside director; or
|
|
|
|
the total number of shares held by non-controlling shareholders
and voted against the election of the outside director does not
exceed one percent of the aggregate voting rights in the company.
|
The initial term of an outside director is three years and he or
she may be reelected to one additional term of three years by a
majority vote at a shareholders meeting, subject to the
conditions described above for election of outside directors.
Outside directors may only be removed by the same percentage of
shareholders as is required for their election, or by a court,
and then only if the outside directors cease to meet the
statutory requirements for their appointment or if they violate
their duty of loyalty to the company. If an outside directorship
becomes vacant, a companys board of directors is required
under the Companies Law to call a shareholders meeting
immediately to appoint a new outside director.
Each committee of a companys board of directors is
required to include at least one outside director and the audit
committee is required to include all of the outside directors.
An outside director is entitled to compensation as provided in
regulations promulgated under the Companies Law and is otherwise
prohibited from receiving any other compensation, directly or
indirectly, in connection with services provided as an outside
director. The regulations provide three alternatives for cash
compensation to outside directors: (1) a fixed amount
determined by the regulations, (2) an amount within a range
contained in the regulations, or (3) an amount proportional
to the amount paid to the other directors of the company
provided that such proportional amount (A) may not be lower
than the compensation granted to all other directors of the
company who are not controlling shareholders of the company or
employees or service providers of the company or its affiliates
and (B) does not exceed the average compensation granted to
all such directors. A company may also issue shares or options
to an outside director in an average amount which (A) may
not be lower than the amount granted to directors who are not
controlling shareholders of the company or employees or service
providers of the company or its affiliates; and (B) may not
exceed the average amount granted to all such directors.
Compensation determined in any manner (other than cash
compensation at the fixed amount determined by the regulations)
requires the approval of a companys shareholders. All
outside directors must receive identical compensation.
57
Under the rules of The Nasdaq National Market, a majority of
directors must meet the definition of independence contained in
the rules. Our board of directors has determined that all of our
directors, other than our Chief Executive Officer and Chairman,
Dr. Boaz Eitan, and our President, Kobi Rozengarten, meet
the majority independence standards contained in the rules of
The Nasdaq National Market. We do not believe that any of these
directors have a relationship that would preclude a finding of
independence under these rules and, in reaching their
determination, our board of directors determined that the other
relationships that these directors have with us do not impair
their independence.
Audit
Committee
|
|
|
Companies
Law Requirements
|
Under the Companies Law, the board of directors of any company
whose shares are listed on any exchange must also appoint an
audit committee comprised of at least three directors including
all of the outside directors, but excluding the:
|
|
|
|
|
chairman of the board of directors;
|
|
|
|
general manager;
|
|
|
|
chief executive officer;
|
|
|
|
controlling shareholder; and
|
|
|
|
any director employed by the company or who provides services to
the company on a regular basis.
|
Under The Nasdaq National Market rules, we are required to
maintain an audit committee consisting of at least three
independent directors, all of whom are financially literate and
one of whom has accounting or related financial management
expertise. Our audit committee members are required to meet
additional independence standards, including minimum standards
set forth in rules of the Securities and Exchange Commission and
adopted by The Nasdaq National Market.
|
|
|
Approval
of Transactions with Office Holders and Controlling
Shareholders
|
The approval of the audit committee is required to effect
specified actions and transactions with office holders and
controlling shareholders. The term controlling shareholder
includes a shareholder that holds 50.0% or more of the voting
rights in a public company; if the company has no shareholder
that owns more than 50.0% of its voting rights, then the term
also includes any shareholder that holds 25.0% or more of the
voting rights of the company. The audit committee may not
approve an action or a transaction with a controlling
shareholder or with an office holder unless at the time of
approval the company has two outside directors, both of whom are
serving as members of the audit committee and at least one of
whom was present at the meeting at which the approval was
granted.
Our board of directors has adopted an audit committee charter
setting forth the responsibilities of the audit committee
consistent with the rules of the Securities and Exchange
Commission and The Nasdaq National Market rules which include:
|
|
|
|
|
retaining and terminating the companys independent
accountants, subject to shareholder ratification;
|
|
|
|
pre-approval of audit and non-audit services provided by the
independent accountants; and
|
|
|
|
approval of transactions with office holders and controlling
shareholders, as described above, and other related-party
transactions.
|
Additionally, under the Companies Law, the role of the audit
committee is to identify irregularities in the business
management of the company in consultation with the internal
auditor and the companys independent accountants and
suggest an appropriate course of action. The audit committee
charter states that in fulfilling this role the committee is
entitled to rely on interviews and consultations with our
management, our internal
58
auditor and our independent public accountant, and is not
obligated to conduct any independent investigation or
verification.
Our audit committee consists of our directors, George Hervey
(Chairperson), Matty Karp and Ida Keidar-Malits. The financial
expert on the audit committee pursuant to the definition of the
Securities and Exchange Commission is George Hervey.
Compensation,
Nominating and Governance Committee
We comply with the rules of The Nasdaq National Market with
respect to the establishment and composition of a compensation
committee and a nominating committee. This committee will also
oversee matters related to our corporate governance practices.
Our compensation, nominating and governance committee consists
of our directors, Ken Levy (Chairperson), Yossi Sela and Ida
Keidar Malits. Our board of directors has adopted a
compensation, nominating and governance committee charter
setting forth the responsibilities of the committee consistent
with The Nasdaq National Market rules which include:
|
|
|
|
|
determining the compensation of our Chief Executive Officer and
other executive officers;
|
|
|
|
granting options to our employees and the employees of our
subsidiaries;
|
|
|
|
recommending candidates for nomination as members of our board
of directors; and
|
|
|
|
developing and recommending to the board corporate governance
guidelines and a code of business ethics and conduct in
accordance with applicable laws.
|
Internal
Auditor
Under the Companies Law, the board of directors must appoint an
internal auditor nominated by the audit committee. The role of
the internal auditor is to examine whether a companys
actions comply with applicable law and orderly business
procedure. Under the Companies Law, the internal auditor may be
an employee of the company but not an interested party or an
office holder, or affiliate, or a relative of an interested
party or an office holder, nor may the internal auditor be the
companys independent accountant or its representative. An
interested party is defined in the Companies Law as a 5.0% or
greater shareholder, any person or entity who has the right to
designate one director or more or the chief executive officer of
the company or any person who serves as a director or as a chief
executive officer. In December 2005, our board of directors
appointed the firm of Chaikan-Cohen as our internal auditor.
As of December 31, 2005, we had 236 employees of whom 233
were based in Israel and three in the United States. The
breakdown of our employees by department is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
Department
|
|
2002
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Research and
development(1) (2)
|
|
|
94
|
|
|
|
121
|
|
|
|
165
|
|
|
|
206
|
|
Sales and marketing
|
|
|
4
|
|
|
|
9
|
|
|
|
9
|
|
|
|
12
|
|
Management and administration
|
|
|
5
|
|
|
|
7
|
|
|
|
11
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
103
|
|
|
|
137
|
|
|
|
185
|
|
|
|
236
|
|
|
|
|
(1) |
|
Research and development personnel are engaged in internal
research and development efforts and in providing design and
product development services to our licensees. |
|
(2) |
|
Includes employees temporarily loaned to our former joint
venture, Infineon Technologies Flash in 2003 and 2004. |
Under applicable Israeli law, we and our employees are subject
to protective labor provisions, including restrictions on
working hours, minimum wages, minimum vacation, sick pay,
severance pay and social security as well as equal opportunity
and anti-discrimination laws. Orders issued by the Israeli
Ministry of Labor and Welfare make certain industry-wide
collective bargaining agreements applicable to us. These
agreements affect matters such as cost of living adjustments to
salaries, length of working hours and week, recuperation, travel
expenses, and pension rights. Our employees are not represented
by a labor union. We provide our employees with benefits and
working conditions above the required minimum and which we
believe are competitive with
59
benefits and working conditions provided by similar companies in
Israel. We have entered into employment agreements with all of
our Israeli employees and with our senior non-Israeli employees.
Competition for qualified personnel in our industry is intense
and we dedicate significant resources to employee retention. We
have never experienced labor-related work stoppages and believe
that our relations with our employees are good.
Share
Ownership by Directors and Executive Officers
For information regarding ownership of our ordinary shares by
our directors and executive officers, see Item 7
Major Shareholders and Related Party Transactions.
Share
Option Plans
We have adopted three share option/incentive plans and, as of
February 28, 2006, we had 5,684,390 ordinary shares
reserved for issuance under these plans of which options to
purchase 4,609,441 ordinary shares at a weighted average
exercise price of $11.73 per share are outstanding. This
amount includes 728,125 ordinary shares that we have issued
and that are unpaid and are held in trust by the trust company
of our Israeli counsel, Eitan, Mehulal, Pappo, Kugler,
Advocates Patent Attorneys, for delivery to the
Companys employee option plan trustee upon exercise of
options outstanding under our share option plans. As of
February 28, 2006, 1,830,970 options were vested and
exercisable. In addition, we have 30,800 options
outstanding, which were not granted under our stock option plan,
of which 30,800 are vested and exercisable.
Our 2003 share option plan provides for the grant of
options to our directors, employees, consultants and service
providers, and to the directors, employees, consultants and
service providers of our subsidiaries and affiliates. The
2003 share option plan also permits the issuance of
restricted shares under terms and conditions to be further
determined by our board of directors.
As of February 28, 2006, there were 1,074,949 ordinary
shares available for issuance under the plan, and options to
purchase 3,169,032 ordinary shares have been granted (not
including exchanged options from the 1997 and 2001 plans) and
1,344,358 were vested and exercisable. The number of shares
available for issuance under the plan is automatically increased
on the first trading day in January of each calendar year during
the term of the 2003 share option plan beginning with
calendar year 2005 by the lowest of (1) 1,333,333 ordinary
shares, subject to adjustments as provided in the plan,
(2) a number equal to 4% of our outstanding ordinary shares
on December 31 in the previous calendar year, and
(3) an amount determined by our board of directors. Any
unvested or other option that terminate without exercise revert
to the plan and become available for future issuance.
The plan is administered by our compensation, nominating and
governance committee which makes recommendations to our board of
directors regarding grantees of options and the terms of the
grant, including, exercise prices, method of payment, vesting
schedules, acceleration of vesting and the other matters
necessary in the administration of the plan. Options granted
under the plan to eligible employees and office holders who are
Israeli residents may be granted under Section 102(b)(2) of
the Israeli Income Tax Ordinance pursuant to which the options
or the ordinary shares issued upon their exercise and/or other
shares received subsequently following any realization of
rights, including without limitation bonus shares, must be
allocated or issued to a trustee and be held in trust for the
lesser of (a) 30 months, or (b) two years
following the end of the tax year in which the options are
granted, provided that options granted after January 1,
2006 are only subject to being held in trust for two years.
Under Section 102, (1) any tax payable by an employee
from the grant or exercise of the options is deferred until the
transfer of the options or ordinary shares by the trustee to the
employee or upon the sale of the options or ordinary shares and
(2) gains are subject to capital gains tax of 25.0%. We
will not be entitled to a tax deduction with respect of the
issuance or exercise of options.
60
Options granted under the plan to U.S. residents may
qualify as incentive stock options within the meaning of
Section 422 of the Code. The exercise price for incentive
stock options must not be less than the fair market value on the
date the option is granted, or 110.0% of the fair market value
if the optionholder holds more than 10.0% of our share capital.
Options granted under our share option plans generally vest over
five years such that 40.0% vest after two years and an
additional 20.0% each year thereafter. Typically, options
granted upon promotion of employees vest over five years such
that 20.0% vest each year. In addition, we have granted options
under our stock option plans that vest at the end of five years.
Generally, any option not exercised within 10 years from
the grant date expires unless extended by the board of
directors. If we terminate an employee for cause, all of the
employees vested and unvested options expire at the time
of delivery of the notice of discharge, unless determined
otherwise by the committee. Upon termination of employment for
any other reason, an employee may exercise his or her vested
options within three months of the date of termination, unless
prescribed otherwise by the committee. Upon termination of
employment due to death or disability, an employee may exercise
his or her vested options within a period of between six and
twelve months from the date of death or disability, depending on
the terms of the employees option agreement. Upon
termination, any option not exercised within the aforesaid
periods or unvested options return to the plan for re-issuance.
In the event of a merger, consolidation, reorganization or
similar transaction in which our ordinary shares are exchanged
for shares of another corporation, each optionholder will be
entitled to purchase the number of shares of the other
corporation as it would have received if he or she had exercised
its option immediately prior to such transaction. In the event
of a change of control, or merger, consolidation, reorganization
or similar transaction resulting in the acquisition of at least
50.0% of our voting power, or the sale of all or substantially
all of our assets, each optionholder is required to participate
in the transaction and sell or exchange their shares received
pursuant to the exercise of an option.
Our 2001 share option plan provides for the grant of
options to our directors, employees, consultants and service
providers, and to the directors, employees, consultants and
service providers of our subsidiaries. As of February 28,
2006, we have granted options to
purchase 665,789 shares under our 2001 share
option plan of which 615,789 were exchanged to the
2003 share option plan subsequent to the Israeli tax reform
in 2003 and 42,000 are vested and exercisable.
Generally, options granted under the plan to eligible employees
who are Israeli residents have been granted under
Section 102 of the Israeli Income Tax Ordinance (as was
then in effect), pursuant to which the options or the ordinary
shares issued upon their exercise and/or other shares received
subsequently following any realization of rights, including
without limitation bonus shares must be allocated or issued to a
trustee and held in trust for at least two years following the
date of grant. Under Section 102 (then in effect) the
employee will recognize capital gain on the earlier of:
(i) transfer of the options or ordinary shares from the
trustee to the employee; or (ii) upon the sale of ordinary
shares issued upon exercise of options. Generally, under
Section 102 (then in effect) when the employee is required
to recognize income, gains are subject to tax according to the
employees marginal tax rate. We will be entitled for a tax
deduction with respect to such capital gain.
If we terminate an employee for cause, all of the
employees vested and unvested options expire at the time
of delivery of the notice of discharge. Upon termination of
employment for any other reason, an employee may exercise his or
her vested options within three months of the date of
termination. Upon termination of employment due to death or
disability, an employee may exercise his or her vested options
within six months after termination. The committee may prescribe
post-termination exercise periods different from the above. Upon
termination, any option not exercised within the aforesaid
periods or unvested options return to the plan for re-issuance.
In the event of a consolidation, reorganization or merger in
which we are not the surviving entity, or the sale of all or
substantially all of our assets or shares, the options will be
assumed or substituted with the
61
appropriate number of options to purchase shares of the other
corporation with the same rights to be granted to our ordinary
shareholders.
Our 1997 share option plan provides for the grant of
options to our directors and employees. As of February 28,
2006, we have granted options to
purchase 774,620 shares under our 1997 stock option
plan of which 330,008 options were exchanged to the
2003 share option plan subsequent to the Israeli tax reform
in 2003 and 444,612 are vested and exercisable under this plan.
Generally, options granted under the plan to eligible employees
who are Israeli residents have been granted under
Section 102 of the Israeli Income Tax Ordinance (as was
then in effect), pursuant to which the options or the ordinary
shares issued upon their exercise and/or other shares received
subsequently following any realization of rights, including
without limitation bonus shares must be allocated or issued to a
trustee and held in trust for at least two years following the
date of grant. Under Section 102 (then in effect) the
employee will recognize capital gain on the earlier of:
(i) transfer of the options or ordinary shares from the
trustee to the employee; or (ii) upon the sale of ordinary
shares issued upon exercise of options. Generally, under
Section 102 (then in effect) when the employee is required
to recognize income, gains are subject to tax according to the
employees marginal tax rate. We will be entitled for a tax
deduction with respect to such capital gain.
If we terminate an employee for cause, all of the
employees vested and unvested options expire at the time
of delivery the notice of discharge. Upon termination of
employment for any other reason, all of an employees
unvested options, other than options that may be exercised
within a certain period of time after cessation of employment,
expire. All vested options and options that may be exercised
within a certain period of time after cessation of employment
and which are not exercised within the prescribed period
terminate upon the expiration of such period. Upon termination
of employment due to retirement, disability or death, an
employee will, subject to the approval of the share option
committee, continue to enjoy rights under the plan on such terms
as the committee may determine.
In the event of a merger, consolidation, recapitalization or
similar transaction in which our ordinary shares are exchanged
for shares of another corporation, each optionholder will be
entitled to purchase such number of shares of the other
corporation as were exchangeable for the number of our ordinary
shares which such optionholder would have been entitled to
purchase except for such action.
Employee
Stock Purchase Plan
We have adopted an employee stock purchase plan, or ESPP,
pursuant to which our employees and employees of our
subsidiaries may elect to have payroll deductions (or, when not
allowed under local laws or regulations, another form of
payment) made on each pay day during the offering period in an
amount not exceeding fifteen percent of the compensation which
the employees receives on each pay day during the offering
period.
On the first day of each offering period, each participating
employee will be granted an option to purchase on the exercise
date of such offering period up to a number of the
companys ordinary shares determined by dividing
(1) the employees payroll deductions accumulated
prior to such exercise date and retained in the employees
account as of the exercise date by (2) the applicable
purchase price. The applicable purchase price may be adjusted by
the board of directors and the board of directors is entitled to
determine that the purchase price shall be the discount
percentage equal to the lesser of (1) the fair market value
of an ordinary share on the exercise date, or (2) the fair
market value of an ordinary share on the offering date.
To date, we have not granted employees the right to make
purchases under the plan.
62
|
|
ITEM 7.
|
MAJOR
SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
|
The following table sets forth certain information regarding the
beneficial ownership of our outstanding ordinary shares as of
the date of this Annual Report:
|
|
|
|
|
each person who we know beneficially owns 5.0% or more of the
outstanding ordinary shares;
|
|
|
|
each of our directors individually;
|
|
|
|
each of our executive officers individually; and
|
|
|
|
all of our directors and executive officers as a group.
|
Beneficial ownership of shares is determined under rules of the
Securities and Exchange Commission and generally includes any
shares over which a person exercises sole or shared voting or
investment power. The following table includes the number of
shares underlying options that are exercisable within
60 days of the date of this Annual Report. Ordinary shares
subject to these options are deemed to be outstanding for the
purpose of computing the ownership percentage of the person
holding these options, but are not deemed to be outstanding for
the purpose of computing the ownership percentage of any other
person. The table assumes 30,532,699 ordinary shares outstanding
as of April 6, 2006.
As of the date of this Annual Report, we are aware of 15
U.S. persons that are holders of record of our ordinary
shares holding an aggregate of 2,573,214 shares.
Unless otherwise noted below, each shareholders address is
c/o Saifun Semiconductors Ltd., ELROD Building, 45
Hamelacha Street, Sappir Industrial Park, Netanya, Israel.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of
|
|
|
|
Number of Shares
|
|
|
Shares Beneficially
|
|
Name and Address
|
|
Beneficially Owned
|
|
|
Owned
|
|
|
Principal
shareholders:
|
|
|
|
|
|
|
|
|
Dr. Boaz Eitan(1)
|
|
|
11,027,415
|
|
|
|
36.1
|
%
|
IDB Holding Corporation Ltd.(2)
|
|
|
2,708,859
|
|
|
|
8.9
|
|
Argos Capital Appreciation Master
Fund LP(3)
|
|
|
1,589,891
|
|
|
|
5.2
|
|
Directors and executive
officers:
|
|
|
|
|
|
|
|
|
Dr. Boaz Eitan(1)
|
|
|
11,027,415
|
|
|
|
36.1
|
%
|
Kobi Rozengarten(4)
|
|
|
400,610
|
|
|
|
1.3
|
|
Ramy Langer
|
|
|
|
|
|
|
|
|
Igal Shany
|
|
|
|
|
|
|
|
|
Eduardo Maayan
|
|
|
|
|
|
|
|
|
Dr. Meir Janai(5)
|
|
|
56,000
|
|
|
|
*
|
|
Dr. Guy Cohen(6)
|
|
|
5,600
|
|
|
|
*
|
|
Kenneth Levy(7)
|
|
|
105,083
|
|
|
|
*
|
|
Matty Karp(8)
|
|
|
1,037,048
|
|
|
|
3.4
|
|
Dr. Shlomo Kalish(9)
|
|
|
32,083
|
|
|
|
*
|
|
Yossi Sela(10)
|
|
|
1,243,524
|
|
|
|
4.1
|
|
George Hervey(11)
|
|
|
33,750
|
|
|
|
*
|
|
Ida Keidar-Malits
|
|
|
|
|
|
|
|
|
All directors and executive
officers as a group
|
|
|
13,941,113
|
|
|
|
45.3
|
%
|
|
|
|
(1) |
|
Based on a Schedule 13G filed on February 14, 2006 and
on other information provided to us, the number of shares
beneficially owned consists of 5,003,774 ordinary shares and
options to purchase 22,523 ordinary shares held directly by
Dr. Eitan, 1,905,780 ordinary shares held by Adi &
Gal Ltd., 1,429,336 ordinary shares held by Sharon &
Yoav Ltd., 1,200,000 ordinary shares held by Shikmat Eitan Ltd.,
952,892 ordinary shares held by Yonatan & Maya
Ltd., 476,444 ordinary shares held by Batya and Yoseph Ltd. and
10,000 ordinary shares held by MIRAGE BVBA. Each of these
entities is jointly owned and controlled by Dr. Eitan and
his wife. This number also includes 26,666 ordinary shares owned
by Dr. Eitans wife. Dr. Eitan disclaims
beneficial ownership of the shares held by the foregoing except
to the extent of his pecuniary interest therein. |
63
|
|
|
(2) |
|
Based on a Schedule 13G filed on February 6, 2006 and
on other information provided to us, the number of shares
beneficially owned consists of 2,708,859 ordinary shares held by
Clal Electronic Industries Ltd. Clal Electronic Industries is
indirectly controlled by IDB Holding Corporation Ltd.
(IDBH). IDBH is a public company traded on the Tel
Aviv Stock Exchange. Approximately 52.0% of the outstanding
share capital of IDBH is owned by a group comprised of
(i) Ganden Investments I.D.B. Ltd., or Ganden, a private
Israeli company controlled by Nochi Dankner and his sister,
Shelly Bergman, which holds 31.02% of the equity of and voting
power in IDBH; (ii) Manor Investments-IDB Ltd., or
Manor, a private Israeli company controlled by Ruth
Manor, which holds 10.34% of the equity of and voting power in
IDBH; and (iii) Avraham Livnat Investments
(2002) Ltd., or Livnat, a private Israeli company
controlled by Avraham Livnat, which holds 10.34% of the equity
of and voting power in IDBH. Ganden, Manor and Livnat, owning in
the aggregate approximately 51.7% of the equity of and voting
power in IDBH, entered into a Shareholders Agreement relating,
among other things, to their joint control of IDBH, the term of
which is until May 19, 2023. In addition, Shelly Bergman
beneficially holds approximately 7.3% of the equity of and
voting power in IDBH. The address of Nochi Dankner is The
Triangular Tower, 44th Floor, 3 Azrieli Center, Tel Aviv
67023, Israel. The address of Shelly Bergman is 12 Recanati
Street, Ramat Aviv Gimmel, Tel Aviv, Israel. The address of Ruth
Manor is 26 Hagderot Street, Savyon, Israel. The address of
Mr. Avraham Livnat is Taavura Junction, Ramle, Israel.
These individuals disclaim beneficial ownership of the shares
owned by the foregoing entities except to the extent of their
pecuniary interest therein. |
|
(3) |
|
Based on a Schedule 13G filed on January 31, 2006 and
on other information provided to us, the number of shares
beneficially owned consists of 1,589,891 ordinary shares. The
general partner of Argos Appreciation Master Fund LP is
Argo Capital Management, Inc. which is wholly-owned by Ephraim
Gildor. The address of Argos Capital Appreciation Master
Fund LP is 211 West 61st Street, New York, New
York. |
|
(4) |
|
The number of shares beneficially owned consists of 389,850
ordinary shares and options to purchase 10,760 ordinary shares. |
|
(5) |
|
The number of shares beneficially owned consists of options to
purchase 56,000 ordinary shares. |
|
(6) |
|
The number of shares beneficially owned consists of options to
purchase 5,600 ordinary shares. |
|
(7) |
|
The number of shares beneficially owned consists of 83,000
ordinary shares and options to purchase 22,083 ordinary shares. |
|
(8) |
|
Based on a Schedule 13G filed on February 14, 2006 and
on other information provided to us, the number of shares
beneficially owned consists of 730,744 ordinary shares held by
K.T. Concord Venture Fund (Cayman) L.P. and
146,051 ordinary shares held by K.T. Concord Venture Fund
(Israel) L.P. and 128,143 ordinary shares held by Concord
Venture I Annex-B L.P. and options to purchase 32,083 ordinary
shares held by Mr. Karp. Mr. Karp is a managing
partner of Concord Ventures and, by virtue of his position, may
be deemed to have voting and investment power, and thus
beneficial ownership, with respect to the shares held by these
entities. Mr. Karp disclaims such beneficial ownership
except to the extent of his pecuniary interest therein. |
|
(9) |
|
The number of shares beneficially owned consists of options to
purchase 32,083 ordinary shares. |
|
(10) |
|
Based on a Schedule 13G filed on February 9, 2006 and
on other information provided to us, the number of shares
beneficially owned consists of 1,216,774 ordinary shares held by
entities affiliated with Gemini Israel Funds Ltd., which include
Gemini Israel II Parallel Fund L.P., Gemini Israel II L.P.,
Gemini Israel III L.P., Advent PGGM Gemini L.P., Gemini Israel
III Parallel Fund L.P., Gemini Partner Investors L.P., and
Gemini Israel III Overflow Fund L.P., and options to purchase
26,750 ordinary shares held by Mr. Sela. Mr. Sela is a
managing partner of Gemini Israel Funds and, by virtue of his
position, may be deemed to have voting and investment power, and
thus beneficial ownership, with respect to the shares held by
the Gemini entities. Mr. Sela disclaims such beneficial
ownership except to the extent of his pecuniary interest therein. |
|
(11) |
|
The number of shares beneficially owned consists of options to
purchase 33,750 ordinary shares. |
64
During the fourth quarter of 2004 and the first quarter of 2005,
certain of our principal shareholders sold our ordinary shares.
Ordinary shares beneficially owned by Tower Semiconductors,
representing 11.9% of our outstanding ordinary shares, were sold
in the fourth quarter of 2004 primarily to IDB Holding
Corporation Ltd., as well as to entities affiliated with Gemini
Israel Funds, entities affiliated with Concord Ventures, and
certain other shareholders. In February 2005, our ordinary
shares beneficially owned by Infineon Technologies were sold to
Argos Capital Appreciation Master Fund LP. Concurrently
with the sale by Infineon Technologies of its ordinary shares,
our Chief Executive Officer and Chairman, Boaz Eitan, and our
President, Kobi Rozengarten, sold 265,000 and
132,530 shares, respectively, to Argos Capital Appreciation
Master Fund L.P. In March 2005, 96,774 ordinary shares
owned by Dr. Boaz Eitan were sold to two of our individual
shareholders.
Our majority shareholders may have different voting rights under
particular circumstances. See Item 10 Memorandum and
Articles of Association for more information.
|
|
B.
|
RELATED
PARTY TRANSACTIONS
|
Our policy is to enter into transactions with related parties on
terms that, on the whole, are no more favorable, or no less
favorable, than those available from unaffiliated third parties.
Based on our experience in the business sectors in which we
operate and the terms of our transactions with unaffiliated
third parties, we believe that all of the transactions described
below met this policy standard at the time they occurred.
Sale of
Shares to Argos Capital Appreciation Master Fund
In February 2005, concurrently with the sale by Infineon
Technologies of 1,072,407 of our ordinary shares, our Chief
Executive Officer and Chairman, Boaz Eitan, and our President,
Kobi Rozengarten, sold 265,000 and 132,530 shares,
respectively, to Argos Capital Appreciation Master
Fund L.P. at a price per share of $20.75.
At the time of the sale, Argos Capital Appreciation Fund
undertook to us not to offer, sell, contract to sell, pledge or
otherwise dispose of the shares purchased from Infineon
Technologies and Messrs. Eitan and Rozengarten without our
prior written consent prior to February 25, 2007, other
than in connection with an acquisition of our company.
Registration
Rights
Demand
registration rights
At any time after nine months following the completion of our
initial public offering, at the request of one or more of our
former preferred shareholders that hold at least 33% of our then
outstanding ordinary shares held by our former preferred
shareholders, we must use our best efforts to register any or
all of these shareholders ordinary shares as follows:
|
|
|
|
|
before we become eligible under applicable securities laws to
file a registration statement on
Form F-3,
which will not be until at least 12 months after the
closing of our initial public offering, we are required to
effect up to two such registrations, but only if the minimum
aggregate offering price of the shares to be registered, net of
underwriting discounts and commissions, exceeds
$5.0 million, and
|
|
|
|
after we become eligible under applicable securities laws to
file a registration statement on
Form F-3,
we are required to effect an unlimited number of registrations,
but only (1) if the minimum aggregate offering price of the
shares to be registered, net of underwriting discounts and
commissions, exceeds $500,000, and (2) if we have not
effected an offering pursuant to a demand registration or a
piggy back registration within the preceding
six-month period in which all requesting shareholders were able
to sell the number of ordinary shares they requested to include.
|
Upon receipt of a request, we must also give notice of the
registration to our other former preferred shareholders and to
our other shareholders who held ordinary shares issued prior to
our initial public offering, including entities controlled by
Dr. Boaz Eitan, our Chief Executive Officer and Chairman,
and include in the registration any ordinary shares that they
request to include.
65
Piggyback
registration rights
Our former preferred shareholders and our other shareholders who
held ordinary shares issued prior to our initial public
offering, including entities controlled by Dr. Boaz Eitan,
our Chief Executive Officer and Chairman, have the right to
request that we include their ordinary shares in any
registration statements filed by us in the future for the
purposes of a public offering, subject to specified limitations.
Termination
All registration rights terminate on the fifth anniversary of
the closing of our initial public offering and, with respect to
any individual shareholder, at such time as all registrable
securities of such shareholder may be sold publicly without
restriction pursuant to Rule 144(k) under the Securities
Act.
Expenses
We will pay all expenses incurred in carrying out the above
registrations (excluding underwriters commissions and fees
or any fees of others employed by selling shareholders), as well
as the reasonable fees and expenses of one legal counsel for the
selling shareholders in each registration.
Agreements
with Directors and Officers
Employment
agreements
We have entered into employment agreements with each of our
officers. All of these agreements contain industry-standard
provisions regarding non-competition, confidentiality of
information and assignment of inventions. The enforceability of
covenants not to compete in Israel is limited.
Our employment agreement with Dr. Boaz Eitan, our Chairman
and Chief Executive Officer, effective as of July 1, 2004,
shall continue unless terminated by either Dr. Eitan or the
Company upon one year notice. We shall have the right not to
take advantage of the notice period (in full or in part) and may
terminate the employment of Dr. Eitan at any time during
the notice period, provided that we shall pay Dr. Eitan
consideration, payments and social benefits for the remainder of
the notice period. We may also terminate the agreement
immediately for cause.
Loan
agreements
We have entered into loan agreements with a number of our
directors and executive officers. None of these agreements has
been materially modified since we made them. Additionally, all
loans made to directors and executive officers have been repaid
except for the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and accrued
|
|
|
|
|
|
|
|
|
|
|
|
|
|
interest as of
|
|
|
|
|
|
Date of
|
|
|
|
|
Nature of
|
|
|
December 31,
|
|
|
|
Name
|
|
loan
|
|
|
Terms
|
|
transaction
|
|
|
2005
|
|
|
Repayment
|
|
Eduardo Maayan
Vice President Product Development
|
|
|
June 2001
|
|
|
Loan in the amount of $125,000
bearing interest which accrues annually at a rate of 4% plus
applicable Israeli value added tax.
|
|
|
|
|
|
$
|
154,842
|
|
|
Will be repaid following the
completion of a proposed follow-on offering.*
|
|
|
* |
In addition, at our option, the loan is repayable prior to a
merger or acquisition or sale of substantially all of our assets
or any similar transactions.
|
Exculpation,
indemnification and insurance
Our Articles of Association permit us to exculpate, indemnify
and insure our directors and officers to the fullest extent
permitted by the Companies Law. We have entered into agreements
with each of our office holders undertaking to indemnify them to
the fullest extent permitted by law, to the extent that these
liabilities are not covered by insurance.
66
Legal
Services
One of the senior partners of our legal counsel in Israel,
Eitan, Mehulal, Pappo, Kugler, Advocates Patent
Attorneys, is the wife of our Chief Executive Officer and
Chairman, Dr. Boaz Eitan. Our expenses to Eitan, Mehulal,
Pappo, Kugler, Advocates-Patent Attorneys or its predecessors
for fees for legal services and disbursements totaled $599,000
in 2003, $695,000 in 2004 and $865,000 in 2005.
|
|
C.
|
INTERESTS
OF EXPERTS AND COUNSEL
|
Not applicable.
|
|
ITEM 8.
|
FINANCIAL
INFORMATION
|
|
|
A.
|
CONSOLIDATED
STATEMENTS AND OTHER FINANCIAL INFORMATION
|
Financial
Statements
See Item 18 for audited consolidated financial statements.
Legal
Proceedings
Former CEO of Ingentix Ltd. In October 2002, the former
Chief Executive Officer of Ingentix Ltd., the predecessor of
Infineon Technologies Flash Israel, filed a claim against us and
Ingentix in the Tel Aviv Labor Court seeking an order requiring
us to reinstate options to purchase 420,000 of our ordinary
shares at an exercise price of $1.69 per share. In
addition, the plaintiff is seeking from Infineon Technologies
Flash Israel cash damages of approximately $299,000 and
reinstatement of stock appreciation rights granted by Ingentix.
In January 2004, we submitted our response to the
plaintiffs claim. Subsequently, we agreed to commence
mediation in August 2004 at the suggestion of the court in an
effort to resolve without further court proceedings. The
mediation ended with no resolution to the proceedings. We
believe that we have meritorious defenses to the claims alleged
by the plaintiff and intend to defend this suit vigorously in
the event court proceedings resume. We have also submitted in
the Tel Aviv District court a counter claim against the
plaintiff for breach of contract and fiduciary duty seeking cash
damages of approximately $2.4 million, which we intend to
pursue vigorously. We have recorded a provision with respect to
this claim, based on an estimate of our management and based on
the opinion of our legal counsel.
Tower Semiconductor Ltd. In May 2002, Tower
Semiconductors agreed to pay us up to $2.5 million in
exchange for certain concessions we agreed to make to one of our
licensees with whom Tower was negotiating a separate agreement
at such time. In early June 2005, Tower informed us that it
believes it was no longer required to make such payments. We
believe that Tower must continue making these payments to us
and, accordingly, in the third and fourth quarters of 2005,
after Tower did not make any such payments, we offset an
aggregate of $100,000 from payments we made to Tower under our
license agreement with it. Subsequently, in December 2005, as a
result of further discussions with Tower, we agreed not to
unilaterally take any further offsets until the third quarter of
2006, so that we and Tower could try to resolve the disagreement
amicably.
On March 14, 2006, shortly after the initial filing of the
registration statement in connection with a proposed follow-on
offering, Tower forwarded to us a letter from Towers
counsel, which alleged that we had breached various provisions
of our license agreement with Tower. Among other allegations,
the letter alleges that we failed to make certain payments to
Tower, failed to include in certain license agreements
provisions regarding the licensees possible manufacture of
their licensed products at Tower, failed to manufacture certain
of our own products at Tower, and that we were not entitled to
take the offsets described above. We believe that we have
meritorious defenses to the allegations contained in the letter
or any damages Tower may claim it has suffered. Further, while
we cannot quantify the amount of damages that Tower could claim
from us in a formal legal proceeding, based on our understanding
of the breaches alleged by Tower to date, and without accounting
for the defenses and counterclaims that we believe we have, we
do not believe any formal legal proceeding related to these
allegations would have a material effect on our business,
financial condition or results of operations if such proceedings
were determined adversely to us.
67
Although no assurance can be provided that we will prevail, in
the event that Tower commences any formal legal proceeding
against us based upon the allegations in the letter, we intend
to contest Towers claims vigorously and to seek to recover
amounts due to us from Tower, as well as damages for any harm
caused to us.
We are not currently a party to any other disputes or legal
proceedings other than those described above.
Dividend
Policy
We have never declared or paid any cash dividends on our
ordinary shares and we do not anticipate paying any cash
dividends on our ordinary shares in the future. We currently
intend to retain all future earnings to finance our operations
and to expand our business. Any future determination relating to
our dividend policy will be made at the discretion of our board
of directors and will depend on a number of factors, including
future earnings, capital requirements, financial condition and
future prospects and other factors our board of directors may
deem relevant.
B. SIGNIFICANT
CHANGES
Except as otherwise disclosed in this Annual Report, there has
been no significant change in our financial position since
December 31, 2005.
|
|
ITEM 9.
|
THE
OFFER AND LISTING
|
|
|
A.
|
OFFER AND
LISTING DETAILS
|
Our ordinary shares began trading publicly on The Nasdaq
National Market on November 9, 2005. Prior to that date,
there was no public market for our ordinary shares. The
following table lists the high and low closing sale prices for
our ordinary shares for the periods indicated as reported by The
Nasdaq National Market.
|
|
|
|
|
|
|
|
|
Most Recent Five
Months
|
|
High
|
|
|
Low
|
|
|
March 2006 (through April 10,
2006)
|
|
$
|
33.14
|
|
|
$
|
27.86
|
|
February 2006
|
|
$
|
33.81
|
|
|
$
|
28.93
|
|
January 2006
|
|
$
|
37.90
|
|
|
$
|
33.77
|
|
December 2005
|
|
$
|
31.47
|
|
|
$
|
27.69
|
|
November 2005
|
|
$
|
35.38
|
|
|
$
|
29.00
|
|
On April 10, 2006, the last reported sale price of our
ordinary shares on The Nasdaq National Market was $33.00 per
share. According to the our transfer agent, as of April 10,
2006, there were approximately 86 holders of record of our
ordinary shares.
Not applicable.
Our ordinary shares have traded publicly on the Nasdaq National
Market under the symbol SFUN since November 9,
2005.
Not applicable.
Not applicable.
68
Not applicable.
|
|
ITEM 10.
|
ADDITIONAL
INFORMATION
|
Not applicable.
|
|
B.
|
MEMORANDUM
AND ARTICLES OF ASSOCIATION
|
We are registered with the Israeli Registrar of Companies in
Jerusalem. Our registration number
is 51-239733-2
Objects
Our objects under our memorandum of association are to engage in
any lawful activity in order to achieve our purposes. According
to our memorandum of association, the purposes for which we were
established are: (1) to develop, manufacture and sell
semiconductor technologies and related products, (2) to
engage in the operation and exploitation of software business,
and (3) to perform any activity permitted by law.
Transfer
of Shares and Notices
Fully paid ordinary shares are issued in registered form and may
be freely transferred under our Articles of Association unless
the transfer is restricted or prohibited by another instrument,
Israeli law or the rules of a stock exchange on which the shares
are traded. Our Articles of Association provide that each
shareholder of record is entitled to receive at least
21 days prior notice of any shareholders
meeting.
Election
of Directors
Our ordinary shares do not have cumulative voting rights for the
election of directors. Rather, under our Articles of Association
our directors are elected by the holders of a simple majority of
our ordinary shares at a general shareholder meeting. As a
result, the holders of our ordinary shares that represent more
than 50.0% of the voting power represented at a shareholder
meeting have the power to elect any or all of our directors
whose positions are being filled at that meeting, subject to the
special approval requirements for outside directors under the
Israeli Companies Law described under Item 6 Board
Practice Outside Directors.
Dividend
and Liquidation Rights
Our board of directors may declare a dividend to be paid to the
holders of ordinary shares in proportion to the paid up capital
attributable to the shares that they hold. Dividends may only be
paid out of our profits and other surplus funds, as defined in
the Israeli Companies Law, as of the end of the most recent
fiscal year or as accrued over a period of two years, whichever
is higher, provided that there is no reasonable concern that a
payment of a dividend will prevent us from satisfying our
existing and foreseeable obligations as they become due. In the
event of our liquidation, after satisfaction of liabilities to
creditors, our assets will be distributed to the holders of
ordinary shares in proportion to the paid up capital
attributable to the shares that they hold. This right may be
affected by the grant of preferential dividend or distribution
rights to the holders of a class of shares with preferential
rights that may be authorized in the future.
Shareholder
Meetings
We are required to convene an annual general meeting of our
shareholders once every calendar year within a period of not
more than 15 months following the preceding annual general
meeting. Our board of directors is required to convene a special
general meeting of our shareholders at the request of two
directors or one quarter of the members of our board of
directors or at the request of one or more holders of 5.0% or
more of our share capital and 1.0% of our voting power or the
holder or holders of 5.0% or more of our voting
69
power. All shareholder meetings require prior notice of at least
21 days. The chairperson of our board of directors presides
over our general meetings. Subject to the provisions of the
Companies Law and the regulations promulgated thereunder,
shareholders entitled to participate and vote at general
meetings are the shareholders of record on a date to be decided
by the board of directors, which may be between four and
60 days prior to the date of the meeting.
Quorum
In accordance with our Articles of Association, the quorum
required for an ordinary meeting of shareholders consists of at
least two shareholders present, in person or by proxy, who hold
or represent between them at least
331/3%
of our issued share capital. A meeting adjourned for lack of a
quorum generally is adjourned to the same day in the following
week at the same time and place or any time and place as the
directors designate in a notice to the shareholders. At the
reconvened meeting, the required quorum consists of at least two
shareholders present, in person or by proxy, who hold or
represent between them at least 20% of our issued share capital.
If within half an hour of the time appointed for the reconvened
meeting, the required quorum is not present, the reconvened
meeting shall be convened, provided at least two or more
shareholders present in person or by proxy, unless the meeting
was called pursuant to a request by our shareholders in which
case the quorum required is the number of shareholders required
to call the meeting as described under
Shareholder Meetings.
Voting
Except as provided below under Limitations on
Voting, holders of our ordinary shares have one vote for
each ordinary share held on all matters submitted to a vote of
shareholders at a shareholder meeting. Shareholders may vote at
a shareholder meeting either in person or by proxy. Israeli law
does not provide for public companies such as us to have
shareholder resolutions adopted by means of a written consent in
lieu of a shareholder meeting. Shareholder voting rights may be
affected by the grant of any special voting rights to the
holders of a class of shares with preferential rights that may
be authorized in the future. The Companies Law provides that a
shareholder, in exercising his or her rights and performing his
or her obligations toward the company and its other
shareholders, must act in good faith and in an acceptable
manner, and avoid abusing his or her powers. This is required
when voting at general meetings on matters such as changes to
the articles of association, increasing the companys
registered capital, mergers and approval of related party
transactions. A shareholder also has a general duty to refrain
from depriving any other shareholder of their rights as a
shareholder. In addition, any controlling shareholder, any
shareholder who knows that its vote can determine the outcome of
a shareholder vote and any shareholder who, under the
companys articles of association, can appoint or prevent
the appointment of an office holder, is required to act with
fairness towards the company. The Companies Law does not
describe the substance of this duty, except to state that the
remedies generally available upon a breach of contract will
apply also in the event of a breach of the duty to act with
fairness, and there is no binding case law that addresses this
subject directly. Any voting agreement is also subject to
observance of these duties.
Limitations
on Voting
In general, and except as provided below, shareholders have one
vote for each ordinary share held by them and are entitled to
vote, on a non-cumulative basis, at all meetings of
shareholders. However, pursuant to a mechanism specified in our
Articles of Association, the voting rights exercisable by a
shareholder may be limited. In any situation in which the
controlled shares (as defined below) of any United
States person (as defined below) would constitute 9.9% or more
of the votes conferred by our issued and outstanding ordinary
shares, the excess shares will be considered dormant
shares under the Israeli Companies Law with the result
that they will not be entitled to any voting rights, provided
that the existence of any dormant shares may not cause a
U.S. person to exceed the 9.9% limitation as a result
of such allocation and may not cause the controlled shares of
the permitted United States shareholder (as defined below) to
constitute more than 49.9% of the voting power of all issued and
outstanding shares. The holder of dormant shares will be
entitled to receive dividends and other distributions.
70
A United States person means a United States person
as defined in Section 957(c) of the Code. Controlled
shares include, among other things, all ordinary shares
that a person owns directly, indirectly or constructively
(within the meaning of Section 958 of the Code). The
permitted United States shareholder means the United States
person, among all United States persons, the controlled shares
of which constitute as of September 29, 2005 the greatest
percentage of the total voting power of all issued and
outstanding shares of the Company.
Resolutions
An ordinary resolution requires approval by the holders of a
simple majority of the voting rights represented at the meeting,
in person, by proxy or by written ballot, and voting on the
resolution.
Under the Companies Law, unless otherwise provided in the
articles of association or applicable law, all resolutions of
the shareholders require a simple majority. A resolution for the
voluntary winding up of the company requires the approval by
holders of 75.0% of the voting rights represented at the
meeting, in person, by proxy or by written ballot and voting on
the resolution. Under our Articles of Association
(1) certain shareholders resolutions require the
approval of a special majority of the holders of at least 75.0%
of the voting rights represented at the meeting, in person, by
proxy or by written ballot and voting on the resolution, and
(2) certain shareholders resolutions require the
approval of a special majority of the holders of at least
two-thirds of the voting securities of the company then
outstanding.
Access to
Corporate Records
Under the Companies Law, all shareholders generally have the
right to review minutes of our general meetings, our shareholder
register, our Articles of Association and any document we are
required by law to file publicly with the Israeli Companies
Registrar. Any shareholder who specifies the purpose of its
request may request to review any document in our possession
that relates to any action or transaction with a related party
which requires shareholder approval under the Companies Law. We
may deny a request to review a document if we determine that the
request was not made in good faith, that the document contains a
commercial secret or a patent or that the documents
disclosure may otherwise harm our interests.
Acquisitions
under Israeli Law
Tender Offer. A person wishing to acquire
shares or any class of shares of a publicly traded Israeli
company and who would as a result hold over 90.0% of the
companys issued and outstanding share capital or of a
class of shares which are listed is required by the Companies
Law to make a tender offer to all of the companys
shareholders for the purchase of all of the issued and
outstanding shares of the company. If the shareholders who do
not respond to the offer hold less than 5.0% of the issued share
capital of the company, all of the shares that the acquirer
offered to purchase will be transferred to the acquirer by
operation of law. However, the shareholders may petition the
court to alter the consideration for the acquisition. If the
dissenting shareholders hold more than 5.0% of the issued and
outstanding share capital of the company, the acquirer may not
acquire additional shares of the company from shareholders who
accepted the tender offer if following such acquisition the
acquirer would then own over 90.0% of the companys
issued and outstanding share capital.
The Companies Law provides that an acquisition of shares of a
public company must be made by means of a tender offer if as a
result of the acquisition the purchaser would hold 25.0% or more
of the voting rights at the companys general meeting,
unless one of the exemptions described in the Companies Law is
met. This rule does not apply if there is already another
shareholder who holds 25.0% or more of the voting rights at the
companys general meeting. Our Chief Executive Officer and
Chairman, Dr. Boaz Eitan, currently holds more than 25.0%
of our outstanding ordinary shares as determined in accordance
with the Companies Law. Similarly, the Companies Law provides
that an acquisition of shares in a public company must be made
by means of a tender offer if as a result of the acquisition the
purchaser would hold more than 45.0% of the voting rights of the
company, if there is no other shareholder of the company who
holds more than 45.0% of the voting rights in the company. A
tender offer is not required in the following circumstances:
(i) the purchase
71
was made in a private offer that was approved by the
shareholders as a private offer and was meant to grant the
purchaser more than 25% of the voting rights of a company in
which no other shareholder holds more than 25.0% of the voting
rights, or to grant the purchaser more than 45.0% of the voting
rights of a company in which no other shareholder holds more
than 45.0% of the voting rights, (ii) the purchaser would
hold more than 25.0% of the voting rights after purchasing
shares from a person that held more than 25% of the voting
rights, or (iii) the purchaser would hold more than 45.0%
of the voting rights after purchasing shares from a person that
held more than 45.0% of the voting rights.
Merger. The Companies Law permits merger
transactions if approved by each partys board of directors
and, unless certain requirements described under the Companies
Law are met, the majority of each partys shares voted on
the proposed merger at a shareholders meeting called on at
least 21 days prior notice. Under the Companies Law,
if the approval of a general meeting of the shareholders is
required, merger transactions may be approved by holders of a
simple majority of our shares present, in person or by proxy, at
a general meeting and voting on the transaction. In determining
whether the required majority has approved the merger, if shares
of the Company are held by the other party to the merger, or by
any person holding at least 25.0% of the outstanding voting
shares or 25.0% of the means of appointing directors of the
other party to the merger, then a vote against the merger by
holders of the majority of the shares present and voting,
excluding shares held by the other party or by such person, or
anyone acting on behalf of either of them, is sufficient to
reject the merger transaction. If the transaction would have
been approved but for the exclusion of the votes of certain
shareholders as provided above, a court may still approve the
merger upon the request of holders of at least 25.0% of the
voting rights of a company, if the court holds that the merger
is fair and reasonable, taking into account the value of the
parties to the merger and the consideration offered to the
shareholders. Upon the request of a creditor of either party to
the proposed merger, the court may delay or prevent the merger
if it concludes that there exists a reasonable concern that, as
a result of the merger, the surviving company will be unable to
satisfy the obligations of any of the parties to the merger. In
addition, a merger may not be completed unless at least
50 days have passed from the date that a proposal for
approval of the merger was filed with the Israeli Registrar of
Companies and 30 days from the date that shareholder
approval of both merging companies was obtained.
Anti-Takeover
Measures
Undesignated preferred stock. The Companies
Law allows us to create and issue shares having rights different
than those attached to our ordinary shares, including shares
providing certain preferred or additional rights to voting,
distributions or other matters and shares having preemptive
rights. We do not have any authorized or issued shares other
than ordinary shares. In the future, if we do create and issue a
class of shares other than ordinary shares, such class of
shares, depending on the specific rights that may be attached to
them, may delay or prevent a takeover or otherwise prevent our
shareholders from realizing a potential premium over the market
value of their ordinary shares. The authorization of a new class
of shares will require an amendment to our Articles of
Association which requires the prior approval of a majority of
our shareholders at a general meeting. Shareholders voting at
such a meeting will be subject to the restrictions under the
Companies Law described in Voting.
Transactions with interested shareholders. Our
Articles of Association contain a provision that prohibits us
from engaging in any business combination with any interested
shareholder for a period of three years following the date that
the stockholder became an interested shareholder, unless:
|
|
|
|
|
prior to that date, the board of directors of the corporation
approved either the business combination or the transaction that
resulted in the shareholder becoming an interested shareholder;
|
|
|
|
upon consummation of the transaction that resulted in the
shareholder becoming an interested shareholder, the interested
shareholder owned at least 75% of the voting share of the
corporation outstanding at the time the transaction commenced,
excluding, for purposes of determining the number of shares
outstanding, unissued shares of the company which may be issued
pursuant to any agreement, arrangement or understanding, or upon
exercise of conversion rights, warrants or options, or otherwise.
|
72
A business combination is defined to include the
following:
|
|
|
|
|
any merger or consolidation involving the corporation and the
interested shareholder;
|
|
|
|
any sale, transfer, pledge or other disposition of 10% or more
of the assets of the corporation involving the interested
shareholder;
|
|
|
|
subject to certain exceptions, any transaction that results in
the issuance or transfer by the corporation of any shares of the
corporation to the interested shareholder;
|
|
|
|
any transaction involving the corporation that has the effect of
increasing the proportionate share of the shares of any class or
series of the corporation beneficially owned by the interested
shareholder; or
|
|
|
|
the receipt by the interested shareholder or the benefit of any
loans, advances, guarantees, pledges or other financial benefits
provided by or through the corporation.
|
An interested shareholder is defined as an entity or
person beneficially owning 15% or more of the outstanding voting
shares of the company and any entity or person affiliated with
or controlling or controlled by any of these entities or persons.
Supermajority voting. Under our Articles of
Association (1) certain shareholders resolutions
require the approval of a special majority of the holders of at
least 75.0% of the voting rights represented at the
meeting, in person, by proxy or by written ballot and voting on
the resolution, and (2) certain shareholders
resolutions require the approval of a special majority of the
holders of at least two-thirds of the voting securities of the
company then outstanding.
Classified board of directors. Our amended and
restated Articles of Association provide for a classified board
of directors. See Management Board of
Directors and Officers.
Transfer
Agent and Registrar
The transfer agent and registrar for our ordinary shares is
American Stock Transfer & Trust Company. Its address is
59 Maiden Lane, New York, New York 10038 and its telephone
number at this location is
(212) 936-5100.
Summaries of the following material contracts are included in
this Annual Report in the places indicated:
|
|
|
Material Contract
|
|
Location
|
|
Termination of Joint Venture
Agreement and Related Transactions with Infineon Technologies
|
|
Item 5:
Operating and Financial Review and
Prospects Part A: Operating
Results Exit From Joint Venture with Infineon
Technologies.
|
License Agreement with Infineon
Technologies
|
|
Item 4.B:
Information on the Company Part B:
Business Overview Licensees.
|
License Agreement with Macronix
|
|
Item 4.B:
Information on the Company Part B:
Business Overview Licensees.
|
License Agreement with Spansion
|
|
Item 4.B:
Information on the Company Part B:
Business Overview Licensees.
|
In 1998, Israeli currency control regulations were liberalized
significantly, so that Israeli residents generally may freely
deal in foreign currency and foreign assets, and non-residents
may freely deal in Israeli currency and Israeli assets. There
are currently no Israeli currency control restrictions on
remittances of dividends on the ordinary shares or the proceeds
from the sale of the shares provided that all taxes were paid or
withheld; however, legislation remains in effect pursuant to
which currency controls can be imposed by administrative action
at any time.
73
Non-residents of Israel may freely hold and trade our
securities. Neither our memorandum of association nor our
articles of association nor the laws of the State of Israel
restrict in any way the ownership or voting of ordinary shares
by non-residents, except that such restrictions may exist with
respect to citizens of countries which are in a state of war
with Israel. Israeli residents are allowed to purchase our
ordinary shares.
Israeli
Tax Considerations and Government Programs
The following is a general discussion only and is not exhaustive
of all possible tax considerations. It is not intended, and
should not be construed, as legal or professional tax advice and
should not be relied upon for tax planning purposes. In
addition, this discussion does not address all of the tax
consequences that may be relevant to purchasers of our ordinary
shares in light of their particular circumstances, or certain
types of purchasers of our ordinary shares subject to special
tax treatment. Examples of this kind of investor include
residents of Israel and traders in securities who are subject to
special tax regimes not covered in this discussion. Each
individual/entity should consult its own tax or legal advisor as
to the Israeli tax consequences of the purchase, ownership and
disposition of our ordinary shares.
To the extent that part of the discussion is based on new tax
legislation, which has not been subject to judicial or
administrative interpretation, we cannot assure that the tax
authorities or the courts will accept the views expressed in
this section.
The following summary describes the current tax structure
applicable to companies in Israel, with special reference to its
effect on us. The following also contains a discussion of the
material Israeli tax consequences to holders of our ordinary
shares.
General Corporate Tax Structure. Generally,
Israeli companies are subject to corporate tax at the rate of
34% on taxable income for the year 2005 and are subject to
capital gains tax at a rate of 25% on capital gains (other than
gains derived from the sale of listed securities that are taxed
at the prevailing corporate tax rates) derived after
January 1, 2003. However, the effective tax rate payable by
a company that derives income from an approved enterprise (as
discussed below) may be considerably lower. Depending on the
relevant tax treaties at issue, dividends or interest received
by an Israeli company from foreign subsidiaries are generally
subject to tax regardless of the companys status as an
Approved Enterprise. Under recently adopted legislation, taxes
paid by Israeli companies will be gradually reduced to a rate of
31% for the 2006 tax year, 29% for the 2007 tax year, 27% for
the 2008 tax year, 26% for the 2009 tax year and 25% for the
2010 tax year and thereafter.
Tax Benefits and Grants for Research and
Development. Israeli tax law allows, under
specified conditions, a tax deduction for expenditures,
including capital expenditures, for the year in which they are
incurred. These expenses must relate to scientific research and
development projects and must be approved by the relevant
Israeli government ministry, determined by the field of
research. Furthermore, the research and development must be for
the promotion of the companys business and carried out by
or on behalf of the company seeking such tax deduction. However,
the amount of such deductible expenses is reduced by the sum of
funds received through government grants for the finance of such
scientific research and development projects. Expenditures not
so approved are deductible over a three-year period.
We have applied to the Office of the Chief Scientist of Israel,
in order to receive approval for a tax deduction for all
research and development expenses during the year incurred.
There is no assurance that our application will be accepted.
Tax Benefits Under the Law for the Encouragement of Industry
(Taxes), 1969. According to the Law for the
Encouragement of Industry (Taxes), 1969 (Industry
Encouragement Law), industrial companies are entitled to
the following tax benefits, among others:
|
|
|
|
|
deduction of purchases of know-how and patents over an
eight-year period for tax purposes;
|
74
|
|
|
|
|
expenses involved with the issuance and listing of shares on The
Tel Aviv Stock Exchange or on a recognized stock market
outside of Israel, are deductible over a three-year period;
|
|
|
|
the right to elect, under specified conditions, to file a
consolidated tax return with other related Israeli industrial
companies; and
|
|
|
|
accelerated depreciation rates on equipment and buildings.
|
According to the law, an industrial company is
defined as a company resident in Israel, at least 90% of the
income of which, in any tax year, determined in Israeli currency
(exclusive of income from government loans, capital gains,
interest and dividends) is derived from an industrial
enterprise owned by it. An industrial
enterprise is defined as an enterprise whose major
activity in a given tax year is industrial production activity.
Eligibility for benefits under the Industry Encouragement Law is
not subject to receipt of prior approval from any governmental
authority.
We believe that we currently qualify as an industrial company
within the definition under the Industry Encouragement Law.
However, we cannot give any assurance that we will continue to
qualify as an industrial company or that the benefits described
above will be available in the future.
Law for the Encouragement of Capital Investments,
1959. The Law for the Encouragement of Capital
Investments, 1959, as amended (the Investments Law),
provides that a capital investment in eligible facilities may,
upon application to the Investment Center of the Ministry of
Industry and Commerce of the State of Israel, be designated as
an Approved Enterprise. Each certificate of approval
for an approved enterprise relates to a specific investment
program, delineated both by the financial scope of the
investment and by the physical characteristics of the facility
or the asset. An approved enterprise is entitled to benefits
including Israeli Government cash grants and tax benefits in
specified development areas. The benefits are dependent upon the
fulfillment of conditions stipulated in the Investment Law and
its regulations, including the criteria set forth in the
specific certificate of approval. The tax benefits from any
certificate of approval relate only to taxable profits
attributable to the specific approved enterprise. If a company
has more than one approval or only a portion of its enterprise
is approved, its effective tax rate is the result of a weighted
average of the applicable rates (such weighted average is
calculated in accordance with the guidelines of the Investment
Law).
Tax benefits given under the Investment Law also apply to income
generated by a company from the grant of a usage right with
respect to know-how developed by the approved enterprise, income
generated from royalties, and income derived from a service
which is auxiliary to such usage right or royalties, provided
that such income is generated in the course of the approved
enterprises ordinary course of business.
Each application to the Investment Center is reviewed separately
and a decision as to whether or not to approve such application
is based, among other things, on the then-prevailing criteria
set forth in the law, the specific objectives of the applicant
company set forth in such application and certain financial
criteria of the applicant company. Accordingly, there can be no
assurance that any future application will be approved. In
addition, as described above, the benefits available to an
approved enterprise are dependent upon the fulfillment of
certain conditions stipulated in the Investments Law and its
regulations and the criteria set forth in the specific
certificate of approval. In the event that these conditions are
violated, in whole or in part, we would be required to refund
the amount of tax benefits, with the addition of the Israeli
consumer price index linkage adjustment and interest. We believe
our approved enterprise operates in substantial compliance with
all such conditions and criteria.
On April 1, 2005, a comprehensive amendment to the
Investments Law came into effect. As the amended Investments Law
does not retroactively apply to investments programs having an
approved enterprise approval certificate issued by the Israeli
Investment Center prior to December 31, 2004, our current
tax benefits are subject to the provisions of the Investments
Law prior to its revision. New benefits that may be received in
the future will be subject to the provisions of the Investments
Law. Accordingly, the following description includes a summary
of the Investments Law prior to its amendment as well as the
relevant changes contained in the Investments Law.
75
In 1998, our investment program in our facility in Netanya was
approved as an approved enterprise under the alternative
program provided by the Investments Law. Our requests for
expansion of our approved enterprise were approved in November
2000 and December 2002. Under the terms of our approved
enterprise, once we begin generating taxable net income, we will
be entitled to a tax exemption with respect to the income
derived from our approved enterprise program for two years and
will be subject to a reduced company tax rate of between 10% and
25% for the following five to eight years, depending on the
extent of foreign (non-Israeli) investment in our company during
the relevant year. The tax rate will be 20% if the foreign
investment level is more than 49% but less than 74%, 15% if the
foreign investment level is more than 74% but less than 90%, and
10% if the foreign investment level is 90% or more. The lowest
level of foreign investment during a particular year will be
used to determine the relevant tax rate for that year. The
period in which we receive these tax benefits is limited to
12 years from the year in which operations or production by
the enterprise commenced or 14 years from the year in which
approval was granted, whichever is the earlier. Dividends
distributed from tax-exempt income would be taxed according to
the company tax rate that would have been applicable had the
company not been exempt from taxation that year. This rate is
generally 10% to 25% depending on the extent of foreign
investment in the company. The dividend recipient is subject to
withholding tax at the rate applicable to dividends from
approved enterprises (15%), unless a different rate is provided
according to a treaty between Israel and the shareholders
country of residence (if the dividend is distributed during the
tax exemption period or within 12 years thereafter). The
company must withhold this tax at source.
The Investments Law also provides that an approved enterprise is
entitled to accelerated depreciation on its property and
equipment that are included in an approved investment program.
We have not utilized this benefit.
Grants and other incentives received by a company in accordance
with the Investments Law remain subject to final ratification by
the Investment Center of the Israeli Ministry of Industry and
Trade, such ratification being conditional upon fulfillment of
all terms of the approved program. We received ratification from
the Investment Center for our approved enterprise program in
2001, and in 2003 for the request for expansion of such program
which was approved in November 2000. Pursuant to the recent
amendment to the Investment Law the basic condition for
receiving the benefits (both under the grant and the tax
benefits programs) is the enterprises contribution to the
economic independence of Israel and its contribution to the
gross domestic product. In order to fulfill these conditions,
the enterprise is required to be categorized as an industrial
enterprise which complies with any of the following:
|
|
|
|
|
its major activity is in the field of biotechnology or
nano-technology;
|
|
|
|
its revenues during the applicable tax year from any single
market (i.e. country or a separate customs territory) do not
exceed 75% of the privileged enterprises aggregate
revenues during such year; or
|
|
|
|
25% or more of its revenues during the applicable tax year are
generated from sales into a single market (i.e. country or a
separate customs territory) with a population of at least
12 million residents.
|
It should be noted that the amendment to the Investments Law
further addresses benefits that are being granted to enterprises
and the length of the benefits period.
There can be no assurance that we will comply with the above
conditions in the future or that we will be entitled to any
additional benefits under the amended Investments Law.
According to the amendment to the Investments Law, only approved
enterprises receiving cash grants require the approval of the
Investment Center. Approved enterprises, which do not receive
benefits in the form of governmental cash grants, such as
benefits in the form of tax benefits, are no longer required to
obtain this approval (such enterprises are referred to as
privileged enterprises). In order to be eligible for
the tax benefits, privileged enterprises are required to comply
with certain requirements and make certain investments as
specified in the amended Investments Law. The privileged
enterprises are subject to the responsibility of the Israeli Tax
Authority and may, at their discretion, in order to provide
greater certainty, elect to apply for a pre-ruling from the
Israeli tax authorities confirming that they are in compliance
with the provisions of the amended Investments Law and therefore
are entitled to receive the benefits provided under the amended
76
Investments Law. We recently applied for a
pre-ruling
in order to confirm that we are in compliance with the amended
law. The amended Investment Law also specifies which income of
the privileged enterprise is entitled to tax benefits (for
example income generated from the sale of products that were
manufactured by the privileged enterprise, income generated from
usage right with respect to know-how developed by the privileged
enterprise, etc.).
There can be no assurance that we will comply with the
conditions required for privileged enterprises under the amended
Investment Law in the future or that we will be entitled to any
additional benefits under the amended Investments Law.
In addition, the amended Investment Law changed the definition
of foreign investment according to the Investment
Law so that the definition, instead of a foreign currency
investment, now requires a minimal investment of NIS
5 million by foreign investors. Furthermore, such
definition now also includes the purchase of shares of a company
from another shareholder (secondary market purchase), provided
that the companys outstanding and
paid-up
share capital exceed NIS 5 million. Such changes to
the aforementioned definition will take effect retroactively
from 2003.
In order to manage certain investments, we have established a
wholly owned subsidiary, Saifun (BVI) Limited, a company
incorporated under the laws of the British Virgin Islands. Under
our Approved Enterprise status, we are not entitled to receive
any tax benefits from any income derived from investments made
through Saifun (BVI) Limited. As of December 31, 2005,
carryforward losses related to Saifun (BVI) Limited
amounted for approximately $3.3 million, which may be
carried forward indefinitely. After the carryforward losses are
utilized, we will be subject to Israeli income tax, which will
be considered a deemed dividend and taxed at 25% tax
rate.
Special Provisions Relating to Taxation Under Inflationary
Conditions. The Income Tax Law (Inflationary
Adjustments), 1985, generally referred to as the Inflationary
Adjustments Law, represents an attempt to overcome the problems
presented to a traditional tax system by an economy undergoing
rapid inflation. The Inflationary Adjustments Law is highly
complex. The features that are material to us can be described
as follows:
|
|
|
|
|
When the value of a companys equity, as calculated under
the Inflationary Adjustments Law, exceeds the depreciated cost
of its fixed assets (as defined in the Inflationary Adjustments
Law), a deduction from taxable income is permitted equal to the
excess multiplied by the applicable annual rate of inflation.
The maximum deduction permitted in any single tax year is 70% of
taxable income, with the unused portion permitted to be carried
forward, linked to the increase in the consumer price index.
|
|
|
|
If the depreciated cost of the companys fixed assets
exceeds its equity, then the excess multiplied by the applicable
annual rate of inflation is added to taxable income.
|
|
|
|
Subject to certain limitations, depreciation deductions on fixed
assets and losses carried forward are adjusted for inflation
based on the increase in the Israeli consumer price index.
|
The Minister of Finance may, with the approval of the Knesset
Finance Committee, determine by decree, during a certain fiscal
year (or until February 28th of the following year) in
which the rate of increase of the Israeli consumer price index
would not exceed or did not exceed 3%, that some or all of the
provisions of the Inflationary Adjustments Law shall not apply
with respect to such fiscal year, or, that the rate of increase
of the Israeli consumer price index relating to such fiscal year
shall be deemed to be 0%, and to make the adjustments required
to be made as a result of such determination. The Minister made
no such determination in respect of 2005, even though the price
index in 2005 rose by a rate of less than 3%.
The ITO and regulations promulgated thereunder allow
Foreign-Invested Companies, (as defined in the
Investments Law) that maintain their accounts in
U.S. dollars in compliance with regulations published by
the Israeli Minister of Finance, to base their tax returns on
their operating results as reflected in their U.S. dollar
financial statements or to adjust their tax returns based on
exchange rate changes rather than changes in the Israeli
consumer price index, in lieu of the principles set forth by the
Inflationary Adjustments Law. For these purposes, a
Foreign-Invested Company is a company (1) more than 25% of
whose share capital, in terms of
77
rights to profits, voting and appointment of directors are held
by persons who are not residents of Israel, and (2) more
than 25% of whose combined share and loan capital is held by
persons who are not residents of Israel. A company that elects
to measure its results for tax purposes based on the
U.S. dollar exchange rate cannot change such election for a
period of three years following the election. We have elected to
measure our results for tax purposes based on the
U.S. dollar exchange rate as of January 1, 2006.
|
|
|
Taxation
of our Shareholders
|
Taxation of Non-Israeli Shareholders on Receipt of
Dividends. Non-residents of Israel are generally
subject to Israeli income tax on the receipt of dividends paid
on our ordinary shares at the rate of 20% or 15% for dividends
or income generated by an approved enterprise, which tax will be
withheld at source, unless a different rate is provided in a
treaty between Israel and the shareholders country of
residence.
However, the tax rate on dividends paid to a substantial
shareholder (which is someone who alone, or together with
another person, holds, directly or indirectly, at least 10% in
one or all of any of the means of control in the corporation) is
25%.
Under the
U.S.-Israel
Tax Treaty, the maximum rate of tax withheld in Israel on
dividends paid to a holder of our ordinary shares who is a
U.S. resident (within the meaning of the
U.S.-Israel
Tax Treaty) is 25%. However, dividends paid from income derived
from our Approved Enterprise are subject to withholding at the
rate of 15%, although we cannot assure you that we will
designate the profits that are being distributed in a way that
will reduce shareholders tax liability according to the
U.S.-Israel
Tax Treaty. Furthermore, the maximum rate of withholding tax on
dividends, not generated by our Approved Enterprise, that are
paid to a U.S. corporation holding 10% or more of our
outstanding voting capital during the part of the tax year that
precedes the date of the payment of the dividend and during the
whole of its prior tax year, is 12.5%. This reduced rate will
not apply if more than 25% of the Israel companys gross
income consists of interest or dividends, other than dividends
or interest received from a subsidiary corporation 50% or more
of the outstanding shares of the voting shares of which are
owned by the company.
A non-resident of Israel who receives dividends from which tax
was fully paid is generally exempt from the duty to file returns
in Israel in respect of such income, provided such income was
not derived from a business conducted in Israel by the taxpayer,
and the taxpayer has no other taxable sources of income in
Israel.
Capital Gains Taxes Applicable to Non-Israeli
Shareholders. In general, Israel imposes capital
gains tax on the sale of capital assets, including shares of
Israeli companies by both Israeli residents and non-Israeli
resident shareholders, unless a specific exemption is available
or unless a tax treaty between Israel and the shareholders
country of residence provided otherwise. Shareholders that are
not Israeli residents are generally exempt from Israeli capital
gains tax on any gains derived from the sale of our ordinary
shares, provided that (1) such shareholders did not acquire
their shares prior to our initial public offering, (2) the
shares are listed for trading on a stock exchange in a
jurisdiction with which Israel has a treaty, (3) the
provisions of the Inflationary Adjustments Law or
section 130A of the ITO do not apply to such gain, and
(4) such gains did not derive from a permanent
establishment of such shareholders in Israel. However,
non-Israeli corporations will not be entitled to the foregoing
exemptions if an Israeli resident (i) has a controlling
interest of 25% or more in such non-Israeli corporation, or
(ii) is the beneficiary of or is entitled to 25% or more of
the revenues or profits of such non-Israeli corporation, whether
directly or indirectly.
In certain instances where our non-Israeli shareholders may be
liable to Israeli tax on the sale of their ordinary shares, the
payment of the consideration may be subject to Israeli
withholding tax.
In addition, the sale, exchange or disposition of our ordinary
shares by shareholders who are U.S. residents (within the
meaning of the
U.S.-Israel
Tax Treaty) holding the ordinary shares as a capital asset will
be also exempt from Israeli capital gains tax under the
U.S.-Israel
Tax Treaty unless either (i) the shareholders hold,
directly or indirectly, shares representing 10% or more of our
voting capital during any part of the
12-month
period preceding such sale, exchange or disposition, or
(ii) the capital gains arising from such sale, exchange or
disposition are attributable to a permanent establishment of the
shareholders located in Israel. In such case
78
the shareholders would be subject to Israeli capital gain tax,
to the extent applicable, as mentioned above. However, under the
U.S.-Israel
Tax Treaty, the U.S. resident would be permitted to claim a
credit for such taxes against the U.S. federal income tax
imposed on the sale, exchange or disposition, subject to the
limitation in the U.S. law applicable to foreign tax
credits. The
U.S.-Israel
Tax Treaty does not relate to U.S. state or local taxes.
United
States Federal Income Taxation
The following is a description of the material United States
federal income tax consequences of the ownership of our ordinary
shares. This description addresses only the United States
federal income tax considerations of holders that will hold our
ordinary shares as capital assets. This description does not
address tax considerations applicable to holders that may be
subject to special tax rules, including:
|
|
|
|
|
financial institutions or insurance companies;
|
|
|
|
real estate investment trusts, regulated investment companies or
grantor trusts;
|
|
|
|
dealers or traders in securities or currencies;
|
|
|
|
tax-exempt entities;
|
|
|
|
persons that received our shares as compensation for the
performance of services;
|
|
|
|
persons that will hold our shares as part of a
hedging or conversion transaction or as
a position in a straddle for United States federal
income tax purposes;
|
|
|
|
certain former citizens or residents of the United States;
|
|
|
|
persons whose functional currency is not the United
States dollar; or
|
|
|
|
holders that own directly, indirectly or through attribution 10%
or more, of the voting power or value, of our shares.
|
Moreover, this description does not address the United States
federal estate and gift or alternative minimum tax consequences
of the acquisition, ownership and disposition of our ordinary
shares.
This description is based on the Code, existing, proposed and
temporary United States Treasury Regulations and judicial and
administrative interpretations thereof, in each case as in
effect and available on the date of this Annual Report. All of
the foregoing are subject to change, which change could apply
retroactively and could affect the tax consequences described
below.
For purposes of this description, a U.S. Holder
is a beneficial owner of our ordinary shares that, for United
States federal income tax purposes, is:
|
|
|
|
|
a citizen or resident of the United States;
|
|
|
|
a partnership or corporation created or organized in or under
the laws of the United States or any state thereof, including
the District of Columbia;
|
|
|
|
an estate the income of which is subject to United States
federal income taxation regardless of its source; or
|
|
|
|
a trust if such trust has validly elected to be treated as a
United States person for United States federal income tax
purposes or if (1) a court within the United States is able
to exercise primary supervision over its administration and
(2) one or more United States persons have the authority to
control all of the substantial decisions of such trust.
|
A
Non-U.S. Holder
is a beneficial owner of our ordinary shares that is not a
U.S. Holder.
79
If a partnership (or any other entity treated as a partnership
for United States federal income tax purposes) holds our
ordinary shares, the tax treatment of a partner in such
partnership will generally depend on the status of the partner
and the activities of the partnership. Such a partner or
partnership should consult its tax advisor as to its tax
consequences.
You should consult your tax advisor with respect to the
United States federal, state, local and foreign tax consequences
of acquiring, owning or disposing of our ordinary shares.
Subject to the discussion below under Passive Foreign
Investment Company Considerations and
Controlled Foreign Corporation Considerations,
if you are a U.S. Holder, for United States federal income
tax purposes, the gross amount of any distribution made to you,
with respect to your ordinary shares before reduction for any
Israeli taxes withheld therefrom, will be includible in your
income as dividend income to the extent such distribution is
paid out of our current or accumulated earnings and profits as
determined under United States federal income tax principles.
Subject to the discussion below under Passive Foreign
Investment Company Considerations, non-corporate
U.S. Holders may qualify for the lower rates of taxation
with respect to dividends on ordinary shares applicable to
long-term capital gains (i.e., gains from the sale of capital
assets held for more than one year) with respect to taxable
years beginning on or before December 31, 2008, provided
that certain conditions are met, including certain holding
period requirements and the absence of certain risk reduction
transactions. However, such dividends will not be eligible for
the dividends received deduction generally allowed to corporate
U.S. Holders. Subject to the discussion below under
Passive Foreign Investment Company Considerations
and Controlled Foreign Corporation Considerations,
to the extent, if any, that the amount of any distribution by us
exceeds our current and accumulated earnings and profits as
determined under United States federal income tax principles, it
will be treated first as a tax-free return of your adjusted tax
basis in your ordinary shares and thereafter as capital gain. We
do not expect to maintain calculations of our earnings and
profits under United States federal income tax principles.
If you are a U.S. Holder, dividends paid to you with
respect to your ordinary shares will be treated as foreign
source income, which may be relevant in calculating your foreign
tax credit limitation. Subject to certain conditions and
limitations, Israeli tax withheld on dividends may be deducted
from your taxable income or credited against your United States
federal income tax liability. The limitation on foreign taxes
eligible for credit is calculated separately with respect to
specific classes of income. For this purpose, dividends that we
distribute generally will constitute passive income,
or, in the case of certain U.S. Holders, financial
services income. U.S. Holders should note, however,
that the financial services income category will be
eliminated for taxable years beginning after December 31,
2006. Thereafter, the foreign tax credit limitation categories
are limited to passive category income and
general category income. The rules relating to the
determination of the foreign tax credit are complex, and you
should consult your personal tax advisors to determine whether
and to what extent you would be entitled to this credit.
Subject to the discussion below under Backup Withholding
Tax and Information Reporting Requirements, if you are a
Non-U.S. Holder,
you generally will not be subject to United States federal
income or withholding tax on dividends received by you on your
ordinary shares, unless you conduct a trade or business in the
United States and such income is effectively connected with that
trade or business.
|
|
|
Sale
or Exchange of Ordinary Shares
|
Subject to the discussion below under Passive Foreign
Investment Company Considerations and Controlled
Foreign Corporation Considerations, if you are a
U.S. Holder, you generally will recognize gain or loss on
the sale, exchange or other disposition of your ordinary shares
equal to the difference between the amount realized on such
sale, exchange or other disposition and your adjusted tax basis
in your ordinary shares. Such gain or loss will be capital gain
or loss. If you are a noncorporate U.S. Holder, capital
gain from the sale, exchange or other disposition of ordinary
shares is eligible for the preferential rate of taxation
applicable to long-term capital gains, with respect to taxable
years beginning on or before December 31, 2008,
80
if your holding period for such ordinary shares exceeds one year
(i.e., such gain is long-term capital gain). Gain or loss,
if any, recognized by you generally will be treated as United
States source income or loss for United States foreign tax
credit purposes. The deductibility of capital losses for
U.S. federal income tax purposes is subject to limitations.
Subject to the discussion below under Backup Withholding
Tax and Information Reporting Requirements, if you are a
Non-U.S. Holder,
you generally will not be subject to United States federal
income or withholding tax on any gain realized on the sale or
exchange of such ordinary shares unless:
|
|
|
|
|
such gain is effectively connected with your conduct of a trade
or business in the United States; or
|
|
|
|
you are an individual and have been present in the United States
for 183 days or more in the taxable year of such sale or
exchange and certain other conditions are met.
|
|
|
|
Passive
Foreign Investment Company Considerations
|
A
non-U.S. corporation
will be classified as a passive foreign investment
company, or a PFIC, for United States federal income tax
purposes in any taxable year in which, after applying certain
look-through rules, either
|
|
|
|
|
at least 75 percent of its gross income is passive
income; or
|
|
|
|
at least 50 percent of the average value of its gross
assets is attributable to assets that produce passive
income or are held for the production of passive income.
|
Passive income for this purpose generally includes dividends,
interest, royalties, rents, gains from commodities and
securities transactions, the excess of gains over losses from
the disposition of assets which produce passive income, and
includes amounts derived by reason of the temporary investment
of funds raised in offerings of our ordinary shares. Based on
our estimated gross income, the average value of our gross
assets (determined by reference to the market value of our
shares and valuing our intangible assets using the methods
prescribed for publicly traded corporations) and the nature of
our business, we believe that we will not be classified as a
PFIC for the taxable year ended December 31, 2005. Our
status in future years will depend on our income, assets and
activities in those years, although you will be treated as
continuing to own an interest in a PFIC if we are a PFIC in any
year while you own your shares unless you make certain
elections. While we intend to manage our business so as to avoid
PFIC status, to the extent consistent with our other business
goals, we cannot predict whether our business plans will allow
us to avoid PFIC status determination. We have no reason to
believe that our income, assets or activities will change in a
manner that would cause us to be classified as a PFIC, but
because the market price of our ordinary shares is likely to
fluctuate and the market price of the shares of technology
companies has been especially volatile, and because that market
price may affect the determination of whether we will be
considered a PFIC, we cannot assure you that we will not be
considered a PFIC for any taxable year. If we were a PFIC, you
generally would be subject to imputed interest charges and other
disadvantageous tax treatment (including the denial of the
taxation of such dividends at the lower rates applicable to
long-term capital gains, as discussed above under
Distributions) with respect to any gain from the
sale or exchange of, and excess distributions with respect to,
the ordinary shares.
If we were a PFIC, you could make a variety of elections that
may alleviate the tax consequences referred to above, and one of
these elections may be made retroactively. However, it is
expected that the conditions necessary for making certain of
such elections will not apply in the case of our ordinary
shares. You should consult your own tax advisor regarding our
potential status as a PFIC and the tax consequences that would
arise if we were treated as a PFIC.
Controlled
Foreign Corporation Considerations
A
non-U.S. corporation
will be classified as a controlled foreign
corporation, or a CFC, for United States federal income
tax purposes in any taxable year in which more than 50.0% of
either
81
|
|
|
|
|
the total combined voting power of all classes of stock of such
corporation entitled to vote, or
|
|
|
|
the total value of the stock of such corporation
|
is owned or considered owned, on any day during such taxable
year, by United States persons who own or are considered to own
10.0% or more of the total combined voting power of all classes
of stock entitled to vote of such corporation (Ten Percent
Shareholders).
The CFC rules provide that, even if the CFC has made no
distributions to its shareholders, each Ten Percent Shareholder
of a CFC is required to include in income each year such Ten
Percent Shareholders pro rata share of the CFCs
Subpart F income and investment of earnings in
U.S. property. The CFC rules also provide that gains, if
any, realized by a Ten Percent Shareholder on the sale of shares
in a CFC generally will be recharacterized as dividend income
and subject to tax at ordinary income tax rates to the extent of
any undistributed earnings and profits of the CFC, as determined
under United States federal income tax principles. Although we
were a CFC in the beginning of the 2005 tax year, we believe
based on our current ownership that we are no longer so
classified and expect that we will not be classified as a CFC in
future years.
In order to reduce the risk that we will once again be
considered a CFC, our articles of association provide that any
United States persons that purchase our shares will be limited
to voting a maximum of 9.9% of our total combined voting power,
to the extent that their voting rights notwithstanding such
limitation would cause us to be considered a CFC.
|
|
|
Backup
Withholding Tax and Information Reporting
Requirements
|
United States backup withholding tax and information reporting
requirements generally apply to certain payments to certain
non-corporate holders of stock. Information reporting generally
will apply to payments of dividends on, and to proceeds from the
sale or redemption of, ordinary shares made within the United
States, or by a United States payor or United States middleman,
to a holder of ordinary shares, other than an exempt recipient
(including a corporation, a payee that is not a United States
person that provides an appropriate certification and certain
other persons). A payor will be required to withhold backup
withholding tax from any payments of dividends on, or the
proceeds from the sale or redemption of, ordinary shares within
the United States, or by a United States payor or United States
middleman, to a holder, other than an exempt recipient, if such
holder fails to furnish its correct taxpayer identification
number or otherwise fails to comply with, or establish an
exemption from, such backup withholding tax requirements. The
backup withholding tax rate is 28.0% for years through 2010.
In the case of such payments made within the United States to a
foreign simple trust, a foreign grantor trust or a foreign
partnership, other than payments to a foreign simple trust, a
foreign grantor trust or a foreign partnership that qualifies as
a withholding foreign trust or a withholding
foreign partnership within the meaning of the applicable
United States Treasury Regulations and payments to a foreign
simple trust, a foreign grantor trust or a foreign partnership
that are effectively connected with the conduct of a trade or
business in the United States, the beneficiaries of the foreign
simple trust, the persons treated as the owners of the foreign
grantor trust or the partners of the foreign partnership, as the
case may be, will be required to provide the certification
discussed above in order to establish an exemption from backup
withholding tax and information reporting requirements.
Moreover, a payor may rely on a certification provided by a
payee that is not a United States person only if such payor does
not have actual knowledge or a reason to know that any
information or certification stated in such certificate is
incorrect.
Any amounts withheld under the backup withholding rules will be
allowed as a refund or credit against the beneficial
owners United States federal income tax liability, if any,
provided that the required information is furnished to the IRS.
The above description is not intended to constitute a
complete analysis of all tax consequences relating to
acquisition, ownership and disposition of our ordinary shares.
You should consult your tax advisor concerning the tax
consequences of your particular situation.
82
|
|
F.
|
DIVIDENDS
AND PAYING AGENTS
|
Not applicable.
Not applicable.
We are currently subject to the information and periodic
reporting requirements of the U.S. Securities Exchange Act
of 1934, as amended (the Exchange Act), and file
periodic reports and other information with the Securities and
Exchange Commission through its electronic data gathering,
analysis and retrieval (EDGAR) system. Our securities filings,
including this Annual Report and the exhibits thereto, are
available for inspection and copying at the public reference
facilities of the Securities and Exchange Commission located at
Room 1024, 450 Fifth Street, N.W.,
Washington, D.C. 20549 and at the Securities and Exchange
Commissions regional office at Citicorp Center,
500 West Madison Street, Suite 1400, Chicago,
Illinois 60661. You may also obtain copies of the documents
at prescribed rates by writing to the Public Reference Section
of the Securities and Exchange Commission at 450 Fifth
Street, NW, Washington, DC 20549. Please call the Securities and
Exchange Commission at
1-800-SEC-0330
for further information on the public reference room. The
Commission also maintains a website at http://www.sec.gov from
which certain filings may be accessed.
As a foreign private issuer, we are exempt from the rules under
the Exchange Act relating to the furnishing and content of proxy
statements, and our officers, directors and principal
shareholders will be exempt from the reporting and short-swing
profit recovery provisions contained in Section 16 of the
Exchange Act. In addition, we are not required under the
Exchange Act to file periodic reports and financial statements
with the Securities and Exchange Commission as frequently or as
promptly as United States companies whose securities are
registered under the Exchange Act.
|
|
I.
|
SUBSIDIARY
INFORMATION
|
Not applicable.
|
|
ITEM 11.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
Market risk is the risk of loss related to changes in market
prices, including interest rates and foreign exchange rates, of
financial instruments that may adversely impact our consolidated
financial position, results of operations or cash flows.
We do not use derivative financial instruments for trading
purposes. Accordingly, we have concluded that there is no
material market risk exposure of the type contemplated by
Item 11, and that no quantitative tabular disclosures are
required. We are exposed to certain other types of market risks
as described below.
|
|
|
Risk
of Interest Rate Fluctuation
|
We do not have any long-term borrowings. Our investments consist
of cash and cash equivalents, short-term bank deposits and
interest bearing, investment-grade investments in marketable
securities with maturities of up to three years, which currently
consist mainly of corporate debt securities and auction rate
securities, and may in the future include commercial paper,
money market funds, government and non-government debt
securities. The primary objective of our investment activities
is to preserve principal while maximizing the income that we
receive from our investments without significantly increasing
risk and loss. Our investments are exposed to market risk due to
fluctuation in interest rates, which may affect our interest
income and the fair market value of our investments. We manage
this exposure by performing ongoing evaluations of our
investments. Due to the short and medium-term maturities of our
investments to date, the carrying value
83
approximates the fair value. It is our policy to hold
investments to maturity in order to avoid recognizing the effect
of interest rate fluctuations in our financial statements.
|
|
|
Foreign
Currency Exchange Risk
|
Our foreign currency exposures give rise to market risk
associated with exchange rate movements of the U.S. dollar,
our functional and reporting currency, against the shekel and
the euro. We are exposed to the risk of fluctuation in the
U.S. dollar/shekel exchange rate. In 2005, we derived all
of our revenues in U.S. dollars. However, 46% of our
expenses were denominated in shekels. Our shekel-denominated
expenses consist principally of salaries and related personnel
expenses, as well as vehicle lease payments. We anticipate that
a material portion of our expenses will continue to be
denominated in shekels. If the U.S. dollar weakens against
the shekel, we will experience a negative impact on our profit
margins. To manage this risk, from time to time, we have entered
into forward exchange contracts to hedge some of our foreign
currency exposure. As of December 31, 2005, we had
outstanding forward exchange contracts for the acquisition of
26.5 million shekels in consideration for $5.8 million
maturing in a period of up to six months from that date. As of
December 31, 2005, the fair value of these contracts was
$38,000. Neither a ten percent increase nor decrease in current
exchange rates would have a material effect on our consolidated
financial statements in the next six months.
To date, the amount of royalties payable to us is based on the
dollar-denominated value of our licensees net sales of
products incorporating our intellectual property. Therefore, to
the extent that our licensees sales to third parties are
not denominated in U.S. dollars, any royalties that we
receive as a result of such sales could be subject to
fluctuations in the exchange rate between the currency of the
sale and the U.S. dollar. If the U.S. dollar
strengthens against the currency in which any of our licensees
makes its sales, the dollar-denominated amount of the royalties
that we receive would be reduced.
All financial instruments are managed and controlled under a
program of risk management in accordance with established
policies. We do not hold derivative financial instruments for
speculative purposes, and we do not issue any derivative
financial instruments for trading or speculative purposes. The
only derivative financial instruments we have are in place to
manage exposure to fluctuations in foreign exchange rates.
We believe that the rate of inflation in Israel has had a minor
effect on our business to date. However, our U.S. dollar
costs in Israel will increase if inflation in Israel exceeds the
devaluation of the shekel against the U.S. dollar or if the
timing of such devaluation lags behind inflation in Israel.
|
|
ITEM 12.
|
DESCRIPTION
OF SECURITIES OTHER THAN EQUITY SECURITIES
|
Not applicable.
84
PART II
|
|
ITEM 13.
|
DEFAULTS,
DIVIDEND ARREARAGES AND DELINQUENCIES
|
None.
|
|
ITEM 14.
|
MATERIAL
MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF
PROCEEDS
|
There are no material modifications to the rights of security
holders that are required to be disclosed.
The effective date of the registration statement (no.
333-129-167)
for our initial public offering of ordinary shares, par value
NIS 0.01, was November 8, 2005. The offering commenced on
November 9, 2005 and terminated after the sale of all the
securities registered. Lehman Brothers Inc. acted as the sole
book-running manager for the offering and, along with Deutsche
Bank Securities Inc., CIBC World Markets Corp., William
Blair & Company, L.L.C. and Raymond James &
Associates, Inc., as representatives of the underwriters. We
registered 5,750,000 ordinary shares in the offering, including
shares issued pursuant to the exercise of the underwriters
over-allotment option. We sold 5,750,000 ordinary shares at an
aggregate offering price of $135.1 million at a price per
share of $23.50. Under the terms of the offering, we incurred
aggregate underwriting discounts of $9.5 million. We also
incurred expenses of $4.8 million in connection with the
offering. The net proceeds that we received as a result of the
offering were $120.9 million. As of December 31, 2005,
the net proceeds had been used as follows:
|
|
|
|
|
|
|
Use of Proceeds
|
|
Description
|
|
Amount
|
|
|
|
(In thousands)
|
|
|
Construction of plant, buildings
and facilities
|
|
|
|
|
|
|
Purchase and installation of
machinery and equipment
|
|
|
|
|
|
|
Purchase of real estate
|
|
|
|
|
|
|
Repayment of indebtedness
|
|
|
|
|
|
|
Working capital
|
|
|
|
|
|
|
Temporary investments
|
|
Cash equivalents
and marketable
securities
|
|
$
|
120,853
|
|
Any other use involving $100,000
of the proceeds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
$
|
120,853
|
|
None of the net proceeds of the offering was paid directly or
indirectly to any director, officer, general partner of ours or
to their associates, persons owning ten percent or more of any
class of our equity securities, or to any of our affiliates.
|
|
ITEM 15.
|
CONTROLS
AND PROCEDURES
|
We maintain disclosure controls and procedures that are designed
to provide reasonable assurance that information required to be
disclosed in our periodic filings with the SEC is recorded,
processed, summarized and reported within the time periods
specified in the SECs rules and forms, and that such
information is accumulated and communicated to our management,
including our Chief Executive Officer (CEO) and Chief Financial
Officer (CFO), as appropriate, to allow timely decisions
regarding required disclosure. In designing and evaluating the
disclosure controls and procedures, management recognized that
any controls and procedures, no matter how well designed and
operated, can provide only reasonable assurance of achieving the
desired control objectives. Furthermore, management necessarily
was required to use its judgment in evaluating the cost to
benefit relationship of possible disclosure controls and
procedures.
As of the end of the period covered by this report, we performed
an evaluation of the effectiveness of the design and operation
of our disclosure controls and procedures. The evaluation was
performed with the participation of senior management of each
business segment and key corporate functions, and under the
supervision of our CEO and CFO. Based on the evaluation, our
management, including the CEO and CFO, concluded that our
disclosure controls and procedures were effective at the
reasonable assurance level as of
85
December 31, 2005. During the period covered by this Annual
Report, there have not been any changes in our internal control
over financial reporting that have materially affected, or that
are reasonably likely to materially affect, our internal control
over financial reporting.
ITEM 16A. AUDIT
COMMITTEE FINANCIAL EXPERT
The board of directors has determined that George Hervey is the
financial expert serving on its audit committee and that
Mr. Hervey is independent under the rules of the Nasdaq
National Market.
ITEM 16B. CODE
OF ETHICS
We have adopted a code of ethics applicable to our Chief
Executive Officer, Chief Financial Officer, controller and
persons performing similar functions. This code has been posted
on our website, www.saifun.com.
ITEM 16C. PRINCIPAL
ACCOUNTANT FEES AND SERVICES
The following table sets forth the total remuneration that was
paid by us and our subsidiaries to our independent accountants,
Kost, Forer, Gabbay and Kasierer, a member of Ernst &
Young Global, in each of our previous two fiscal years:
|
|
|
|
|
|
|
|
|
|
|
2004
|
|
|
2005
|
|
|
|
(Unaudited)
|
|
|
Audit fees
|
|
$
|
33,548
|
|
|
$
|
66,381
|
|
Audit-related fees(1)
|
|
|
160,003
|
|
|
|
316,508
|
|
Tax fees(2)
|
|
|
3,730
|
|
|
|
29,419
|
|
All other fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
197,281
|
|
|
$
|
412,308
|
|
|
|
|
(1) |
|
Audit-related fees includes fees for services
performed in connection with our registration statement on
Form F-1
for our initial public offering and our Annual Report on
Form 20-F. |
|
(2) |
|
Tax fees includes fees for professional services
rendered by our auditors for tax compliance and tax advice on
actual or contemplated transactions. |
Our audit committee pre-approved all audit and non-audit
services provided to us and to our subsidiaries during the
periods listed above.
ITEM 16D. EXEMPTIONS
FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES
None.
|
|
ITEM 16E.
|
PURCHASES
OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED
PURCHASERS
|
None.
86
PART III
|
|
ITEM 17.
|
FINANCIAL
STATEMENTS
|
Not applicable.
|
|
ITEM 18.
|
FINANCIAL
STATEMENTS
|
See pages F-1 to F-67 incorporated herein by reference.
ITEM 19. EXHIBITS
|
|
|
|
|
Exhibit
|
|
Description
|
|
|
1
|
.1
|
|
Articles of Association
(incorporated by reference to Exhibit 3.4 of the
Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
2
|
.1
|
|
Registration Rights Agreement,
dated October 2, 2000, by and among the Registrant and the
parties thereto (incorporated by reference to Exhibit 10.2
of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
2
|
.2
|
|
Amendment to Registration Rights
Agreement and Shareholder Rights Agreement, dated as of
September 29, 2005, by and among the parties thereto and
the Registrant (incorporated by reference to Exhibit 10.2
of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.1
|
|
Technology Agreement, dated
May 4, 2000, by and between Macronix International Co.,
Ltd. and the Registrant (incorporated by reference to
Exhibit 10.7 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.2
|
|
Amendment to the Technology
Agreement, dated April 10, 2003, by and between Macronix
International Co., Ltd. and the Registrant (incorporated by
reference to Exhibit 10.8 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.3
|
|
Second Addendum to the Technology
Agreement, dated April 22, 2004, by and between Macronix
International Co., Ltd. and the Registrant (incorporated by
reference to Exhibit 10.9 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.4
|
|
Termination of Joint Venture
Agreement and Related Transactions, dated December 20,
2004, by and among Infineon Technologies AG, Saifun Ventures
Ltd. and the Registrant (incorporated by reference to
Exhibit 10.10 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.5
|
|
Settlement and License Agreement,
dated July 1, 2002, by and between Advanced Micro Devices,
Inc., Fujitsu Limited and the Registrant (incorporated by
reference to Exhibit 10.11 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.6
|
|
License Agreement, dated
January 13, 2005, by and among Infineon Technologies AG and
its subsidiaries and the Registrant and its subsidiaries
(incorporated by reference to Exhibit 10.12 of the
Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.7
|
|
Basic Agreement of Development
Orders, dated December 20, 2004, by and between Infineon
Technologies AG and the Registrant (incorporated by reference to
Exhibit 10.13 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.8
|
|
Form of Director and Officer
Letter of Indemnification (incorporated by reference to
Exhibit 10.18 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
8
|
.1
|
|
List of Subsidiaries of the
Registrant (incorporated by reference to Exhibit 21.1 of
the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on November 4, 2005)
|
|
11
|
.1
|
|
Code of Ethics effective as of
September 2005
|
87
|
|
|
|
|
Exhibit
|
|
Description
|
|
|
12
|
.1
|
|
Certification of Chief Executive
Officer of the Registrant pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
12
|
.2
|
|
Certification of Chief Financial
Officer of the Registrant pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
13
|
.1
|
|
Certification of Chief Executive
Officer of the Registrant pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002*
|
|
13
|
.2
|
|
Certification of Chief Financial
Officer of the Registrant pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002*
|
|
|
|
* |
|
This document is being furnished in accordance with SEC Release
Nos. 33-8212
and 34-47551. |
|
|
|
Portions of this exhibit were omitted and have been filed
separately with the Secretary of the Securities and Exchange
Commission pursuant to the Registrants application
requesting confidential treatment under Rule 406 of the
Securities Act. |
88
SIGNATURES
Pursuant to the requirements of Section 12 of the
Securities Exchange Act of 1934, the registrant hereby certifies
that it meets all of the requirements for filing on
Form 20-F
and that it has duly caused and authorized the undersigned to
sign this Annual Report on its behalf.
SAIFUN SEMICONDUCTORS LTD.
Name: Dr. Boaz Eitan
Title: Chief Executive Officer and Chairman
Name: Igal Shany
Title: Chief Financial Officer
Date: April 11, 2006
SAIFUN
SEMICONDUCTORS LTD.
INDEX TO FINANCIAL STATEMENTS
|
|
|
|
|
|
|
Page
|
|
|
SAIFUN SEMICONDUCTORS LTD. AND
ITS SUBSIDIARIES
|
|
|
|
|
Consolidated Financial
Statements
|
|
|
|
|
|
|
|
F-2
|
|
|
|
|
F-3
|
|
|
|
|
F-5
|
|
|
|
|
F-6
|
|
|
|
|
F-8
|
|
|
|
|
F-9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INFINEON TECHNOLOGIES FLASH
LTD.
|
|
|
|
|
Financial Statements
|
|
|
|
|
|
|
|
F-33
|
|
|
|
|
F-34
|
|
|
|
|
F-35
|
|
|
|
|
F-36
|
|
|
|
|
F-37
|
|
|
|
|
F-38
|
|
|
|
|
F-39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INFINEON TECHNOLOGIES FLASH
GMBH & CO. KG, DRESDEN
|
|
|
|
|
Financial Statements
|
|
|
|
|
|
|
|
F-51
|
|
|
|
|
F-52
|
|
|
|
|
F-53
|
|
|
|
|
F-54
|
|
|
|
|
F-55
|
|
|
|
|
F-56
|
|
F-1
(ERNST & YOUNG LOGO)
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders of
SAIFUN SEMICONDUCTORS LTD.
We have audited the accompanying consolidated balance sheets of
Saifun Semiconductors Ltd. (the Company) and its
subsidiaries as of December 26, 2004 and December 31,
2005, and the related consolidated statements of operations,
changes in shareholders equity and cash flows for the
52-week
periods ended December 28, 2003 and December 26, 2004
and for the period from December 27, 2004 through
December 31, 2005. These financial statements are the
responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements based on our audits. We did not audit the financial
statements of Infineon Technologies Flash Ltd. and Infineon
Technologies Flash GmbH & Co. KG., accounted for by the
equity method, the equity in net loss in which amounted to
$13,026 thousand and $26,741 thousand for the periods ended
December 28, 2003 and December 26, 2004, respectively.
The financial statements of these entities were audited by other
auditors, whose reports have been furnished to us, and our
opinion, insofar as it relates to the amounts included for such
entities, is based solely on the reports of the other auditors.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. We were not engaged to perform an
audit of the Companys internal control over financial
reporting. Our audits included consideration of internal control
over financial reporting as a basis for designing audit
procedures that are appropriate in the circumstances, but not
for the purpose of expressing an opinion on the effectiveness of
the Companys internal control over financial reporting.
Accordingly, we express no such opinion. An audit also includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits and the
reports of other auditors provide a reasonable basis for our
opinion.
In our opinion, based on our audits and the reports of other
auditors, the consolidated financial statements referred to
above present fairly, in all material respects, the consolidated
financial position of the Company and its subsidiaries as of
December 26, 2004 and December 31, 2005, and the
consolidated results of their operations and their cash flows
for the
52-week
periods ended December 28, 2003 and December 26, 2004
and for the period from December 27, 2004 through
December 31, 2005, in conformity with U.S. generally
accepted accounting principles.
As discussed in Note 2 to the consolidated financial
statements, in 2004, the Company changed its method of
accounting for stock-based compensation.
/s/ Kost
Forer Gabbay & Kaisierer
KOST FORER GABBAY & KASIERER
A Member of Ernst & Young Global
Tel-Aviv, Israel
February 7, 2006
F-2
SAIFUN
SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
Note
|
|
|
2004*
|
|
|
2005
|
|
|
ASSETS
|
CURRENT ASSETS:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
|
$
|
27,228
|
|
|
$
|
100,327
|
|
Short-term investments
|
|
|
|
|
|
|
161
|
|
|
|
|
|
Held-to-maturity
marketable securities
|
|
|
3
|
|
|
|
14,662
|
|
|
|
75,501
|
|
Trade receivables
|
|
|
|
|
|
|
7,471
|
|
|
|
2,663
|
|
Loans to employees
|
|
|
5
|
|
|
|
|
|
|
|
613
|
|
Other accounts receivable and
prepaid expenses
|
|
|
|
|
|
|
880
|
|
|
|
2,181
|
|
Total assets attributed to
discontinued operations
|
|
|
9
|
|
|
|
5,151
|
|
|
|
212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
|
|
|
|
55,553
|
|
|
|
181,497
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-to-maturity
marketable securities
|
|
|
3
|
|
|
|
2,403
|
|
|
|
5,995
|
|
Property and equipment, net
|
|
|
6
|
|
|
|
1,910
|
|
|
|
2,668
|
|
Loans to employees
|
|
|
5
|
|
|
|
2,714
|
|
|
|
1,097
|
|
Severance pay fund
|
|
|
|
|
|
|
1,549
|
|
|
|
2,122
|
|
Lease deposits
|
|
|
|
|
|
|
245
|
|
|
|
289
|
|
Other assets
|
|
|
4
|
|
|
|
560
|
|
|
|
70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,381
|
|
|
|
12,241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
|
$
|
64,934
|
|
|
$
|
193,738
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Reclassified, see Note 9.
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-3
SAIFUN
SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands, except share and per share
data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
Note
|
|
|
2004*
|
|
|
2005
|
|
|
LIABILITIES AND SHAREHOLDERS
EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade payables
|
|
|
|
|
|
$
|
1,412
|
|
|
$
|
1,165
|
|
Accrued expenses and other
liabilities
|
|
|
7
|
|
|
|
5,548
|
|
|
|
9,913
|
|
Deferred revenues
|
|
|
4
|
|
|
|
47,222
|
|
|
|
3,786
|
|
Total liabilities attributed to
discontinued operations
|
|
|
9
|
|
|
|
3,804
|
|
|
|
146
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
|
|
|
|
57,986
|
|
|
|
15,010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ACCRUED SEVERANCE PAY
|
|
|
|
|
|
|
2,010
|
|
|
|
2,655
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENT
LIABILITIES
|
|
|
8
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY:
|
|
|
10
|
|
|
|
|
|
|
|
|
|
Share capital
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Convertible Preferred
shares of NIS 0.01 par value: Authorized: 4,000,000 and
zero shares at December 26, 2004 and December 31,
2005, respectively; Issued and outstanding: 2,288,092 and zero
shares at December 26, 2004 and December 31, 2005,
respectively
|
|
|
|
|
|
|
5
|
|
|
|
|
|
Class B Convertible Preferred
shares of NIS 0.01 par value: Authorized: 2,400,000 and
zero shares at December 26, 2004 and December 31,
2005, respectively; Issued and outstanding: 2,327,324 and zero
shares at December 26, 2004 and December 31, 2005,
respectively
|
|
|
|
|
|
|
6
|
|
|
|
|
|
Ordinary shares of NIS
0.01 par value: Authorized: 193,600,000 and
200,000,000 shares at December 26, 2004 and
December 31, 2005, respectively; Issued: 18,852,057 and
30,251,247 shares at December 26, 2004 and
December 31, 2005, respectively; Outstanding: 16,937,421
and 29,456,722 shares at December 26, 2004 and
December 31, 2005, respectively
|
|
|
|
|
|
|
49
|
|
|
|
120
|
|
Additional paid-in capital
|
|
|
|
|
|
|
85,426
|
|
|
|
211,706
|
|
Subscription receivables
|
|
|
|
|
|
|
(250
|
)
|
|
|
|
|
Accumulated other comprehensive
income
|
|
|
|
|
|
|
|
|
|
|
38
|
|
Accumulated deficit
|
|
|
|
|
|
|
(80,298
|
)
|
|
|
(35,791
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
|
|
|
|
4,938
|
|
|
|
176,073
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
shareholders equity
|
|
|
|
|
|
$
|
64,934
|
|
|
$
|
193,738
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Reclassified, see Note 9.
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-4
SAIFUN
SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands, except share and per
share data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
Note
|
|
|
2003*
|
|
|
2004*
|
|
|
2005
|
|
|
Revenues**:
|
|
|
13,4c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Licenses
|
|
|
|
|
|
$
|
7,817
|
|
|
$
|
22,640
|
|
|
$
|
65,790
|
|
Services
|
|
|
|
|
|
|
6,639
|
|
|
|
7,926
|
|
|
|
12,811
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,456
|
|
|
|
30,566
|
|
|
|
78,601
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Services***
|
|
|
|
|
|
|
4,147
|
|
|
|
7,084
|
|
|
|
12,048
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
10,309
|
|
|
|
23,482
|
|
|
|
66,553
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development***
|
|
|
|
|
|
|
9,132
|
|
|
|
6,792
|
|
|
|
7,427
|
|
Marketing and selling***
|
|
|
|
|
|
|
2,543
|
|
|
|
2,914
|
|
|
|
4,889
|
|
General and administrative***
|
|
|
|
|
|
|
1,779
|
|
|
|
2,115
|
|
|
|
6,216
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
|
|
|
|
13,454
|
|
|
|
11,821
|
|
|
|
18,532
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
|
|
|
|
(3,145
|
)
|
|
|
11,661
|
|
|
|
48,021
|
|
Financial income, net
|
|
|
14
|
|
|
|
1,137
|
|
|
|
1,699
|
|
|
|
1,749
|
|
Equity in losses of equity method
investees
|
|
|
4
|
|
|
|
(12,820
|
)
|
|
|
(26,172
|
)
|
|
|
|
|
Compensation expense related to
issuance of options to employees of equity method investees
|
|
|
4
|
|
|
|
(206
|
)
|
|
|
(569
|
)
|
|
|
|
|
Capital loss from sale of equity
method investees
|
|
|
4
|
|
|
|
|
|
|
|
(17,334
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing
operations
|
|
|
|
|
|
|
(15,034
|
)
|
|
|
(30,715
|
)
|
|
|
49,770
|
|
Loss from discontinued operations***
|
|
|
9
|
|
|
|
(156
|
)
|
|
|
(7,189
|
)
|
|
|
(5,263
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
|
|
|
$
|
(15,190
|
)
|
|
$
|
(37,904
|
)
|
|
$
|
44,507
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss) per share:
|
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per Ordinary
share from continuing operations
|
|
|
|
|
|
$
|
(0.89
|
)
|
|
$
|
(1.81
|
)
|
|
$
|
0.46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss per Ordinary share from
discontinued operations
|
|
|
|
|
|
$
|
(0.01
|
)
|
|
$
|
(0.43
|
)
|
|
$
|
(0.29
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net earnings (loss) per
Ordinary share
|
|
|
|
|
|
$
|
(0.90
|
)
|
|
$
|
(2.24
|
)
|
|
$
|
0.17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per
Ordinary share from continuing operations
|
|
|
|
|
|
$
|
(0.89
|
)
|
|
$
|
(1.81
|
)
|
|
$
|
0.36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted loss per Ordinary share
from discontinued operations
|
|
|
|
|
|
$
|
(0.01
|
)
|
|
$
|
(0.43
|
)
|
|
$
|
(0.20
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net earnings (loss) per
Ordinary share
|
|
|
|
|
|
$
|
(0.90
|
)
|
|
$
|
(2.24
|
)
|
|
$
|
0.16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Reclassified, see Note 9.
|
|
|
|
|
**
|
Includes revenues from related parties (principally service
revenues from the Companys joint venture) for the periods
ended December 28, 2003 and December 26, 2004 in the
amount of $6,440 and $8,425, respectively.
|
|
|
*** |
Expenses include stock-based compensation related to options
granted to employees and others as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Cost of services
|
|
$
|
|
|
|
$
|
175
|
|
|
$
|
834
|
|
Research and development
|
|
|
|
|
|
|
220
|
|
|
|
330
|
|
Marketing and selling
|
|
|
|
|
|
|
87
|
|
|
|
667
|
|
General and administrative
|
|
|
|
|
|
|
96
|
|
|
|
2,410
|
|
Loss from discontinued operations
|
|
|
|
|
|
|
23
|
|
|
|
54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
|
|
|
$
|
601
|
|
|
$
|
4,295
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-5
SAIFUN
SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY
U.S. dollars in thousands, except share data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
Deferred
|
|
|
other
|
|
|
|
|
|
|
|
|
comprehensive
|
|
|
Total
|
|
|
|
Number of shares
|
|
|
Share
|
|
|
paid-in
|
|
|
Subscription
|
|
|
stock
|
|
|
comprehensive
|
|
|
Accumulated
|
|
|
Treasury
|
|
|
income
|
|
|
shareholders
|
|
|
|
Preferred
|
|
|
Ordinary
|
|
|
capital
|
|
|
capital
|
|
|
receivables
|
|
|
compensation
|
|
|
income
|
|
|
deficit
|
|
|
shares
|
|
|
(loss)
|
|
|
equity
|
|
|
Balance as of January 1, 2003
|
|
|
4,609,686
|
|
|
|
16,875,301
|
|
|
$
|
60
|
|
|
$
|
78,658
|
|
|
$
|
(11,175
|
)
|
|
$
|
|
|
|
$
|
508
|
|
|
$
|
(27,204
|
)
|
|
$
|
(6,723
|
)
|
|
|
|
|
|
$
|
34,124
|
|
Receipts on account of shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,800
|
|
Options exercised
|
|
|
|
|
|
|
45,960
|
|
|
|
|
*
|
|
|
61
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
61
|
|
Deferred stock compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
367
|
|
|
|
|
|
|
|
(367
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on issuance of shares by
development stage entities accounted for by the equity method
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,370
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,607
|
|
|
|
|
|
|
|
6,977
|
|
Compensation expense related to
issuance of options to an employee of an equity method investee
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
206
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
206
|
|
Comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(122
|
)
|
|
|
|
|
|
|
|
|
|
$
|
(122
|
)
|
|
|
(122
|
)
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,190
|
)
|
|
|
|
|
|
|
(15,190
|
)
|
|
|
(15,190
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(15,312
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 28, 2003
|
|
|
4,609,686
|
|
|
|
16,921,261
|
|
|
|
60
|
|
|
|
83,662
|
|
|
|
(7,375
|
)
|
|
|
(367
|
)
|
|
|
386
|
|
|
|
(42,394
|
)
|
|
|
(4,116
|
)
|
|
|
|
|
|
|
29,856
|
|
Receipts on account of shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
845
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
845
|
|
Options exercised
|
|
|
5,730
|
|
|
|
16,160
|
|
|
|
|
*
|
|
|
130
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
130
|
|
Compensation expense related to
issuance of options to employees of equity method investees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
813
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
813
|
|
Amortization of deferred stock
compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(367
|
)
|
|
|
|
|
|
|
367
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation related to
options issued to employees and others
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,539
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,539
|
|
Reissuance of treasury shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
871
|
|
|
|
6,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,116
|
|
|
|
|
|
|
|
11,267
|
|
Deferred costs relating to initial
public offering
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,222
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,222
|
)
|
Comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(386
|
)
|
|
|
|
|
|
|
|
|
|
$
|
(386
|
)
|
|
|
(386
|
)
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(37,904
|
)
|
|
|
|
|
|
|
(37,904
|
)
|
|
|
(37,904
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(38,290
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 26, 2004
|
|
|
4,615,416
|
|
|
|
16,937,421
|
|
|
|
60
|
|
|
|
85,426
|
|
|
|
(250
|
)
|
|
|
|
|
|
|
|
|
|
|
(80,298
|
)
|
|
|
|
|
|
|
|
|
|
|
4,938
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Represents an amount lower than $1.
|
|
|
** |
Net of issuance expenses of $13,050, see Note 10a.
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-6
SAIFUN
SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands, except share data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
Deferred
|
|
|
other
|
|
|
|
|
|
|
|
|
comprehensive
|
|
|
Total
|
|
|
|
Number of shares
|
|
|
Share
|
|
|
paid-in
|
|
|
Subscription
|
|
|
stock
|
|
|
comprehensive
|
|
|
Accumulated
|
|
|
Treasury
|
|
|
income
|
|
|
shareholders
|
|
|
|
Preferred
|
|
|
Ordinary
|
|
|
capital
|
|
|
capital
|
|
|
receivables
|
|
|
compensation
|
|
|
income
|
|
|
deficit
|
|
|
shares
|
|
|
(loss)
|
|
|
equity
|
|
|
Balance as of December 26, 2004
|
|
|
4,615,416
|
|
|
|
16,937,421
|
|
|
|
60
|
|
|
|
85,426
|
|
|
|
(250
|
)
|
|
|
|
|
|
|
|
|
|
|
(80,298
|
)
|
|
|
|
|
|
|
|
|
|
|
4,938
|
|
Issuance of share capital upon
initial public offering, net
|
|
|
|
|
|
|
5,750,000
|
|
|
|
12
|
|
|
|
122,063
|
**
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
122,075
|
|
Options exercised
|
|
|
984,283
|
|
|
|
1,140,111
|
|
|
|
48
|
|
|
|
488
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
536
|
|
Conversion of Convertible Preferred
shares
|
|
|
(5,599,699
|
)
|
|
|
5,599,699
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants exercised
|
|
|
|
|
|
|
29,491
|
|
|
|
|
*
|
|
|
550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
550
|
|
Receipts on account of shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250
|
|
Stock-based compensation related to
options issued to employees and others
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,179
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,179
|
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in fair value of cash flow
derivative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38
|
|
|
|
|
|
|
|
|
|
|
$
|
38
|
|
|
|
38
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44,507
|
|
|
|
|
|
|
|
44,507
|
|
|
|
44,507
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
44,545
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2005
|
|
|
|
|
|
|
29,456,722
|
|
|
$
|
120
|
|
|
$
|
211,706
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
38
|
|
|
$
|
(35,791
|
)
|
|
$
|
|
|
|
|
|
|
|
$
|
176,073
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Represents an amount lower than $1.
|
|
|
** |
Net of issuance expenses of $13,050, see Note 10a.
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-7
SAIFUN
SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003*
|
|
|
2004*
|
|
|
2005
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(15,190
|
)
|
|
$
|
(37,904
|
)
|
|
$
|
44,507
|
|
Adjustments to reconcile net income
(loss) to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in losses of equity method
investees
|
|
|
12,820
|
|
|
|
26,172
|
|
|
|
|
|
Compensation expense related to
issuance of options to employees of equity method investees
|
|
|
206
|
|
|
|
569
|
|
|
|
|
|
Depreciation
|
|
|
1,656
|
|
|
|
1,070
|
|
|
|
1,195
|
|
Stock-based compensation related to
options issued to employees and others
|
|
|
|
|
|
|
601
|
|
|
|
4,295
|
|
Non-cash deferred revenues (see
Note 4c)
|
|
|
|
|
|
|
19,182
|
|
|
|
(19,182
|
)
|
Capital loss from sale of equity
method investees
|
|
|
|
|
|
|
17,334
|
|
|
|
|
|
Accrued severance pay, net
|
|
|
130
|
|
|
|
185
|
|
|
|
72
|
|
Amortization of premium, net and
accrued interest on
held-to-maturity
marketable securities
|
|
|
8
|
|
|
|
546
|
|
|
|
889
|
|
Amortization and impairment of
other assets
|
|
|
|
|
|
|
|
|
|
|
490
|
|
Accrued interest on loans to
employees
|
|
|
(104
|
)
|
|
|
(136
|
)
|
|
|
(84
|
)
|
Increase in accrued interest on
loans granted to equity method investees
|
|
|
(62
|
)
|
|
|
(149
|
)
|
|
|
|
|
Decrease (increase) in trade
receivables
|
|
|
(2,064
|
)
|
|
|
(2,228
|
)
|
|
|
4,808
|
|
Decrease (increase) in other
accounts receivable and prepaid expenses
|
|
|
350
|
|
|
|
(407
|
)
|
|
|
(1,263
|
)
|
Decrease (increase) in total assets
attributed to discontinued operations
|
|
|
(255
|
)
|
|
|
(4,776
|
)
|
|
|
4,939
|
|
Increase (decrease) in trade
payables
|
|
|
279
|
|
|
|
(396
|
)
|
|
|
(458
|
)
|
Increase in accrued expenses and
other liabilities
|
|
|
1,731
|
|
|
|
625
|
|
|
|
1,820
|
|
Increase (decrease) in deferred
revenues
|
|
|
2,813
|
|
|
|
(6,128
|
)
|
|
|
(24,254
|
)
|
Increase (decrease) in total
liabilities attributed to discontinued operations
|
|
|
|
|
|
|
3,804
|
|
|
|
(3,658
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
|
2,318
|
|
|
|
17,964
|
|
|
|
14,116
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Collection of short-term bank
deposits, net
|
|
|
257
|
|
|
|
353
|
|
|
|
161
|
|
Purchase of
held-to-maturity
marketable securities
|
|
|
(10,876
|
)
|
|
|
(12,471
|
)
|
|
|
(85,934
|
)
|
Proceeds from maturity of
held-to-maturity
marketable securities
|
|
|
|
|
|
|
5,727
|
|
|
|
20,614
|
|
Investment in equity method
investees
|
|
|
(2,025
|
)
|
|
|
|
|
|
|
|
|
Loans granted to equity method
investees
|
|
|
(3,244
|
)
|
|
|
(13,104
|
)
|
|
|
|
|
Lease deposits
|
|
|
(43
|
)
|
|
|
(57
|
)
|
|
|
(44
|
)
|
Purchase of property and equipment
|
|
|
(1,041
|
)
|
|
|
(765
|
)
|
|
|
(1,953
|
)
|
Loans granted to employees
|
|
|
(399
|
)
|
|
|
(241
|
)
|
|
|
(154
|
)
|
Loans repaid by employees
|
|
|
|
|
|
|
182
|
|
|
|
1,242
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(17,371
|
)
|
|
|
(20,376
|
)
|
|
|
(66,068
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Ordinary shares in
respect of Companys initial public offering, net
|
|
|
|
|
|
|
|
|
|
|
125,666
|
|
Issuance costs in respect of the
Companys initial public offering
|
|
|
|
|
|
|
(719
|
)
|
|
|
(1,951
|
)
|
Proceeds from issuance of shares
|
|
|
3,800
|
|
|
|
845
|
|
|
|
250
|
|
Proceeds from options and warrants
exercised
|
|
|
61
|
|
|
|
130
|
|
|
|
1,086
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing
activities
|
|
|
3,861
|
|
|
|
256
|
|
|
|
125,051
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in cash and
cash equivalents
|
|
|
(11,192
|
)
|
|
|
(2,156
|
)
|
|
|
73,099
|
|
Cash and cash equivalents at
beginning of year
|
|
|
40,576
|
|
|
|
29,384
|
|
|
|
27,228
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of
year
|
|
$
|
29,384
|
|
|
$
|
27,228
|
|
|
$
|
100,327
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash
transactions see Note 4c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Reclassified, see Note 9.
|
The accompanying notes are an integral part of the consolidated
financial statements.
F-8
SAIFUN
SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
U.S. dollars in thousands, except share data
Saifun Semiconductors Ltd., established in 1996, is a supplier
of advanced Non Volatile Memory (NVM) solutions. The
nitride-read-only-memory (NROM) technology of Saifun
Semiconductors Ltd. (collectively with its subsidiaries
(Note 2d), the Company or Saifun)
enhances the design and manufacturing of NVM devices (i.e. Code
Flash, Data Flash, Embedded Flash), enabling high-density
applications. Saifuns NROM Technology is serving the fast
growing portable markets, such as mobile phones, digital
cameras, personal digital assistants (PDAs), USB flash drives,
communication applications, and computer and peripherals
applications. During 2005, a majority of the Companys
revenues were derived from three major customers (see
Note 13c).
In November 2005, the Company consummated an initial public
offering (IPO) on the NASDAQ national market and
issued 5,750,000 Ordinary shares for net proceeds of $120,853.
|
|
NOTE 2:
|
SIGNIFICANT
ACCOUNTING POLICIES
|
The accompanying consolidated financial statements are prepared
in accordance with U.S. generally accepted accounting
principles (U.S. GAAP).
a. Use of estimates:
The preparation of financial statements in conformity with
U.S. GAAP requires management to make estimates and
assumptions that affect the amounts reported in the financial
statements and accompanying notes. Actual results could differ
from those estimates.
b. Financial statements in U.S. dollars:
All of the Companys revenues are denominated in United
States dollars (dollars). In addition, a substantial
portion of the Companys costs is denominated in dollars.
The Companys management believes that the dollar is the
primary currency of the economic environment in which Saifun
Semiconductors Ltd. and each of its subsidiaries operate. Thus,
the dollar is their functional and reporting currency.
Accordingly, monetary accounts maintained in currencies other
than the dollar are remeasured into dollars in accordance with
Statement of Financial Accounting Standard (SFAS)
No. 52, Foreign Currency Translation. Changes
in currency exchange rates between the Companys functional
currency and the currency in which a transaction is denominated
are included in the Companys results of operations as
financial income (expense) in the period in which the currency
exchange rates change.
The representative rate of exchange between the dollar and the
New Israeli Shekel (NIS) as of December 31,
2005 was $1.00 = NIS 4.603 (December 26,
2004 $1.00 = NIS 4.331 and December 28,
2003 $1.00 = NIS 4.366).
The financial statements of Infineon Technologies Flash
GmbH & Co. KG (IFL KG), which were
accounted for under the equity method until December 2004, the
functional currency of which is not the U.S. dollar, have
been translated into dollars in accordance with
SFAS No. 52. All balance sheet accounts have been
translated using the exchange rates in effect at the balance
sheet date of 2004 and 2003. Statement of operations amounts
have been translated using the average exchange rate prevailing
during the year. The resulting aggregate translation adjustments
were reported as a component of accumulated other comprehensive
income in shareholders equity. In December 2004, the
Company divested its entire interest in IFL KG and, accordingly,
the entire balance of accumulated other comprehensive income in
the amount of $651 was realized (see Note 4).
c. Basis of presentation:
During fiscal year 2005, the Company changed its fiscal year
from a
52-week
fiscal year ending on the last Sunday in December to a calendar
year end on the last day of December. For fiscal 2004, the
fiscal year
F-9
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
ended on December 26. For fiscal 2003, the fiscal year ended on
December 28. Accordingly, the financial statements for the
period from December 27, 2004 through December 31,
2005 are not necessarily comparable to prior periods. The
Company believes that this difference is immaterial.
d. Principles of consolidation:
The consolidated financial statements include the accounts of
the Companys wholly-owned subsidiaries, Saifun Ventures
Ltd. (ceased operations at the beginning of 2005), Saifun
Semiconductors USA, Inc. , Saifun BVI (Limited) and Tulip
Semiconductor LP. All intercompany balances and transactions
have been eliminated upon consolidation.
In January 2003, the Financial Accounting Standards Board (FASB)
issued FASB Interpretation 46, Consolidation of Variable
Interest Entities, an Interpretation of ARB No. 51
(FIN 46) which was modified in December 2003
(FIN 46(R)). FIN 46(R) provides a new
framework for identifying variable interest entities
(VIEs) and determining when a company should include
the assets, liabilities, non-controlling interests and results
of activities of a VIE in its consolidated financial statements.
FIN 46(R) requires a VIE to be consolidated if a party with
an ownership, contractual or other financial interest in the VIE
is obligated to absorb a majority of the risk of loss from the
VIEs activities, is entitled to receive a majority of the
VIEs residual returns (if no party absorbs a majority of
the VIEs losses), or both. FIN 46(R) also requires
disclosures about VIEs that the variable interest holder is not
required to consolidate but in which it has a significant
variable interest.
Upon the adoption of FIN 46(R) in 2004, the Company
determined that there was no impact on its balance sheet, as it
is not the primary beneficiary of the Joint Venture (see
Note 4). However, the Company has identified its former
Joint Venture to be a VIE.
Because of the Companys significant ownership and
contractual arrangement with the Joint Venture, the Company was
determined to have a significant variable interest in the Joint
Venture and as such provided appropriate disclosures in
Note 4.
e. Cash and cash equivalents:
Cash equivalents are short-term, highly liquid investments that
are readily convertible to cash, with an original maturity of
three months or less when purchased.
This item includes cash in the banks in the amount of $67,630
(2004 $16,266), bank deposits in
U.S. dollars in the amount of $31,949
(2004 $10,915), bank deposits in NIS in the
amount of $734 (2004 $0) and bank deposits in
Euro in the amount of $14 (2004 $47).
f. Short-term investments:
Short-term investments include bank deposits with maturities of
more than three months but less than one year. The short-term
deposits are presented at cost, including accrued interest.
g. Held-to-maturity
marketable securities:
The Company accounts for certain investments in debt securities
in accordance with Statement of Financial Accounting Standard
No. 115, Accounting for Certain Investments in Debt
and Equity Securities
(SFAS No. 115). Management determines the
appropriate classification of its investments in debt securities
at the time of purchase and reevaluates such determinations at
each balance sheet date. Debt securities are classified as
held-to-maturity
when the Company has the positive intent and ability to hold the
securities to maturity and are stated at amortized cost. The
amortized cost of
held-to-maturity
securities is adjusted for amortization of premiums and
accretion of discounts to maturity. Such amortization,
impairment of value judged to be other than temporary, and
interest are included in financial income, net.
F-10
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
h. Discontinued operations inventories:
Inventories are stated at the lower of cost or market value and
are comprised of work in progress ($1,818 and $0 as of
December 26, 2004 and December 31, 2005, respectively)
and finished goods ($413 and $0 as of December 26, 2004 and
December 31, 2005, respectively). Cost is determined by the
weighted average method and is recorded on the basis of direct
manufacturing costs. Inventory write-offs are provided to cover
risks primarily arising from market prices that are lower than
cost. Inventory write-offs for the years ended December 28,
2003, December 26, 2004 and December 31, 2005, were
$156, $3,019 and $2,893, respectively. During 2005, the Company
discontinued its product business and accordingly, the results
of operations of product sales operations were reported
separately as discontinued operations for all periods presented
(see Note 9).
i. Property and equipment, net:
Property and equipment are stated at cost, net of accumulated
depreciation. Depreciation is calculated by the straight-line
method over the estimated useful lives of the assets. Annual
rates of depreciation are as follows:
|
|
|
|
|
%
|
|
Laboratory equipment
|
|
15 33
|
Computers and software
|
|
33
|
Furniture and fixtures
|
|
6 33
|
Leasehold improvements
|
|
20 95
|
Leasehold improvements are amortized over the shorter of the
estimated useful life or the lease term.
j. Research and development costs:
Research and development costs consist primarily of salary and
related costs for personnel, as well as costs related to
materials, supplies and equipment depreciation. All research and
development costs are expensed as incurred.
k. Stock-based compensation:
1. During the third quarter of 2004, the Company adopted
the fair value recognition provisions of FASB Statement
No. 123, Accounting for Stock-Based
Compensation (SFAS 123), as amended by
FASB Statement No. 148, Accounting for Stock-Based
Compensation Transition and Disclosure
(SFAS 148), for stock-based employee
compensation. Effective December 29, 2003, the Company
elected to apply the Modified Prospective Method under
SFAS 148, i.e. unvested options were accounted for under
the fair value recognition provision of SFAS 123 from
December 29, 2003 as if the fair value method had been
applied since the date of grant. The impact of the adoptions of
the fair value method of accounting for stock-based compensation
was an increase in stock-based compensation expense of
approximately $341 for the year ended December 26, 2004.
Prior to December 29, 2003, the Company accounted for its
stock-based employee compensation plans using the
intrinsic-value method of accounting set forth in Accounting
Principles Board Opinion No. 25, Accounting for Stock
Issued to Employees (APB 25), but
disclosed the pro forma effects on net loss as if the fair value
of the options had been expensed. In accordance with APB 25
and related interpretations, compensation expense for stock
options is recognized in income based on the excess, if any, of
the fair value of the share at the grant date of the award or
other measurement date over the amount an employee must pay to
acquire the share.
Generally, the exercise price for share options granted to
employees equals the fair market value of the share at the date
of grant, thereby resulting in no recognition of compensation
expense. For awards that
F-11
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
generate compensation expense as defined under APB 25, the
Company calculates the amount of compensation expense and
recognizes the expense over the vesting period of the award.
Had compensation cost for Saifuns share option plans been
determined based on the fair value method set forth in
SFAS 123 for periods prior to December 29, 2003, net
loss and basic and diluted net loss per Ordinary share would
have been changed to the pro forma amounts indicated below:
In calculating the fair value of the options granted until June
2004 (initial filing date with the SEC), the Company applied the
minimum value method as prescribed by SFAS 123 for private
companies. Volatility of comparable publicly traded companies
was used for options granted after June 2004. The fair value of
each option granted was estimated at the date of grant using a
Black-Scholes options pricing model with the following weighted
average assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Dividend yield
|
|
|
0%
|
|
|
|
0%
|
|
|
|
0%
|
|
Expected volatility
|
|
|
0%
|
|
|
|
0-45%
|
|
|
|
45%
|
|
Risk-free interest
|
|
|
2.6-3.3%
|
|
|
|
2.6-3.3%
|
|
|
|
2.6-4.4%
|
|
Expected life of
|
|
|
3.2-5 years
|
|
|
|
3.2-5 years
|
|
|
|
1-5 years
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
|
2003
|
|
|
Net loss as reported
|
|
$
|
(15,190
|
)
|
Add: stock-based employee
compensation determined under intrinsic value method
|
|
|
|
|
Deduct: stock-based employee
compensation determined under fair value method
|
|
|
(403
|
)
|
|
|
|
|
|
Pro forma net loss
|
|
$
|
(15,593
|
)
|
|
|
|
|
|
Basic and diluted net loss per
share:
|
|
|
|
|
As reported
|
|
$
|
(0.90
|
)
|
|
|
|
|
|
Pro forma
|
|
$
|
(0.92
|
)
|
|
|
|
|
|
The Company applies SFAS 123 and Emerging Issues Task Force
No. 96-18, Accounting for Equity Instruments that are
Issued to other than Employees for Acquiring, or in Conjunction
with Selling, Goods or Services
(EITF 96-18), with respect to options and
warrants issued to non-employees. SFAS 123 and
EITF 96-18 require the use of option valuation models to
measure the fair value of the options and warrants at the
measurement date.
2. The Company undertook a liability relating to a Stock
Appreciation Rights Plan (the SARP) as a result of
the sale of its entire interest in the Joint Venture (see
Note 4c). The SARP liability is recorded at the intrinsic
value of the underlying shares as required by SFAS 123.
l. Revenue recognition:
The Companys revenues consist of license revenues and
design and development services. License revenues are generated
from agreements with semiconductor companies to provide licenses
for the Companys technology. Service revenues are
generated from design and development services provided by the
Company.
In most cases, the licenses provided allow a semiconductor
manufacturer to use the Companys patents and trade
secrets, and an implied right to receive initial support in
order to implement the Companys technology in the
licensees products.
F-12
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company recognizes revenues in accordance with Staff
Accounting Bulletin No. 104, Revenue
Recognition (SAB No. 104) and when
necessary to allocated proceeds to multiple elements, Emerging
Issues Task Force Issue
No. 00-21,
Revenue Arrangements with Multiple Deliverables
(EITF No. 00-21).
License revenues are recognized when persuasive evidence of an
arrangement exists, delivery has occurred or the service has
been rendered, the fee is fixed or determinable and
collectibility is probable. The fees for the licenses provided
under these agreements are comprised of license and support
fees, as well as in certain cases, non refundable, prepaid
royalties. Generally, such fees are accounted for as one unit of
accounting in accordance with EITF
No. 00-21,
since it is not possible to determine objective and reliable
evidence of fair value of the contract elements in order to
separate the fees among the elements. The license fees are
payable upon the achievement of certain technological or
time-based milestones. Accordingly, revenues from such license
fees are recognized ratably over the period during which the
initial customer support is expected to be provided in order to
implement the Companys technology in the licensees
products and only when all other criteria for revenue
recognition are met. In addition, revenue recognition is limited
to the amount that is due or billable under the agreement. The
Company reviews assumptions regarding the support periods on a
regular basis. If it determines that it is necessary to revise
its estimates of the customer support periods, the total amount
of revenue recognized over the life of the contract would not be
affected.
However, to the extent the new assumptions regarding the post
contract customer support periods were less than the original
assumptions, the license fees would be recognized ratably over
the shorter period. Conversely, if the new estimated periods
were longer than the original assumptions, the license fees
would be recognized over a longer period. The excess of contract
fees received over revenues recognized is presented in the
balance sheet as deferred revenues.
Revenues from royalties are recognized as earned.
Revenues from design and development services provided to the
former Joint Venture based on a fixed fee per employee are
recognized as the services are rendered in accordance with
SAB No. 104.
Revenues from design and development services provided to
licensees in fixed fee service contracts that are separable from
the license agreement are recognized based on the proportional
performance model, using hours of employee services rendered as
a percentage of total project hours. However, revenues are
always limited to output measures (technological milestones) or
amounts due or billable under the agreement.
|
|
|
Discontinued
operations Product revenues
|
Revenues from product sales are recognized in accordance with
SAB No. 104 when persuasive evidence of an agreement
exists, delivery has occurred, the fee is fixed or determinable,
no further obligation exists and collectibility is probable.
The Company generally does not grant a right of return to its
customers. However, the Company grants certain distributors a
limited right of return on unsold products. When a right of
return exists, the Company records a provision against revenues
based upon the agreed upon return rights until the right of
return expires, at which time revenue is recognized provided
that all other revenue recognition criteria are met. The Company
provides product warranties for up to one year. Based on
managements estimate, the provision for warranties is
immaterial as of the balance sheet date.
During 2005, the Company discontinued its product business and
accordingly, the results of operations of the product business
were reported separately as discontinued operations for all
periods presented (see Note 9).
F-13
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The liabilities attributed to discontinued operations include an
estimate of the cost of warranty provided on the discontinued
products sales.
m. Equity method investment:
The Companys investment in entities which are held to the
extent of 20% to 50% and with respect to which it has the
ability to exercise significant influence over operating and
financial policies are accounted for under the equity method.
The Company applies Emerging Issues Task
Force 99-10,
Percentage Used to Determine the Amount of Equity Method
Losses. Accordingly, losses of the investees are
recognized based on the ownership level of the particular
investee security or loans held by the investor.
n. Income taxes:
The Company accounts for income taxes in accordance with
Statement of Financial Accounting Standard No. 109,
Accounting for Income Taxes
(SFAS No. 109). SFAS No. 109
prescribes the use of the liability method whereby deferred tax
asset and liability account balances are determined based on
differences between the financial reporting and tax bases of
assets and liabilities and are measured using the enacted tax
rates and laws that will be in effect when the differences are
expected to reverse. The Company provides a valuation allowance,
if necessary, to reduce deferred tax assets to their estimated
realizable value.
Results for tax purposes are measured and reflected in real
terms in accordance with the change in the Israeli Consumer
Price Index (CPI). As explained in b. above,
the consolidated financial statements are presented in dollars.
In accordance with paragraph 9(f) of
SFAS No. 109, the Company has not provided deferred
income taxes on the differences resulting from changes in
exchange rates and indexing for tax purposes.
o. Fair value of financial instruments:
The carrying amount reported in the consolidated balance sheet
for cash and cash equivalents, short-term investments,
receivables and payables approximates their fair value due to
the short-term maturities of such instruments.
The fair value of
held-to-maturity
marketable securities is based on quoted market prices and does
not differ significantly from the carrying amount.
The fair value of the loans to employees is estimated by
discounting the future cash flows using current interest rates
for loans of similar terms and maturities. The carrying amount
of the loans approximates their fair value.
p. Impairment of long-lived assets:
The Companys long-lived assets and other assets are
reviewed for impairment in accordance with Statement of
Financial Accounting Standards No. 144, Accounting
for the Impairment or Disposal of Long-Lived Assets
(SFAS No. 144) whenever events or changes
in circumstances indicate that the carrying amount of the asset
may not be recoverable. Recoverability of an asset to be held
and used is measured by a comparison of the carrying amount of
an asset to the future undiscounted cash flows expected to be
generated by the asset. If such asset is considered to be
impaired, the impairment to be recognized is measured by the
amount by which the carrying amount of the asset exceeds its
fair value.
q. Severance pay:
The Companys liability for severance pay is calculated
pursuant to Israels Severance Pay Law, based on the most
recent salary of the employees multiplied by the number of years
of employment, as of the balance sheet date. Employees are
entitled to one months salary for each year of employment
or a portion thereof. The Companys liability for all of
its Israeli employees is covered by monthly deposits for
insurance policies and/or pension funds and by an accrual. The
value of these policies and/or funds is recorded as an asset in
the
F-14
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Companys balance sheet. The deposited funds include
profits accumulated to the balance sheet date. The deposited
amounts may be withdrawn only upon the fulfillment of the
obligations pursuant to the Israels Severance Pay Law or
labor agreements. The value of the deposited funds is based on
the cash surrendered value of these policies, and includes
immaterial profits.
Severance expense for the years ended December 28, 2003,
December 26, 2004 and December 31, 2005 amounted to
$432, $745 and $645, respectively.
r. Concentrations of credit risk:
Financial instruments that potentially subject the Company to
concentrations of credit risk consist principally of cash and
cash equivalents, short-term investments, marketable securities
and trade receivables.
Cash and cash equivalents and short-term bank deposits are
invested in dollars, Euros and NIS (mainly in dollars) with
major banks in the United States, Switzerland, France and
Israel. Management believes that the financial institutions that
hold the Companys investments are financially sound and,
accordingly, minimal credit risk exists with respect to these
investments.
The Companys investments in marketable securities include
investments in debentures of U.S. and European corporations and
government institutions. Management believes that these
corporations are financially sound, the portfolio is well
diversified and accordingly, minimal credit risk exists with
respect to these marketable securities.
The Companys trade receivables, are generally derived from
license revenues and services rendered to large and well
established organizations located primarily in the Asia-Pacific
region, the United States and Europe (see Note 13a). The
Company has not experienced any material losses to date.
No off-balance sheet concentrations of credit risk exist.
s. Net earnings (loss) per share:
The Company applies the two-class method as required by
EITF No. 03-6,
Participating Securities and the
Two Class Method under FASB Statement
No. 128, Earnings per Share (EITF
No. 03-6).
EITF
No. 03-6
requires the earnings per share for each class of shares
(Ordinary shares and Preferred shares) to be calculated assuming
100% of the Companys earnings are distributed as dividends
to each class of shares based on their contractual rights.
Accordingly, until the Company reaches a certain company
valuation, each holder of the Class B Preferred shares is
entitled to receive, prior to and in preference to payments to
the holders of Class A Preferred shares and Ordinary
shares, an amount equal to 128% of the amount of its investment
in the Company and, thereafter, on a pro rata basis among all
shareholders. In 2005, earnings per share was calculated
assuming that all of the Companys profit generated for the
period December 27, 2004 through November 8, 2005
(the IPO Date) was first distributed to the holder
of Class B Preferred shares as if it were a deemed
liquidation event (for the period from December 27, 2004
until the date of the IPO, whereby the Class B Preferred
shares were converted to Ordinary shares).
In compliance with
EITF No. 03-6,
the series of Preferred shares do not participate in losses, and
therefore are not included in the computation of net loss per
share.
Basic net earnings (loss) per share is computed using the
weighted average number of Ordinary shares outstanding during
the period. In 2005, the weighted average number of Ordinary
shares outstanding was calculated separately for two isolated
periods (from December 27, 2004 until the IPO Date and from
the IPO Date until December 31, 2005). Diluted net earnings
(loss) per share is computed based on the weighted average
number of Ordinary shares outstanding during the two periods
described above, plus dilutive potential Ordinary shares
considered outstanding during each of the two periods in
accordance with Statement of Financial Accounting Standards
No. 128, Earnings Per Share.
F-15
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
For the years ended December 28, 2003 and December 26,
2004, all outstanding stock options, warrants and Convertible
Preferred shares have been excluded from the calculation of the
diluted net loss per share since their effect was anti-dilutive.
For the year ended December 31, 2005, 189,823 stock options
and 89,100 shares exercisable as a result of the SARPs have
been excluded from the calculation of the diluted net earnings
per share since their effect was anti-dilutive.
Basic and diluted pro forma net earnings (loss) per share, as
presented in Note 15b, has been calculated as described
above and gives effect to the automatic conversion of the
Convertible Preferred shares (Class A and Class B) and
options into Ordinary shares that occurred upon the completion
of the Companys IPO on November 8, 2005 (using the
as if converted method as if the conversion occurred
as of the beginning of the year ended December 31, 2005).
t. Derivative instruments:
The Company sometimes uses derivative financial instruments to
manage its exposure to fluctuations in foreign exchange rates.
The Company accounts for derivative financial instruments in
accordance with SFAS 133, Accounting for Derivative
Instruments and Hedging Activities
(SFAS No. 133). Under
SFAS No. 133, all derivatives are recorded as either
assets or liabilities in the consolidated balance sheet, and
periodically adjusted to fair value. The classification of gains
and losses resulting from changes in the fair values of
derivatives is dependent on the intended use of the derivative
and its resulting designation. Adjustments to reflect changes in
fair values of derivatives not designated as hedging instruments
are reflected in earnings. For derivative instruments that are
designated and qualify as a cash flow hedge, the effective
portion of the gain or loss on the derivative instrument is
reported as a component of other comprehensive income and
reclassified into earnings in the same line item associated with
the forecasted transaction in the same period during which the
hedge transaction affects earnings.
u. Recently issued Accounting Standards:
On December 16, 2004, the Financial Accounting Standards
Board issued Statement No. 123 (revised 2004),
Share-Based Payment
(Statement 123(R)), which is a revision of FASB
Statement No. 123, Accounting for Stock-Based
Compensation (Statement 123). Generally,
the approach in Statement 123(R) is similar to the approach
described in Statement 123. However, Statement 123
permitted, but did not require, share-based payments to
employees to be recognized based on their fair values while
Statement 123(R) requires all share-based payments to
employees to be recognized based on their fair values.
Statement 123(R) also revises, clarifies and expands
guidance in several areas, including measuring fair value,
classifying an award as equity or as a liability and attributing
compensation cost to reporting periods. The new Standard will be
effective for the Company in the first fiscal year beginning
January 1, 2006. The adoption of Statement 123(R) is
not expected to have a significant effect on the Companys
results of operations.
The Company plans to adopt Statement 123(R) using the
modified-prospective method.
The Company adopted the fair-value-based method of accounting
for share-based payments effective December 29, 2003 using
the modified prospective method described in
SFAS 148. Currently, the Company uses the Black-Scholes
formula to estimate the value of stock options granted to
employees and expects to continue to use an acceptable option
valuation model upon the required adoption of
Statement 123(R) on January 1, 2006.
In March 2005, the SEC released SEC Staff Accounting Bulletin
No. 107, Share-Based Payment
(SAB 107). SAB 107 provides the SEC
Staffs position regarding the application of
Statement 123(R) and contains interpretive guidance related
to the interaction between Statement 123(R) and certain SEC
rules and regulations, and also provides the SEC Staffs
views regarding the valuation of share-based payment
arrangements for public companies. SAB 107 highlights the
importance of disclosures made relating to the
F-16
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
accounting for share-based payment transactions. The Company
does not believe that SAB 107 will have a material effect
on its financial position, results of operations or cash flows.
In May 2005, the FASB issued Statement of Financial Accounting
Standard No. 154 (SFAS 154),
Accounting Changes and Error Corrections, a
replacement of APB No. 20, Accounting
Changes and SFAS No. 3, Reporting
Accounting Changes in Interim Financial Statements.
SFAS 154 provides guidance on the accounting for and
reporting of accounting changes and error corrections.
APB No. 20 previously required that most voluntary
changes in accounting principles be recognized by including in
net income for the period of the change the cumulative effect of
changing to the new accounting principle. SFAS 154 requires
retroactive application to prior periods financial
statements of a voluntary change in accounting principles unless
it is impracticable. SFAS 154 is effective for accounting
changes and corrections of errors made in fiscal years beginning
after December 15, 2005.
In November 2005, the FASB issued FSP
FAS 115-1.
The FSP addresses the determination as to when an investment is
considered impaired, whether that impairment is other than
temporary, and the measurement of an impairment loss. The FSP
also includes accounting considerations subsequent to the
recognition of other than-temporary impairment and requires
certain disclosures about unrealized losses that have not been
recognized as other-than-temporary impairments. The guidance in
this FSP amends FASB Statements No. 115, Accounting
for Certain Investments in Debt and Equity. The FSP
replaces the impairment evaluation guidance of EITF Issue
No. 03-1,
The Meaning of other-than-Temporary Impairment and its
Application to Certain Investments, with references to the
existing other-than-temporary impairment guidance. The FSP
clarifies that an investor should recognize an impairment loss
no later than when the impairment is deemed
other-than-temporary, even if a decision to sell an impaired
security has not been made. The guidance in this FSP is to be
applied to reporting periods beginning after December 15,
2005. The Company does not expect that the adoption of FSP
FAS 115-1
will have a material effect on its financial position or results
of operations.
|
|
NOTE 3:
|
HELD-TO-MATURITY
MARKETABLE SECURITIES
|
The investment in
held-to-maturity
securities consists of debt securities (approximately 94% and
19% commercial bonds, 0% and 76% in auction rate securities, and
6% and 5% government bonds as of December 26, 2004 and
December 31, 2005, respectively). The maturities of the
bonds are as follows:
|
|
|
|
|
|
|
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
First year
|
|
$
|
14,662
|
|
|
$
|
75,501
|
|
Second year
|
|
|
2,403
|
|
|
|
4,138
|
|
Third year
|
|
|
|
|
|
|
1,857
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
17,065
|
|
|
$
|
81,496
|
|
|
|
|
|
|
|
|
|
|
As of December 26, 2004 and December 31, 2005, the
fair value of the securities ($16,805 and $81,432, respectively)
approximated their carrying amount.
|
|
NOTE 4:
|
OBLIGATION
TO FINANCE EQUITY METHOD INVESTEES
|
a. In 2001, the Company and Infineon Technologies
(Infineon) established a Joint Venture, which was
engaged in the development, production and distribution of flash
products. The Joint Venture consisted of an Israeli corporation,
Infineon Technologies Flash Ltd. (IFL Ltd.), and a
German partnership, Infineon Technologies Flash GmbH &
Co. KG. (IFL KG).
As of December 26, 2004, the Company has no ownership of
each of the affiliated entities (see c below).
F-17
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
During 2003, an amendment to the Joint Venture agreement was
signed with Infineon. Under this agreement, Infineon made an
additional investment in the affiliated entities in the amount
of $21,346, diluting the Companys equity interest in the
Joint Venture from 49% to 30%. This investment was made during
2003 and the dilution in the Companys interest took place
in February 2003.
The gain resulting from the aforementioned dilution amounted to
$4,370 and was recorded as additional paid-in capital since the
Joint Venture incurred losses and the Company has committed to
further invest in those entities. In addition, the Company
reduced its investment in treasury shares by $2,607 (see c
below). The investment as of December 23, 2004 (prior to
the termination of the Joint Venture agreement) was composed as
follows:
|
|
|
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
Investment in shares
|
|
$
|
18,556
|
|
Gain on issuance of shares
|
|
|
4,370
|
|
Options issued to employees of
equity method investee (Note 10d)
|
|
|
246
|
|
Less equity
loss(*)
|
|
|
(49,311
|
)
|
Currency translation adjustments
|
|
|
(2,463
|
)
|
|
|
|
|
|
|
|
|
(28,602
|
)
|
Loans(**)
|
|
|
24,440
|
|
|
|
|
|
|
|
|
|
(4,162
|
)
|
Less treasury
shares(***)
|
|
|
(4,116
|
)
|
Less subscription
receivable(***)
|
|
|
(6,280
|
)
|
|
|
|
|
|
|
|
$
|
(14,558
|
)
|
|
|
|
|
|
Sale of the Joint Venture interest
(see c below):
|
|
|
|
|
Re-issuance of treasury shares
(including $871 increase in additional paid-in
capital see Note 10e)
|
|
$
|
4,987
|
|
Assignment of subscription
receivable
|
|
|
6,280
|
|
Write-off of interest receivables
on loans granted to the Joint Venture
|
|
|
275
|
|
Realization of comprehensive
income (see Note 2b)
|
|
|
651
|
|
|
|
|
|
|
|
|
|
(2,365
|
)
|
Less fair value
of the Companys interest in the Joint Venture
|
|
|
(19,699
|
)
|
|
|
|
|
|
Capital loss
|
|
$
|
17,334
|
|
|
|
|
|
|
|
|
|
|
(*)
|
In addition to the above equity losses, the Company recorded a
non-cash compensation expense related to options issued to
employees of the Companys equity method investees, in the
amount of $206 and $569 for the years ended December 28,
2003 and December 26, 2004, respectively.
|
|
|
|
|
(**)
|
As of December 23, 2004, the loans were comprised of a loan
of $6,280 for a
36-month
period ending in October 2004, which bore interest at an annual
rate of 4.0%, and from additional loans of 13,410
thousand ($18,160) as of December 23, 2004, for a period of
less than one year, which bore interest at an annual average
rate of 4.6%. The loans have been forgiven as part of the sale
of the Companys interest in the Joint Venture (see c
below).
|
In connection with a former share compensation plan for the
employees of IFL Ltd., IFL Ltd. purchased 1,072,407 Ordinary
shares of the Company in 2001 for approximately $20,000. This
purchase was financed by
F-18
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
a loan granted to IFL Ltd. by the Company amounting to $6,280,
as well as by an equity contribution of $13,720 provided by the
Company and Infineon. The Companys share in the above
investment (including the loan) amounting to $13,003 was
presented as treasury shares and subscription receivable, as a
deduction from the Companys shareholders equity.
Following the Companys dilution from a 49% interest to a
30% interest in the Joint Venture in 2003, the Companys
share in the aforementioned investment was reduced to $10,396.
Accordingly, the Company reduced its investment in treasury
shares by $2,607. In January 2005, as part of the sale of the
Joint Venture, the shares were sold by IFL Ltd. to Infineon. The
Company accounted for the sale as re-issuance of the treasury
shares to Infineon (see c below).
b. Summarized financial information of the Joint Venture
until the termination of the Joint Venture:
The following summarizes an aggregate information of IFL Ltd.
and IFL KG:
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
|
2003
|
|
|
2004
|
|
|
Revenues
|
|
$
|
39,732
|
|
|
$
|
58,111
|
|
Gross profit (loss)
|
|
$
|
1,129
|
|
|
$
|
(23,488
|
)
|
Loss from continuing operations
|
|
$
|
(41,012
|
)
|
|
$
|
(86,906
|
)
|
Net loss
|
|
$
|
(41,012
|
)
|
|
$
|
(86,906
|
)
|
c. Sale of Joint Venture:
On December 23, 2004, the Company and Infineon consummated
a series of agreements that led to the termination of their
Joint Venture interests, the establishment of new agreements
that govern the licensing of the Companys technology to
Infineon and performance of certain development services. The
Company sold its 30% equity interest in the Joint Venture to
Infineon, which holds the remaining interest in the Joint
Venture.
1. Termination of the Joint Venture and related
transactions (the Agreement) was signed by the two
parties, whereby in accordance with the Agreement:
|
|
|
|
a)
|
All former agreements signed by the two parties were terminated,
|
|
|
b)
|
Both parties rights and obligations in respect of
financing arrangements were terminated, releasing them from any
past, present or future obligations to provide further financing
to the Joint Venture,
|
|
|
c)
|
The Companys right to receive repayment of the
subscription receivable of $6,280 was assigned to Infineon,
|
|
|
d)
|
The Company was obligated to offer employment to certain of IFL
Ltd.s employees (workforce), valued at $560,
|
|
|
e)
|
The Company undertook certain liabilities relating to the Stock
Appreciation Rights Plan of IFL Ltd. (the SARP),
valued at $1,140 (see Note 7).
|
2. License agreement:
In addition to the termination of the Joint Venture, the Company
entered into an Amended License Agreement (the License
Agreement) with Infineon. Under the agreement, in
consideration of a new license that was granted, the Company
will receive: (1) nonrefundable license fees payable in
quarterly installments over 10 years from the date of the
License Agreement pursuant to a fixed payment schedule,
(2) additional, nonrefundable license fees capped at a
certain amount of the proceeds received by Infineon from the
sale of the Companys treasury shares (that were reissued
to Infineon), payable over eight quarters following the sale of
the shares and (3) running royalties based on Infineon
sales. Infineon may
F-19
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
terminate the license at any time, and Saifun will not receive
any additional consideration, beyond payments already received
or due on the termination date. On June 28, 2005, Infineon
exercised its cancellation privileges for certain of the
licensed technologies, thereby reducing its maximum remaining
obligation to Saifun.
3. Development services agreement:
Under the development services agreement, the Company will
provide development services to Infineon in accordance with a
basic agreement on development orders.
As the above mentioned agreements were signed in contemplation
of one another, for accounting purposes, the total net
consideration (cash, workforce received, liabilities assumed)
derived from the above agreements was allocated to the proceeds
from the sale of the Joint Venture, the development services and
the license. Since the fair value of the Joint Venture and
development services was more reliably measurable, the Company
performed a valuation of the Joint Venture and allocated the
consideration based on the fair value determined. Accordingly,
the residual amount of the consideration from the agreements was
allocated to the license. This allocation resulted in $19,182
non-cash revenues for the year ended December 31, 2005.
The fair value of the elements above was determined as follows:
|
|
|
Interest
in the Joint Venture
|
The fair value of the Companys interest in the Joint
Venture was deemed to be zero, after giving recognition to the
forgiveness of loans and future capital commitments ($19,699) by
the Company and Infineon, based on a valuation prepared using
the adjusted book value method. It was determined that
substantially all of the waived commitments represented non-cash
license revenues in the amount of $19,182 in respect of the
amended license granted by the Company to Infineon.
The development services are charged based on a fixed fee per
employee. The fair value of these services was determined based
on fees for similar services provided by the Company.
The Company recorded the re-issuance of treasury shares at fair
value (treasury shares were previously presented at cost). The
difference between the fair value and the book value of the
treasury shares in the amount of $871 was recorded as an
increase in additional paid-in capital.
The capital loss recorded by the Company as a result of the sale
of its entire interest in the Joint Venture amounted to $17,334.
The workforce received by the Company is recorded at fair value
based on a Company valuation and amortized over an estimated
useful life of two years. The SARP liability is recorded at the
intrinsic value of the underlying shares as required by
SFAS 123 (see Note 2m). Subsequent to balance sheet
date, the majority of the holders of the SARPs exercised their
rights.
F-20
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 5:
|
LOANS TO
EMPLOYEES
|
The loans to employees are to be repaid within five years from
date of grant and bear interest at an annual rate of 4%. An
amount of $1,174 is in dollars and the remainder is in NIS,
linked to the changes in the Israeli CPI. The loans are recourse
loans and are secured by certain assets of the employees,
including share options granted to them. As of December 31,
2005, the maturities of the loans were as follows:
|
|
|
|
|
2006
|
|
$
|
613
|
|
2007
|
|
|
384
|
|
2008
|
|
|
307
|
|
2009
|
|
|
260
|
|
2010
|
|
|
146
|
|
|
|
|
|
|
|
|
$
|
1,710
|
|
|
|
|
|
|
|
|
NOTE 6:
|
PROPERTY
AND EQUIPMENT, NET
|
|
|
|
|
|
|
|
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
Cost:
|
|
|
|
|
|
|
|
|
Laboratory equipment
|
|
$
|
2,522
|
|
|
$
|
3,594
|
|
Computers and software
|
|
|
4,327
|
|
|
|
4,981
|
|
Furniture and fixtures
|
|
|
296
|
|
|
|
387
|
|
Leasehold improvements
|
|
|
736
|
|
|
|
872
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,881
|
|
|
|
9,834
|
|
|
|
|
|
|
|
|
|
|
Accumulated depreciation:
|
|
|
|
|
|
|
|
|
Laboratory equipment
|
|
|
1,926
|
|
|
|
2,307
|
|
Computers and software
|
|
|
3,556
|
|
|
|
4,112
|
|
Furniture and fixtures
|
|
|
106
|
|
|
|
132
|
|
Leasehold improvements
|
|
|
383
|
|
|
|
615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,971
|
|
|
|
7,166
|
|
|
|
|
|
|
|
|
|
|
Depreciated cost
|
|
$
|
1,910
|
|
|
$
|
2,668
|
|
|
|
|
|
|
|
|
|
|
Substantively all of the property and equipment are located in
Israel. Depreciation expense for the years ended
December 28, 2003, December 26, 2004 and
December 31, 2005 was $1,656, $1,070 and $1,195,
respectively.
F-21
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 7:
|
ACCRUED
EXPENSES AND OTHER LIABILITIES
|
|
|
|
|
|
|
|
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
Payroll and related expenses(*)
|
|
$
|
2,459
|
|
|
$
|
3,434
|
|
Accrued issuance expenses
|
|
|
426
|
|
|
|
(**)1,859
|
|
Other accrued expenses
|
|
|
1,523
|
|
|
|
2,369
|
|
SARP liability(***)
|
|
|
1,140
|
|
|
|
2,251
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,548
|
|
|
$
|
9,913
|
|
|
|
|
|
|
|
|
|
|
(*) Includes
accrued vacation pay
|
|
$
|
795
|
|
|
$
|
853
|
|
|
|
|
|
|
|
|
|
|
|
|
(**)
|
Includes a stamp tax provision in the amount of $1,351.
|
|
(***)
|
See Note 4c.
|
|
|
NOTE 8:
|
COMMITMENTS
AND CONTINGENT LIABILITIES
|
a. The Companys principal facilities in Israel are
leased under operating leases that expire in December 2006, with
an option to extend the lease until August 2008 and an
additional option to further extend the lease until August 2011
(with a rent increase of 5%). The Company also leases additional
spaces in the same building pursuant to leases that expire in
September 2009, September 2010 and November 2010. In addition,
the Companys facilities in the United States are leased
under an operating lease that expires on January 31, 2007.
In addition, the Company has leased its motor vehicles and
certain software under operating leases.
Annual minimum commitments under non-cancelable leases are as
follows:
|
|
|
|
|
Year ended December
31,
|
|
|
|
|
2006
|
|
$
|
3,414
|
|
2007
|
|
|
2,659
|
|
2008
|
|
|
1,628
|
|
2009
|
|
|
123
|
|
2010
|
|
|
69
|
|
|
|
|
|
|
|
|
$
|
7,893
|
|
|
|
|
|
|
Rental expense for the years ended December 28, 2003,
December 26, 2004 and December 31, 2005 amounted to
$1,694, $2,612 and $3,722, respectively.
b. The Company is required to pay one of its former
shareholders a certain percentage of its annual license and
royalty revenues that it receives from certain third party
licensees; furthermore, above a certain amount of revenues, the
Company is required to pay only a percentage of royalties that
it receives from such third party licensees. The Company
recorded expenses to the former shareholder for the years ended
December 28, 2003, December 26, 2004 and
December 31, 2005 in the amount of $446, $802 and $1,367,
respectively.
c. The Company recorded a lien on a short-term bank deposit
in the amount of approximately $161 and $0 as of
December 26, 2004 and December 31, 2005, respectively,
as collateral for the forward transactions entered with the
banks (presented in short-term investments in the balance sheet)
mentioned below.
a. Several years ago, the Company received an approval from
the U.S. Israel BIRD Foundation (BIRD) for
royalty-bearing participation in its research and development,
of approximately $250. The Company is obligated to pay royalties
at the rate of 2.5% in the first year and 5.0% thereafter on 30%
of sales of products for which participations were received in
the research and development of those products. The royalties
are
F-22
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
limited to between 100%-150% of the participations received,
depending on the extent of the period during which the royalties
are paid. The Companys total commitment for royalties
payable with respect to future sales, based on participations
received or accrued, net of royalties paid or accrued, totaled
approximately $183 as of December 31, 2005.
b. In October 2002, the former Chief Executive Officer of
IFL Ltd. filed a claim against IFL Ltd. for certain rights and
compensation and against the Company for 420,000 share
options with an exercise price of $1.69 per share. The
Companys management believes it has meritorious defenses
to the claims above. A provision has been recorded in respect of
the above claim based on an estimate by the Companys
management, as well as the opinion of its legal counsel.
c. Derivative financial instruments:
As of December 31, 2005, the Company has forward exchange
contracts for the acquisition of approximately NIS 26,467
thousand, in consideration for $5,750, maturing in a period of
up to six months. The fair value of said contracts as of
December 31, 2005 was $38 (see Note 2t).
|
|
NOTE 9:
|
DISCONTINUED
OPERATIONS
|
In April 2005, the Company decided to discontinue its product
business (manufacturing, marketing and sale of Serial Flash
products). As a result, the Company (i) scrapped certain
inventory items not suitable for sale; (ii) sold its
remaining inventory and (iii) terminated the employment of
certain employees. During the third quarter of 2005, the Company
completed the process of winding down the product business and
ceased sales activities. Accordingly, the discontinued product
operations were accounted for in accordance with Financial
Accounting Standards Board (FASB) No. 144,
Accounting for the Impairment or Disposal of Long-Lived
Assets, and the results of operations of the product sales
operations were reported separately as discontinued operations
for all periods presented.
a. The results of the operations of the product business
included in discontinued operations for the years ended
December 28, 2003, December 26, 2004 and
December 31, 2005, respectively are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Revenues
|
|
$
|
|
|
|
$
|
1,673
|
|
|
$
|
4,495
|
|
Cost of revenues
|
|
|
|
|
|
|
5,894
|
|
|
|
8,458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross loss
|
|
|
|
|
|
|
(4,221
|
)
|
|
|
(3,963
|
)
|
Research and development expenses
|
|
|
156
|
|
|
|
1,732
|
|
|
|
568
|
|
Marketing and selling expenses
|
|
|
|
|
|
|
1,160
|
|
|
|
684
|
|
General and administrative expenses
|
|
|
|
|
|
|
76
|
|
|
|
48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations
|
|
$
|
(156
|
)
|
|
$
|
(7,189
|
)
|
|
$
|
(5,263
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-23
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
b. The breakdown of assets and liabilities attributed to
the discontinued operations as of December 26, 2004 and
December 31, 2005 was as follows:
|
|
|
|
|
|
|
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
Trade receivables
|
|
$
|
633
|
|
|
$
|
212
|
|
Inventories
|
|
|
2,231
|
|
|
|
|
|
Other accounts receivable and
prepaid expenses
|
|
|
2,034
|
|
|
|
|
|
Property and equipment, net
|
|
|
253
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,151
|
|
|
$
|
212
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
Trade payables
|
|
$
|
3,411
|
|
|
$
|
55
|
|
Accrued expenses and other
liabilities
|
|
|
313
|
|
|
|
91
|
|
Deferred revenues
|
|
|
80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,804
|
|
|
$
|
146
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE 10:
|
SHAREHOLDERS
EQUITY
|
a. Share capital:
1) On November 8, 2005, 5,750,000 Ordinary shares
(including 750,000 Ordinary shares resulting from the exercise
of an option granted to the underwriters) were issued in an IPO
for $23.50 per share in consideration of net proceeds of
$120,853 (net of $14,272 issuance expenses, of which $1,222 were
already recorded in shareholders equity as of
December 26, 2004).
Upon the completion of the IPO, all of the Companys
outstanding Convertible Preferred shares (see a(3) and
c below), were converted into 5,599,699 Ordinary shares.
2) The Companys Ordinary shares include shares
reserved for allocation in respect of employee options granted
but not yet exercised, held by a trustee. The total number of
Ordinary shares held by the trustee was 1,914,636 and
794,525 shares as of December 26, 2004 and
December 31, 2005, respectively. Ordinary shares generally
confer upon their holders the right to receive notice to
participate and vote in general meetings of the Company and the
right to receive dividends, if declared. The Ordinary shares
held by the trustee are unpaid and, therefore, do not benefit
from any of these rights and are not considered outstanding for
the purpose of calculating earnings per share or otherwise.
3) The Companys Preferred shares entitle their
holders to have all the rights of the Ordinary shares and in
addition, they have preferences in the event of liquidation,
dividend participation, registration and anti-dilution rights.
Each Preferred share is convertible into one Ordinary share at
any time, at the holders discretion, and automatically
upon an IPO of the Companys shares. Class B Preferred
shares have preference over Class A Preferred shares in
connection with the abovementioned rights. Upon the completion
of the IPO, all of the Companys outstanding Convertible
Preferred shares were converted into Ordinary shares.
b. Warrants:
In connection with a line of credit from a bank granted to the
Company in 2000 (which was cancelled during 2001), the Company
issued a warrant to the bank to purchase 10,724 Ordinary
shares at an exercise price of $18.65 per share. The
warrant was exercised in October 2005.
F-24
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In connection with a line of credit in the amount of $7,000 from
a bank granted to the Company in 2001 (which expired in October
2004), the Company issued to a bank a warrant to
purchase 18,767 Ordinary shares at an exercise price of
$18.65 per share. The warrant was exercised in October 2005.
c. Share options:
In 1998, the Company granted the purchasers of Class A
Preferred shares options to purchase 1,140,598 Class A
Preferred shares at an exercise price of $3.15 per share
exercisable at any time prior to the completion of an IPO.
During 2004, 5,730 options to purchase Class A Preferred
shares were exercised. During 2005, 11,460 options were
exercised into 11,460 Preferred shares (5,730 Preferred shares
upon the completion of the IPO) and 1,123,408 options were
exercised into 972,823 Preferred shares (in a cashless exercise)
upon the completion of the IPO, and were then converted into
Ordinary shares.
d. Share option plans:
In 1997, 2001 and 2003, the Company adopted Share Option Plans
(the Plans), according to which up to 6,973,421
options to purchase Ordinary shares may be granted to employees,
directors, consultants and affiliates of the Company.
The number of shares available for issuance under the 2003 Plan
is automatically increased on the first trading day in January
of each calendar year during the term of the 2003 Plan,
beginning with calendar year 2005 by the lowest of
(1) 1,333,333 Ordinary shares, subject to adjustments as
provided in the 2003 Plan (2) a number equal to 4% of the
Companys outstanding Ordinary shares on December 31
of the previous calendar year, and (3) an amount determined
by the board of directors. The 2003 Plan complies with the
Israeli tax reform.
With regard to the Plans, the exercise period may not exceed
10 years from the date of grant. The options vest ratably
mainly over a period of up to five years of employment. As of
December 26, 2004 and December 31, 2005, 547,390 and
1,076,574 options were available for future grants under the
Plans, respectively. Options which are forfeited or cancelled
revert to the pool of options available for future grants.
A summary of the Companys share option activity under the
Plans is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28, 2003
|
|
|
December 26, 2004
|
|
|
December 31, 2005
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
Amount
|
|
|
average
|
|
|
Amount
|
|
|
average
|
|
|
Amount
|
|
|
average
|
|
|
|
of
|
|
|
exercise
|
|
|
of
|
|
|
exercise
|
|
|
of
|
|
|
exercise
|
|
|
|
options
|
|
|
price
|
|
|
options
|
|
|
price
|
|
|
options
|
|
|
price
|
|
|
Outstanding beginning
of the year
|
|
|
3,296,399
|
|
|
$
|
2.91
|
|
|
|
4,192,548
|
|
|
$
|
4.96
|
|
|
|
5,096,494
|
|
|
$
|
7.66
|
|
Granted
|
|
|
1,385,974
|
*
|
|
$
|
9.00
|
|
|
|
1,312,776
|
**
|
|
$
|
13.97
|
|
|
|
1,045,013
|
|
|
$
|
21.49
|
|
Exercised
|
|
|
(45,960
|
)
|
|
$
|
1.31
|
|
|
|
(16,160
|
)
|
|
$
|
6.93
|
|
|
|
(1,140,111
|
)
|
|
$
|
0.50
|
|
Forfeited
|
|
|
(443,865
|
)
|
|
$
|
2.80
|
|
|
|
(392,670
|
)
|
|
$
|
8.05
|
|
|
|
(296,380
|
)
|
|
$
|
10.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding end
of the year
|
|
|
4,192,548
|
|
|
$
|
4.96
|
|
|
|
5,096,494
|
|
|
$
|
7.66
|
|
|
|
4,705,016
|
|
|
$
|
11.61
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercisable at the end of
the year
|
|
|
1,730,103
|
|
|
$
|
1.12
|
|
|
|
2,189,428
|
|
|
$
|
2.15
|
|
|
|
1,805,251
|
|
|
$
|
6.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Includes 50,000 options granted to employees of the
Companys equity method investees during the year ended
December 28, 2003. These options were accounted for in
accordance with
EITF 00-12,
Accounting by an Investor for Stock-Based Compensation
Granted to Employees of an Equity Method Investee (see
Note 4a), SFAS 123 and EITF 96-18, based on the
fair value of the options granted. Fair value was measured based
on the Black-Scholes pricing model assuming a risk free interest
rate of 2.5%, a volatility factor of 40%, dividend yield of 0%
and a contractual life of ten years.
|
F-25
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
** |
Includes immediately vested 94,260 options granted to former IFL
Ltd. employees subsequent to the termination of the Joint
Venture (see Note 4c).
|
The following table summarizes information about options
outstanding and exercisable as of December 31, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding
|
|
|
Options exercisable
|
|
|
|
Amount
|
|
|
|
|
|
|
|
|
Amount
|
|
|
|
|
|
|
outstanding
|
|
|
|
|
|
|
|
|
outstanding
|
|
|
|
|
|
|
as
|
|
|
Weighted
|
|
|
|
|
|
as
|
|
|
|
|
|
|
of
|
|
|
average
|
|
|
Weighted
|
|
|
of
|
|
|
Weighted
|
|
|
|
December
|
|
|
remaining
|
|
|
average
|
|
|
December
|
|
|
average
|
|
|
|
31,
|
|
|
contractual
|
|
|
exercise
|
|
|
31,
|
|
|
exercise
|
|
Exercise price
|
|
2005
|
|
|
life
|
|
|
price
|
|
|
2005
|
|
|
price
|
|
|
|
|
|
|
(years)
|
|
|
|
|
|
|
|
|
|
|
|
$0.09
|
|
|
16,000
|
|
|
|
1.38
|
|
|
$
|
0.09
|
|
|
|
16,000
|
|
|
$
|
0.09
|
|
$0.44 - $0.88
|
|
|
167,400
|
|
|
|
2.28
|
|
|
$
|
0.81
|
|
|
|
167,400
|
|
|
$
|
0.81
|
|
$1.25 - $1.69
|
|
|
368,020
|
|
|
|
3.70
|
|
|
$
|
1.41
|
|
|
|
368,020
|
|
|
$
|
1.41
|
|
$3.75
|
|
|
6,000
|
|
|
|
2.99
|
|
|
$
|
3.75
|
|
|
|
6,000
|
|
|
$
|
3.75
|
|
$6.25
|
|
|
931,149
|
|
|
|
6.09
|
|
|
$
|
6.25
|
|
|
|
562,080
|
|
|
$
|
6.25
|
|
$8.12 - $9.00
|
|
|
1,082,748
|
|
|
|
7.50
|
|
|
$
|
8.99
|
|
|
|
438,620
|
|
|
$
|
8.98
|
|
$13.00
|
|
|
389,675
|
|
|
|
8.24
|
|
|
$
|
13.00
|
|
|
|
126,749
|
|
|
$
|
13.00
|
|
$15.00 - $5.50
|
|
|
868,891
|
|
|
|
8.97
|
|
|
$
|
15.50
|
|
|
|
98,650
|
|
|
$
|
15.50
|
|
$18.75
|
|
|
4,400
|
|
|
|
6.47
|
|
|
$
|
18.75
|
|
|
|
2,400
|
|
|
$
|
18.75
|
|
$20.75 - $21.50
|
|
|
681,470
|
|
|
|
9.56
|
|
|
$
|
20.83
|
|
|
|
19,332
|
|
|
$
|
20.75
|
|
$29.59
|
|
|
189,263
|
|
|
|
6.89
|
|
|
$
|
29.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,705,016
|
|
|
|
7.32
|
|
|
$
|
11.61
|
|
|
|
1,805,251
|
|
|
$
|
6.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The weighted average fair values of the options granted during
the years ended December 28, 2003, December 26, 2004
and December 31, 2005 were $1.16, $4.47 and $8.23 per
share, respectively. Substantially all options were granted with
an exercise price equal to the fair value of the shares at the
date of grant. Compensation expense recognized amounted to $206,
$1,170 and $4,295 for the years ended December 28, 2003,
December 26, 2004 and December 31, 2005, respectively.
e. Treasury shares:
The treasury shares were in respect of the Companys shares
issued to an equity method investee. Until December 2004, the
Companys share in the consideration paid by the investee
for the shares issued was recorded as treasury shares, which
were reissued as part of the sale of the Companys entire
equity interest, see Note 4. In connection with the
termination agreement, the treasury shares were deemed reissued,
resulting in an increase in additional paid-in capital of $871
in December 2004.
f. Loan to director:
In 2000, the Company granted a loan included in subscription
receivables, in the amount of $250 to one of its directors for
the purchase of 60,000 restricted Ordinary shares of the Company
for a price of $6.25 per share. The loan bears interest at
an annual rate of 4.0% and is payable at the earlier of
(1) five years from the grant date of the loan; (2) an
IPO or (3) 60 days from the directors
termination of rendering services to the Company. The loan was
repaid in October 2005.
F-26
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 11: RELATED
PARTY BALANCES AND TRANSACTIONS
a. Balances with related parties:
|
|
|
|
|
|
|
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
Loan to employee (shareholder)(3)
|
|
$
|
207
|
|
|
$
|
|
|
Loan to director(4)
|
|
$
|
250
|
|
|
$
|
|
|
Other accounts receivable and
prepaid expenses (shareholder)(2)
|
|
$
|
221
|
|
|
$
|
|
|
Trade payables and accrued
expenses (related party)(1)(2)
|
|
$
|
885
|
|
|
$
|
328
|
|
|
|
(1)
|
One of the related parties is a legal firm that provides
services to the Company, and in which a senior partner of the
firm is an immediate family member of one of the Companys
shareholders.
|
|
(2)
|
The above balances are derived from services provided or
received in the ongoing course of business. Accordingly, these
balances have normal credit terms.
|
|
(3)
|
The loan was repaid during 2005.
|
|
(4)
|
See Note 10f above.
|
b. Transactions with related parties:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Revenues (shareholder and Joint
Venture)
|
|
$
|
6,440
|
|
|
$
|
8,425
|
|
|
$
|
|
|
Sales and marketing expenses
(shareholder and related party)
|
|
$
|
529
|
|
|
$
|
925
|
|
|
$
|
86
|
|
General and administrative
expenses (related party)
|
|
$
|
536
|
|
|
$
|
612
|
|
|
$
|
586
|
|
Interest income (Joint Venture)
|
|
$
|
272
|
|
|
$
|
604
|
|
|
$
|
|
|
Issuance expenses (recorded in
shareholders equity)
|
|
$
|
|
|
|
$
|
195
|
|
|
$
|
220
|
|
NOTE 12: TAXES
ON INCOME
a. Measurement of taxable income under the Income Tax
(Inflationary Adjustments) Law, 1985:
In accordance with the above law, results for tax purposes are
measured and reflected in real terms in accordance with the
change in the CPI.
b. Tax benefits under the Law For Encouragement of Capital
Investments, 1959:
In 1998, the Companys investment plan in equipment in the
amount of approximately $2,200 received approval in accordance
with the Law for the Encouragement of Capital Investments, 1959
(Approved Enterprise status). In 2000 and 2002, the
Companys additional investment programs totaling $2,485
and $6,615 were granted Approved Enterprise status.
The Company has chosen to receive its benefits through the
Alternative Benefits track, and as such, is eligible
for various tax benefits. These benefits include accelerated
depreciation of equipment used in the investment program, as
well as a full tax exemption on undistributed income for a
period of two years and reduced tax rate (25%) for an additional
period of up to five years. The 25% rate may be reduced further,
depending on the rate of foreign share ownership in the Company.
The period of tax benefits, detailed above, is subject to a
limit of 12 years from the commencement of production, or
14 years from the approval date, whichever is earlier
(2011-2015). The entitlement to the above benefits is
conditional upon Saifun fulfilling the conditions stipulated by
the above law, regulations published thereunder and the letters
of approval for the specific investments in Approved
Enterprises. In the event of
F-27
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
failure to comply with these conditions, the benefits may be
cancelled and Saifun may be required to refund the amount of the
benefits, in whole or in part, including interest. As of
December 31, 2005, management believes that the Company is
meeting all of the aforementioned conditions.
As of December 31, 2005, the Company does not have retained
earnings and accordingly, no tax-exempt income. Tax-exempt
income attributable to the Approved Enterprise
cannot be distributed to shareholders without subjecting the
Company to taxes except upon complete liquidation of the
Company. If the retained tax-exempt income is distributed in a
manner other than upon the complete liquidation of the Company,
it would be taxed at the corporate tax rate applicable to such
profits as if the Company had not elected alternative tax
benefits (currently 25%). The Companys
board of directors does not intend to distribute any amounts of
its undistributed tax exempt income as dividends.
Income from sources other than the Approved
Enterprise during the benefit period will be subject to
tax at the regular corporate tax rate. Israeli companies are
subject to income tax at the corporate tax rate of 35% for the
2004 tax year and 34% for the 2005 tax year. On July 25,
2005, the Knesset (Israeli Parliament) passed the Law for the
Amendment of the Income Tax Ordinance (No. 147), 2005, which
prescribes, among others, a gradual decrease in the corporate
tax rate in Israel to the following tax rates: in
2006 31%, in 2007 29%, in 2008
-27%, in 2009 26% and in 2010 and
thereafter 25%.
Due to reported losses for tax purposes, the benefit period
under the Approved Enterprise program has not yet
commenced.
c. As of December 31, 2005, Saifun Semiconductors Ltd.
had carryforward losses in the amount of approximately $22,000,
including a carryforward capital loss amounting to approximately
$5,300, which may be carried forward indefinitely. As of
December 31, 2005, carryforward losses related to Saifun
Semiconductors USA, Inc. amounted to approximately $2,495 and
have an expiration date of 2025. Utilization of U.S. net
operating losses may be subject to substantial annual limitation
due to the change in ownership provisions of the
Internal Revenue Code of 1986 and similar state provisions. The
annual limitation may result in the expiration of net operating
losses before utilization. As of December 31, 2005,
carryforward losses related to Saifun BVI (Limited) amounted to
approximately $3,300, which may be carried forward indefinitely.
After the carryforward losses are utilized, the Company will be
subject to Israeli income tax, which will be considered a
deemed dividend and taxed at a tax rate of 25%.
The Company expects that during the period in which these tax
losses related to Saifun Semiconductors Ltd. are utilized, its
income would be substantially tax exempt. Accordingly, there
will be no tax benefit available from such losses and no
deferred income taxes have been included in these financial
statements. Deferred taxes in respect of other temporary
differences are immaterial.
d. Income (loss) before taxes on income is comprised as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Israel*
|
|
$
|
(14,483
|
)
|
|
$
|
(36,824
|
)
|
|
$
|
45,356
|
|
Foreign
|
|
|
(707
|
)
|
|
|
(1,080
|
)
|
|
|
(849
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(15,190
|
)
|
|
$
|
(37,904
|
)
|
|
$
|
44,507
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Includes loss attributed to Saifun BVI (Limited).
|
F-28
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
e. Deferred income taxes:
Deferred income taxes reflect the net tax effect of temporary
differences between the carrying amounts of assets and
liabilities for financial reporting purposes and the amounts
used for income tax purposes. Significant components of the
Companys deferred tax liabilities and assets are as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
Operating loss carryforwards
(Saifun Semiconductors USA, Inc. and Saifun BVI (Limited))
|
|
$
|
432
|
|
|
$
|
1,848
|
|
Valuation allowance
|
|
|
(432
|
)
|
|
|
(1,848
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred tax asset
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Management currently believes that it is more likely than not
that the deferred tax assets related to the carryforward losses
of Saifun Semiconductors USA, Inc. and Saifun BVI (Limited) will
not be realized in the foreseeable future. Accordingly, a
valuation allowance has been recorded for the entire amount.
NOTE 13: MAJOR
CUSTOMERS AND GEOGRAPHIC INFORMATION
The Company manages its business on a basis of one reportable
segment.
a. Revenues are attributed to geographic areas based on
location of end customers as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Taiwan
|
|
$
|
5,168
|
|
|
$
|
11,417
|
|
|
$
|
14,047
|
|
Israel
|
|
|
6,440
|
*
|
|
|
7,276
|
*
|
|
|
32
|
|
United States
|
|
|
2,656
|
|
|
|
7,701
|
|
|
|
9,265
|
|
Japan
|
|
|
192
|
|
|
|
3,022
|
|
|
|
9,793
|
|
Germany
|
|
|
|
|
|
|
1,150
|
|
|
|
44,796
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
14,456
|
|
|
$
|
30,566
|
|
|
$
|
78,601
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Includes mainly services provided to the Joint Venture through
IFL Ltd.
|
b. Long-lived assets:
Substantially all of the Companys long-lived assets are
located in Israel.
c. Sales to major customers representing more than 10% of
total revenues are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Licensing and services:
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer A
|
|
|
36
|
%
|
|
|
37
|
%
|
|
|
18
|
%
|
Customer B
|
|
|
18
|
%
|
|
|
25
|
%
|
|
|
12
|
%
|
Customer C
|
|
|
45
|
%
|
|
|
28
|
%
|
|
|
57
|
%
|
F-29
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 14: FINANCIAL
INCOME, NET
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest on cash equivalents,
marketable securities and premium on
held-to-maturity
marketable securities
|
|
$
|
677
|
|
|
$
|
555
|
|
|
$
|
2,163
|
|
Foreign currency exchange
differences
|
|
|
148
|
|
|
|
487
|
|
|
|
|
|
Interest from loans issued to
equity method investees
|
|
|
251
|
|
|
|
604
|
|
|
|
|
|
Interest from loans to employees
|
|
|
99
|
|
|
|
120
|
|
|
|
108
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Bank commissions
|
|
|
(38
|
)
|
|
|
(67
|
)
|
|
|
(46
|
)
|
Foreign currency exchange
differences
|
|
|
|
|
|
|
|
|
|
|
(476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,137
|
|
|
$
|
1,699
|
|
|
$
|
1,749
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-30
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
NOTE 15: NET
EARNINGS (LOSS) PER SHARE
a. The following table sets forth the computation of basic
and diluted earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 28,
|
|
|
December 26,
|
|
|
December 31,
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss)
|
|
$
|
(15,190
|
)
|
|
$
|
(37,904
|
)
|
|
$
|
44,507
|
|
Allocation of undistributed
earnings to Convertible Preferred shares
|
|
|
|
|
|
|
|
|
|
|
(39,529
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator attributed to Ordinary
shares after allocation of undistributed earnings
|
|
$
|
(15,190
|
)
|
|
$
|
(37,904
|
)
|
|
$
|
4,978
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
Ordinary shares outstanding during the year used to compute
basic net earnings (loss) per share (in thousands)
|
|
|
16,896
|
|
|
|
16,927
|
|
|
|
29,453
|
*
|
Incremental shares attributable to
exercise of outstanding options and warrants (in thousands)
|
|
|
|
|
|
|
|
|
|
|
2,494
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
Ordinary shares outstanding during the year used to compute
diluted net earnings (loss) per share (in thousands)
|
|
|
16,896
|
|
|
|
16,927
|
|
|
|
31,947
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per Ordinary
share from continuing operations
|
|
$
|
(0.89
|
)
|
|
$
|
(1.81
|
)
|
|
$
|
0.46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss per Ordinary share from
discontinued operations
|
|
$
|
(0.01
|
)
|
|
$
|
(0.43
|
)
|
|
$
|
(0.29
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net earnings (loss) per
Ordinary share
|
|
$
|
(0.90
|
)
|
|
$
|
(2.24
|
)
|
|
$
|
0.17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per
Ordinary share from continuing operations
|
|
$
|
(0.89
|
)
|
|
$
|
(1.81
|
)
|
|
$
|
0.36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted loss per Ordinary share
from discontinued operations
|
|
$
|
(0.01
|
)
|
|
$
|
(0.43
|
)
|
|
$
|
(0.20
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net earnings (loss) per
Ordinary share
|
|
$
|
(0.90
|
)
|
|
$
|
(2.24
|
)
|
|
$
|
0.16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
The sum of the proportionate weighted average of Ordinary shares
outstanding was calculated separately for the two periods (from
December 27, 2004 until the IPO Date (November 8,
2005) and from the IPO Date until December 31, 2005). Prior
to the IPO, all of the Companys earnings were allocated to
the convertible Preferred shares.
|
F-31
SAIFUN SEMICONDUCTORS LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
b. The following table sets forth the computation of pro
forma basic and diluted net earnings (loss) per share that would
have resulted had the Preferred shares and options been
converted at the beginning of fiscal year ended
December 31, 2005:
|
|
|
|
|
|
|
Year ended
|
|
|
|
December 31,
|
|
|
|
2005
|
|
|
Numerator:
|
|
|
|
|
Net earning
|
|
$
|
44,507
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
Weighted average number of
Ordinary shares outstanding during the year used to compute pro
forma basic net earnings per share (in thousands)
|
|
|
24,154
|
|
Incremental shares attributable to
exercise of outstanding options and warrants (in thousands)
|
|
|
2,087
|
|
|
|
|
|
|
Weighted average number of
Ordinary shares outstanding during the year used to compute pro
forma diluted net earnings per share (in thousands)
|
|
|
26,241
|
|
|
|
|
|
|
Pro forma basic earnings per
Ordinary share from continuing operations
|
|
$
|
2.06
|
|
|
|
|
|
|
Pro forma basic loss per Ordinary
share from discontinued operations
|
|
$
|
(0.22
|
)
|
|
|
|
|
|
Pro forma basic net earnings per
Ordinary share
|
|
$
|
1.84
|
|
|
|
|
|
|
Pro forma diluted earnings per
Ordinary share from continuing operations
|
|
$
|
1.90
|
|
|
|
|
|
|
Pro forma diluted loss per
Ordinary share from discontinued operations
|
|
$
|
(0.20
|
)
|
|
|
|
|
|
Pro forma diluted net earnings per
Ordinary share
|
|
$
|
1.70
|
|
|
|
|
|
|
F-32
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The
Shareholders of Infineon Technologies Flash Ltd.
We have audited the accompanying statements of operations,
shareholders equity and cash flows of Infineon
Technologies Flash Ltd. (the Company) for the year
ended December 31, 2003 and the period from January 1,
2004 to December 23, 2004. In addition, we have audited the
accompanying net assets in liquidation of the Company as at
December 23, 2004. These financial statements are the
responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance that the financial statements are free of
material misstatement. The Company is not required to have, nor
were we engaged to perform, an audit of its internal control
over financial reporting. Our audit included consideration of
internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion
on the effectiveness of the Companys internal control over
financial reporting. Accordingly, we express no such opinion. An
audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An
audit also includes assessing the accounting principles used and
significant estimates made by the management, as well as
evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for our
opinion.
As described in Note 1 to the financial statements, on
December 23, 2004 the shareholders of the Company entered
into a Termination Agreement, according to which the Company is
intended to be dissolved on a voluntary basis during 2005, in
accordance with applicable laws. Accordingly, the Company
changed its basis of accounting for periods subsequent to
December 23, 2004, from the going concern basis to a
liquidation basis.
In our opinion, the financial statements referred to above,
present fairly in all material respects, the Companys
results of operations and cash flows for the year ended
December 31, 2003 and the period from January 1, 2004
to December 23, 2004 and its net assets in liquidation as
at December 23, 2004, in conformity with
U.S. generally accepted accounting principles, applied on
the basis described in the preceding paragraph.
/s/ Somekh Chaikin
Somekh Chaikin
Certified Public Accountants (Isr.)
Member firm of KPMG International
Tel Aviv, Israel
August 9, 2005
F-33
INFINEON
TECHNOLOGIES FLASH LTD.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
|
|
|
|
December 23,
|
|
|
|
Note
|
|
|
2004
|
|
|
|
|
|
|
US$ thousands
|
|
|
Assets
|
Cash and cash equivalents
|
|
|
|
|
|
|
1,736
|
|
Accounts
receivable related party
|
|
|
3
|
|
|
|
5,766
|
|
Other current assets
|
|
|
4
|
|
|
|
132
|
|
Investment in Saifun
Semiconductors held for sale
|
|
|
5
|
|
|
|
15,014
|
|
Restricted assets for employee
termination benefits
|
|
|
11
|
|
|
|
99
|
|
Furniture and equipment, held for
sale
|
|
|
7
|
|
|
|
740
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
|
|
23,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
Current maturities of long-term
loans with related parties
|
|
|
10
|
|
|
|
6,280
|
|
Accounts payable
|
|
|
8
|
|
|
|
4,631
|
|
Accounts payable to related parties
|
|
|
|
|
|
|
6
|
|
Other current liabilities
|
|
|
9
|
|
|
|
264
|
|
Liability for employee termination
benefits
|
|
|
11
|
|
|
|
124
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
|
|
|
|
11,305
|
|
|
|
|
|
|
|
|
|
|
Net assets in liquidation
|
|
|
|
|
|
|
12,182
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the financial
statements.
F-34
INFINEON
TECHNOLOGIES FLASH LTD.
STATEMENTS OF OPERATIONS (Going Concern Basis)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
|
|
|
year ended
|
|
|
period ended
|
|
|
|
|
|
|
December 31,
|
|
|
December 23,
|
|
|
|
Note
|
|
|
2003
|
|
|
2004
|
|
|
|
|
|
|
US$ thousands
|
|
|
Revenue from research and
development agreement with related party
|
|
|
|
|
|
|
11,407
|
|
|
|
12,563
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,407
|
|
|
|
12,563
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development expenses
|
|
|
|
|
|
|
10,901
|
|
|
|
13,676
|
|
Selling expenses
|
|
|
|
|
|
|
29
|
|
|
|
|
|
General and administrative expenses
|
|
|
|
|
|
|
475
|
|
|
|
660
|
|
Other expenses
|
|
|
5
|
|
|
|
|
|
|
|
4,986
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
|
|
|
|
11,405
|
|
|
|
19,322
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income
|
|
|
|
|
|
|
2
|
|
|
|
(6,759
|
)
|
Interest expense, net
|
|
|
14
|
|
|
|
385
|
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
|
|
|
|
(383
|
)
|
|
|
(6,785
|
)
|
Income taxes
|
|
|
6
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
(383
|
)
|
|
|
(6,785
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the financial
statements.
F-35
INFINEON
TECHNOLOGIES FLASH LTD.
STATEMENTS OF CHANGES IN NET ASSETS IN LIQUIDATION
|
|
|
|
|
|
|
For the
|
|
|
|
period from
|
|
|
|
December 23,
|
|
|
|
2004 to
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
|
US$ thousands
|
|
|
Stockholders equity at
December 23, 2004
|
|
|
12,182
|
|
Liquidation basis adjustments:
|
|
|
|
|
Net assets in liquidations on
December 23, 2004
|
|
|
12,182
|
|
Distribution to stockholders
|
|
|
|
|
|
|
|
|
|
Net assets in liquidations on
December 23, 2004
|
|
|
12,182
|
|
|
|
|
|
|
The accompanying notes are an integral part of the financial
statements.
F-36
INFINEON
TECHNOLOGIES FLASH LTD.
STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (Going Concern
Basis)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
|
|
|
Issued Ordinary Shares
|
|
|
paid-in
|
|
|
Accumulated
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
capital
|
|
|
deficit
|
|
|
Total
|
|
|
|
NIS
|
|
|
US$ thousands
|
|
|
|
0.01
|
|
|
|
|
|
|
per
|
|
|
|
|
|
|
share
|
|
|
|
|
|
Balance as of December 31,
2002
|
|
|
1,000,000
|
|
|
|
2
|
|
|
|
23,718
|
|
|
|
(10,376
|
)
|
|
|
13,344
|
|
Issuance of ordinary shares
|
|
|
634,000
|
|
|
|
2
|
|
|
|
4,000
|
|
|
|
|
|
|
|
4,002
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(383
|
)
|
|
|
(383
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31,
2003
|
|
|
1,634,000
|
|
|
|
4
|
|
|
|
27,718
|
|
|
|
(10,759
|
)
|
|
|
16,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31,
2003
|
|
|
1,634,000
|
|
|
|
4
|
|
|
|
27,718
|
|
|
|
(10,759
|
)
|
|
|
16,963
|
|
Capital contribution
|
|
|
|
|
|
|
|
|
|
|
1,908
|
|
|
|
|
|
|
|
1,908
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,785
|
)
|
|
|
(6,785
|
)
|
Stock based compensation
|
|
|
|
|
|
|
|
|
|
|
96
|
|
|
|
|
|
|
|
96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 23,
2004
|
|
|
1,634,000
|
|
|
|
4
|
|
|
|
29,722
|
|
|
|
(17,544
|
)
|
|
|
12,182
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the financial
statements.
F-37
INFINEON
TECHNOLOGIES FLASH LTD.
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
year ended
|
|
|
period ended
|
|
|
|
December 31,
|
|
|
December 23,
|
|
|
|
2003
|
|
|
2004
|
|
|
|
US$ thousands
|
|
|
US$ thousands
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(383
|
)
|
|
|
(6,785
|
)
|
Adjustments required to reconcile
net loss to net cash from operating activities:
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
341
|
|
|
|
352
|
|
Severance benefits, net
|
|
|
2
|
|
|
|
11
|
|
Stock based compensation
|
|
|
|
|
|
|
96
|
|
SAR compensation expense
|
|
|
|
|
|
|
1,908
|
|
Impairment of investment
|
|
|
|
|
|
|
4,986
|
|
Increase in accounts
receivable related parties
|
|
|
(3,275
|
)
|
|
|
(2,467
|
)
|
Decrease (increase) in other assets
|
|
|
(173
|
)
|
|
|
274
|
|
Increase (decrease) in accounts
payable
|
|
|
(37
|
)
|
|
|
4,576
|
|
Increase (decrease) in other
liabilities
|
|
|
595
|
|
|
|
(1,915
|
)
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
operating activities
|
|
|
(2,930
|
)
|
|
|
1,036
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
Acquisitions of equipment
|
|
|
(265
|
)
|
|
|
(486
|
)
|
Issuance of short-term loan to
related party
|
|
|
|
|
|
|
(500
|
)
|
Repayment of loan to related party
|
|
|
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(265
|
)
|
|
|
(486
|
)
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
Proceeds from (payment of)
long-term loan from shareholders
|
|
|
(525
|
)
|
|
|
|
|
Proceeds from the issuance of
ordinary shares
|
|
|
4,002
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing
activities
|
|
|
3,477
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
282
|
|
|
|
550
|
|
Cash and cash equivalents at
beginning of period
|
|
|
904
|
|
|
|
1,186
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end
of period
|
|
|
1,186
|
|
|
|
1,736
|
|
|
|
|
|
|
|
|
|
|
Supplemental cash flow information
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
|
418
|
|
|
|
126
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these financial
statements.
F-38
INFINEON
TECHNOLOGIES FLASH LTD.
(US$ in thousands, except where otherwise stated)
Note 1 Description
of Business and Basis of Presentation
Infineon Technologies Flash Ltd., formerly Ingentix Ltd.,
(hereinafter the Company), was incorporated in
Israel on March 22, 2001 (commenced operations on
June 1, 2001) pursuant to the establishment of a Joint
Venture Agreement (hereinafter the
JVA) between Infineon Technologies AG
(hereinafter Infineon) and Saifun
Ventures Ltd. (hereinafter Saifun).
The Company was established to develop, produce and market
non-volatile memory products. The Company changed its name to
Infineon Technologies Flash Ltd. on February 13, 2003.
As of the balance sheet date, the Companys sole
shareholder is Infineon. Infineon initially held 70% and Saifun
30% of the equity interests in the Company. On December 23,
2004, Infineon and Saifun consummated an Agreement on
Termination of Joint Venture Agreement and Related Transaction
(hereinafter the Termination
Agreement). Pursuant to the Termination Agreement, Saifun
sold and transferred its entire interest, consisting of 490,000
ordinary shares in the Company to Infineon. As a result of
Infineons acquisition on December 23, 2004, Infineon
became the sole shareholder of the Company and held 100% of the
Companys shares.
Concurrent with the foundation of the Company, Infineon and
Saifun also established another joint venture, Infineon
Technologies Flash GmbH & Co. KG, formerly Ingentix
GmbH & Co. KG, (hereinafter Flash
Germany), which is based in Germany.
As part of the foundation of the Company, Saifun and Infineon
each agreed to license certain patented technology to the
Company to develop Non Volatile Memory (NROM) code
and data flash products, with royalties payable on the sale of
such products. Through December 23, 2004, the Company was
not engaged in product sales activities.
In August 2003, the Company entered into a research and
development agreement with Flash Germany
(hereinafter the R&D
agreement). The R&D agreement provided for the
retroactive reimbursement of all direct and indirect
costs plus a margin, as defined in the R&D agreement,
incurred by the Company in connection with research and
development efforts undertaken at the direction of Flash Germany
since March 2003. Payments for research and development projects
were not contingent upon the success of such development
efforts. In connection with the Termination Agreement, the
R&D agreement was terminated.
The Company is organized in one operating segment, Flash memory
products. On a geographic basis, all assets are held in Israel
and all revenues are derived from Flash Germany.
In connection with the Termination Agreement, Infineon
acknowledged that it has the intention of taking all necessary
steps to facilitate and procure the voluntary dissolution of the
Company. The Company is intended to be dissolved during 2005, on
a voluntary basis, in accordance with applicable laws.
Accordingly, the key features of Infineons plan to
dissolve the Company are to (1) file a Certificate of
Dissolution with the Registrar of Companies; (2) cease
conducting normal business operations, except as may be required
to wind up the Companys business affairs; (3) attempt to
convert all of the Companys remaining assets into cash or
cash equivalents in an orderly fashion; (4) pay or attempt
to adequately provide for the payment of all of the
Companys known obligations and liabilities; and
(5) distribute in one or more liquidating distributions all
of the Companys remaining assets to Infineon.
Note 2 Significant
Accounting Principles
The accompanying financial statements have been prepared in
accordance with accounting principles generally accepted in the
United States of America (US GAAP).
F-39
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
The financial statements for the period January 1, 2004 to
December 23, 2004 and for the year ended December 31,
2003 were prepared on a going concern basis of accounting, which
contemplates realization of assets and satisfaction of
liabilities in the normal course of business. As a result of
Infineons plan to dissolve the Company and the imminent
nature of the liquidation, the Company adopted a liquidation
basis of accounting effective December 23, 2004. This basis
of accounting is considered appropriate when, among other
things, liquidation of a company is probable and the net
realizable value of assets is reasonably determinable. Under
this basis of accounting, assets are valued at their estimated
net realizable values and liabilities are stated at their
estimated settlement amounts.
The conversion from a going concern to liquidation basis of
accounting required management to make estimates and judgments.
In order to record assets at their estimated net realizable
value and liabilities at their estimated settlement amounts
under the liquidation basis of accounting on the one hand and
due to the fact that most of the assets were sold to Infineon on
the other hand, the Company did not have to record any
adjustments to record its assets and liabilities to fair value
as of December 23, 2004, the date of adoption of the
liquidation basis of accounting.
The preparation of financial statements in conformity with US
GAAP requires management to make estimates and assumptions that
affect amounts reported in the financial statements and
accompanying notes. Actual results could differ from those
estimates.
|
|
C.
|
Functional
and reporting currency
|
The currency of the primary economic environment in which the
operations of the Company are conducted is the U.S. dollar
(Dollar or US$), which is also its
reporting currency.
The Companys transactions and balances denominated in
U.S. Dollars are presented at their original amounts.
Non-Dollar transactions and balances have been remeasured to
U.S. Dollars in accordance with Statement of the Financial
Accounting Standards (SFAS) No. 52, Foreign Currency
Translation, of the Financial Accounting Standards Board
(FASB). All transaction gains and losses from
remeasurement of monetary balance sheet items denominated in
non-Dollar currencies, principally accounts payable and loans
from related parties, are reflected in the Statements of
Operations as interest income or expenses, as appropriate.
The exchange rate of U.S. Dollar and New Israel Shekel
(NIS) is as follows:
|
|
|
|
|
|
|
Exchange rate
|
|
|
|
of US$1
|
|
|
December 23, 2004
|
|
|
NIS 4.336
|
|
December 31, 2003
|
|
|
NIS 4.379
|
|
|
|
D.
|
Cash and
cash equivalents
|
Cash and cash equivalents represent cash, deposits and liquid
short-term investments with original maturities of three months
or less. Cash equivalents amounted to $1,303 at
December 23, 2004.
|
|
E.
|
Investment
in Saifun Semiconductor Ltd.
|
Investments in ordinary shares of Saifun are accounted for at
cost, because they are currently not marketable.
F-40
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
The Company assesses declines in the value of cost method
investments to determine whether such declines are
other-than-temporary, thereby rendering the investment impaired.
This assessment is made by considering available evidence,
including changes in general market conditions, specific
industry and individual company data, the length of time and the
extent to which the market value has been less than cost, the
financial condition and near-term prospects of the individual
company, and the Companys intent and ability to hold the
investment for a period sufficient to allow for any anticipated
recovery in value.
During the period ended December 23, 2004, the Company
recorded an impairment charge of $4,986 as it determined that an
other-than-temporary decline in the fair value of the investment
in Saifun had occurred, pursuant to the provisions of this
policy.
|
|
F.
|
Furniture
and equipment
|
Furniture and equipment is valued at cost less accumulated
depreciation. Depreciation is computed by the straight-line
method over the estimated useful lives of the assets.
Annual depreciation rates are as follows:
|
|
|
|
|
Computers, software and auxiliary
equipment
|
|
|
33
|
%
|
Furniture and office equipment
|
|
|
6 - 10
|
%
|
Lab equipment
|
|
|
33
|
%
|
Leasehold improvements
|
|
|
10
|
%
|
Furniture and equipment held for sale are presented as current
assets at their estimated sale value less selling costs at
December 23, 2004.
Pursuant to the terms of the Termination Agreement, on January
2005, Infineon Flash KG. purchased all equipment held by the
Company for its carrying value as of the date of disposal.
|
|
G.
|
Impairment
of long-lived assets
|
The Company reviews long-lived assets, including property, plant
and equipment and intangible assets subject to amortization, for
impairment whenever events or changes in circumstances indicate
that the carrying amount of the asset may not be recoverable.
Recoverability of assets to be held and used is measured by a
comparison of the carrying amount of the asset (asset group) to
future net cash flows expected to be generated by the asset
(asset group). If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which
the carrying amount of the assets (asset groups) exceeds its
fair value. Fair value is generally estimated based on either
appraised value or measured by discounted estimated future cash
flows. Considerable management judgment is necessary to estimate
discounted future cash flows.
The fair value of the Companys loan and accounts
receivable and accounts payable from related parties, as well as
cash and cash equivalent and accounts payable, approximate its
carrying value due to their short-term nature.
Revenue, to date represents revenue from research and
development agreements with a related party, is recognized,
pursuant to SEC Staff Accounting Bulletin (SAB) 104,
when persuasive evidence of an arrangement exists, the price is
fixed or determinable, services are performed and collectibility
is reasonably assured.
F-41
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
Revenue from related parties, principally Flash Germany, is
recognized based on the contract between the parties, at the
time services are rendered. The research and development
agreement between the parties provides that such services be
charged to Flash Germany on a basis of all direct and indirect
costs plus a service fee on all non-subcontracted work performed.
The Company accounts for income taxes under Statement of
Financial Accounting Standards No. 109 Accounting for
Income Taxes (SFAS 109).
Under SFAS 109 deferred tax assets or liabilities are
recognized in respect of temporary differences between the tax
bases of assets and liabilities and their financial reporting
amounts as well as in respect of tax losses and other deductions
which may be deductible for tax purposes in future years, based
on enacted statutory tax rates applicable to the periods in
which such deferred taxes will be realized. Valuation allowances
are established when necessary to reduce deferred tax assets to
the amount expected to be realized.
|
|
K.
|
Research
and development costs
|
Research and development costs are expensed as incurred.
|
|
L.
|
Stock
compensation plans
|
|
|
(1)
|
Stock
appreciation rights plan
|
The Company has awarded its employees stock appreciation rights
(SARs) which were based on shares of Saifun. At the
Companys inception, it acquired Saifuns shares for
this purpose. Due to the terms of the SAR plan, the awarded SARs
were accounted for as a written option and recorded at fair
value with the corresponding compensation expense recognized
over the vesting period. As described in Note 13, subject
to the vesting periods, the ultimate exercise of the SARs was
contingent on the occurrence of an initial public offering
(IPO) of Saifun. The fair value of the SARs was
determined based on, amongst other factors, the volatility of
Saifuns share price, the exercise price of the SARs and
the probability of a Saifuns IPO.
As described in Note 1, the Company will be dissolved
during 2005 and the shareholders have agreed to terminate the
SAR plan and Saifun, which re-employed the majority of the
employees, assumed any and all liabilities and obligations
arising out of the plan (see Note 13).
|
|
(2)
|
Stock-based
compensation plan to employees granted by Saifun
|
The Company has adopted the provisions of EITF Issue
No. 00-12
Accounting by an Investor for Stock-Based Compensation
Granted to Employees of an Equity Method Investee.
Accordingly, the Company has recognized the costs of the
stock-based compensation incurred by Saifun, and a corresponding
capital contribution. The stock-based compensation costs were
recorded based on fair value in accordance with SFAS 123,
Accounting for Stock-Based Compensation, and EITF
Issue No. 96-18, Accounting for Equity Instruments
That Are Issued to Other Than Employees for Acquiring or in
conjunction with Selling, Goods or Services.
The Company recognized stock based compensation expense of $96
during the period from January 1, 2004 to December 23,
2004, related to the issuance by Saifun of stock options to the
employees of the Company.
F-42
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
|
|
M.
|
Other
comprehensive income (loss)
|
For the year ended December 31, 2003, and the period from
January 1, 2004 to December 23, 2004, net loss equaled
comprehensive income (loss) since the Company did not have any
items of other comprehensive income (loss).
|
|
N.
|
Recent
accounting pronouncements
|
|
|
a.
|
FASB
Statement No. 123 (Revision 2004), Share-Based
Payment
|
In December 2004, the FASB issued SFAS No. 123
(Revision 2004), Share-Based Payment,
(SFAS No. 123R), that addresses the accounting for
share-based payment transactions in which employee services are
received in exchange for either equity instruments of the
Company, or liabilities that are based on the fair value of the
Companys equity instruments or that may be settled by the
issuance of such equity instruments. SFAS No. 123R
eliminates the ability to account for share-based compensation
transactions using the intrinsic value method as prescribed in
APB Opinion No. 25, Accounting for Stock Issued to
Employees. Instead, SFAS No. 123R requires that
such transactions be accounted for using a fair-value-based
method and that compensation expense be recognized in the
statement of operations rather than disclosing the pro forma
impact of the stock based compensation.
SFAS No. 123R provides two alternative adoption
methods. The first method is a modified prospective transition
method whereby a company would recognize share-based employee
costs from the beginning of the fiscal period in which the
recognition provisions are first applied as if the
fair-value-based accounting method had been used to account for
all employee awards granted, modified, or settled after the
effective date and to any awards that were not fully vested as
of the effective date. Measurement and attribution of
compensation cost for awards that are unvested as of the
effective date of SFAS No. 123R would be based on the
same estimate of the grant-date fair value and the same
attribution method used previously under SFAS No. 123,
Accounting for Stock-Based Compensation
(SFAS No. 123). The second adoption method is a
modified retrospective transition method whereby a company would
recognize employee compensation cost for periods presented prior
to the adoption of SFAS No. 123R, in accordance with
the original provisions of SFAS No. 123; that is, an
entity would recognize employee compensation costs in the
amounts reported in the pro forma disclosures provided in
accordance with SFAS No. 123. A company would not be
permitted to make any changes to those amounts upon adoption of
SFAS No. 123R unless those changes represent a
correction of an error.
The provisions of SFAS No. 123R are effective for
annual periods beginning after June 15, 2005. This Standard
will be effective for the Company as of January 1, 2006.
Since the Company does not have any outstanding granted options
to employees (see Note 13) and it is intended to be
dissolved during 2005, the adoption of SFAS 123R is not
expected to have any impact on future results of operations.
|
|
b.
|
EITF 03-1
The Meaning of Other-Than-Temporary Impairment and Its
Application to Certain Investments
|
In November 2003, the FASB ratified the consensus reached by the
Task Force on EITF Issue
No. 03-1,
The Meaning of Other-Than-Temporary Impairment and Its
Application to Certain Investments
(EITF 03-1)
regarding disclosures for certain SFAS 115 investment
securities and investments accounted for under SFAS 124. In
March 2004, the FASB ratified other consensus reached by the
Task Force on
EITF 03-1.
The objective of
EITF 03-1
is to provide guidance on determining when an investment is
considered impaired, whether that impairment is
other-than-temporary, and the measurement of an impairment loss.
The guidance also includes accounting considerations subsequent
to the recognition of an other-than-temporary impairment
F-43
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
and requires certain disclosures about unrealized losses that
have not been recognized as other-than-temporary impairments. In
September 2004, the FASB delayed the effective date for the
measurement and recognition guidance included in
EITF 03-1.
The FASB recently announced that it intends to reconsider
EITF 03-1
in its entirety, and all other guidance on disclosing,
measuring, and recognizing other-than temporary impairments of
debt and equity securities. Until new guidance is issued,
companies must continue to comply with the disclosure
requirements of
EITF 03-1
and all relevant measurement and recognition requirements in
other accounting literature. The Company has adopted the
disclosure provisions of
EITF 03-1
in its financial statements.
Note 3 Accounts
Receivable Related Party
Accounts receivable represent amounts to be reimbursed by Flash
Germany for research and development services rendered by the
Company, pursuant to an agreement entered in March 2003 with
retroactive effect (see Note 1 and Note 15).
Note 4 Other
Current Assets
|
|
|
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
Government
institutions VAT
|
|
|
125
|
|
Government
institutions tax
|
|
|
|
|
Prepaid expenses
|
|
|
|
|
Advances to services providers and
others
|
|
|
7
|
|
|
|
|
|
|
|
|
|
132
|
|
|
|
|
|
|
Note 5 Investment
in Saifun Semiconductors
Upon incorporation, the Company acquired Saifuns ordinary
shares (representing a 4.57% shareholding at December 23,
2004) for $20 million. The shares were held by a Trustee to
settle all transactions related to the Companys SAR plan
(see Note 13).
During the period ended December 23, 2004, the Company
recorded an impairment charge of $4,986 as it determined that an
other than temporary decline in the fair value of the investment
in Saifun had occurred, pursuant to the provisions of its
investment impairment policy.
As a result of the execution of the Termination Agreement and
the Infineon plan to dissolve and dispose of the Company, the
investment in Saifun has been reclassified as a current asset
held for sale at December 23, 2004.
Subsequent to the balance sheet date, in January 2005, the
Company sold the investment in Saifun to Infineon in
consideration for a payment of $16,620.
F-44
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
Note 6 Income
Taxes
|
|
A.
|
Loss before
income taxes is attributable to the following geographic
locations for the year ended December 31, 2003, and the
period from January 1, 2004 to December 23, 2004:
|
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
year ended
|
|
|
period ended
|
|
|
|
December 31,
|
|
|
December 23,
|
|
|
|
2003
|
|
|
2004
|
|
|
Israel
|
|
|
(383
|
)
|
|
|
(4,877
|
)
|
Foreign
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(383
|
)
|
|
|
(4,877
|
)
|
|
|
|
|
|
|
|
|
|
|
|
B.
|
Reconciliation
of income tax expense:
|
The corporate tax rate applicable to the Companys taxable
income for 2003 is 36%, and for 2004 is 35% (see D hereunder). A
reconciliation of income taxes for the year ended
December 31, 2003, and the period from January 1, 2004
to December 23, 2004, determined using the Israel corporate
tax rate after certain adjustments for changes in the Israeli
Consumer Price Index (CPI) is as follows:
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
year ended
|
|
|
period ended
|
|
|
|
December 31,
|
|
|
December 23,
|
|
|
|
2003
|
|
|
2004
|
|
|
Loss before income taxes
|
|
|
(383
|
)
|
|
|
(4,877
|
)
|
Israel corporate tax rate
|
|
|
36
|
%
|
|
|
35
|
%
|
|
|
|
|
|
|
|
|
|
Expected benefit at the statutory
tax rate
|
|
|
138
|
|
|
|
1,707
|
|
Decrease in tax loss resulting
from non-deductible expenses
|
|
|
(33
|
)
|
|
|
(59
|
)
|
Effect of change in tax rates
|
|
|
|
|
|
|
(108
|
)
|
Increase in tax loss resulting
from other
|
|
|
28
|
|
|
|
1
|
|
Valuation allowance
|
|
|
(133
|
)
|
|
|
(1,541
|
)
|
|
|
|
|
|
|
|
|
|
Income tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C.
|
Components
of deferred income tax
|
Deferred income taxes were provided for temporary differences
between carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes.
SFAS No. 109 creates an exception which prohibits the
recognition of deferred tax liabilities or assets that arise
from differences between the financial reporting and tax bases
of assets and liabilities that are remeasured from the local
currency into U.S. Dollars using historical exchange rates
and that result from (i) changes in exchange rates or
(ii) indexing for tax purposes.
|
|
|
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
Net operating loss carryforward
|
|
|
5,371
|
|
Accrued employee rights
|
|
|
38
|
|
|
|
|
|
|
Deferred tax asset
|
|
|
5,409
|
|
Valuation allowance
|
|
|
(5,409
|
)
|
|
|
|
|
|
Net deferred tax asset
|
|
|
|
|
|
|
|
|
|
F-45
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
The Company had operating loss carryforwards for tax purposes,
as of December 23, 2004 of approximately $15,346, which
included $4,986 derived from the impairment of the investment in
Saifun, which will be recognized for tax purposes in 2005 upon
the sale of the shares.
Pursuant to SFAS No. 109, the Company has assessed its
deferred tax asset and the need for a valuation allowance. Such
assessment considers whether it is more likely than not that
some portion or all of the deferred tax assets may not be
realized. The assessment requires considerable judgment on the
part of management, with respect to, amongst others, benefits
that could be realized from available tax strategies and future
taxable income, as well as other positive and negative factors.
The ultimate realization of deferred tax assets is dependent
upon the Companys ability to generate the appropriate
character of future taxable income sufficient to utilize tax
loss carryforwards or tax credits before their expiration.
In determining the potential requirement to establish a
valuation allowance, the Company evaluated all positive and
negative evidence, including the Companys historical
operating losses, its April 2003 research and development
agreement with Flash Germany, its investment in shares of Saifun
and its intended dissolution. The underlying assumptions
utilized in forecasting its future taxable income require
judgment and may be subject to revisions based on future
business developments. As a result of this assessment, the
Company has recorded a full valuation allowance on its deferred
tax assets.
On June 29, 2004, the Knesset passed Income Tax Ordinary
Amendment (No. 140 and Temporary Order) 2004
(the Amendment).
The Amendment provides a gradual reduction in the Companys
tax rate from 36% to 30% in the following manner: in 2004 the
tax rate was 35%, in 2005 the tax rate will be 34%, in 2006 the
tax rate will be 32% and from 2007 onward the tax rate will be
30%.
Note 7 Furniture
and Equipment, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Computers,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
software
|
|
|
Furniture
|
|
|
|
|
|
|
|
|
|
|
|
|
and
|
|
|
and
|
|
|
|
|
|
|
|
|
|
|
|
|
auxiliary
|
|
|
office
|
|
|
Lab
|
|
|
Leasehold
|
|
|
|
|
|
|
equipment
|
|
|
equipment
|
|
|
equipment
|
|
|
improvements
|
|
|
Total
|
|
|
Cost:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2003
|
|
|
455
|
|
|
|
76
|
|
|
|
586
|
|
|
|
121
|
|
|
|
1,238
|
|
Additions
|
|
|
82
|
|
|
|
8
|
|
|
|
365
|
|
|
|
31
|
|
|
|
486
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 23, 2004
|
|
|
537
|
|
|
|
84
|
|
|
|
951
|
|
|
|
152
|
|
|
|
1,724
|
|
Accumulated depreciation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2003
|
|
|
247
|
|
|
|
10
|
|
|
|
352
|
|
|
|
23
|
|
|
|
632
|
|
Depreciation
|
|
|
142
|
|
|
|
8
|
|
|
|
188
|
|
|
|
14
|
|
|
|
352
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 23, 2004
|
|
|
389
|
|
|
|
18
|
|
|
|
540
|
|
|
|
37
|
|
|
|
984
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Furniture and equipment, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 23, 2004
|
|
|
148
|
|
|
|
66
|
|
|
|
411
|
|
|
|
115
|
|
|
|
740
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Property, plant and equipment, net, intended for sale is
presented as current assets. According to the Termination
Agreement, the Company will sell and transfer to Flash Germany
its tangible assets at their net book value.
|
F-46
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
Note 8 Accounts
Payable
|
|
|
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
Trade
payables invoiced
|
|
|
4,601
|
*
|
Trade
payables accrued
|
|
|
30
|
|
|
|
|
|
|
|
|
|
4,631
|
|
|
|
|
|
|
|
|
* |
Including $4,560 payable to Saifun (former shareholder), (see
Note 1), which was paid in January 2005.
|
Note 9 Other
Current Liabilities
|
|
|
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
Employees and payroll accruals
|
|
|
207
|
|
Liability for vacation and
recreation pay
|
|
|
57
|
|
|
|
|
|
|
|
|
|
264
|
|
|
|
|
|
|
Note 10 Long-Term
Loan From Related Parties
|
|
|
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
Loans from related
parties current Loan from
shareholder(1)
|
|
|
6,280
|
|
|
|
|
|
|
Loans from related
parties long term Loan from
shareholder(1)
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
The Company received an unsecured loan from Saifun in May 2001
in the amount of $6,280 for 36 months. The loan bore
interest at an annual rate of 4%. On February 20, 2004,
Saifun agreed to extend the maturity of the loan until October
2004.
|
Pursuant to the terms of the Termination Agreement, Saifun
assigned the loan to Infineon. The loan was repaid during 2005.
Interest expense for the year ended December 31, 2003 and
for the period from January 1, 2004 to December 23,
2004 were $377 and $123, respectively.
Note 11 Employee
Benefits
In accordance with Israeli law and labor agreements, the Company
is required to pay severance benefits to employees
voluntarily leaving and including termination, under specified
circumstances. The Companys liability for severance
benefits is funded through the deposits made with insurance
carriers for the purchase of insurance policies.
At December 23, 2004, the Company has accrued for such
employee termination benefits in accordance with the required
formula pursuant to Israeli labor law and the Companys
labor agreements. At December 23, 2004, restricted assets
for employee termination benefits represent the deposits made
with insurance companies, which may be subject to withdrawal by
the Company under conditions specified by Israeli labor law and
the Companys labor agreements.
Pursuant to the Termination Agreement, the Company terminated
the employment of most of its employees on December 23,
2004. Therefore, the Companys liability for severance
benefits for the remaining
F-47
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
employees and the Companys restricted assets for such
employee termination benefits at December 23, 2004, are
presented as current liabilities and current assets,
respectively.
Note 12 Commitments
and Contingencies
The Company has entered into motor vehicle operating lease
agreements for the lease of 18 motor vehicles for a period of
three years. The Company deposited $43 pursuant to the terms of
the operating lease agreements.
The Company has also entered into an agreement for the sub-lease
of office premises from Saifun for a period of 60 months
commencing November 15, 2001, with renewal options for
additional periods aggregating up to 60 months (first
option 24 months, second
option 36 months).
In connection with the Termination Agreement, the Company shall
assign to Saifun the car lease agreements used by its employees.
Saifun shall terminate the sublease agreement with the Company.
Rental expenses were $370 and $345, for the year ended
December 31, 2003, and the period from January 1, 2004
to December 23, 2004, respectively.
In October 2002, a lawsuit was filed against the Company by the
Companys former chief executive officer. The lawsuit seeks
damages of NIS 1,200 thousand ($280) in wage differences and a
declaration of entitlement to purchase 420,000 SARs
(see Note 13). Liabilities related to legal proceedings are
recorded when it is probable that a liability has been incurred
and the associated amount can be reasonably estimated. The
Company, based on its legal counsels opinion, believes
that it has valid and meritorious defenses and will likely
prevail in this action. Accordingly, no provision in the
accompanying financial statements has been made relating to this
litigation.
Note 13 Stock
Appreciation Rights Plan
Pursuant to the terms of the April 2001 Joint Venture Agreement,
Infineon and Saifun agreed to implement a Stock Appreciation
Rights Plan (the Plan) for the Company.
Upon incorporation, the Company purchased ordinary shares of
Saifun (Saifuns Shares) and transferred them
to an independent trustee (the Trustee). The
agreement between the Company and the Trustee provided, inter
alia, that Saifuns Shares will be held in trust in
connection with the Plan and will be utilized to fund the
liabilities of the Plan. The Saifun Shares would have been
subject to the liabilities of the creditors of the Company in
the event of insolvency.
Pursuant to the provisions of the Plan, SARs were issued at an
exercise price established by the Plan administrator, generally
at fair value at the date of grant. The holders of the SARs were
entitled to receive either in cash or Saifun shares in an amount
based upon the increase in aggregate value of the Company and
Flash Germany, however, limited to the increase in value of
Saifun ordinary shares, with carryforward features for any
shortfalls. The SARs vest over a five year period.
Pursuant to a June 2003 amendment, the SAR plan was
retroactively amended to value each SAR at an amount equivalent
to one-half of an ordinary share of Saifun stock payable either
in cash or in ordinary shares of Saifun. On October 24,
2003, the Board of Directors passed a resolution prohibiting any
further SAR issuance.
The Plan was terminated pursuant to the provisions of the
Termination Agreement. As a result of the employment by Saifun
of the employees terminated by the Company, Saifun agreed to
assume the obligations provided under the Plan to these
employees.
F-48
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
The SAR would have been vested according to the following
vesting schedule:
|
|
|
|
|
|
|
Vesting (in
|
|
Portion of grants
|
|
months)
|
|
|
40%
|
|
|
24
|
|
20%
|
|
|
36
|
|
20%
|
|
|
48
|
|
20%
|
|
|
60
|
|
Subject to the above vesting periods, the SARs should not have
been exercisable until the later of: (i) January 1,
2005, or (ii) consummation of Saifuns initial public
offering. Since the ultimate exercisability was contingent on
the occurrence of a Saifuns IPO, compensation expense was
based on an assessment of the probability of the occurrence of a
Saifuns IPO at the balance sheet date.
Through December 31, 2003, the Company determined that the
probability of consummation of a Saifun IPO was remote and,
accordingly, compensation expense related to the awarded SARs
was immaterial. Upon increased likelihood of the consummation of
a Saifun IPO, during the first three quarters of 2004, the
Company was required to immediately recognize compensation
expense related to the vested portion of the previously issued
SARs at that date. Since the SAR plan has been aborted in
connection with the Termination Agreement, the net SARs
liability amounting to $1,908 was reclassified as a shareholder
contribution.
The changes in the number of SARs outstanding during the period
indicated was as follows:
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Weighted average
|
|
|
|
SARs
|
|
|
exercise price
|
|
|
|
US$
|
|
|
US$
|
|
|
Balance at December 31, 2002
|
|
|
872,650
|
|
|
|
3.27
|
|
Granted
|
|
|
50,000
|
|
|
|
3.12
|
|
Forfeited
|
|
|
(196,700
|
)
|
|
|
3.23
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2003
|
|
|
725,950
|
|
|
|
3.27
|
|
Granted
|
|
|
|
|
|
|
|
|
Forfeited, including terminated
(see above)
|
|
|
(725,950
|
)
|
|
|
3.27
|
|
|
|
|
|
|
|
|
|
|
Balance at December 23, 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 14 Interest
Expenses, Net
Interest expenses, net, consists of:
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
year ended
|
|
|
period ended
|
|
|
|
December 31,
|
|
|
December 23,
|
|
|
|
2003
|
|
|
2004
|
|
|
Interest expense on loans from
related parties*
|
|
|
377
|
|
|
|
123
|
|
Exchange rate differential on
short-term bank deposits
|
|
|
17
|
|
|
|
(91
|
)
|
Interest income on short-term bank
deposits
|
|
|
(26
|
)
|
|
|
(19
|
)
|
Other
|
|
|
17
|
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
385
|
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
F-49
INFINEON TECHNOLOGIES FLASH LTD.
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
(US in thousands, except where otherwise stated)
Note 15 Related
Parties
|
|
A.
|
Related
party balances arise from the ordinary course of business and
are as follows:
|
The Company had transactions in the normal course of business
with Infineon and Saifun, including research and development
agreements and financing agreements, as well as royalty and
software licensing agreements.
Related parties balances are reflected in the balance
sheet as follows:
|
|
|
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
Accounts receivable (Note 3)
|
|
|
5,766
|
|
Accounts payable
|
|
|
6
|
|
Loans (Note 10)
|
|
|
6,280
|
|
All of the above-mentioned amounts were settled during the first
months of 2005.
|
|
B.
|
Related
party transactions were reflected in the statements of
operations as follows:
|
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
year ended
|
|
|
period ended
|
|
|
|
December 31,
|
|
|
December 23,
|
|
|
|
2003
|
|
|
2004
|
|
|
Revenues Flash Germany
|
|
|
11,407
|
|
|
|
12,563
|
|
Expenses associated with related
parties:
|
|
|
|
|
|
|
|
|
Research and development costs:
|
|
|
|
|
|
|
|
|
Infineon
|
|
|
203
|
|
|
|
20
|
|
Saifun
|
|
|
6,746
|
|
|
|
7,435
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,949
|
|
|
|
7,455
|
|
|
|
|
|
|
|
|
|
|
General and administrative
expenses:
|
|
|
|
|
|
|
|
|
Infineon
|
|
|
|
|
|
|
|
|
Saifun
|
|
|
97
|
|
|
|
51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97
|
|
|
|
51
|
|
|
|
|
|
|
|
|
|
|
Interest expenses:
|
|
|
|
|
|
|
|
|
Infineon
|
|
|
126
|
|
|
|
|
|
Saifun
|
|
|
251
|
|
|
|
123
|
|
|
|
|
|
|
|
|
|
|
|
|
|
377
|
|
|
|
123
|
|
|
|
|
|
|
|
|
|
|
F-50
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and the General Partner of
Infineon Technologies Flash GmbH & Co. KG:
We have audited the accompanying balance sheet of Infineon
Technologies Flash GmbH & Co. KG as of
December 23, 2004, and the related statements of
operations, partners equity, and cash flows for the year
ended December 26, 2003 and the period ended
December 23, 2004. These financial statements are the
responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above
present fairly, in all material respects, the financial position
of Infineon Technologies Flash GmbH & Co. KG (the
Company) as of December 23, 2004, and the
related statements of operations, partners equity, and
cash flows for the year ended December 26, 2003 and the
period ended December 23, 2004, in conformity with
accounting principles generally accepted in Germany.
Accounting principles generally accepted in Germany vary in
certain significant respects from U.S. generally accepted
accounting principles. Application of U.S. generally
accepted accounting principles would have affected
partners equity as of December 23, 2004 and results
of operations for the year ended December 26, 2003 and the
period ended December 23, 2004 to the extent summarized in
Note 6 to the financial statements.
The Company has incurred operating losses since inception, with
a net loss of 70,969,000 during the period ended
December 23, 2004, and has an accumulated deficit of
122,783,000 at December 23, 2004. As described
in note 5, the Company is dependent on its partner,
Infineon Technologies AG, currently in the form of financing
agreements, to sustain its operations.
Dresden, Germany
August 9, 2005
/s/ KPMG Deutsche Treuhand AG
KPMG DEUTSCHE TREUHAND-GESELLSCHAFT
AKTIENGESELLSCHAFT
WIRTSCHAFTSPRÜFUNGSGESELLSCHAFT
F-51
INFINEON
TECHNOLOGIES FLASH GMBH & CO. KG, DRESDEN
For the period ended December 23, 2004 and the year
ended
December 26, 2003
( in thousands)
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
period ended
|
|
|
year ended
|
|
|
|
December 23,
|
|
|
December 26,
|
|
|
|
2004
|
|
|
2003
|
|
|
1. Net sales
|
|
|
46,839
|
|
|
|
35,133
|
|
2. Cost of goods sold
|
|
|
(60,021
|
)
|
|
|
(33,434
|
)
|
|
|
|
|
|
|
|
|
|
3. Gross profit (loss)
|
|
|
(13,182
|
)
|
|
|
1,699
|
|
4. Research and development
expenses
|
|
|
(44,016
|
)
|
|
|
(31,550
|
)
|
5. Selling expenses
|
|
|
(6,948
|
)
|
|
|
(3,588
|
)
|
6. General and administrative
expenses
|
|
|
(6,040
|
)
|
|
|
(4,534
|
)
|
7. Other operating income
|
|
|
23,136
|
|
|
|
3,346
|
|
8. Other operating expenses
|
|
|
(9
|
)
|
|
|
(2
|
)
|
9. Other interest and similar
income thereof from affiliated parties:
26 (2003: 48)
|
|
|
65
|
|
|
|
96
|
|
10. Interest and similar
expenses thereof to affiliated parties:
1,862 (2003: 26)
|
|
|
(2,480
|
)
|
|
|
(82
|
)
|
|
|
|
|
|
|
|
|
|
11. Net loss
|
|
|
(49,474
|
)
|
|
|
(34,615
|
)
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the financial
statements.
F-52
INFINEON
TECHNOLOGIES FLASH GMBH & CO. KG, DRESDEN
As of December 23, 2004 ( in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 23,
|
|
|
|
|
|
|
|
2004
|
|
|
Assets
|
A.
|
|
Fixed assets
|
|
|
I.
|
|
Intangible assets
|
|
|
82
|
|
|
|
II.
|
|
Property, plant and equipment, net
|
|
|
|
|
|
|
|
|
1. Plant and machinery
|
|
|
10
|
|
|
|
|
|
2. Technical and office
equipment
|
|
|
15,450
|
|
|
|
|
|
3. Construction in
progress
|
|
|
745
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,287
|
|
B.
|
|
Current assets
|
|
|
I.
|
|
Inventories
|
|
|
3,565
|
|
|
|
II.
|
|
Receivables and other assets
|
|
|
|
|
|
|
|
|
1. Receivables due from
affiliated companies
|
|
|
35,416
|
|
|
|
|
|
thereof
from partners: 35,416
|
|
|
|
|
|
|
|
|
2. Other assets
|
|
|
5,998
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41,414
|
|
|
|
III.
|
|
Cash and cash equivalents
|
|
|
1,737
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46,716
|
|
C.
|
|
Deficit not covered by
partners equity
|
|
|
61,697
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124,700
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
A.
|
|
Partners equity
|
|
|
I.
|
|
Equity shares of limited partners
|
|
|
817
|
|
|
|
II.
|
|
Reserves
|
|
|
32,751
|
|
|
|
III.
|
|
Accumulated deficit
|
|
|
(95,265
|
)
|
|
|
IV.
|
|
Loss not covered by partners
equity
|
|
|
61,697
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
B.
|
|
Provisions
|
|
|
|
|
1. Provisions for
pensions and similar obligations
|
|
|
476
|
|
|
|
|
|
2. Other provisions
|
|
|
5,249
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,725
|
|
|
|
|
|
|
|
|
|
|
C.
|
|
Liabilities
|
|
|
|
|
1. Trade accounts
payable
|
|
|
2,657
|
|
|
|
|
|
2. Accounts payable due
to affiliated companies thereof due to
partners: 110,014
|
|
|
115,526
|
|
|
|
|
|
3. Other liabilities
|
|
|
792
|
|
|
|
|
|
thereof
taxes: 183
|
|
|
|
|
|
|
|
|
thereof
for social security: 172
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
118,975
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124,700
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these financial
statements.
F-53
INFINEON
TECHNOLOGIES FLASH GMBH & CO. KG, DRESDEN
For the period ended December 23, 2004 and the
year ended December 26, 2003
( in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transfer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual
|
|
|
between
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
net
|
|
|
partners
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
loss
|
|
|
(Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
before
|
|
|
Agreement,
|
|
|
|
|
|
|
December
|
|
|
|
|
|
Annual
|
|
|
December
|
|
|
transfer
|
|
|
see
|
|
|
December
|
|
|
|
27,
|
|
|
Paid
|
|
|
net
|
|
|
26,
|
|
|
between
|
|
|
note
|
|
|
23,
|
|
|
|
2002
|
|
|
in
|
|
|
loss
|
|
|
2003
|
|
|
partners
|
|
|
1)
|
|
|
2004
|
|
|
Infineon
Technologies AG
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital account I (capital
contribution)
|
|
|
255
|
|
|
|
317
|
|
|
|
|
|
|
|
572
|
|
|
|
|
|
|
|
245
|
|
|
|
817
|
|
Capital account II (capital
contribution)
|
|
|
5,709
|
|
|
|
19,762
|
|
|
|
|
|
|
|
25,471
|
|
|
|
|
|
|
|
7,280
|
|
|
|
32,751
|
|
Capital account III (earnings
reserves/accumulated deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital account IV (clearing
account)
|
|
|
(5,700
|
)
|
|
|
|
|
|
|
(24,130
|
)
|
|
|
(29,830
|
)
|
|
|
(44,255
|
)
|
|
|
(21,180
|
)
|
|
|
(95,265
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
264
|
|
|
|
20,079
|
|
|
|
(24,130
|
)
|
|
|
(3,787
|
)
|
|
|
(44,255
|
)
|
|
|
(13,655
|
)
|
|
|
(61,697
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Saifun
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital account I (capital
contribution)
|
|
|
245
|
|
|
|
|
|
|
|
|
|
|
|
245
|
|
|
|
|
|
|
|
(245
|
)
|
|
|
|
|
Capital account II (capital
contribution)
|
|
|
5,480
|
|
|
|
1,800
|
|
|
|
|
|
|
|
7,280
|
|
|
|
|
|
|
|
(7,280
|
)
|
|
|
|
|
Capital account III (earnings
reserves/accumulated deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital account IV (clearing
account)
|
|
|
(5,476
|
)
|
|
|
|
|
|
|
(10,485
|
)
|
|
|
(15,961
|
)
|
|
|
(18,967
|
)
|
|
|
34,928
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
249
|
|
|
|
1,800
|
|
|
|
(10,485
|
)
|
|
|
(8,436
|
)
|
|
|
(18,967
|
)
|
|
|
27,403
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
513
|
|
|
|
21,879
|
|
|
|
(34,615
|
)
|
|
|
(12,223
|
)
|
|
|
(63,222
|
)
|
|
|
13,748
|
|
|
|
(61,697
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the financial
statements.
F-54
INFINEON
TECHNOLOGIES FLASH GMBH & CO. KG, DRESDEN
For the period ended December 23, 2004 and the
year ended December 26, 2003
( in thousands)
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
period ended
|
|
|
year ended
|
|
|
|
December 23,
|
|
|
December 26,
|
|
|
|
2004
|
|
|
2003
|
|
|
Net loss
|
|
|
(49,474
|
)
|
|
|
(34,615
|
)
|
Adjustments to reconcile net loss
to cash used in operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
2,311
|
|
|
|
679
|
|
Income of tax free subsidies
(Investitionszulage)
|
|
|
(3,610
|
)
|
|
|
(849
|
)
|
Book losses from deposition of
fixed assets
|
|
|
6
|
|
|
|
|
|
Changes in operating assets and
liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable related party
|
|
|
(32,547
|
)
|
|
|
831
|
|
Inventories
|
|
|
(2,459
|
)
|
|
|
2,516
|
|
Other assets
|
|
|
(760
|
)
|
|
|
(764
|
)
|
Provisions
|
|
|
2,235
|
|
|
|
2,823
|
|
Trade accounts payable
|
|
|
(1,674
|
)
|
|
|
1,244
|
|
Accounts payable related party
|
|
|
18,469
|
|
|
|
5,377
|
|
Other liabilities
|
|
|
268
|
|
|
|
246
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating
activities
|
|
|
(67,235
|
)
|
|
|
(22,512
|
)
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
Purchase of intangible assets
|
|
|
(4
|
)
|
|
|
(100
|
)
|
Purchase of property, plant and
equipment
|
|
|
(12,545
|
)
|
|
|
(5,463
|
)
|
Proceeds from sales of property,
plant and equipment
|
|
|
|
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(12,549
|
)
|
|
|
(5,547
|
)
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
Proceeds from issuance of
partners equity
|
|
|
|
|
|
|
21,879
|
|
Proceeds from related party loans
|
|
|
79,400
|
|
|
|
7,550
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing
activities
|
|
|
79,400
|
|
|
|
29,429
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash
equivalents
|
|
|
(384
|
)
|
|
|
1,370
|
|
Cash and cash equivalents at
beginning of period
|
|
|
2,121
|
|
|
|
751
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end
of period
|
|
|
1,737
|
|
|
|
2,121
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Net of liabilities due to banks of 11.
|
The accompanying notes are an integral part of these financial
statements.
F-55
INFINEON
TECHNOLOGIES FLASH GMBH & CO. KG, DRESDEN
( in thousands, except where otherwise stated)
|
|
1.
|
Description
of Business, Formation and Basis of Presentation
|
Infineon Technologies Flash GmbH & Co. KG, formerly
Ingentix GmbH & Co. KG, (hereinafter the
Company), was incorporated on April 17, 2001 and is
based in Dresden, Germany. The Company was established to
develop, produce and market non-volatile memory products. The
Company changed its name to Infineon Technologies Flash
GmbH & Co. KG on February 13, 2003.
Until December 23, 2004 the companys limited partners
were Infineon Technologies AG (hereinafter
Infineon), holding a 70% interest, and Saifun
Ventures Ltd., which is based in Netanya, Israel (hereinafter
Saifun Ventures), holding a 30% interest of the
Company. Saifun Ventures is a wholly owned subsidiary of Saifun
Semiconductors Ltd., Netanya, Israel (Saifun
Semiconductors). Regulated in the Agreement on Termination
of Joint Venture Agreement and Related Transactions, effective
December 23, 2004, the Company became a
100% subsidiary of Infineon.
As part of the foundation of the Company, Saifun Semiconductors
and Infineon each agreed to license certain patented technology
to the Company to develop Non Volatile Memory (NROM)
code and data flash products, with royalties payable on the sale
of such products.
In August 2003, the Company entered into a research and
development agreement with Infineon Technologies Flash Ltd.,
Israel (Flash Israel). The agreement provides for
the reimbursement of all direct and indirect costs,
as defined in the agreement, incurred by Flash Israel in
connection with research and development efforts undertaken at
the direction of the Company.
On December 20, 2004, Infineon Technologies AG and Saifun
Semiconductors Ltd. and, Saifun Ventures Ltd. (jointly
Saifun) entered into an Agreement on
Termination of Joint Venture Agreement and Related
Transactions (the Termination Agreement),
which provides for the terms of the termination of the Joint
Venture.
Pursuant thereto, Saifun transferred its 30% ownership interest
in Infineon Flash KG, as well as its interest in the other
related joint venture company, to Infineon on December 23,
2004. In accordance with the Termination Agreement, all former
agreements signed between the two companies were terminated as
were both companies rights and obligations in respect of
past and existing financing agreements.
The Termination Agreement also subjected the parties to enter
into additional contracts, including an amended license
agreement (the Amended License Agreement) which was
entered into on January 13, 2005, and nullified and
replaced the previous license agreement between Saifun and
Infineon Flash KG. The Amended License Agreement provides the
Company with a license over certain of Saifuns NROM
patented technology, subject to specified cancellation
privileges. On June 28, 2005, Infineon exercised its
cancellation privileges for certain of the technologies
licensed, reducing its maximum remaining obligation to Saifun.
The net consideration paid as a result of the Termination
Agreement and the Amended License Agreement included cash,
forgiveness of Saifuns past and existing financing
commitments, the cancellation of the existing license agreement
and forgiveness of related liabilities owed to Saifun, and the
Amended License Agreement. Since the above mentioned agreements
were negotiated concurrently, the total consideration paid in
connection with the Termination Agreement and the Amended
License Agreement was allocated to the various elements based on
their respective fair values. The resulting purchase price
allocation resulted in goodwill at the Companys parent
level. Under US GAAP, the acquisition of the minority interest
of the Company by Infineon is accounted for as a step
acquisition and all purchase accounting adjustments are recorded
at the Company level (see Note 6j).
The Company has incurred operating losses since inception, with
a net loss of 49,474 (after consideration of the
alteration of partners) during the period from December 27,
2003 to December 23, 2004 ( 34,615 during the
year ended December 26, 2003), and had an accumulated
deficit of 95,265 at December 23, 2004.
F-56
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
The Company is dependent upon the continued financial support of
Infineon in the form of financing agreements, to sustain its
operations (see Note 5).
As discussed above, the Company has significant transactions and
relationships with related parties. Because of these
relationships, it is possible that the terms of the transactions
are not necessarily the same as those that would result from
transactions among unrelated parties.
The accompanying financial statements of the Company have been
prepared in accordance with the provisions of German Commercial
Law (Handelsgesetzbuch or HGB) governing
the accounting, valuation and classification procedures to be
used by partnerships as defined in § 264a HGB and also
the accounting, valuation and classification procedures to be
used by large corporations. The results of operations have been
prepared in accordance with the
cost-of-sales
format (as defined in § 275 (3) HGB).
Infineon and its subsidiaries are hereinafter referred to as
affiliated companies.
|
|
2.
|
Accounting
and Valuation Methods
|
Property, plant and equipment and intangibles assets are
valued at cost of acquisition or cost of manufacture,
respectively, less depreciation.
The scheduled depreciation is based on the service life
specified in the German tax depreciation tables and additions to
assets have been depreciated over its service life using a
straight-line or a declining balance method.
Under HGB until December 31, 2003 all tangible fixed assets
acquired were depreciated assuming a full year period of
depreciation, for tangible fixed assets acquired, a half year of
depreciation was assumed (in line with the tax law
simplification rules stated in Chapter. 44 (2) EStR.
With effect from January 1, 2004, all new purchased
tangible fixed assets are depreciated using a straight-line
method (pro rata temporis approach) for HGB purposes.
Low value assets (up to Euro 410) have been written off in full
in the year of acquisition (in accordance with § 6
(2) EStG (Einkommensteuergesetz or German
Income Tax Rules). These assets are disclosed under acquisition
and disposal in the same year.
Inventories are valued at lower of cost and market, with
cost being generally determined on the basis of an average
method.
Receivables and other assets are valued at face value. A
general allowance of 1% is provided for trade accounts
receivables to take the general risk exposure into account.
The responsible tax authority confirmed a legal right for a
governmental investment grant to be granted to the Company. Due
to the fact that the Company made qualifying investments in the
current fiscal year, which meet the conditions for the
investment grant (§ 3 InvZulG 1999), receivables due
from tax authorities are included in other assets of the balance
sheet and the related income has been recognized.
Cash and cash equivalents are valued at face value
and if in a foreign
currency at the rate prevailing on the date of
the balance sheet.
Provisions reflect risks currently identifiable and
contingent liabilities and are valued in accordance with sound
business principles. Pension provisions are valued on an
actuarial basis as defined in § 6a EStG (in connection
with R 41 EStR and mortality tables of Professor Dr. Klaus
Heubeck from 1998) using an interest rate of 6%.
Liabilities are presented at repayment cost. Liabilities
denominated in a foreign currency are valued at the rate
prevailing on the balance sheet date.
F-57
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
Revenue from products sold to customers is recognized
when persuasive evidence of an arrangement exists, the price is
fixed or determinable, shipment is made and collectibility is
reasonably assured.
Research and development costs are expensed as incurred.
Going-concern-assumption: The Companys
financial statements are prepared on the basis of a going
concern.
|
|
3.
|
Comments
on the Balance Sheets
|
Assets
Changes to individual assets and a breakdown of the annual
depreciation are disclosed in the table of Movements of Fixed
Assets (attached at the end of these notes).
Other assets amounting to 5 have a remaining term in
excess of one year. All other receivables and other current
assets have a remaining term not exceeding one year.
Receivables due from affiliated companies consist of the
following as of December 23, 2004:
|
|
|
|
|
|
|
|
|
|
|
December 23, 2004
|
|
|
|
Total
|
|
|
Thereof Infineon
|
|
|
Trade accounts receivable
|
|
|
31,985
|
|
|
|
31,985
|
|
Other receivables
|
|
|
3,431
|
|
|
|
3,430
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,416
|
|
|
|
35,415
|
|
|
|
|
|
|
|
|
|
|
There were no receivables due from associated companies as of
December 23, 2004.
Partners
equity
The equity shares of the limited partners (capital
account I) amounting to 817 are fully paid in.
In January 2003, Infineon increased its equity shares by
317 pursuant to the Amended and restated Joint
Venture Agreement dated January 9, 2003 and the
amended Partners agreement, which changed the
partners respective participation percentage. As of
December 26, 2003, 70% of the equity was held by Infineon
and 30% was held by Saifun Ventures.
As of December 23, 2004, Saifun sold its 30% share of the
Company to Infineon. Thereafter, the Company became a
100% subsidiary of Infineon.
Liabilities
The Company participates in the pension plan of Infineon for its
employees. Provisions for pension and similar obligations have
been actuarially determined and represent the projected benefit
obligation.
F-58
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
Other provisions consist of the following as of
December 23, 2004:
|
|
|
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
Litigation matters
|
|
|
2,530
|
|
Royalty accruals
|
|
|
1,462
|
|
Bonus and extra payments
|
|
|
655
|
|
Vacation provision
|
|
|
325
|
|
Mark-to-market
losses on derivatives
|
|
|
151
|
|
Other
|
|
|
126
|
|
|
|
|
|
|
|
|
|
5,249
|
|
|
|
|
|
|
Mark-to-market
losses on derivatives reflects the foreign exchange loss for
contracts denominated in foreign currencies.
Payables due to affiliated companies consist of the following as
of December 23, 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 23, 2004
|
|
|
|
|
|
|
|
|
|
Thereof IFL
|
|
|
|
Total
|
|
|
Thereof Infineon
|
|
|
GmbH*
|
|
|
Trade accounts payable
|
|
|
29,138
|
|
|
|
23,693
|
|
|
|
|
|
Other liabilities
|
|
|
86,388
|
|
|
|
86,308
|
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
115,526
|
|
|
|
110,001
|
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Infineon Technologies Geschäftsführungs GmbH, Dresden
|
The other liabilities due to Infineon include loans amounting to
82,940.
As of December 23, 2004, liabilities due to partners with a
remaining term through December 31, 2005 amount to
98,564. The remaining amount of 11,450
at December 23, 2004 refers to loans from Infineon and have
the following payment terms:
|
|
|
|
|
|
|
Amount
|
|
|
November 10, 2006
|
|
|
3,150
|
|
April 1, 2007
|
|
|
4,500
|
|
June 9, 2007
|
|
|
3,800
|
|
|
|
|
|
|
|
|
|
11,450
|
|
|
|
|
|
|
All other liabilities become due within one year. All
liabilities are unsecured.
|
|
4.
|
Comments
on the Statements of Operations
|
Net
Sales
The net sales consist exclusively of domestic sales resulting
from the sale of card products to Infineon.
Other
Operating Income
Other operating income includes government grants amounting to
3,610 during the period from December 27, 2003
to December 23, 2004 ( 849 during the year ended
December 26, 2003) and income from waiving of loans payable
to Saifun Semiconductors amounting to 13,748
(including interest; see note 1).
F-59
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
Material
Costs
Material costs consist of the following items:
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
period ended
|
|
|
year ended
|
|
|
|
December 23,
|
|
|
December 26,
|
|
|
|
2004
|
|
|
2003
|
|
|
Cost of raw materials and supplies
and goods purchased for resale
|
|
|
52,438
|
|
|
|
29,628
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52,438
|
|
|
|
29,628
|
|
|
|
|
|
|
|
|
|
|
Personnel
Costs
Personnel costs consist of the following:
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
period ended
|
|
|
year ended
|
|
|
|
December 23,
|
|
|
December 26,
|
|
|
|
2004
|
|
|
2003
|
|
|
Wages and salaries
|
|
|
6,890
|
|
|
|
3,550
|
|
Social security contributions and
staff welfare costs
|
|
|
788
|
|
|
|
295
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,678
|
|
|
|
3,845
|
|
|
|
|
|
|
|
|
|
|
Social security contributions and staff welfare costs include
pension costs of 91 and 46, for the
period ended December 23, 2004 and the year ended
December 26, 2003, respectively.
Employees
During the period from December 27, 2003 to
December 23, 2004, the Company had an average staff of 89
employees. During the year ended December 26, 2003, the
Company had an average staff of 48 employees (all figures
including part-time staff). These employees have been engaged
primarily in the area of product development and marketing.
Stock
Options
The employees of the Company have been granted Infineon stock
options pursuant to Infineons stock option plans. The
exercise price of the stock options equal to or exceeded the
market price of the underlying Infineon shares on each grant
date. If such options are exercised, the employees are given
Infineon shares in exchange for payment of the exercise price to
Infineon.
Financial
Obligations and other financial commitments
The Company had no financial obligations and commitments as
defined in § 251 HGB and
§ 268 (7) HGB as of December 23, 2004.
Financial obligations in connection with purchase orders as of
December 23, 2004 arose in the normal course of business
activities.
On January 9, 2003, the Company entered into a license
agreement with Saifun Semiconductors. Subject to this license
agreement the Company is obliged to pay license fees amounting
to USD 10 million, of which USD 7 million
were due on July 1, 2004 and USD 3 million will
become due on July 1, 2005. The license fees are only
payable if the Company has sufficient net income. Since the
Company incurred net losses during the periods ended
December 23, 2004, no accrual was recorded for this
contingent obligation.
F-60
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
Infineon entered into a new license agreement with Saifun
effective January 13, 2005 and terminated the
January 9, 2003 license agreement. On June 28, 2005,
Infineon exercised its cancellation privileges for certain of
the technologies licensed according the new license agreement.
Distribution
of net income/loss
According to § 17(3) of the partnership agreement, net
losses of the Company are distributed to the partners in
proportion to their capital contribution, provided that the
legal regulations that govern the limited liability of the
limited partners do not state otherwise.
Bodies of
the Company
The bodies of the Company consist of:
|
|
|
|
|
the managing partner,
|
|
|
|
board of directors and
|
|
|
|
the partners assembly
|
Infineon Technologies Flash Geschäftsführungs GmbH
(full partner without capital contribution), Dresden (formerly
Ingentix Geschäftsführungs GmbH, Munich) is the
managing partner. The nominal capital of the managing partner
amounts to 41.
As long as acting exclusively for the Company the managing
partner receives a reimbursement of all costs and expenditures
occurring from its managing duties in accordance with
§ 15 (1) of the partnership agreement. In
addition the managing partner receives a variable payment for
assuming the liability risk and its managing duties according to
§ 15 (2) of the partnership agreement.
Responsible general manager of Infineon Flash
Geschäftsführungs GmbH are:
|
|
|
|
|
Mr. Dr. Peter Kücher (from February 26, 2003
to October 1, 2004)
|
|
|
|
Mr. Ramy Langer (from February 26, 2003 to
February 15, 2005)
|
|
|
|
Mr. Frank Tillner (since October 1, 2004)
|
|
|
|
Mr. Dr. Michael Majerus (from February 25, 2005
to May 31, 2005)
|
Total remuneration of the general management amounted to
408 for the period from December 27, 2003 to
December 23, 2004 and to 183 for the period
from December 28, 2002 to December 26, 2003.
The Company established a board of directors
(Beirat) according to § 10 of its
partnership agreement. In the reporting period the following
persons were members of this board:
|
|
|
|
|
Thomas Seifert (Chairman), Group Vice President and General
Manager Memory Products Group of Infineon, was appointed member
of the board of directors, effective as of July 20, 2004
|
|
|
|
Dr. Michael Majerus, Group Vice President Finance and
Business Administration Memory Products Group of Infineon, was
appointed member of the board of directors, effective as of
February 19, 2003
|
|
|
|
Dr. Harald Eggers, former Chief Executive Officer Memory
Products Group of Infineon, was appointed member of the board of
directors, effective as of February 19, 2003 and belonged
to the board until July 20, 2004
|
|
|
|
Michael Buckermann, General Manager Business Unit Computing,
Memory Products Group of Infineon, was appointed member of the
board of directors, effective as of February 19, 2003 and
belonged to the board until May 20, 2005
|
F-61
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
Dr. Boaz Eitan (Deputy Chairman) Founder and Chief
Executive Officer, Saifun Semiconductors, was elected member of
the board of directors by a partners resolution, as of
May 21, 2001 and belonged to the board until
December 23, 2004
|
|
|
|
Kobi Rozengarten, President, Saifun Semiconductors, was elected
member of the board of directors by a partners resolution,
as of May 21, 2001 and belonged to the board until the
December 23, 2004
|
The members of the board of directors do not receive any salary
for their services.
Group
Relationship
According to § 290 (1) HGB, the Company is an
affiliated company of Infineon and is included in the
consolidated financial statements of Infineon. Such consolidated
financial statements are published in the Federal Office Gazette
and are available at the Munich commercial register.
Risk of
Insolvency and Financing
As of December 23, 2004, the Company had a deficit not
covered by partners equity amounting to
61,697. The Company has also forecasted an increased
loss in the 2005 financial year.
The Company has forecasted in its 2005 operational budget to
have cash outflows in the 2005 financial year due to further
R&D expenditures, capital expenditures, and increased
receivables associated with increasing revenues. The Company
also forecasts operating losses beyond the 2005 financial year.
The Companys liquidity requirements are planned to be
financed by further loans from Infineon. The Company also plans
to apply for additional government grants.
As a result of the Companys over-indebtedness, and to
assure liquidity, both Infineon and Saifun Semiconductors had
issued financing undertakings pursuant to an agreement dated
May 11, 2004, aggregating 114,000. Pursuant to
this agreement, Infineon extended credit up to
83,400 and Saifun Semiconductors extended credit up
to 30,600. In connection with these credit lines,
Infineon and Saifun Semiconductors had each issued a
subordination agreement for 51,800 and
22,200, committing not to pursue its subordinated
claims against the Company for as long as and insofar as the
partial or complete settlement of these claims would lead to
over-indebtedness on part of the Company within the meaning of
§ 19 InsO (Germany Insolvency law). In connection with
the Termination Agreement entered into on December 20,
2004, all loans outstanding from Saifun Semiconductors were
waived, and the existing partners subordination agreements
were cancelled.
Infineon extended credit aggregating to 82,940 as of
December 23, 2004. Subsequent to the date of the
accompanying financial statements, Infineon and one of its
wholly owned subsidiaries issued new financing guarantees up to
172,000 and subordination agreements for
170,000.
For reasons stated above, the Companys financial
statements are prepared on a going-concern basis.
F-62
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
|
|
6.
|
Summary
of Significant Differences between Accounting Principles
Followed by the Company and Generally Accepted Accounting
Principles in the United States
|
The accompanying financial statements have been prepared in
accordance with generally accepted accounting principles of the
German Commercial Law (HGB), which differ in the
following respects from generally accepted accounting principles
in the United States (U.S. GAAP) as related to
the Company:
a) Assets
depreciation
There are alternatives allowed in HGB in terms of depreciation
methods and useful life measurements, which cause differences in
book value of depreciable assets. As a result, due to
differences in book value basis, different amounts are
recognized as gains or losses in the course of assets disposals.
The following table illustrates the different depreciation
methods applied:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
US GAAP
|
|
German HGB
|
|
|
Years of
|
|
|
Depreciation
|
|
Years of
|
|
|
Depreciation
|
|
|
useful life
|
|
|
method
|
|
useful life
|
|
|
method
|
|
Technical equipment
|
|
|
5
|
|
|
Straight-line
|
|
|
10
|
|
|
Straight-line*
|
Office and general equipment
|
|
|
3
|
|
|
Straight-line
|
|
|
8
|
|
|
Straight-line*
|
Testing machinery
|
|
|
3
|
|
|
Straight-line
|
|
|
8
|
|
|
Straight-line*
|
Communication equipment
|
|
|
3
|
|
|
Straight-line
|
|
|
6
|
|
|
Straight-line*
|
|
|
* |
since January 1, 2004 for all new purchased fixed assets.
For the fixed assets purchased until December 31, 2003 the
initial depreciation method was maintained.
|
In addition, as explained in c) below, the different
recognition of government grants and subsidies under
U.S. GAAP and HGB also causes differences in depreciation.
b) License
amortization
Under HGB, expenses are accrued only when they are not subject
to a condition that is dependent on future operating income and
when potential cash outflow is reasonably assured. Therefore,
the non-refundable licensee fees payable to Saifun
Semiconductors have not been expensed, nor was the liability
accrued, since as per the contract, such amounts are only
payable out of Companys profits, as defined. However,
under U.S. GAAP, such contractual obligations are deemed
probable and entail probable future sacrifices of economic
benefits arising from present obligations of the Company.
Accordingly, the acquired technologies are capitalized as
intangible assets, and amortized over the useful life of the
technology.
c) Grants
recognition
Under HGB, non-taxable investment grants and interest subsidies
are usually recognized in income in full when the claim is
validated. Under U.S. GAAP, these amounts are deferred and
recognized as a reduction of depreciation expense over the
useful life of the corresponding assets.
d) Pension
obligations
Under U.S. GAAP, pension obligations are recognized based
on the projected benefit obligation using the projected unit
credit method. This is also permitted under HGB. However, due to
different valuation methods and assumptions on certain economic
parameters such as inflation and tax rates, the amounts accrued
in each period are different.
F-63
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
|
|
e)
|
Stock-based
compensation and contribution by partner
|
Under U.S. GAAP, the Company recognized compensation costs
related to stock options granted by Saifun to the Companys
employees with a corresponding capital contribution. The
stock-based compensation cost was based on fair value using an
option pricing model.
f) Distribution
to partner
Under U.S. GAAP, the excess in the amount of pension plan
transfers over remittances received from Infineon to the Company
is reflected as a distribution to partner in the Statement of
Partners Equity. Under HGB, the excess is charged to the
statement of operations.
g) Tax
effect
Under U.S. GAAP, deferred tax assets are recorded for net
operating losses and a valuation allowance is established when
it is deemed more likely than not that the deferred
tax asset will not be realized. Under HGB, no deferred tax
assets are recorded for net operating losses. Due to the
accumulated losses of the Company, a full valuation allowance is
made for the net operating losses. Accordingly, there is no tax
effect for differences between HGB and U.S. GAAP for the
Company during the periods presented.
|
|
h)
|
Unrealized
exchange gains on foreign currency translations from monetary
balance sheet items
|
Under U.S. GAAP unrealized exchange gains on foreign
currency translations from monetary balance sheet items are
recognized in the statement of operations. This is not permitted
under HGB.
|
|
i)
|
Waiving
of loans of Saifun Semiconductors
|
Pursuant to the Agreement on Termination of Joint Venture
Agreement and Related Transactions the loans of Saifun
Semiconductors of 13,748 were waived. Under HGB it
is recognized in the statement of operations. Under US GAAP, the
waiver of the debt is considered a component of the purchase
accounting applied to the acquisition of the minority interest
of the Company purchased by Infineon.
j) Goodwill
recognition
The net consideration paid as a result of the Termination
Agreement and the Amended License Agreement included cash,
forgiveness of Saifuns past and existing financing
commitments, the cancellation of the existing license agreement
and forgiveness of related liabilities owed to Saifun, and the
Amended License Agreement. Since the above-mentioned agreements
were negotiated concurrently, the total consideration paid in
connection with the Termination Agreement and the Amended
License Agreement was allocated to the various elements based on
their respective fair values. The resulting purchase price
allocation resulted in goodwill at the Companys parent
level. Under US GAAP, the acquisition of the minority
interest of the Company by Infineon is accounted for as a step
acquisition and all purchase accounting adjustments are
reflected at the Company level. The preliminary allocation of
the purchase price to the assets and liabilities acquired as of
December 23, 2004, the effective date of the Termination
Agreement, resulted in goodwill of 4,465.
On January 13, 2005, the existing license agreement was
cancelled, the related liabilities owed to Saifun were forgiven,
and the Amended License Agreement was entered into. As a result,
the preliminary purchase
F-64
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
price allocation was adjusted, whereby a license asset and a
corresponding liability were recorded, the existing license
asset and corresponding liability were removed, and goodwill was
increased to 8,662.
|
|
|
|
|
|
|
|
|
|
|
For the
|
|
|
For the
|
|
|
|
period ended
|
|
|
year ended
|
|
|
|
December 23,
|
|
|
December 26,
|
|
|
|
2004
|
|
|
2003
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
Net loss based on German HGB
|
|
|
(49,474
|
)
|
|
|
(34,615
|
)
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
a. Depreciation
|
|
|
(1,902
|
)
|
|
|
(253
|
)
|
b. License amortization
|
|
|
(2,341
|
)
|
|
|
(4,551
|
)
|
c. Grant recognition
|
|
|
(3,610
|
)
|
|
|
(849
|
)
|
d. Pension obligation
|
|
|
225
|
|
|
|
(46
|
)
|
e. Stock-based compensation
|
|
|
(553
|
)
|
|
|
(164
|
)
|
g. Tax effect
|
|
|
|
|
|
|
|
|
h. Unrealized exchange gains
on foreign currency translations from monetary balance sheet
items
|
|
|
434
|
|
|
|
|
|
i. waiving of loans of Saifun
Semiconductors
|
|
|
(13,748
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in net loss
|
|
|
(21,495
|
)
|
|
|
(5,863
|
)
|
|
|
|
|
|
|
|
|
|
Approximate net
loss based on U.S. GAAP
|
|
|
(70,969
|
)
|
|
|
(40,478
|
)
|
|
|
|
|
|
|
|
|
|
Partners capital
(deficit)
|
|
|
|
|
|
|
|
|
Partners capital
(deficit) based on German HGB
|
|
|
(61,697
|
)
|
|
|
(12,223
|
)
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
a. Depreciation
|
|
|
(3,004
|
)
|
|
|
(403
|
)
|
b. License amortization
|
|
|
(6,892
|
)
|
|
|
(4,551
|
)
|
c. Grant recognition
|
|
|
(3,702
|
)
|
|
|
(791
|
)
|
d. Pension obligation
|
|
|
32
|
|
|
|
(193
|
)
|
g. Tax effect
|
|
|
|
|
|
|
|
|
h. Unrealized exchange gains
on foreign currency translations from monetary balance sheet
items
|
|
|
434
|
|
|
|
|
|
j. APIC from Goodwill
recognition
|
|
|
4,465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net decrease in partners
capital
|
|
|
(8,667
|
)
|
|
|
(5,938
|
)
|
|
|
|
|
|
|
|
|
|
Approximate partners
capital based on U.S. GAAP
|
|
|
(70,364
|
)
|
|
|
(18,161
|
)
|
|
|
|
|
|
|
|
|
|
Changes in partners
capital based on U.S. GAAP
|
|
|
|
|
|
|
|
|
Balance, beginning of period
|
|
|
(18,161
|
)
|
|
|
338
|
|
Increase Partners
Capital/APIC
|
|
|
|
|
|
|
21,879
|
|
Contribution by Partner (see
note 6e)
|
|
|
553
|
|
|
|
164
|
|
Waiving of loans of Saifun
Semiconductors (see note 6i)
|
|
|
13,748
|
|
|
|
|
|
Distribution to Partner (see
note 6f)
|
|
|
|
|
|
|
(64
|
)
|
APIC from Goodwill recognition
(see note 6j)
|
|
|
4,465
|
|
|
|
|
|
Net loss
|
|
|
(70,969
|
)
|
|
|
(40,478
|
)
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
|
(70,364
|
)
|
|
|
(18,161
|
)
|
|
|
|
|
|
|
|
|
|
F-65
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
The summarized U.S. GAAP balance sheet is as follows:
|
|
|
|
|
|
|
December 23,
|
|
|
|
2004
|
|
|
Assets:
|
|
|
|
|
Current assets:
|
|
|
|
|
Cash and cash equivalents
|
|
|
1,737
|
|
Receivables related parties, net
|
|
|
35,416
|
|
Inventories
|
|
|
3,565
|
|
Other current assets
|
|
|
5,998
|
|
|
|
|
|
|
Total current assets
|
|
|
46,716
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
13,202
|
|
Other assets
|
|
|
1,220
|
|
Goodwill
|
|
|
4,465
|
|
|
|
|
|
|
Total assets
|
|
|
65,603
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and stockholders
equity (deficit):
|
Current liabilities:
|
|
|
|
|
Trade accounts payable
|
|
|
34,012
|
|
Loans from affiliated companies
|
|
|
82,940
|
|
Accrued liabilities
|
|
|
13,724
|
|
Other current liabilities
|
|
|
1,589
|
|
|
|
|
|
|
Total current liabilities
|
|
|
132,265
|
|
|
|
|
|
|
Other non-current liabilities
|
|
|
3,702
|
|
|
|
|
|
|
Total liabilities
|
|
|
135,967
|
|
|
|
|
|
|
Stockholders equity
(deficit):
|
|
|
|
|
Ordinary share capital
|
|
|
817
|
|
Additional paid-in capital
|
|
|
51,602
|
|
Accumulated deficit
|
|
|
(122,783
|
)
|
|
|
|
|
|
Total stockholders equity
(deficit)
|
|
|
(70,364
|
)
|
|
|
|
|
|
Total liabilities and
stockholders equity (deficit)
|
|
|
65,603
|
|
|
|
|
|
|
F-66
INFINEON TECHNOLOGIES FLASH GMBH & CO. KG,
DRESDEN
NOTES TO THE FINANCIAL
STATEMENTS (Continued)
Movement
of Fixed Assets for the period from December 27, 2003 to
December 23, 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of Acquisition
|
|
|
Depreciation
|
|
|
Net Book Value
|
|
|
|
December
|
|
|
|
|
|
|
|
|
|
|
|
December
|
|
|
December
|
|
|
|
|
|
|
|
|
December
|
|
|
December
|
|
|
December
|
|
|
|
27,
|
|
|
|
|
|
|
|
|
|
|
|
23,
|
|
|
27,
|
|
|
|
|
|
|
|
|
23,
|
|
|
23,
|
|
|
26,
|
|
|
|
2003
|
|
|
Additions
|
|
|
Disposals
|
|
|
Transfer
|
|
|
2004
|
|
|
2003
|
|
|
Additions
|
|
|
Disposals
|
|
|
2004
|
|
|
2004
|
|
|
2003
|
|
|
I. Intangible Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Software
|
|
|
212
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
216
|
|
|
|
62
|
|
|
|
72
|
|
|
|
|
|
|
|
134
|
|
|
|
82
|
|
|
|
150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
II. Tangible Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1. Plant and machinery
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14
|
|
|
|
2
|
|
|
|
2
|
|
|
|
|
|
|
|
4
|
|
|
|
10
|
|
|
|
12
|
|
2. Technical and office
equipment
|
|
|
5,324
|
|
|
|
11,800
|
|
|
|
58
|
|
|
|
1,580
|
|
|
|
18,646
|
|
|
|
1,011
|
|
|
|
2,237
|
|
|
|
52
|
|
|
|
3,196
|
|
|
|
15,450
|
|
|
|
4,313
|
|
3. Payments on account
|
|
|
1,580
|
|
|
|
745
|
|
|
|
0
|
|
|
|
(1,580
|
)
|
|
|
745
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
745
|
|
|
|
1,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,918
|
|
|
|
12,545
|
|
|
|
58
|
|
|
|
|
|
|
|
19,405
|
|
|
|
1,013
|
|
|
|
2,239
|
|
|
|
52
|
|
|
|
3,200
|
|
|
|
16,205
|
|
|
|
5,905
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,130
|
|
|
|
12,549
|
|
|
|
58
|
|
|
|
|
|
|
|
19,621
|
|
|
|
1,075
|
|
|
|
2,311
|
|
|
|
52
|
|
|
|
3,334
|
|
|
|
16,287
|
|
|
|
6,055
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-67
ANNUAL
REPORT ON
FORM 20-F
INDEX OF EXHIBITS
|
|
|
|
|
Exhibit
|
|
Description
|
|
|
1
|
.1
|
|
Articles of Association
(incorporated by reference to Exhibit 3.4 of the
Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
2
|
.1
|
|
Registration Rights Agreement,
dated October 2, 2000, by and among the Registrant and the
parties thereto (incorporated by reference to Exhibit 10.2
of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
2
|
.2
|
|
Amendment to Registration Rights
Agreement and Shareholder Rights Agreement, dated as of
September 29, 2005, by and among the parties thereto and
the Registrant (incorporated by reference to Exhibit 10.2
of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.1
|
|
Technology Agreement, dated
May 4, 2000, by and between Macronix International Co.,
Ltd. and the Registrant (incorporated by reference to
Exhibit 10.7 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.2
|
|
Amendment to the Technology
Agreement, dated April 10, 2003, by and between Macronix
International Co., Ltd. and the Registrant (incorporated by
reference to Exhibit 10.8 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.3
|
|
Second Addendum to the Technology
Agreement, dated April 22, 2004, by and between Macronix
International Co., Ltd. and the Registrant (incorporated by
reference to Exhibit 10.9 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.4
|
|
Termination of Joint Venture
Agreement and Related Transactions, dated December 20,
2004, by and among Infineon Technologies AG, Saifun Ventures
Ltd. and the Registrant (incorporated by reference to
Exhibit 10.10 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.5
|
|
Settlement and License Agreement,
dated July 1, 2002, by and between Advanced Micro Devices,
Inc., Fujitsu Limited and the Registrant (incorporated by
reference to Exhibit 10.11 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.6
|
|
License Agreement, dated
January 13, 2005, by and among Infineon Technologies AG and
its subsidiaries and the Registrant and its subsidiaries
(incorporated by reference to Exhibit 10.12 of the
Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.7
|
|
Basic Agreement of Development
Orders, dated December 20, 2004, by and between Infineon
Technologies AG and the Registrant (incorporated by reference to
Exhibit 10.13 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
4
|
.8
|
|
Form of Director and Officer
Letter of Indemnification (incorporated by reference to
Exhibit 10.18 of the Registration Statement on
Form F-1
(File
No. 333-129167)
filed with the Commission on October 21, 2005)
|
|
8
|
.1
|
|
List of Subsidiaries of the
Registrant (incorporated by reference to Exhibit 21.1 of
the Registration Statement on Form F-1 filed with the
Commission on November 4, 2005)
|
|
11
|
.1
|
|
Code of Ethics effective as of
September 2005
|
|
12
|
.1
|
|
Certification of Chief Executive
Officer of the Registrant pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
Exhibit
|
|
Description
|
|
|
12
|
.2
|
|
Certification of Chief Financial
Officer of the Registrant pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
13
|
.1
|
|
Certification of Chief Executive
Officer of the Registrant pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002*
|
|
13
|
.2
|
|
Certification of Chief Financial
Officer of the Registrant pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002*
|
|
|
|
* |
|
This document is being furnished in accordance with SEC Release
Nos. 33-8212
and 34-47551. |
|
|
|
Portions of this exhibit were omitted and have been filed
separately with the Secretary of the Securities and Exchange
Commission pursuant to the Registrants application
requesting confidential treatment under Rule 406 of the
Securities Act. |